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Abstract 
 
Salvia officinalis L. (Lamiaceae, common sage) is an aromatic plant that grows in 
Portugal well known for its medical properties. Antioxidant and antidiabetic effects are among 
the medicinal properties attributed to this plant. However, both still lack of biological 
experimental confirmation. Since sage compounds, after gastrointestinal absorption, first pass 
through the liver, giving an opportunity to accumulate to considerable concentrations, the 
antioxidant and antidiabetic studies reported here focused on the liver. In addition, the liver is a 
biotransforming organ, susceptible to toxic effects of xenobiotics and affected by several liver 
diseases where oxidative stress is known to be involved. Therefore, these studies allowed us to 
observe, besides the benefits of sage consumption to the liver, the possible toxic effects of sage 
and interactions with other drugs. Three different extracts of sage were studied: the essential oil 
(EO), a methanolic extract and a water extract (prepared as a tea). 
In chapter 2, sage EO was tested in freshly isolated rat hepatocytes. No direct 
antioxidant effects were observed in liver cells. On the contrary, at higher concentrations (more 
than 2 µl/ml), sage EO induced significant cell death, which was accompanied by GSH 
(glutathione – reduced form) depletion but not by lipid peroxidation. The GSH depletion 
induced by sage EO was probably an important mechanism that explains EO toxic effects. 
Then, after an in vivo experiment with mice, where sage tea drinking (for 14 days) 
improved the liver antioxidant status (chapter 3), the direct effects of sage were studied on 
HepG2 cells (a human hepatoma cell line) in chapter 4. Sage extracts protected against cell 
death induced by tert-butyl hydroperoxide – a model of oxidative stress – revealing their direct 
antioxidant effects at cellular level. Sage was able to act at a cell critical parameter, the GSH 
levels, preventing GSH depletion. The cytoprotective effect of sage was found to be dependent 
on its composition in phenolic compounds and their antiradical activity. 
Also in chapter 4, not only did sage extracts prevent GSH depletion in a situation of 
oxidative stress, they also increased basal GSH levels in HepG2 cells. This fact indicated a 
capacity of sage extracts to improve basal cell antioxidant defences. The increase in basal GSH 
levels may possibly have happened by induction of de novo glutathione synthesis, which was 
corroborated by a different set of experiments using rat hepatocytes in culture (chapter 3). In 
that study, sage tea given in vivo restored hepatocyte GSH levels after collagenase isolation to 
higher levels when compared with controls. Sage tea was, in addition, able to induce 
significantly the activities of GST (chapter 3), GPox and NADPH cytochrome P450 reductase 
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 and also, slightly, some CYP enzymes (chapter 5) in mice liver. These indirect antioxidant 
effects may leave liver cells better prepared to face oxidative stress and toxicants.  
However, contrarily to what was expected, sage tea drinking did not protect carbon 
tetrachloride (CCl4)-induced hepatotoxicity in mice (chapter 5). Instead, sage tea potentiated the 
toxicity of CCl4 in mice liver of both genders. This herb-toxicant interaction may be explained, 
at least in part, by the significant induction of CYP 2E1 protein by sage tea. Since the dose of 
sage tea used in this study was much higher than what is usually taken by humans, sage tea-drug 
interactions are not likely to happen in humans. Nevertheless, these results draw attention to 
possible herb-drug interactions between sage and drugs metabolised by the liver.  
Regarding the antidiabetic effects (chapter 6), sage tea was found to lower fasting 
plasma glucose in mice indicating effects on gluconeogenesis. This was confirmed in the 
experiments using normal rat hepatocytes in culture, where sage tea drinking induced a decrease 
in gluconeogenesis in response to glucagon. In addition, sage tea drinking increased glucose 
uptake capacity and, sage EO further increased hepatocyte sensitivity to insulin and inhibited 
gluconeogenesis. Overall, these effects resemble those obtained with the pharmaceutical drug 
metformin used in the treatment and prevention of type 2 diabetes mellitus. In primary cultures 
of hepatocytes isolated from streptozotocin-induced diabetic rats none of these activities, 
however, was observed. Nevertheless, the metformin-like effect observed here suggests a 
possible type 2 diabetes preventive potential of sage tea, mainly in people at risk of developing 
it. 
In conclusion, the antioxidant effects of sage, at cellular and liver levels, were 
demonstrated by these results as well as its hypoglycaemic effects. In order to apply sage 
products as a therapeutical tool for diabetes and liver diseases more research has, however, to be 
done. Nevertheless, sage products may now be considered as a functional food or a food 
supplements that could have a beneficial impact in low cost prevention strategies of diabetes 
and liver diseases. In addition, the treatment and/or the prevention of other kind of diseases 
where oxidative stress is known to be involved, such as cancer and neurodegenerative diseases, 
may also benefit from the regular consumption of sage. Care should be taken, however, not to 
use high doses of sage products, over extended periods of time, in combination with 
conventional pharmaceutical drugs, since undesired herb-drugs interaction may take place. 
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 Efeitos de Salvia officinalis no fígado: 
Relevância dos níveis de glutationa 
 
Resumo 
 
Salvia officinalis L (Lamiaceae, salva comum) é uma planta aromática que cresce 
espontaneamente em Portugal, bastante conhecida pelas suas propriedades medicinais. Duas das 
principais propriedades medicinais atribuídas a esta planta são como antioxidante e 
antidiabética. No entanto, ainda não existem suficientes evidências experimentais que 
demonstrem estes efeitos e em particular os mecanismos inerentes em sistemas biológicos. No 
presente trabalho, os estudos dos efeitos antioxidantes e antidiabéticos foram realizados no 
fígado e em hepatócitos. Uma vez que os compostos da salva passam primeiro pelo fígado após 
a absorção gastrointestinal, estes podem atingir concentrações consideráveis neste órgão 
possibilitando a indução de efeitos biológicos. Além disso, o fígado tem uma grande capacidade 
de biotransformação, é bastante susceptível a efeitos tóxicos de xenobióticos e é também 
afectado por bastantes doenças onde se reconhece o envolvimento de stresse oxidativo. Deste 
modo, para além dos prováveis benefícios do consumo de salva para o fígado, estes estudos 
permitiram-nos observar possíveis efeitos tóxicos desta planta e interacções com outros 
compostos. Três tipos de extractos foram estudados: o óleo essencial (OE), um extracto 
metanólico e a extracto aquoso de salva preparado sob a forma de um chá. 
Numa primeira série de experiências (capítulo 2), usando ensaios com suspensões de 
hepatócitos de rato, observou-se que o OE de salva não teve efeitos antioxidantes. Pelo contrário, 
a altas concentrações (maiores que 2 µl/ml), o óleo de salva induziu significativamente morte nas 
células, a qual foi acompanhada por uma depleção nos níveis de GSH (forma reduzida da 
glutationa) mas não por uma indução da peroxidação lipídica. A diminuição dos níveis de GSH foi 
provavelmente um dos mecanismos responsáveis pelos efeitos tóxicos do OE. 
Em seguida, após uma experiência in vivo com ratinhos onde se verificou que o chá de 
salva melhorava a resposta antioxidante do fígado (capítulo 3), no capítulo 4 foram estudados os 
efeitos directos de salva em células HepG2 (linha celular de hepatoma humano). A salva 
protegeu contra a morte celular induzida pelo tert-butil hidroperóxido – um modelo de stresse 
oxidativo – revelando o seu potencial antioxidante directo em células. A sua acção nos níveis de 
GSH foi muito importante, prevenindo significativamente a sua depleção. O efeito citoprotector 
dos extractos da salva foi dependente da composição dos extractos em compostos fenólicos bem 
como da sua actividade antiradicalar. 
Também no capítulo 4, verificou-se que os mesmos extractos eram capazes de elevar os 
níveis basais de GSH em células HepG2, indicando uma capacidade em melhorar as defesas 
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 antioxidantes. O aumento de GSH poderá ter acontecido através da indução da síntese de novo 
da glutationa, o que é também corroborado por uma experiência anterior com hepatócitos de 
rato em cultura (capítulo 3). Nessa experiência, o chá de salva dado in vivo fez recuperar os 
níveis de GSH dos hepatócitos, após o isolamento com colagenase, para valores mais altos do 
que na situação controlo. Adicionalmente, o chá de salva induziu significativamente as 
actividades das enzimas GST (capítulo 3), GPox e NADPH citocromo P450 redutase bem 
como, em alguma extensão, algumas enzimas citocromo P450 em fígado de ratinho (capítulo 5). 
Estes efeitos antioxidantes indirectos parecem deixar o fígado mais bem preparado para 
combater uma situação de stresse oxidativo e o efeito tóxico de xenobióticos. 
No entanto, contrariamente ao que era esperado, o tratamento prévio com chá de salva 
não protegeu a hepatotoxicidade induzida pelo tetracloreto de carbono (CCl4) em ratinhos 
(capítulo 5). Em vez disso, ocorreu uma potenciação da toxicidade do CCl4. Esta interacção 
pode ser explicada, pelo menos em parte, pelo aumento significativo induzido pelo chá da 
proteína CYP 2E1. Estes resultados chamam a atenção para possíveis interacções entre a salva e 
fármacos ou outros xenobióticos metabolizados pelo fígado. No entanto, isso provavelmente 
não acontecerá, a menos que uma elevada quantidade de salva for consumida por um longo 
período de tempo. 
Em relação aos estudos das actividades antidiabéticas da salva, descritos no capítulo 6, 
verificou-se que o chá desta planta reduziu a glucose plasmática em jejum em ratinhos, 
indicando efeitos ao nível da gluconeogénese. Isto foi confirmado com experiências utilizando 
hepatócitos em cultura isolados de ratos, nos quais o chá de salva reduziu a indução da 
gluconeogénese pelo glucagon. Além disso, verificou-se que o chá de salva aumentou o 
consumo de glucose pelas células e que o OE aumentou a sensibilidade das células à insulina e 
inibiu a gluconeogénese. No geral, estes efeitos assemelham-se aos obtidos com o fármaco 
metformina, usado no tratamento e prevenção da diabetes. No entanto, em hepatócitos isolados 
de ratos diabéticos induzidos pela estreptozotocina, estes efeitos não foram observados. Os 
resultados sugerem contudo, que a salva poderá ser utilizada na prevenção da diabetes tipo 2, 
principalmente em pessoas em risco de a desenvolver. 
Em conclusão, os resultados aqui apresentados confirmam os efeitos antioxidantes e 
hipoglicémicos de salva em sistemas biológicos, embora o seu uso terapêutico contra doenças do 
fígado e a diabetes necessite de mais investigação. No entanto, neste momento a salva pode ser 
encarada como um suplemento alimentar que poderá ter efeitos benéficos na prevenção, a baixo 
custo, da diabetes tipo 2 e de doenças do fígado. Para além disso, a prevenção de outro tipo de 
doenças também poderá ser considerada, principalmente aquelas onde é conhecido o envolvimento 
de stresse oxidativo, tal como o cancro e doenças neurodegenerativas. Por último, torna-se relevante 
relembrar que o consumo de salva, por períodos prolongados de tempo, em conjunto com certos 
fármacos poderá levar a efeitos indesejados devido a interacções planta-fármaco. 
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Preface
 
1 
Preface 
 
 In Portugal, agriculture is still an important source of income for many families. With 
the European common market, many agricultural products from other European countries 
appear in Portugal at much lower price. Consequently, Portuguese agriculture is facing a severe 
crisis and alternative added value crops are urgently needed. 
 Some studies are ongoing in the Department of Biology in the University of Minho with 
aromatic and medicinal plants that grow spontaneously or are cultivated in Portugal aiming to 
help identify new and advantageous agricultural products for the Portuguese producers. 
Aromatic plants have for long been used as sources of fragrances to the cosmetic and perfume 
industries as well as source of flavours for food and beverage industries. In addition, medicinal 
plants are known to possess bioactive compounds that are also used in the pharmaceutical 
industries. Therefore, the production of selected added value bioactive compounds (“molecular 
farming”) may constitute an advantageous alternative to Portuguese agriculture. 
 A way to add value to a plant product is to find new pharmaceutical applications for it. 
The classification of a given plant as medicinal has been based in its empirical use, since ancient 
times, in the treatment of several disorders. Confirming attributed medicinal properties and 
researching new ones is necessary to increase the pharmaceutical interest of a particular 
medicinal plant. Therefore, this research project arose from the necessity to find and study new 
bioactivities and bioactive compounds as a part of an integrated program of research and 
exploitation of aromatic and medicinal plants to be implemented in Portugal. In particular, this 
work aimed to increase our knowledge about two recognised effects of Salvia officinalis – the 
antioxidant and antidiabetic effects. 
 Furthermore, we are witnessing a growing interest in the use of natural products over 
synthetic ones by consumers, and, therefore, also by the food, pharmaceutical, cosmetic and 
other industries in order to embrace the emerging market interests. As a result of the increasing 
interest of phytopharmaceutic products and the need to ensure the safety of consumers, there is 
an effort of the European Union to create a simple and applicable legislation for this type of 
products. It was also our concern to clarify possible toxic effects of S. officinalis and interactions 
with pharmaceutical drugs, which may condition the application of products of this plant. 
 Finally, as in a pharmaceutical research, the use of cells and animals were an inevitable 
way to reach the proposed objectives. The 3 R’s policy (Replacement, Reduction and 
Refinement) were, however, always taken in consideration. Whenever possible, the use of 
animals were avoided and replaced by cellular or chemical assays. The experiments using 
laboratory animals followed the Guidelines for the Humane Use and Care of Animals in 
Experimentation [Van Zutphen LFM, Baumans V & Beynen AC (2001) Principles of 
Laboratory Animal Science, revised edition. Elsevier Science BV, Amsterdam]. 
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Chapter 1                                                                                                                                                      Introduction 
 
1.1. Chapter overview 
 
Since immemorial times, Man has been using plants not only for their nourishment but 
also for the therapy of diverse of their ailments. Mainly through the method of trial and error, 
several herbs were chosen to heal diverse disorders and this knowledge brought to the present 
from generation to generation. Nowadays, many medicinal plants have been researched and 
some of their attributed empiric therapeutic properties proved to be true. 
Salvia officinalis (common sage) is one of the most known and used aromatic and 
medicinal plant, to which several ethnopharmaceutical properties are attributed. Many of them 
are thought to be mediated by many bioactive compounds present in this plant, such as phenolic 
compounds and terpenes. As an aromatic plant, sage produces essential oil where a variety of 
monoterpenes and sesquiterpenes can be found. As medicinal plant, sage produces strong 
antioxidant compounds, such as rosmarinic acid (main compound) and other phenolic-based 
compounds, which are thought to be the key for several therapeutic properties attributed to sage. 
Since oxidative stress and free radicals have been implicated in the origin and 
progression of several age-related chronic diseases, plant antioxidants have been proposed as 
therapeutic agents to counteract them. However, besides their antioxidant effects, such type of 
plant compounds are known to be beneficial against several disorders also by their modulation 
of several enzyme activities, protein expression and important cell signalling cascades. 
The liver is an important organ in the metabolic homeostasis of the body. However, due 
to its metabolic features and localisation, it is very vulnerable to toxic effects of xenobiotics, 
which can induce several steps of liver damages – from inflammatory to fibrotic processes. 
Antioxidants have also been proposed as therapeutic agents to counteract liver diseases, since 
reactive species are known to play a crucial role in liver diseases induction and progression. 
Additionally, because plant compounds are xenobiotics, they can induce toxicity to the liver, 
which highlight the importance of performing studies with liver cells. Moreover, possible 
enzyme and protein induction conferred by these products could provide an opportunity to 
mechanisms of interaction with other important drugs. 
From the mechanisms behind liver cells injury, glutathione takes a vital place. The liver 
is the human organ with highest concentrations of glutathione. More than in other tissues, the 
levels of this intracellular antioxidant are very important in the protection against oxidative 
stress originated in the liver cells. Also, a drastic decrease of the reduced form of this tripeptide 
is known to be the central step in a cascade of events that culminate in extensive cell damage 
and death. Moreover, besides the detoxifying function of cellular glutathione, the recognition 
that this thiol can modulate signal transduction processes has recently been increasing. 
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The liver is also very important in the regulation of the plasma levels of glucose. In the 
diabetes disease, which is characterised by a hyperglycaemic situation originated by a 
deregulation of insulin function and/or secretion, liver cells did not do their work properly. 
Diabetes mellitus attained epidemic proportions in many countries and the available medication 
is far from resolving the problem, which makes it as a major public health concern. The liver is 
one of the potential targets for the treatment of diabetes and plants are currently again being 
used in the search for new possible drugs for its management. Diabetes is also associated with 
several complications where oxidative stress is known to be implicated, which make plant 
antioxidants interesting compounds to be researched against this chronic disease. 
 
 
1.2. Salvia officinalis 
 
Salvia officinalis L. (common sage, garden sage or Dalmatian sage) is a medicinal and 
aromatic plant of the Lamiaceae (= Labiatae) family, native to Mediterranean countries 
(mentioned in the Pharmacopeia of Portugal), which today is cultivated all over the world. Sage 
is a small, evergreen perennial plant with short woody stems that branch extensively, with blue 
and in some cases violet flowers (Fig. 1). 
S. officinalis is a popular herb commonly used as a culinary spice for flavouring and 
seasoning that has also been used for centuries in folk medicine for the treatment of a variety of 
ailments. The botanical name of sage is a clear reference to the important curative properties of 
the plant: the genus name Salvia comes from the Latin salvāre meaning “to save” or “to heal” 
and officinalis means medicinal (Dweck, 2000; Miura et al., 2002). Its ancient use as a 
medicinal plant can be shown by several old reports. For 
example, as cited by Dweck (2000), in an Anglo-Saxon 
manuscript we can read “why should man die when he has 
sage?” 
Because of the wide range of traditional medicinal 
effects, sage enjoys the reputation of being a panacea: it has 
been used as anti-inflammatory and against perspiration and 
fever (antihydrotic properties); as spasmolytic, antiseptic/ 
bactericidal and astringent; in skin and hair care; against 
rheumatism and sexual debility; for menstrual and 
menopausal problems; to treat nervous and mental 
conditions; among others (Lu & Foo, 1999; Dweck, 2000; 
Wang et al., 2000). 
 
 
Fig. 1. Salvia officinalis L. (Lamia-
ceae) plant. 
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Sage extracts, mostly essential oil (EO), are also widely used in the food, drug, 
beverage, cosmetic and fragrance industries. In the past decades, sage has been submitted to 
extensive studies due to its antioxidant properties. Because of the side-effects of synthetic 
antioxidants, such as butylated hydroxytoluene (BHT) used as food preservative, on cancer risk, 
the interest on antioxidants of natural sources has increased considerably in recent years (Deans 
& Simpson, 2000). Sage has become an important source of antioxidants used in food industry, 
which had additional wider implications for the dietary intake of natural antioxidants (Deans & 
Simpson, 2000). Due to the increasing scientific evidence of the health benefits of natural 
antioxidants, S. officinalis turned into a good candidate as a source of those compounds for the 
cosmetic and pharmaceutical industries. 
 
1.2.1. Bioactive compounds 
 
 It is sage’s high production of secondary metabolites that gives it its medicinal and 
aromatic properties and makes it a rich source of bioactive compounds. 
S. officinalis is the specie of the genus Salvia with the highest EO production (Giannouli 
& Kintzios, 2000). EO is a mixture of volatile compounds where there is a predominance of 
terpenes of lower molecular weight, mainly monoterpenes and sesquiterpenes, which for being 
volatile make part of the aroma and fragrance of aromatic plants (Cuppett & Hall, 1998). Plant 
EOs are currently used in food flavouring, in aromatherapy, in health care products, in perfumes 
and as preservatives against food spoilage (Giannouli & Kintzios, 2000). In a direct relationship 
with plant biological effects, EOs have been proven to possess antimicrobial and antifungal 
activities and also insecticide properties (Deans & Waterman, 1993).  
Due to the low boiling points of the EO compounds, they can be recovered from the 
plant tissues by hydrodistillation. The composition of sage EO is very complex and could 
contain more than 50 compounds, being α-thujone (Fig. 2), α-humulene, 1,8-cineole (Fig.2), E-
caryophyllene, camphor and borneol the major constituents (Perry et al., 1999b; Giannouli & 
Kintzios, 2000; Santos-Gomes & Fernandes-Ferreira, 2001). The EO composition varies due to 
many factors such as plant organ, season, culture conditions and culture site (Perry et al., 1999b; 
Santos-Gomes & Fernandes-Ferreira, 2001). For 
example, the major compound, α-thujone (Fig.2), can 
vary from 18% to more than 50% of the EO of the 
plant (Perry et al., 1999b; Giannouli & Kintzios, 
2000; Santos-Gomes & Fernandes-Ferreira, 2001). 
Sage EO has shown some ability to act as food 
antioxidants/preservatives (preventing rancidity in 
 
 
 
Fig. 2. Chemical structures of two of the most 
representative compounds present in Salvia 
officinalis essential oil: the oxygen-containing 
monoterpenes α-thujone (A) and 1,8-cineole 
(B). 
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food) by inhibiting lipid peroxidation (Cuppett & Hall, 1998). The use of sage EO should, 
however, be cautious because of its known neurotoxic and convulsant effects, mainly due to the 
high contents in α-thujone and camphor (Millet et al., 1981; Baricevic & Bartol, 2000; Hold et 
al., 2000). 
Sage also contains important bioactive terpenoids such as the triterpenoids ursolic acid 
(Fig. 3) and oleanolic acid (Ulubelen, 2000; Topcu, 2006). These highly lipophilic compounds, 
although not showing antioxidant activity, may turn in a near future promising in combating 
inflammatory and cancer diseases (Baricevic & Bartol, 2000). Both compounds have been 
shown to have hepatoprotective, anti-inflammatory, 
antihyperlipidemic and antitumorigenic properties 
(Liu, 1995; Baricevic & Bartol, 2000). 
In the 1950s, as a result of the studies 
performed by Chipault and collaborators, plants 
(spices) were shown to possess antioxidant capacity. 
Sage was one of the spices studied by Chipault and 
showed to be a good source of antioxidants useful as 
food preservatives (Cuppett & Hall, 1998). These studies were then extended to other plants, but 
with the use of synthetic antioxidants (e.g. BHT and butylated hydroxyanisole - BHA), the 
natural compounds were for some years forgotten. In the 1990s, the safety of the synthetic 
antioxidants was, however, been questioned, since it was shown that long term exposures to 
these compounds in the diet could produce tumours in animals (Deans & Simpson, 2000). 
Although the actual effects of BHT and BHA on human cancer risk are unknown, these 
concerns have lead to an increased interest in plant antioxidants as food preservatives because of 
their higher safety and acceptability (Deans & Simpson, 2000). As a result, sage becomes one of 
the most interesting plants of research due to its high content in antioxidant compounds. 
 
 
 
Fig. 3. Chemical structure of ursolic acid, a 
pentacyclic triterpenic acid. 
The phenolic rosmarinic acid 
(Fig. 4) is the compound that more 
contributes to the antioxidant activity of 
sage (Lamaison et al., 1991; Wang et al., 
1998; Deans & Simpson, 2000). Besides 
this phenolic acid, phenolic diterpenes 
such as carnosic acid and carnosol (Fig. 4) 
were found in sage and reported to 
possess strong antioxidant activities 
(Cuvelier et al., 1994). Additionally, 
many other phenolic compounds were 
 
 
 
Fig. 4. Chemical structures of rosmarinic acid (A), carnosic 
acid (B), carnosol (C) and luteolin-7-glucoside (D).  
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found in S. officinalis that could contribute to its antioxidant properties, such as sagecoumarin 
and salvianolic acids (caffeic acid derivatives) as well as the flavonoid luteolin-7-glucoside (Fig. 
4) and other phenolic glycosides (Lu & Foo, 1999; Lu et al., 1999; Wang et al., 1999; Lu & 
Foo, 2000; 2001; 2002). Apart from the use in the food processing industry, these phenolic 
compounds are currently appointed as useful in the area of human health (Pearson et al., 1997) 
since they are thought to be the key for the several therapeutic properties attributed to medicinal 
plants. 
 
1.2.2. Biological and pharmacological activities 
 
 Besides their traditional uses, many biological and pharmacological activities have been 
scientifically researched and attributed to S. officinalis. 
 Sage EO is still employed in flavouring condiments, cured meats, liqueurs and bitters 
(Baricevic & Bartol, 2000). Besides its usage as a flavouring and antioxidant agent, sage EO 
exhibit antibacterial and antifungal activities (Baricevic & Bartol, 2000; Araujo et al., 2003; 
Rota et al., 2004; Pereira et al., 2004) as well as antimutagenic and insect repellent effects 
(Simic et al., 1998; Baricevic & Bartol, 2000; Vujosevic & Blagojevic, 2004). Insecticidal 
activity was also reported for the methanolic extract (Pavela, 2004) as well as antimutagenic 
activity for water extract of sage (Samejima et al., 1995). 
 Both the n-hexane and the chloroform extracts of leaves of S. officinalis were reported 
to possess strong anti-inflammatory activities and its activity related with its content in ursolic 
acid (Baricevic & Bartol, 2000; Baricevic et al., 2001). Polysaccharides extracted from sage 
showed recently immunomodulatory activity using the comitogenic thymocyte test (Capek et 
al., 2003; Ebringerovda et al., 2003; Capek & Hribalova, 2004). Sage phenolics were also 
reported to possess immunomodulatory and antileishmanial activities (Radtke et al., 2003). In 
addition, sage extracts obtained with polar solvents showed to possess hypoglycaemic and anti-
hyperlipidemic effects in mice (Alarcon-Aguilar et al., 2002; Ninomiya et al., 2004), and 
spasmolytic and hypotensive actions in other animal models (Todorov et al., 1984). 
 Some studies using human patients showed that sage had antiviral activity against 
herpes infections (Saller et al., 2001), was effective in the treatment of menopausal symptoms 
(de Leo et al., 1998) and was efficacious in the treatment of acute pharyngitis (Hubbert et al., 
2006). 
 The antioxidant properties of sage were extensively studied using in vitro studies. Sage 
alcoholic extracts revealed strong antioxidant activity by increasing the stability of food oils 
(Cuppett & Hall, 1998; Miura et al., 2002; Zainuddin et al., 2002; Ozcan, 2003; Jaswir et al., 
2005) contributing to its application in food industry. The antioxidant activity of sage extracts 
were also shown using other methods, such as by the accelerated autoxidation of methyl 
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linoleate (Cuvelier et al., 1994; Cuvelier et al., 1996), by the ability to scavenge DPPH˙ 
(Lamaison et al., 1991) and ABTS˙ free radicals (Shan et al., 2005) as well as by the oxygen 
radical absorbance capacity (ORAC assay) (Zheng & Wang, 2001). With the increasing interest 
of application of plant antioxidant compounds in the human health over the past 15 years, 
information relating sage antioxidant activity with pharmacological activity begun to appear in 
the literature. Sage extracts were reported to possess superoxide and hydroxyl radicals 
scavenging activities using the electron spin resonance (ESR) spin-trapping technique (Masaki 
et al., 1995; Madsen et al., 1997). Additionally, sage also showed the capacity to inhibit lipid 
peroxidation of liposomes in enzyme-dependent and enzyme-independent lipid peroxidation 
assays (Masaki et al., 1995; Hohmann et al., 1999; Zupko et al., 2001). Since the composition 
in lipids of biological tissues is complex, it is very difficult to assess the health effects of 
antioxidants using an experimental model that uses a single lipid type and oxidation catalysts 
(Decker, 1997). To better relate with human health, the use of cell systems is preferable in the 
evaluation of the bioactivity of an antioxidant. However, only few studies with sage extracts are 
available. Until 2002, only Masaki and its collaborators (1995) performed a small experiment 
using fibroblasts and related sage antioxidant effects with cytoprotective effects. In their study, 
sage extract significantly prevent cell death induced by a superoxide-generating system (Masaki 
et al., 1995). 
 The references in old European books to the memory-improving activities of S. 
officinalis (Perry et al., 1999a) recently led researchers to perform studies aiming the ability of 
sage extracts to attenuate the cognitive decline seen in dementia. In 1996, Perry and 
collaborators reported the anticholinesterase activity of sage EO in human brain tissue (post-
mortem) that could in part explain the reported memory-enhancement properties (Perry et al., 
1999a; Perry et al., 2000). In addition, based on a study with a close specie of S. officinalis, 
Melissa officinalis, modulation of mood and cognitive performance has been suggested for sage 
extracts (Akhondzadeh et al., 2003; Kennedy et al., 2006). Recently, using a rat model, the 
ethanolic extract of sage was shown to potentiate memory retention and to interact with the 
muscarinic and nicotinic cholinergic systems that are involved in the memory retention process 
(Eidi et al., 2006). Moreover, a double-blind, placebo-controlled, and crossover study using 30 
healthy participants confirm the improvement of mood and on cognitive performance by S. 
officinalis (Kennedy et al., 2006). The same study also reported a dose-dependent in vitro 
inhibition of acetylcholinesterase and, to a greater extent, butyrylcholinesterase by an ethanol 
extract of sage. Some of the previous studies suggested S. officinalis as a possible potentially 
novel natural treatment for Alzheimer's disease. In fact, Akhondzadeh et al. (2003) performed a 
randomized double blind placebo-controlled trial using patients with mild to moderate 
Alzheimer's disease. They showed a significantly better outcome of cognitive functions for sage 
than placebo patients group indicating the efficacy of this plant in the management of mild to 
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moderate Alzheimer's disease (Akhondzadeh et al., 2003). In addition, a hydro alcoholic extract 
of sage was also recently reported to have neuroprotective effects against amyloid β (Aβ)-
induced toxicity in PC12 cells, which corroborate the potential use in the treatment of 
Alzheimer's disease (Iuvone et al., 2006). This activity was attributed, at least in part, to 
rosmarinic acid. 
 
 
1.3. Oxidative stress 
 
The appearance of oxygen as a diatomic molecule (O2) in the Earth’s atmosphere over 
2500 millions years ago resulted in the emergence of a new environment. During a long 
evolutionary process, new organisms utilising O2 for production of energy by the use of O2-
dependent electron transport chains arose in this environment – the aerobic organisms. Due to 
the toxicity of O2, these organisms only survived because they developed in parallel efficient 
defences to protect them against it (Fig. 5) (Halliwell & Gutteridge, 1999). 
In normal physiological conditions, the production of free radicals and other reactive 
species (derived from the use of O2) is approximately balanced by the antioxidant defence 
system (Halliwell, 1996; Halliwell & Gutteridge, 1999). The balance is, however, not perfect 
because oxidative damage occurs to DNA, proteins, lipids, and small molecules in living 
systems also under normal oxygen conditions (Halliwell & Gutteridge, 1999; Willcox et al., 
2004). Normally, damaged molecules are repaired or replaced. However, in certain 
circumstances a significant imbalance between reactive species and antioxidant defence system 
can occur, a situation referred as oxidative stress, which can result in extensive damage with 
accumulation of oxidised molecules (Halliwell, 1996; Halliwell & Gutteridge, 1999; Willcox et 
al., 2004). This disturbance between the pro-oxidant and antioxidant state in favour to the 
former can result from a diminishment of antioxidants (for example due to mutations or 
malnutrition) and/or from an increased production of reactive species (Halliwell, 1996; 
Halliwell & Gutteridge, 1999). The latter can, for example, result from the exposure to 
environmental oxidant conditions (Fig. 5), such as ultraviolet radiation, hyperoxia, drugs and 
toxins (for instance present in polluted air and cigarette smoke); and also by increased 
production by cellular systems under pathological conditions (such as in chronic inflammatory 
diseases and ischemia) (Halliwell, 1996; Dalton et al., 1999; Willcox et al., 2004).  
At higher levels of oxidative stress, severe injuries to cell molecules, such as DNA, 
proteins and lipids, may happen, which may result in extensive cell death (see section 1.6.3). 
Nevertheless, cells often tolerate mild oxidative stress by upregulating the synthesis of 
antioxidant defence mechanisms through changes in gene expression (Halliwell, 1996; Halliwell 
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& Gutteridge, 1999; Willcox et al., 2004). Therefore, despite their potential to cause damage, 
reactive species have been shown in recent years to be involved in modulation of signal 
transduction cascades and redirection of gene expression under physiological and pathological 
conditions (Dalton et al., 1999; Finkel & Holbrook, 2000; de Magalhaes & Church, 2006). 
 
1.3.1. Reactive species 
 
 Reactive species are produced in cells as a result of normal metabolism as well as due to 
extracellular agents (Fig. 5) and have a pro-oxidant action if its levels rise above the 
 
 
Fig. 5. Sources and cellular responses to reactive species. Oxidants are generated as a result of normal intracellular 
metabolism in mitochondria and peroxisomes, as well as from a variety of cytosolic enzyme systems. In addition, 
extracellular agents can trigger oxidants production. A sophisticated antioxidant defence system counteracts and 
regulates overall reactive species levels to maintain physiological homeostasis. Lowering oxidants below the 
homeostatic set point may interrupt the physiological role of oxidants in cellular proliferation and host defence. 
Similarly, increased oxidants may also be detrimental and lead to cell death, disease or to acceleration in ageing and 
age-related diseases. The oxidative stress caused by increased reactive species is thought to result from random 
damage to proteins, lipids and DNA. In addition to these effects, a rise in oxidants may also constitute a stress signal 
that activates specific redox-sensitive signalling pathways. Once activated, these diverse signalling pathways may 
have either damaging or potentially protective functions. SOD - superoxide dismutase, GPox - glutathione peroxidase, 
HSP - heat shock proteins. [Adapted from Finkel & Holbrook (2000)] 
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homeostatic set point. The main reactive species produced are (but not limited to) reactive 
oxygen species (ROS) and reactive nitrogen species (RNS). They include free radicals and non-
radical species. A free radical can be defined as any specie capable of independent existence 
that contains one or more unpaired electrons. The presence of unpaired electrons makes free 
radicals highly reactive because they require another electron to complete the last orbital and 
become stable (Halliwell & Gutteridge, 1999; Willcox et al., 2004). 
 ROS encompass a number of chemically reactive molecules derived from oxygen which 
include both free radicals, such as superoxide anion (O2˙¯) and hydroxyl radical (˙OH), and non-
radicals such as hydrogen peroxide (H2O2). Some non-radicals are also considered as reactive 
species because they can act as oxidising agents and/or can be easily converted into radicals 
(Evans & Halliwell, 2001). Some ROS are extremely reactive, such as ˙OH, while some are less 
reactive (poor oxidant), such as O ˙¯ and H O2 2 2 (Nordberg & Arner, 2001). Moreover, some of 
these species, such as O ˙¯ and ˙OH, are extremely unstable whereas others, like H O2 2 2, are 
freely diffusible and relatively long-lived (Finkel & Holbrook, 2000). 
 The superoxide anion, created from molecular oxygen by the addition of an electron, 
lacks the ability to penetrate lipid membranes and is therefore enclosed in the compartment 
where it is produced (Nordberg & Arner, 2001). The most important source of O2˙¯ in 
eukaryotic cells is the leakage of electrons from mitochondrial electron transport chain (Fig. 6). 
It can also be formed by autoxidation reactions and by certain enzymes, such as xanthine 
oxidase, lipoxygenase and cyclooxygenase (Nordberg & Arner, 2001; Halliwell, 2001). 
Superoxide anion cannot directly attack DNA, lipids and many proteins. However, it can 
decrease the activity of certain enzymes including some antioxidant defence enzymes (such as 
catalase and glutathione peroxidase), NADH dehydrogenase and ribonucleotide reductase 
among others (Willcox et al., 2004). At elevated levels, O2˙¯ can also mobilise small amounts of 
iron from the iron-storage protein ferritin and attack the active sites of some enzymes containing 
iron-sulphur clusters, such as aconitase, causing their inactivation. This last process is also 
accompanied by iron release (Halliwell, 2001). Aside from direct damage, O2˙¯ can be more 
cytotoxic by generating other reactive species, such as H2O2, by the addition of one more 
electron (Fig. 6). 
Hydrogen peroxide, apart of its production from the dismutation of superoxide by 
superoxide dismutase (SOD): 
2 O2˙¯ + 2 H+ → H O2 2 + O2 
can also be produced directly by several other enzymes, such as glycollate oxidase and xanthine 
oxidase (Halliwell, 2001). Hydrogen peroxide is poorly reactive with most biomolecules and 
appears unable to directly oxidise DNA, lipids and proteins, except for a few proteins which 
have hyper-reactive thiol groups or methionine residues, such as glyceraldehyde-3-phosphate 
dehydrogenase (Halliwell & Gutteridge, 1999; Halliwell, 2001). Although H O  is not a free 2 2
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radical, it is highly important much because of its ability to penetrate biological membranes 
(Fig. 6) and to form much more damaging species such as ˙OH (Nordberg & Arner, 2001; 
Halliwell, 2001; Willcox et al., 2004). 
The ˙OH can attack and damage all biomolecules (carbohydrates, lipids, proteins and 
DNA) but only at the site where it is produced due to its high reactivity (short half-life) and very 
low diffusion distance (Yu, 1994; Halliwell & Gutteridge, 1999; Nordberg & Arner, 2001; 
Halliwell, 2001). The radical is formed from H2O  in a reaction catalysed by metal ions (Fe2+2  or 
Cu+) known as the Fenton reaction: 
+H2O2 + Cu /Fe2+ 2+ → ˙OH + OH¯ + Cu /Fe3+ (Reaction 1) 
Superoxide plays an important role as reductant agent in connection with Reaction 1 by 
recycling the metal ions: 
2+        O2˙¯ + Cu /Fe3+ + → O2 + Cu /Fe2+  (Reaction 2) 
Ascorbic acid can also act as a reductant agent. Although ascorbate normally acts as a powerful 
scavenger of reactive species, it can become pro-oxidant in the presence of iron (or copper) 
Fe/Cu 
 
 
Fig. 6. Simplified nonstoichiometric scheme of generation of reactive oxygen species in cells and the action of some 
intracellular antioxidants. Superoxide is produced in significant amounts intracellularly, mainly both in the cytosol 
and in mitochondria (due to escape of electrons from the respiratory chain). Two molecules of superoxide rapidly 
dismutate, either spontaneously or via superoxide dismutases to dioxygen and hydrogen peroxide, the latter 
permitting flux of ROS between different cellular compartments. Hydrogen peroxide can be enzymatically 
metabolised to dioxygen and water by a number of different enzyme systems or converted to the hydroxyl radical, 
which is extremely reactive, via a chemical reaction catalysed by transition metals. ER - endoplasmic reticulum, ETC 
- electron transport chains, Ox - oxidases, GSH - reduced glutathione, GSSG - oxidised glutathione, GR - glutathione 
reductase, GPox - glutathione peroxidase, SOD - superoxide dismutase, Prx - peroxiredoxins. Reactive oxygen 
species and endogenous antioxidants are bolded. [Adapted from Nordberg & Arner (2001) and Willcox et al. (2004)] 
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ions, damaging biomolecules by promoting the formation of ˙OH (Halliwell, 2001). The sum of 
Reactions 1 and 2 is the Haber-Weiss reaction (Reaction 3), transition metals thus playing an 
important role in the formation of hydroxyl radicals (Nordberg & Arner, 2001). 
            H2O  + O ˙¯  →  ˙OH + OH¯ + O2 2 2 (Reaction 3) 
 Thus, although iron and copper are required by the human body for its normal function, 
these transition metals are dangerous due to their ability to transfer single electrons (they can be 
considered as radicals; Halliwell & Gutteridge, 1999; Halliwell, 2001). For example, iron can 
oscillate between the ferrous (Fe2+ 3+) and ferric (Fe ) states making it a powerful catalyst of free 
radical reactions. Fortunately, iron and copper ions, in chemical forms that can work as 
catalysts, are in short supply in vivo. The body contains a system of transport and of storage 
proteins that ensure that as much iron and copper as possible is safely sequestered in 
noncatalytic forms (Halliwell, 1996; Gutteridge & Halliwell, 2000). However, oxidative stress 
and cell injury can induce the liberation of metal ions (and, therefore be in a catalytic form) for 
free radical reactions from ferritin and heme proteins (Gutteridge & Halliwell, 2000). As 
mentioned above, O2˙¯ have an important role in these reactions. Besides its importance in the 
formation of ˙OH, transition metal ions can also be deleterious catalysing the formation of 
reactive species by autoxidation reactions and participating in the formation of alkoxyl (RO˙) 
and peroxyl (ROO˙) radicals (Halliwell & Gutteridge, 1999; Halliwell, 2001). 
 Nitric oxide (˙NO) is included in the RNS and in several aspects is similar to O2˙¯.  
Despite its unpaired electron, it does not readily react with most biomolecules. It plays 
important physiological functions, such as vasodilatation and neurotransmission functions 
(Halliwell & Gutteridge, 1999; Halliwell, 2001). Nitric oxide also works as free radical 
scavenger generating mainly less reactive molecules (Nordberg & Arner, 2001). However, in 
excess, ˙NO can inhibit cytochrome oxidase in mitochondria, leading to increased leakage of 
electrons and more O ˙¯ formation (Halliwell, 2001). Then, ˙NO can react with O2 2˙¯ to give 
peroxynitrite (ONOO¯), which is highly cytotoxic (Halliwell & Gutteridge, 1999; Nordberg & 
Arner, 2001; Halliwell, 2001). Peroxynitrite is also responsible for the formation of other 
dangerous reactive species. Thus, generation of ONOO¯ in vivo can lead to oxidation and 
nitration of lipids, DNA and amino acid residues on proteins (Halliwell, 2001). 
 Besides the formation of ROS and RNS, other reactive species can also be formed by 
the metabolism of drugs and toxins. Carbon tetrachloride (CCl4), for example, is metabolised 
forming high reactive free radicals such as ˙CCl  and CCl3 3OO˙ (Halliwell & Gutteridge, 1999; 
Weber et al., 2003). Another example is the organic hydroperoxide – tert-butyl hydroperoxide 
(t-BHP or t-BOOH) which can be metabolised to form peroxyl (t-BHOO˙) and alkoxyl (t-
BHO˙) radicals (Davies, 1989; VanderZee et al., 1996). 
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1.3.2. Cellular antioxidant defences 
 
 Due to the continuous formation of reactive species in vivo, aerobic organisms only 
survived because they develop antioxidant defences. Antioxidant is a term widely used but 
rarely defined. For example, for a chemist an antioxidant is a molecule that has the ability to 
scavenge free radicals. In the food industry, the term is implicitly restricted to chain-breaking 
inhibitors of lipid peroxidation and consequent rancidity in food materials, such as α-
tocopherol. Indeed, food scientists often simply connect antioxidants to inhibitors of lipid 
peroxidation (Halliwell & Gutteridge, 1999). However, reactive species generated in vivo 
damage many targets other than lipids, including proteins and DNA. Therefore, a broader 
definition of an antioxidant has been given by Halliwell and Gutteridge in 1989 to include living 
organisms as ‘any substance that, when present at low concentrations compared to those of an 
oxidisable substrate, significantly delays or prevents oxidation of that substrate’ (Halliwell & 
Gutteridge, 1999). The antioxidants can either directly or indirectly protect cells against the 
adverse effects of reactive species (Mates, 2000). Some antioxidants are strategically 
compartmentalised in subcellular organelles within the cell to provide maximum protection 
(Fig. 6). 
The cellular antioxidants may defend against reactive species by (Fig. 7): 
(1) inhibiting their generation (preventive antioxidants); 
(2) removing or degrading them to less harmful products (removal antioxidants); 
(3) and, presenting themselves for oxidation (scavenging antioxidants). 
Additionally, antioxidants may protect target biomolecules against oxidative damage by other 
mechanisms (e.g. heat shock proteins, which are also repair proteins). Also, ROS/RNS (in 
moderate levels) and certain cellular signal molecules, such as cytokines, can enhance the 
cellular antioxidant defences (for example, by upregulating gene expression) (Halliwell et al., 
1995; Halliwell & Gutteridge, 1999). Since under normal conditions oxidative damage to DNA, 
proteins, lipids and other molecules has been demonstrated in living organisms, scientists have 
realised that the cellular antioxidant defences may be incomplete. Hence, the repair 
antioxidants (Fig. 7) have been added to the antioxidant defences (Halliwell & Gutteridge, 
1999). Critical structures in the cell are protected not only by the ability to maintain reactive 
species in low levels, but also by other mechanisms, such as the repair or elimination of 
damaged molecules (Cui et al., 2004). Therefore, in brief, the antioxidant defence system can 
include any substance that neutralises the potential damaging effects of reactive species. 
 As a first line of defence, the preventive antioxidants suppress radical formation by 
binding to, and sequestering, oxidation promoters and transition metal ions (Fig. 7), such as iron 
and copper, which contain unpaired electrons and strongly accelerate free radical formation (Cui 
et al., 2004). Examples are transferrin and lactoferrin (which bind ferric ions), caeruloplasmin 
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(which binds Cu, catalyzes the oxidation of ferrous ions to ferric due to its ferroxidase activity, 
and increases the binding of iron to transferrin), haptoglobins (which bind hemoglobin), 
hemopexin (which binds heme), and albumin (which binds copper and heme). 
 Next, removal antioxidants catalytically degrade specific reactive species (Fig. 7) 
converting them into less harmful products (Halliwell & Gutteridge, 1999). Examples are the 
antioxidant enzymes superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase 
(GPox). SOD converts O2˙¯ to H2O , 2
2O2˙¯ + 2H+ → H O  + O2 2 2 
which is not a free radical by itself, but is a precursor of the highly reactive hydroxyl radical 
(Fig. 6). Mammalian cells have in the mitochondria a SOD enzyme containing manganese at the 
active site (Mn-SOD). A SOD with copper and zinc at the active site (Cu/Zn-SOD) is also 
present largely in the cytosol (Halliwell, 1996). There is also an extracellular mammalian SOD 
(EC-SOD) (Mates, 2000). Detoxification of hydrogen peroxide (Fig. 6) is carried out by (i) 
CAT, which decomposes H O2 2 to water and oxygen, 
2H2O  → H O + O2 2 2
and is an exclusive peroxisomal enzyme in most tissues (Halliwell et al., 1995); or by (ii) GPox, 
 
 
 
 
Fig. 7. Cellular antioxidants defences against reactive species. The preventive antioxidants suppress radical formation 
whereas the removal antioxidants catalytically degrade specific reactive species converting them into less harmful 
products. Then, oxidative chain reactions initiated by reactive species that escaped from the above antioxidant 
defences are terminated by the scavenging or chain-breaking antioxidants. They act by presenting themselves for 
oxidation at an early stage in the oxidation chain reactions, inhibiting its initiation and preventing chain propagation. 
The repair antioxidants act as the last line of defence by repairing damage or eliminating damaged molecules. SOD -
superoxide dismutase, GPox - glutathione peroxidase, GSH - reduced glutathione, HSP - heat shock protein. 
[Adapted from Willcox et al. (2004)] 
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which reduces H O  to water in the presence of glutathione in reduced form: 2 2
O2 GSH + H2 2 → 2H O + GSSG 2
GPox catalyse also the reduction of others hydroperoxides (ROOH) that may appear in the cell. 
The GPox is assisted by glutathione reductase (GR) to recycle oxidised glutathione (GSSG): 
+ +GSSG + NADPH + H  → 2GSH + NADP
Other H2O2-removing systems exist, such as peroxidases that use the dithiol-containing protein 
thioredoxin as a substrate (peroxiredoxins) (Nordberg & Arner, 2001; Evans & Halliwell, 
2001). The enzymes GR, GPox and peroxiredoxin are present in several cellular compartments, 
including mitochondria (Halliwell, 2001). The antioxidant enzymes work to remove most 
superoxides and peroxides before they react with metal ions to form ˙OH. Since they suppress 
the generation of a more reactive free radical, they are also referred for some authors as 
preventive antioxidants (Willcox et al., 2004). 
 Then, oxidative chain reactions initiated by reactive species that escaped the above 
antioxidant defences may be terminated by low molecular mass scavenging antioxidants (Fig. 
7). The scavenging or chain-breaking antioxidants act by presenting themselves for oxidation at 
an early stage in the oxidation chain reactions, inhibiting its initiation and preventing chain 
propagation (Cui et al., 2004). Lipid soluble and water soluble scavengers act in cellular 
environments that are either hydrophobic or hydrophilic, respectively. The major endogenous 
lipophilic scavengers are coenzyme Q and bilirubin, while glutathione and uric acid function in 
the aqueous environment. Glutathione is an important cell antioxidant that, besides a cofactor 
for GPox, is a potent nucleophilic scavenger of free radicals via conjugation reactions, either 
chemically or enzymatically (catalysed by glutathione S-transferase - GST) (Reed, 1990; Yu, 
1994). Diet plays a vital role in the production of scavenging antioxidants by providing essential 
nutrient antioxidants such as the lipophilic vitamin E (α-tocopherol) and β-carotene as well as 
the hydrophilic vitamin c (ascorbic acid) (Halliwell & Gutteridge, 1999; Willcox et al., 2004). 
Also important for the antioxidant defences are essential minerals obtained from diet, since 
many of them are vital cofactors for enzymatic antioxidants (e.g. selenium), as well as plant 
phenolic compounds, such as flavonoids (see section 1.4.1). 
The repair (antioxidant) system acts as the last line of defence by repairing damage or 
eliminating damaged molecules (Fig. 7). These include lipases, proteases, heat shock proteins, 
DNA repair enzymes, and transferases (Willcox et al., 2004). For example, DNA repair 
enzymes act by excising and replacing damaged bases in the DNA whereas heat shock proteins 
repair or refold slightly damaged proteins and increase the turnover of severe damaged proteins 
(Halliwell & Gutteridge, 1999; Evans & Halliwell, 2001). 
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1.3.3. Oxidative stress and disease 
 
 Because of their high reactivity, accumulation of radicals above cells’ defences may 
affect cellular functionality and integrity by damaging critical molecules, such as the DNA, 
proteins, carbohydrates and lipids, which ultimately can cause cell death. In fact, oxidative 
stress has been recognised to be involved in the aetiology of several age-related and chronic 
diseases such as cancer, diabetes, neurodegenerative and cardiovascular diseases (Tiwari, 2004; 
Cui et al., 2004; Ceriello & Motz, 2004; Klaunig & Kamendulis, 2004; Ballinger, 2005; Gibson 
& Huang, 2005; Rolo & Palmeira, 2006). Even aging and age-related loss of physiological 
fitness have been attributed to oxidative stress (Finkel & Holbrook, 2000; Cadenas & Davies, 
2000). In some human diseases, oxidative stress is, however, a secondary phenomenon, not the 
primary cause of the disease, which does not mean that oxidative stress is in this cases 
unimportant (Halliwell, 1996). 
 
 
1.4. Plant compounds as antioxidants 
 
 Foods and nutrients play a vital role in normal functioning of the body. They are helpful 
in maintaining the health of the individual and in reducing the risk of various diseases. From the 
acceptance of this fact, worldwide evolved the concept of “functional food”, i.e., any altered 
food or ingredient that could give a beneficial effect beyond that provided by the nutrients that it 
normally contains (Ferrari, 2004). On the other hand, a non altered food (or part of it) with 
health or medical benefits is defined by the American Dietetic Association (as cited by Ferrari, 
2004) as “nutraceutical”, which include products such as vitamins, minerals, fruits, plant and 
animal extracts. These nutraceuticals are believed to be useful in the prevention and treatment of 
several diseases (Ferrari, 2004; Ramaa et al., 2006). Based in epidemiologic studies, animal 
research, clinical trials and nutritional biochemistry studies, these dietary supplements are 
currently recognised as beneficial in the coronary heart disease, cancer, osteoporosis and other 
chronic and degenerative diseases, such as diabetes, Parkinson’s and Alzheimer’s diseases 
(Mandel et al., 2005). This gave impetus to investigate the mechanisms of action of 
nutraceuticals and related bioactive compounds.  
 The health benefits of nutraceuticals of plant origin, phytochemicals, are currently the 
most studied. Based on epidemiological studies, diets rich in fruits and vegetables and other 
plant foods (including tea and wine) are associated with a decreased risk of premature death and 
mortality from chronic age-related diseases, such as cardiovascular diseases and some types of 
cancer (Stanner et al., 2004; Ferrari, 2004; Neuhouser, 2004; Liu, 2004). Because oxidative 
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stress plays a central role in aging and chronic and age-related diseases, plant antioxidants, such 
as vitamin C, vitamin E, carotenoids (e.g. β-carotene, lycopene and lutein) and phenolic 
compounds (e.g. flavonoids), have been proposed as components responsible for the health 
promotion of those plant foods (Willcox et al., 2004; Stanner et al., 2004). The hypothesis that 
plant antioxidants are responsible for the health promotion effects is supported by some 
experiments with animals, cultured human cell lines and chemical in vitro studies (Scalbert et 
al., 2005; Halliwell et al., 2005). For example, experimental studies on animals or cultured cells 
support a role for flavonoids and other phenolic compounds in the prevention of cardiovascular 
diseases, cancers, neurodegenerative diseases, diabetes and osteoporosis (Jiang & Dusting, 
2003; Neuhouser, 2004; Tsuda et al., 2004; Scalbert et al., 2005; Nichenametla et al., 2006). 
However, it is very difficult to predict from these results the effects of the intake of phenolic 
compounds on disease prevention in humans. One of the reasons is that these studies have often 
been conducted at doses or concentrations far beyond those observed in humans (Scalbert et al., 
2005). Maximal plasma concentrations achieved are low, usually not more than 1 μM, in part 
because of their poor gastrointestinal absorption and rapid metabolism by human tissues and 
colonic bacteria. Many of the products of metabolism, such as methylated and glucuronidated 
forms, have decreased direct antioxidant activity (Halliwell et al., 2005). Due to the low 
concentrations reached in vivo, phytochemicals and other nutraceuticals have been suggested to 
exert beneficial actions on cells not through their direct antioxidant effects but rather through 
their modulation of proteins (and enzymes), gene expression and cell signalling cascades 
(Williams et al., 2004; Mandel et al., 2005). Moreover, by these mechanisms, the bioactive 
form of a plant antioxidant in vivo is not necessarily the natural phytochemical, but conjugates 
and metabolites arising up on absorption and first pass in the liver (Spencer et al., 2004; 
Williams et al., 2004). 
 Some human clinical trials using plant antioxidants have led to controversial results 
regarding protective action against some chronic age-associated diseases (Stanner et al., 2004; 
Scalbert et al., 2005). These studies usually involved the administration of single antioxidant 
nutrients given at relatively high doses. Results of trials investigating the effect of a balanced 
combination of antioxidants at levels achievable by diet are still awaited (Stanner et al., 2004). 
In fact, as proposed by Liu (2004), it is the additive and synergistic effect of phytochemicals in 
fruits and vegetables that may be responsible for the in vivo antioxidant effects. This would 
explain why no single antioxidant can replace the combination of natural phytochemicals in 
fruits and vegetables to achieve the health benefits (Liu, 2004).  
Successful application of plant antioxidants as drugs require a much greater 
understanding of their pharmacological properties, including their rates of absorption, tissue 
distribution, metabolism and the microenvironment in which they must act (Finkel & Holbrook, 
2000). 
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1.4.1. Phenolic compounds and antioxidant activity 
 
Previous studies have shown that many dietary phenolic compounds derived from plants 
are more effective antioxidants in vitro than vitamins E or C or the carotenoids, and thus might 
contribute significantly to the protective effects in vivo (Rice-Evans et al., 1997). 
Phenolics compounds are ubiquitous in foods of plant origin (e.g. fruits, vegetables, 
cereals, nuts, wines, whiskies, beer, teas and cocoa), although their concentrations can vary by 
many orders of magnitude and are influenced by several factors, including species, variety, 
light, degree of ripeness, processing and storage. Plants produce over 8000 phenolic compounds 
via the shikimate, mevalonate and phenylpropanoid pathways. They are most frequently found 
in nature as conjugates, for example with monosaccharides and disaccharides (glycosides), and 
as such tend to be water soluble. Some of these products of secondary metabolism are essential 
to the plant's physiology, being involved in diverse functions such as pigmentation, pollination, 
protection against UV-B irradiation, and pathogen and predator resistance (Duthie & Crozier, 
2000). 
Fruits like apple, grape, pear, cherry, and various berries contain up to 200–300 mg 
phenolic compounds per 100 g fresh weight. Typically, a glass of red wine or a cup of tea or 
coffee contains about 100 mg phenolic compounds. The total dietary intake is about 1 g/d. It is 
much higher than that of all other known dietary antioxidants, about 10 times higher than that of 
vitamin C and 100 times higher than those of vitamin E and carotenoids (Scalbert et al., 2005). 
 
1.4.1.1. Chemistry of phenolic compounds 
 The term phenolic compound embraces a wide range of plant substances that possess 
one or more aromatic rings with one or more hydroxyl groups (hydroxybenzenes; phenols) and 
generally are categorised as phenolic acids, flavonoids, stilbenes, coumarins, and tannins (Croft, 
1998; Ferguson, 2001; Jiang & Dusting, 2003; Liu, 2004). The nomenclature of natural phenolic 
compounds is sometimes confusing. The term polyphenol is widely used and refer to phenolic 
compounds containing two or more phenol groups. However, currently, the terms polyphenols 
or polyphenolics are used to refer to phenolic compounds regardless of the number of phenol 
groups in the molecules (Jiang & Dusting, 2003). 
1.4.1.1.1. Phenolic acids 
Phenolic acids seem to be universally 
distributed in plants. They are usually divided in two 
main groups (Fig. 8): benzoic acids, containing seven 
carbon atoms (C6–C1), and cinnamic acids, comprising 
nine carbon atoms (C6–C3). These compounds exist 
 
 
  Fig. 8. Generic structure of phenolic acids. 
21 
Effects of Salvia officinalis in the liver: Relevance of glutathione levels                                                       C.F. Lima 
 
predominantly in the hydroxylated form, therefore being generally named hydroxybenzoic and 
hydroxycinnamic acids, respectively (Liu, 2004; Nichenametla et al., 2006; Fresco et al., 2006). 
Phenolic acids derived from hydroxybenzoic acid include gallic acid, vanillic acid, procatechuic 
acid and syringic acid. Phenolic acids derived from hydroxycinnamic acid include p-coumaric 
acid, caffeic acid, and ferulic acid (Liu, 2004; Nichenametla et al., 2006). Natural phenolic 
acids, occurs both in the free or conjugated forms (Fresco et al., 2006). For example, 
chlorogenic acid is the ester of caffeic acid and quinic acid (Liu, 2004). Due to their structural 
similarity, several polyphenols are considered as acid analogs such as rosmarinic acid (Fresco et 
al., 2006). Rosmarinic acid is an ester of caffeic acid and 3,4-dihydroxyphenyllactic acid 
commonly found in the family Lamiaceae (Petersen & Simmonds, 2003). 
 1.4.1.1.2. Flavonoids 
 Flavonoids are ubiquitous in most plants and the largest class of polyphenols with more 
than 4000 distinct compounds identified. They are C15 compounds composed with a common 
phenylbenzopyrone structure (C6-C3-C6), consisting of two aromatic rings (A and B rings) 
linked by 3 carbons that are usually in an oxygenated heterocycle ring, the C ring (Table 1) 
(Ross & Kasum, 2002; Ren et al., 2003; Liu, 2004). The A ring are biosynthetically derived 
from acetate and has a characteristic hydroxylation pattern at the 5 and 7 position. The B ring is 
synthesised from the shikimate and is usually 4’-, 3’4’- (cathecol B ring), or 3’4’5’-
hydroxylated (Croft, 1998; Ross & Kasum, 2002). Differences in the generic structure of the 
heterocycle C ring are used to classify them as chalcones, flavonols, flavones, flavanols, 
flavanones, flavanonols, anthocyanidins, and isoflavones (Table 1). Individual differences 
within each group result from the variation in number and arrangement of the hydroxyl groups 
as well as from the nature and extent of alkylation and/or glycosylation of these groups (Rice-
Evans et al., 1996). Flavones and flavonols have a double bond between 2 and 3 position. 
Flavonols are different from flavones in that they have a hydroxyl group in the 3 position (Table 
1). Flavanones, flavanonols and flavanols are characterised by the presence of a saturated 
carbon bond between position 2 and 3 (Table 1). Flavanones have a keto (oxo) group at position 
4, flavanols have frequently a hydroxyl (OH) group at position 3 whereas flavanonols have both 
a keto group at position 4 and an OH group at position 3 (Nichenametla et al., 2006). Flavanols 
are represented by catechins, which are phenolic compounds mainly present in Camellia 
sinensis. The isoflavonones are derived by cyclisation of the chalcones, such that the B ring is 
located at the 3 position. Because they are structurally similar to estrogens, having estrogen-like 
biological activities, isoflavones are frequently referred to as phytoestrogens (Jiang & Dusting, 
2003; Galati & O'Brien, 2004). Anthocyanidins are highly coloured pigments that give the red 
and blue colours in some fruits and vegetables. 
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Table 1. The chemical structures and major food sources of the 8 major flavonoid subgroups. [Adapted from Birt et 
al. (2001) and Moon et al. (2006)] 
 
 Structure Examples    OH-substitution Major food sources 
   
Basic structure 
 
   
  Chalcones 
Chalcone Hops, beer 
 
   
Flavones Chrysin            5,7 Parsley, thyme, celery, sweet 
red pepper, honey, propolis Apigenin          5,7,4’      
Luteolin           5,7,3’,4’  
   
   Galangin          5,7 Onions, cherries, apples, 
broccoli, kale, tomato, 
Flavonols 
Kaempferol      5,7,4’ 
Fisetin              7,3’,4’ berries, tea, redwine, tartary 
buckwheat Quercetin         5,7,3’,4’ 
Myricetin         5,7,3’,4’,5’  
   
Flavanones   
Naringenin       5,7,4’ Oranges, grapefruit, prunes 
Eriodictyol       5,7,3’,4’ 
 
   
  Flavanonols 
Taxifolin          5,7,3’,4’ Limon, aurantium 
 
   
Flavanols   
Catechin             (+)-OH*  Tea, apples, cocoa, red wine (flavan-3-ols) 
Epicatechin        (−)-OH* 
Epigallocatechin    5’ 
 
   
Anthocyanidins   
Pelargonidin      Cherries, grapes, blueberries
Cyanidin           3’ 
Delphinidin       3’,5’ 
 
   
  Isoflavones 
Daidzein            7,4’     Soya beans, legumes 
Genistein           5,7,4’ 
 
* Position of the OH group at position 3 relative to the phenolic group at position 2. Therefore, the prefix “epi” is given to a cis 
configuration between 3-OH group and 3-phenolic group. 
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1.4.1.2. Antioxidant activity 
 The antioxidant potential of phenolics was one of the earliest activities proposed for 
these compounds, since they were found to stabilise foods by retardation of rancidity and 
extension of shelf-life (Bors et al., 1997). These compounds are, currently, recognised as 
beneficial for health limiting damages imposed by oxidative stress due to their antioxidant 
effects. They can either act directly, i.e. helping regulating overall reactive species levels to 
maintain physiological homeostasis by scavenging them and/or preventing their formation, or 
indirectly by stimulating endogenous antioxidant defence systems (Scalbert et al., 2005). 
 Firstly, flavonoids are considered antioxidants because they are able to scavenge 
electrons of free radicals (Rice-Evans et al., 1996). Phenolic compounds easily donate a 
hydrogen atom from an aromatic OH group to a free radical, because they are able to stabilise 
an unpaired electron through its delocalisation (Duthie & Crozier, 2000). Although numerous 
data exist for phenolic compounds, the correlation between antioxidant activity and chemical 
structure is far from clear. Different methods of assessment, varying substrate systems, and 
differences in concentrations of active antioxidants all have contributed to the confounding of 
the issue (Rice-Evans et al., 1996). Nevertheless, the main structural features of flavonoids 
required for efficient radical scavenging could be summarised as follows (Rice-Evans et al., 
1996; Croft, 1998): 
(1) an ortho-dihydroxy (catechol) structure in the B ring, for electron delocalisation; 
(2) the 2,3 double bond in combination with a 4-keto function in the C ring provides 
electron delocalisation from the B ring; 
(3) the 3- and 5-OH groups with 4-oxo function in A and C rings are required for 
maximum radical scavenging potential, since it provides hydrogen bonding to the 
keto group. 
The addition of other hydroxyl groups can also increase, in some cases, the compound’s 
scavenging activity, as for example the meta 5,7-dihydroxy in the A ring of flavonoids (Rice-
Evans et al., 1997). Phenolic acids may also be good radical scavengers, particularly those 
possessing the catechol-type structure, such as caffeic and rosmarinic acids (Croft, 1998). The 
free radical scavenging activity of phenolic compounds is important for their direct antioxidant 
activity by breaking the free radical chain reactions, inhibiting its initiation and preventing chain 
propagation (Rice-Evans et al., 1996; Croft, 1998). In some conditions, these compounds can, 
however, be pro-oxidant if the resulting phenolic radical is not stable enough and results itself in 
chain-propagating radical. Further oxidation by reaction with another radical can, nevertheless, 
inactivate the phenolic radical (Croft, 1998). 
 Another pathway of direct antioxidant action of phenolic compounds, particularly in 
oxidation systems using transition metal ions such as copper or iron, is chelation of the metal 
ions (Rice-Evans et al., 1997; Croft, 1998). Chelation of catalytic metal ions may prevent their 
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involvement in Fenton-type reactions, which can generate highly reactive hydroxyl radicals  
(Croft, 1998). For metal chelation, the two points of attachment of transition metal ions to 
flavonoid molecule are the 3’,4’ dihydroxy groups in the B ring and the 4-keto in combination 
with either the 5-hydroxy or 3-hydroxy groups in the A and C ring (Rice-Evans et al., 1996; 
Rice-Evans et al., 1997; Mira et al., 2002; Williams et al., 2004). The ability of phenolic 
compounds to react with metal ions may, in certain conditions, also render them pro-oxidant. 
For example, some flavonoids can, presumably, reduce Cu2+ to Cu+ and hence allow the 
formation of initiating radicals (Croft, 1998). 
 However, their classical hydrogen-donating antioxidant activity is unlikely to be the 
sole explanation for cellular antioxidant effects of phenolic compounds, mainly by three reasons 
(Williams et al., 2004; Scalbert et al., 2005): 
 - phenolic compounds are extensively metabolised in the body, decreasing their direct 
antioxidant activity; 
 - antioxidant properties of polyphenols largely depend on their chemical and physico-
chemical environment, which varies according to tissues and physiological conditions; 
 - concentration of flavonoids and their metabolites accumulated in vivo (e.g. in plasma 
or in organs) are lower (high nanomolar, low micromolar) than those recorded for small 
molecule antioxidant nutrients such as ascorbic acid and α-tocopherol. Consequently, phenolic 
compounds are unlikely to express beneficial action in vivo through outcompeting antioxidants 
such as ascorbate, which are present at higher concentrations (high micromolar). 
 It should, therefore, not be a surprise that no correlation between the antioxidant 
potency of various phenolic compounds measured in vitro and their biological activity 
determined in vivo or at the cellular level has ever been published (Scalbert et al., 2005). 
 Phenolic compounds most likely exert their antioxidant effects in vivo by stimulating 
endogenous antioxidant defence systems. Certain polyphenols can induce phase II enzymes 
such as GST that will enhance the excretion of oxidising species, or induce antioxidant enzymes 
such as metallothionein (a metal-binding protein with antioxidant property) (Ferguson, 2001; 
Ross & Kasum, 2002). Polyphenols may also inhibit cytochromes P450 (CYPs) or enzymes 
such as cyclooxygenase or lipoxygenase that have oxidant activities (Ferguson, 2001; Moon et 
al., 2006). Moreover, flavonoids may enhance antioxidant enzymes such as GPox (Ferguson, 
2001). 
 
1.4.1.3. Other biological effects 
Besides their antioxidant effects, phenolic compounds exhibit a wide variety of other 
biological effects that may be beneficial to cells and organism, including antiviral, antibacterial, 
anti-inflammatory, anticarcinogenic and estrogenic-like effects among others (Rice-Evans et al., 
1996). Flavonoids and other phenolic compounds are complex molecules and multiple cellular 
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biological activities have been reported that could account for their biological effects, such as 
telomerase inhibition, modulation of signal transduction pathways, inhibition of 
cyclooxygenases and lipoxygenases, decrease of xanthine oxidase and sulfotransferase 
activities, interaction with sirtuins and cellular drug transport systems, compete with glucose for 
transmembrane transport, interfere with cyclin-dependent regulation of the cell cycle, and affect 
platelet function (Halliwell et al., 2005). For example, focusing only on anticarcinogenic 
effects, many mechanisms of action have been identified for flavonoids and other polyphenols 
(Birt et al., 2001; Ren et al., 2003; Ferguson et al., 2004). They include carcinogen inactivation, 
antiproliferation, cell cycle arrest, induction of apoptosis and differentiation, inhibition of 
angiogenesis, antioxidation, reversal of multidrug resistance, induction of detoxification 
enzymes, regulation of the host immune system, and maintenance of genomic stability. Not only 
one but rather some combination of these mechanisms is expected to result in both cancer 
chemoprevention and chemotherapy (Birt et al., 2001; Ren et al., 2003). 
 There is an emerging view that flavonoids, and their metabolites, act in vivo most likely 
as modulators of protein and lipid kinase signalling cascades. Many of the above activities may 
be accomplished by interactions of flavonoids with specific proteins central to intracellular 
signalling cascades. Inhibitory or stimulatory actions at these pathways are likely to profoundly 
affect cellular function by altering the phosphorylation state of target molecules and/or by 
modulating gene expression (Williams et al., 2004). Again, focusing on the anticarcinogenic 
effects, modulation of several signal transduction pathways have been related to the 
chemopreventive activities of these compounds. These effects are believed to occur by the 
regulation of signalling pathways such as nuclear factor-kB (NF-kB), activator protein-1 (AP-1) 
or mitogen-activated protein kinases (MAPK). By modulating cell signalling pathways, 
polyphenols activate cell death signals and induce apoptosis in precancerous or malignant cells 
resulting in the inhibition of cancer development or progression (Fresco et al., 2006). The 
induction of detoxifying enzymes (increase expression level) by polyphenols are mediated by 
the antioxidant response element (ARE)/electrophile response element (EpRE), which is located 
in the promoter region of related genes (Ferguson, 2001; Chen & Kong, 2004; Fresco et al., 
2006). 
 
 
1.5. Liver 
 
 The liver is a large organ making up about 2 per cent of human body weight (Hinton & 
Grasso, 1995). The liver is strategically positioned in the circulation to perform its task of 
maintaining the body’s metabolic homeostasis. It is the first organ that by the portal vein comes 
26 
Chapter 1                                                                                                                                                      Introduction 
 
in contact with the venous blood after its exposure to the stomach and intestines. Therefore, the 
liver is the first organ exposed to absorbed nutrients, metals, drugs, environmental toxicants and 
metabolic by-products of bacteria present in the gastrointestinal tract, which need to be 
processed before entering the systematic circulation (Moslen, 1996; Haussinger, 1996). 
 Among the many functions of the liver are (Hinton & Grasso, 1995; Moslen, 1996; 
Haussinger, 1996): 
- Bile acid synthesis, bile formation and biliary excretion – exocrine function; 
- Synthesis of most plasma proteins (except immunoglobulins) and very low density 
lipoproteins (VLDL) – endocrine function; 
- Recycling of plasma proteins and old red blood cells; 
- Maintenance of glucose, lipid, amino acid, ammonia and bicarbonate homeostasis 
of the body; 
- Processing of absorbed nutrients as well as endo- and xenobiotics – 
biotransformation and detoxification. 
 
1.5.1. Liver cell types and tissue structural organisation 
 
 The hepatocytes, the parenchymal cells of the liver, comprise about 90% of the cellular 
volume of the liver and exhibit a clearly defined polarity. The polarity of the hepatocyte is 
maintained by three different plasma membrane domains that can be recognised both 
morphologically and functionally. The highly specialised canalicular (or apical) membrane is 
rich in microvilli and comprises 10-15% of the membrane surface area of the cell; the smooth 
lateral membrane accounts for 15% of the surface area, and the sinusoidal (or basolateral) 
membrane, also rich in microvilli, comprises at least 70% of the cell surface (Diaz, 2000). 
Hepatocytes are assembled into sheets, each a single cell thick, which bifurcate and fuse to give 
a most complex network. Through this network run the liver capillaries, termed sinusoids (Fig. 
9A). Between cells within the sheet run small branching channels called bile canaliculus 
(Hinton & Grasso, 1995). 
Four main types of non-parenchymal cells are also present (Fig. 9A), i.e. endothelial 
cells and Kupffer cells (resident macrophages) lining the sinusoids, fat-storing Ito cells, and pit 
cells (liver associated lymphocytes) (Hinton & Grasso, 1995; Puviani et al., 1998). Endothelial 
cells, unlike the endothelial of normal capillaries, do not form a continuous barrier but are 
penetrated by fenestrations which allow a free exchange of proteins between the blood within 
the sinusoids and the “Space of Disse”, which lies between the endothelial cell and the 
hepatocyte (Hinton & Grasso, 1995). 
In terms of cell number, hepatocytes represent about 65% of the liver. The discrepancy 
between cell number and volume is due to the fact that hepatocytes are much larger than the 
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other liver cells. Cell volume of hepatocytes depends, however, on the nutritional status. After 
48 hours of starvation, it may decrease as much as 45% (Puviani et al., 1998). 
The liver is organised into operational units (Fig. 9B): the lobule (classic manner) and 
the acinus. The hexagonal lobule is divided into three regions: the centrilobular (near the hepatic 
vein), midzonal and periportal regions. Nowadays, the acinus is, however, preferred as a 
concept of a functional hepatic unit (Plaa, 1991; Moslen, 1996). The base of the acinus is 
formed by the terminal branches of the portal vein and hepatic artery that extend out the portal 
tracts (Moslen, 1996). The acinus has three zones that, fortunately, coincide with the three 
regions of the lobule (Fig. 9B): zone 1 is closest to the entry of blood and receives the highest 
concentration of oxygen and nutrients; zone 3 is adjacent the terminal hepatic vein; and, zone 2 
is intermediate. The organisation of these operational units leads to a gradient of oxygen and 
nutrients. For example, cells in zone 1 tend to have more mitochondria and higher respiration 
rates than cells in zone 3 (Kedderis, 1996). The zonation of metabolic functions has important 
implications for chemically induced toxicity due in part to the differential expression of 
enzymes and the concentration gradients of nutrients, oxygen, cofactors and toxicant across the 
acinus (Kedderis, 1996). 
  
1.5.2. Liver as a biotransforming organ 
 
 The liver is the highest metabolic organ. As such, many molecules are catabolised in the 
liver by diverse enzymes. Many lipophilic endo- (formed within the body) and xenobiotics 
(foreign molecules to the body, either of natural origin or man-made), potentially toxic, may be 
  
 
Fig. 9. (A) A three-dimensional representation of the organisation of parenchymal (hepatocytes) and non-
parenchymal liver cells. Endothelial and Kuppffer cells line the sinusoids, thereby separating the sinusoidal space 
from the perisinusoidal space of Disse. The two spaces communicate via endothelial fenestrations that allow access of 
blood plasma (but not erythrocytes) to parenchymal cells. [From Haussinger (1996)]; (B) Schematic representation of 
liver operational units: the classic lobule and the acinus. The acinus extends from the terminal portal venule along the 
sinusoids to the draining terminal hepatic venule and is formed by tubes (20-30 cells long) of parenchymal cells. 
[Adapted from Moslen (1996)] 
A B
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easily absorbed and systematically distributed, which makes them difficult to eliminate from the 
body in their original form. The process in which endo- and xenobiotics are changed from 
hydrophobic to hydrophilic molecules to facilitate elimination from the body is called 
biotransformation (Sipes & Gandolfi, 1991; Parkinson, 1996). 
 The highest quantity and diversity of enzymes involved in biotransformation occurs in 
the liver. The reactions metabolised by these drug-metabolising enzymes are generally divided 
into two groups, called phase I and phase II (Fig. 10). Phase I reactions involve chemical 
modification of the molecule by hydrolysis, reduction and oxidation. These reactions expose or 
introduce a functional group (-OH, -NH2, -SH or -COOH) and usually result in only small 
increase in water solubility. Phase II reactions involve biosynthetic reactions where the 
xenobiotic or a phase I-derived metabolite is covalently linked to an endogenous molecule, 
producing a conjugate (Fig. 10). These biotransformations reactions include glucuronidation, 
sulfatation, acetylation, methylation, conjugation with glutathione and amino acids (such as 
glycine, taurine and glutamic acid). Most phase II reactions result in a large increase in 
xenobiotic hydrophobicity, and greatly promote the excretion of foreign chemicals in bile and 
urine (Sipes & Gandolfi, 1991; Hinton & Grasso, 1995; Parkinson, 1996). 
 The most important group of enzymes involved in phase I reactions are the cytochromes 
P450-dependent mixed-function oxygenase (MFO) system in the membranes of endoplasmatic 
reticulum. This system is actually a coupled enzyme system composed by two enzymes: 
NADPH-cytochrome P450 reductases and a heme-containing enzyme, commonly referred to as 
cytochrome P450 enzymes. The system is termed mixed-function oxygenase because electrons 
are taken from NADPH to reduce oxygen and oxidise or hydroxylate substrates. Cytochrome 
P450s are a large group of enzymes classified into families and subfamilies according to their 
amino acid sequences and substrate specificity, which catalyse a wide variety of reactions. The 
endoplasmatic reticulum also contains a second NADPH-dependent mixed-function amine 
oxidase system, the flavin-containing monooxygenases (FMO) (Sipes & Gandolfi, 1991; 
Kedderis, 1996). 
 Among the different phase II enzymes, which are mostly present in cytosol, glutathione 
S-transferase represents an important biotransforming enzyme to the liver. The GST catalyses 
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Fig. 10. Schematic integration of phase I and phase II biotransformation reactions. [Adapted from Sipes & Gandolfi 
(1991)] 
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the reaction of the nucleophilic sulfhydril of glutathione (GS-) with compounds containing 
electophilic carbon (mostly) atoms. Substrates for GST share three common features: they are 
hydrophobic, they contain an electrophilic atom, and they react nonenzymatically with 
glutathione at some measurable rate (Sipes & Gandolfi, 1991; Parkinson, 1996). 
 
1.5.2.1. Biotransformation 
 In general, drug metabolism can be considered as protective or a detoxification process 
in that it converts lipophilic compounds (which accumulation can overwhelm and injury cells) 
and active xenobiotics into water soluble and easily excreted inactive metabolites. However, 
biotransformation is not strictly related to detoxification. Phase I enzymes, and to lesser extent 
some phase II enzymes, can increase the toxicity of a xenobiotic and produce highly reactive 
metabolites from a inert molecule which becomes, therefore, toxic. The formation of products 
with enhanced activity and toxicity is often termed bioactivation and frequently leads to 
mutagenicity and carcinogenicity (Sipes & Gandolfi, 1991; Hinton & Grasso, 1995; Kedderis, 
1996). Additionally, because electron transfer to molecular oxygen occurs during the phase I 
reaction sequence, ROS can occasionally dissociate from the cytochrome prior to oxidation of 
the substrate, leading to oxidative stress and cellular damage (Haussinger, 1996). 
 Reactive intermediates from bioactivation can interact with nucleophilic sites on tissues 
constituents, such as the sulfhydryl group of glutathione and cystein, or the amino or hydroxyl 
groups present in DNA, RNA and proteins. This covalent interaction with tissue 
macromolecules is thought to be the key factor in the toxic effects produced by xenobiotics. For 
many chemicals, these reactive intermediates can be detoxified without adverse cellular effects, 
provided that there is a balance between rates of formation and rates of detoxification. When 
this balance is disturbed, either by enhanced production of reactive intermediates or diminished 
capacity for their detoxification, formation of reactive metabolites can be associated with 
cellular injury (Sipes & Gandolfi, 1991). 
 
1.5.2.2. Drug-drug interactions 
 Phase I enzymes and in particular CYPs are particularly vulnerable to induction 
(increased expression levels) and inhibition (enzyme activity) by a variety of xenobiotics, 
including constituents of herbs (Parkinson, 1996; Zhou et al., 2003). This can lead to adverse 
drug-drug interactions. 
 Induction of CYPs would be expected to increase the activation of procarcinogens to 
DNA-reactive metabolites, leading to increase tumor formation, as well as other toxicants such 
as CCl4 and other haloalkanes (Parkinson, 1996). Therefore, hepatic injury induced by 
chemicals or natural toxins metabolically activated by drug-metabolising enzymes may occur 
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from occupational, household or environmental exposure. Inhibition of CYPs can also be 
deleterious by decreasing the clearance of toxicants in blood. 
 Additionally, the pharmacokinetic behaviour of pharmaceutical drugs can be severely 
affected due to modulation of CYPs by xenobiotics. In case of pharmaceutical drugs that need 
biotransformation to exert their effects, an inhibiton of the CYP needed for the desired reaction 
may compromise the therapeutical goal of a drug therapy. On the contrary, induction of CYP 
can increase rapidly the clearance of pharmaceutical drugs compromising its action (Parkinson, 
1996). 
 Gender and interindividual variations of CYP expression levels (Meibohm et al., 2002; 
Tamasi et al., 2003) could increase the susceptibility of different populations or individuals to 
herb-drug interaction effects. 
 
1.5.3. Liver diseases and oxidative stress 
 
 Liver injury is a common pathology, both acute and chronic, quite often characterised in 
its chronic evolution by a progressive process from steatosis to hepatocellular carcinoma, 
through chronic hepatitis, fibrosis and cirrhosis (Loguercio & Federico, 2003; Vitaglione et al., 
2004). These processes involve apoptosis, necrosis, inflammation, immune responses, ischemia, 
altered gene expression and regeneration in hepatocyte, Kupffer and endothelial cells 
(Loguercio & Federico, 2003). 
The knowledge about the molecular events that induce liver cell damage (see section 
1.6) and disease progression is continuously improving. There is increasing evidences that ROS 
and RNS (and, therefore, oxidative stress) play a crucial role in the various steps that initiate 
and regulate the progression of liver diseases, such as alcoholic liver disease, nonalcoholic 
steatohepatitis and hepatitis type C independently from the type of etiologic agents (Loguercio 
& Federico, 2003; Vitaglione et al., 2004; Tanikawa & Torimura, 2006). Oxidative stress is also 
involved in liver damage induced by alcohol abuse, viral infection, alteration of lipid and 
carbohydrate metabolism and xenobiotics (Loguercio & Federico, 2003; Vitaglione et al., 
2004). 
 Because oxidative stress plays a central role in liver diseases, the use of antioxidants 
(both natural and synthetic) have been proposed as therapeutic agents, as well as drug 
coadjuvants, to counteract liver damage (Loguercio & Federico, 2003; Vitaglione et al., 2004). 
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1.6. Biochemical and molecular mechanisms of cell injury and death 
 
 A wide range of chemicals, environmental pollutants, dietary constituents, 
pharmaceutical agents and natural products can cause hepatotoxicity in humans. The liver is 
particularly susceptible to toxic agents mainly for two reasons (Jaeschke et al., 2002): (1) after 
gastrointestinal absorption, most xenobiotics that enter the blood flow come directly to the liver 
(“first pass”) by the portal vein in a concentrated form before being distributed to other organs; 
and (2) the liver is the primary site for biotransformation, which exposes the liver to 
metabolites, some of which, as a result of bioactivation, may be more toxic than the original 
chemical. The hepatotoxic effects can then be reflected, at the organ level, in diverse liver 
lesions, such as the ones mentioned above (section 1.5.3, hepatitis, steatosis, fibrosis, cirrhosis, 
etc.) (Pessayre et al., 1999). 
 At cellular level (here, mainly hepatocyte), the different biochemical and molecular 
mechanisms of cell injury inflicted by chemicals, can, according to Kedderis (1996), be 
organised in four general categories: direct effects of toxicants, covalent binding of reactive 
metabolites, induction of oxidative stress and disruption of calcium homeostasis, as detailed 
below. It must be stressed that many of the following mechanisms can be induced 
simultaneously by one toxicant. Sometimes different mechanisms can operate at different doses 
of the toxicant. Therefore, there is not one single cause for cell damage and death (Kedderis, 
1996). 
 
1.6.1. Direct effects of toxicants 
 
 The simplest general way involved in cell damage is a direct effect of the toxicant upon 
critical cellular systems. Many organic solvents are capable of causing damage to cells by their 
direct solvent or surfactant effects on the lipid membranes (Berry et al., 1991; Kedderis, 1996). 
These effects will ultimately disrupt cellular volume homeostasis and lead to cell death. Certain 
toxicants bind to actin and disrupt cell cytoskeleton, resulting also in increase plasma membrane 
permeability (Kedderis, 1996). Various chemicals (including metal ions) bind to mithocondrial 
membranes and enzymes, disrupting energy metabolism and cellular respiration, while others 
act as direct inhibitors and uncouplers of mithochondrial electron transport. As a result, 
membrane potential can be lost increasing, therefore, plasma membrane permeability, disrupting 
calcium homeostasis and, ultimately, causing cell death (Kedderis, 1996; Castell et al., 1997). 
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1.6.2. Covalent binding of reactive metabolites 
 
 Many hepatotoxins are metabolically activated to high reactive metabolites (generally 
electron-deficient species termed electrophiles) that can covalently bind, i.e. irreversible 
binding, to cellular macromolecules such as proteins and DNA (Kedderis, 1996; Castell et al., 
1997). Because of their ability to participate in many different biotranformation reactions, CYP 
isozymes are usually involved in reactions leading to covalent binding. Electrophiles, 
intermediate radicals and conjugates can react with nucleophilic functional groups of proteins to 
form stable bonds (Castell et al., 1997). This results in protein and enzyme inactivation which 
can affect and impair critical cellular functions (Kedderis, 1996). Highly reactive electrophiles 
can also, by covalent binding, form DNA adducts which may result in somatic mutations. This 
genotoxic action may in certain circumstances result in a tumour (Kahl, 1999). 
 
1.6.3. Induction of oxidative stress 
 
 Another way by which hepatotoxins can induce liver cell damage and death is the 
generation of oxidative stress either by increasing reactive substances, such as ROS, and/or by 
decreasing cellular antioxidant defences (Kedderis, 1996; Castell et al., 1997). Some 
intermediate ROS formed by the toxicant or even reactive metabolites can initiate lipid 
peroxidation that in turn, by a cascade of reactions, form more reactive substances. Oxidative 
stress, in addition to covalent binding, also leads to a decrease in cellular glutathione levels, 
which has high implications to cell survival (Kedderis, 1996; Castell et al., 1997; Kahl, 1999). 
Cellular glutathione can decrease for several reasons (Castell et al., 1997): (1) oxidation to 
GSSG; (2) conjugation with metabolites or endogenous proteins; and (3) reduced de novo 
synthesis. Lipid peroxidation of mitochondria and depletion of glutathione levels may alter 
calcium homeostasis which induce several cellular processes that ends in cell death (Kedderis, 
1996; Castell et al., 1997; Pessayre et al., 1999). 
 
1.6.3.1. Lipid peroxidation 
 A important type of molecular lesion induced by free radicals is lipid peroxidation of 
polyunsaturated lipids (those that contain two or more carbon-carbon double bonds) of cells, 
particularly present in membranes (Berry et al., 1991; Halliwell & Gutteridge, 1999). The first 
step in this process (Initiation, Fig. 11) is the formation of lipid radicals (Halliwell & 
Gutteridge, 1999). A free radical (R˙) with enough reactivity to abstract a hydrogen atom from a 
methylene group (-CH2-) of a polyunsaturated lipid (LH) leads to a lipid radical (L˙). The 
carbon radical (-˙CH-) is usually stabilised by a molecular rearrangement to form a conjugated 
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diene. This radical quickly adds molecular oxygen to 
form a peroxyl radical (LOO˙). The peroxyl radical 
may react with another lipid molecule to form a 
hydroperoxide (LOOH) and a new lipid radical 
(Halliwell & Gutteridge, 1999; Pessayre et al., 1999; 
Spiteller, 2001). Lipid peroxidation may thus extend 
from one lipid to the other or along the same lipid 
chain (Propagation, Fig. 11). Eventually, during lipid 
peroxidation, unsaturated lipids are oxidised and cut 
into small fragments, such as alkanes, malondialdehyde 
and alkenals (Pessayre et al., 1999). By the Fenton 
reaction, metal ions may react with lipid peroxides in 
a similar way to their reaction with H2O2, producing 
the alkoxyl radical (LO˙) (Halliwell & Gutteridge, 
1999). 
 The first consequence of this process is a 
profound alteration in the physico-chemical proper-
ties of cell membranes (cytosolic, mitochondrial, 
etc.) and the loss  of membrane enzyme activities 
(Castell et al., 1997; Halliwell & Gutteridge, 1999). Lipid radicals, as well as most lipid 
degradation products, such as malondialdehyde and alkenals, are chemically very reactive and, 
if not detoxified or removed from the cell by antioxidant mechanisms, may cause additional 
cellular damage such as enzyme inactivation, protein and DNA damage (Castell et al., 1997). 
 
 
Fig. 11. Representation of the initiation and 
propagation reactions of lipid peroxidation. 
[Adapted from Halliwell & Gutteridge (1999) 
and Spiteller (2001)] 
 
1.6.3.2. Glutathione levels 
 Glutathione (γ-glutamylcysteinylglycine) is a tripeptide composed by glutamate, 
cysteine and glycine, which exists in thiol-reduced (GSH) and disulfide-oxidized (GSSG) forms 
(Kaplowitz et al., 1985; Lu, 1999). Glutathione is a fairly ubiquitous in aerobic organisms, 
found in most plants and animals, being the major low-molecular-mass thiol compound that 
generally exists in millimolar (1-12 mM) concentrations (Kaplowitz et al., 1985; Sies, 1999; 
Dringen et al., 2000). Within the cell, glutathione exists mainly (>98%) as GSH, but some is 
also present as GSSG, thioether, mercaptide or other thioester forms (GSH conjugates) 
(Hammond et al., 2001). Glutathione is synthesised in every cell of the body, but the liver is 
quantitatively the major site of synthesis (Hammond et al., 2001). Therefore, the liver is one of 
the organs with the highest content of GSH (Kaplowitz et al., 1985; Lu, 1999), hepatocytes 
containing about 10% of total body pool of GSH (Loguercio & Federico, 2003). 
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 Glutathione has important functions as antioxidant (is a strong nucleophile), in 
detoxifications reactions and as a transport and storage form of cysteine (Lu, 1999; Dringen et 
al., 2000). Because GSH is the major intracellular nonprotein thiol, it maintains the cellular 
reducing environment in cells keeping sulfhydryl groups of cytosolic proteins in the reduced 
form, which is essential for its optimal activity (Dringen et al., 2000; Hammond et al., 2001). 
Also, there is increasing evidence that glutathione has a role in control of many cellular 
processes such as signal transduction, gene expression and apoptosis (Sies, 1999; Hammond et 
al., 2001). 
 Regarding its role in cellular antioxidant defences, GSH reacts directly with radicals in 
nonenzymatic reactions and is the electron donor in the reduction of peroxides catalysed by 
GPox. GSH is regenerated from GSSG within cells in a reaction catalysed by GR, transferring 
reduction equivalents from NADPH. Glutathione can also inactivate reactive metabolites by 
conjugation via enzymatic mechanisms, reactions catalysed by GST (Reed, 1990; Castell et al., 
1997; Griffith, 1999). Thus, glutathione depletion can impair the cellular antioxidant defences, 
resulting in oxidative stress, which may lead to cell injury and death (Reed, 1990; Kedderis, 
1996; Castell et al., 1997). 
 Glutathione depletion, from excessive consumption of GSH without adequate recovery 
(when needs exceed the capacity of the liver to increase its synthesis), together with the direct 
covalent binding to protein thiols and/or the direct oxidation of protein thiols, tend to decrease 
protein thiols, which also has severe toxicological implications (Castell et al., 1997; Pessayre et 
al., 1999): 
 (1) A first consequence is the formation of disulphur bonds between different molecules 
of actin, forming inactive actin aggregates. This destroys the microfilamentous network of 
cytoskeleton allowing the formation of fragile plasma membrane blebs. 
 (2) A second consequence of the oxidation of protein thiols is to decrease the activity of 
plasma membrane calcium translocases, whose role is constantly to extrude calcium from the 
hepatocytes. It results, therefore, in an increase of cellular calcium which has several 
toxicological consequences (see below, section 1.6.4.). 
 (3) A last consequence of the oxidation of protein tiols is to permeabilise the 
mitochondrial inner membrane, decreasing membrane potential and the ability to form ATP. 
 Because the enzyme catalase is not present in mitochondria, they are totally dependent 
on GPox, and hence GSH, to detoxify hydroperoxides (Castell et al., 1997). Therefore, this and 
the latter consequence of oxidation of protein thiols, make mitochondria particularly susceptible 
to oxidative stress and xenobiotics. 
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1.6.4. Disruption of calcium homeostasis 
 
Calcium regulates a wide variety of crucial physiological functions in the cell. 
Moreover, intracellular calcium is also involved in many pathological and toxicological 
processes where it accumulates in dying cells (Kedderis, 1996; Castell et al., 1997; Halliwell & 
Gutteridge, 1999). The cellular cytosolic free Ca2+ concentration is very low (approximately 0.1 
µM) compared with the concentration of Ca2+ in extracelular fluids (1-2 mM). This gradient is 
maintained by an ATP-dependent Ca2+ extrusion translocases. Inside the cell, Ca2+ concentration 
is also controlled by active sequestration into intracellular stores, such as mitochondria and 
endoplasmatic reticulum, as well as by Ca2+-binding proteins (e.g. calmodulin) (Kedderis, 1996; 
Castell et al., 1997; Halliwell & Gutteridge, 1999). This equilibrium or calcium homeostasis can 
be altered in the course of toxic phenomena, such as by inhibitors of the several cellular calcium 
translocases. However, most toxicants act indirectly by modifying membrane properties, 
reducing the energy available, inducing lipid peroxidation of mitochondria and generalised 
oxidative stress with consequent depletion of GSH (Castell et al., 1997). 
 There are several toxicological consequences of the disruption of cellular calcium 
homeostasis that can lead to cell death (Kedderis, 1996; Castell et al., 1997; Halliwell & 
Gutteridge, 1999; Pessayre et al., 1999): 
 (1) Activation of Ca2+-dependent proteases (calpains) that cleave actin-binding proteins, 
eliminating the plasma membrane ‘anchorage’ of the cytoskeleton and, consequently, allowing 
membrane blebbing. 
 (2) Activation of Ca2+-dependent and calmodulin-dependent phospholipases, leading to 
a stimulation of arachidonate metabolism and increased plasma membrane permeability. 
 (3) Activation of Ca2+-dependent transglutaminases, which form protein aggregates 
causing irreparable damage and functionality of those proteins. 
 (4) Activation of Ca2+-dependent endonucleases, which cut DNA between nucleosomes 
resulting in extensive DNA fragmentation. 
 
1.6.5. Cell death 
 
 The end result of these various cellular and molecular mechanisms may be the death of 
the cell, either by necrosis (pathological and accidental – murder) or apoptosis (physiological 
and programmed - suicide). Among other factors, the type of cell death can depend on the 
concentration of the toxic agent. Moderate concentrations can apparently induce apoptosis, 
while higher concentrations cause cell necrosis (Castell et al., 1997; Halliwell & Gutteridge, 
1999). 
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Necrosis is caused by a rapid collapse of the cell’s internal homeostasis characterised by 
cell swelling, membrane lysis and release of cellular contents (Castell et al., 1997; Halliwell & 
Gutteridge, 1999). This is usually a consequence of the profound loss of mitochondrial function 
and resultant ATP depletion, leading to a loss of ion homeostasis and volume regulation, with 
increased influx of Ca2+. The latter activates a number of nonspecific hydrolases, like proteases, 
nucleases and phospholipases (Kaplowitz, 2002). Necrosis is accompanied by an inflammatory 
response in the surrounding tissue areas. 
Apoptosis involves cell shrinkage, chromatin condensation and nuclear disassembly as 
well as fragmentation of the cell into apoptotic bodies with intact plasma membranes. These are 
rapidly phagocytosed by neighbouring cells or macrophages (Castell et al., 1997; Halliwell & 
Gutteridge, 1999; Kaplowitz, 2002). Apoptosis is under precise genetic control, in which RNA 
and protein synthesis as well as energy (ATP) is required, and the degradation of the cell occurs 
in a much more orderly fashion than in necrosis (Kedderis, 1996; Castell et al., 1997). At the 
molecular level, apoptosis represents a collection of intricate pathways with more than 100 
different proteins actively participating in the apoptotic phenomena, such as signal transduction 
proteins and execution proteins, which results in the dismantling of the cell and inactivation of 
repair (Gosslau & Chen, 2004). The process involves the participation of specialised proteolytic 
enzymes – caspases – which contain cysteine residues at the active sites and cleave at the 
aspartate residues. Thus, specific proteins are cleaved, leading to both activation (execution 
proteins) and inactivation (repair proteins) of specific targets (Kaplowitz, 2002). There are two 
major pathways that initiate apoptosis: an extrinsic (receptor mediated) and intrinsic 
(mitochondrial mediated), which are cross-linked. In addition, mitogenic and stress responsive 
pathways are involved in the regulation of apoptotic signalling (Gosslau & Chen, 2004). 
 
 
1.7. Diabetes 
 
 Diabetes mellitus (the Latin word mellitus meaning ‘honey-sweet’, refers to the taste of 
diabetic urine) is a chronic metabolic disorder characterised by elevated blood glucose 
(hyperglycaemia) and urinary glucose excretion (Halliwell & Gutteridge, 1999). The most 
common forms of diabetes mellitus are type 1 and type 2 diabetes, which result from defects in 
insulin secretion and/or insulin action (Costacou & Mayer-Davis, 2003). Insulin-dependent 
diabetes mellitus (IDDM, or type 1), which accounts for about 10% of all cases of diabetes, 
generally occurs in young patients and is characterised by the marked inability of the pancreas 
to secrete insulin because of autoimmune destruction of the beta cells. Noninsulin-dependent 
diabetes mellitus (NIDDM, or type 2), the more prevalent form of diabetes, is characterised by a 
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combination of peripheral insulin resistance and/or a β-cell insulin-secretory defect that varies 
in severity (Poitout & Robertson, 1996; Mandel et al., 2005; Rolo & Palmeira, 2006). It 
typically occurs in individuals older than 40 years who have a family history of diabetes, but it 
is noteworthy, that the manifestation of type 2 diabetes is frequent now in younger ages 
(Jermendy, 2005; Mandel et al., 2005). 
Chronic elevation of blood glucose is the fundamental cause of diabetic complications, 
affecting multiple organs in both type 1 and type 2 diabetes. Diabetes is associated with 
accelerated atherosclerotic macrovascular disease affecting arteries that supply the heart, brain 
and lower extremities. As a result, patients with diabetes have a much higher risk of myocardial 
infarction, stroke and limb amputation. Diabetes is also associated with microvascular 
complications in the retina, glomerulus and vasa nervorum which can lead to the failure of these 
tissues/organs (Brownlee, 2001). 
The prevalence of type 2 diabetes has been increasing alarmingly worldwide. It has 
been estimated that from 1995 to the year 2025, the prevalence of diabetes will increase by 42% 
among adults living in the developed world and by 170% among adults in developing countries 
(Costacou & Mayer-Davis, 2003). An estimated 300 million people age 20 and older will have 
diabetes by the year 2025, and 366 million by the year 2030 (Costacou & Mayer-Davis, 2003; 
Jermendy, 2005; Rolo & Palmeira, 2006). 
 
1.7.1. Diabetes and the liver 
 
 The liver plays a major role in glucose homeostasis maintaining normal concentrations 
of blood glucose within a very narrow range by its ability to store glucose as glycogen and to 
produce glucose from glycogen breakdown or gluconeogenic precursors (Roden & Bernroider, 
2003; Klover & Mooney, 2004; Rolo & Palmeira, 2006). In healthy individuals, hepatocytes can 
respond, under hormonal control, to either feeding or fasting conditions by storing or producing 
glucose as necessary (Klover & Mooney, 2004). In the fasting state, the effects of glucagon 
avoid hypoglycemia by stimulating gluconeogenesis and glycogenolysis. These pathways are 
related with the hepatic glucose release to systemic circulation to fuel the function of organs and 
tissues (Roden & Bernroider, 2003; Klover & Mooney, 2004; Rolo & Palmeira, 2006). 
Postprandially, insulin prevents hyperglycaemia, in part, by suppressing hepatic 
gluconeogenesis and glycogenolysis and facilitating hepatic glycogen synthesis, in addition to 
its increasing glucose absorption in muscle and adipose tissue (Roden & Bernroider, 2003; 
Klover & Mooney, 2004). 
In type 2 diabetes, dysregulation of insulin action (insulin resistance) will have 
profound effects on hepatic glucose homeostatic pathways and circulating glucose levels. In the 
hepatocyte, glycogenolysis and gluconeogenesis are less efficiently suppressed in response to 
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insulin despite adequate circulating glucose levels (Roden & Bernroider, 2003; Klover & 
Mooney, 2004). This leads to inappropriate glucose release by the liver and results in 
hyperglycaemia which can occur both after meals and during fasting. It should be noted that 
insulin resistance also affects the skeletal muscle which is responsible for much of insulin-
dependent glucose uptake and utilisation and contributes very significantly to the 
hyperglycaemia of this disorder (Klover & Mooney, 2004). In summary, impairments in the 
insulin signal transduction pathway appear to be critical lesions contributing to insulin 
resistance and type 2 diabetes, where glucose is overproduced by the hepatocyte and is 
ineffectively metabolised by other organs (Klover & Mooney, 2004). 
Moreover, it was recently found that the hepatic glutathione is involved in the synthesis 
of a putative hormone referred to as hepatic insulin-sensitising substance (HISS) (Guarino et al., 
2003). Therefore, this recent finding supports the idea that glutathione, an important 
intracellular antioxidant, may also be essential for insulin action. 
Therefore, the liver could be seen as a potential target for the treatment of diabetes and, 
because the available medication is far from resolving this disease and its complications, plants 
are currently being used in the search for new possible drugs for its management. 
 
1.7.2. Diabetes and oxidative stress 
 
Increasing evidence in both experimental and clinical studies suggests that oxidative 
stress plays a major role in the pathogenesis of both types of diabetes mellitus (Maritim et al., 
2003; Willcox et al., 2004). Looking only to studies on the most prevalent type, type 2, the 
association between oxidative stress and diabetes is mainly of two types: diabetic patients 
relative to matched controls possess increased production of ROS (and other free radicals) 
and/or possess impaired antioxidant defences , such as plasma glutathione levels (West, 2000; 
Maritim et al., 2003; Bruce et al., 2003; Willcox et al., 2004). 
However, although a great amount of data shows a link between oxidative stress and 
diabetes, whether oxidative stress is important to the development and progression of diabetes 
and its complications is still under debate. For some authors, oxidative stress does not have a 
primary role in the pathogenesis of diabetes and diabetic complications. They argue that 
oxidative stress does not occur at an early stage in diabetes, preceding the appearance of 
complications. Oxidative stress is viewed as a merely common consequence of the tissue 
damage, reflecting the presence of complications (Baynes & Thorpe, 1999). In this regard, as 
Baynes and Thorpe (1999) said, “the treatment of diabetes with antioxidant therapy is like 
applying water to a burning house, certainly helpful in limiting the conflagration, but also a little 
late in the process”. 
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In spite of the sceptics, it is increasingly accepted that oxidative stress, generated as a 
result of hyperglycaemia, has an important role in causing the secondary complications of 
diabetes, such as atherosclerosis, nephropathy, retinopathy and neuropathy (West, 2000). Four 
main mechanisms, by which the diverse microvascular and macrovascular pathologies may 
result from hyperglycaemia, have been implicated: increased polyol pathway flux; increased 
advanced glycation end-product (AGE) formation; activation of protein kinase C (PKC) 
isoforms; and increased hexosamine pathway flux (Brownlee, 2001; Maritim et al., 2003; Rolo 
& Palmeira, 2006). Until recently, there was no unifying hypothesis linking these four 
mechanisms. This issue may now be resolved, since each of the four different pathogenic 
mechanisms could reflect a single hyperglycaemia-induced process: overproduction of 
superoxide by the mitochondrial electron transport chain (Brownlee, 2001; Rolo & Palmeira, 
2006). Mitochondria are the principal source of ROS in cells as a result from imperfectly 
coupled electron transport. Normally, only 0.1% of total oxygen consumption leaks from the 
respiratory chain to generate ROS, which can be dealt with the endogenous antioxidant system. 
Hyperglycaemia induces an increase in electron flux through the mitochondrial electron 
transport chain, which, consequently, generates higher concentrations of free radical anion 
superoxide (Brownlee, 2001; Rolo & Palmeira, 2006). This overproduction of O2˙¯ may not be 
sustained by the antioxidant system inducing, therefore, a situation of oxidative stress and 
damage. Being ROS a central player in the appearance of various secondary complications in 
diabetes, inhibition of ROS production and/or enhancement of ROS scavenging might be a 
beneficial therapy (Brownlee, 2001; Rolo & Palmeira, 2006). In this context, medicinal plants 
rich in antioxidants compounds may become, therefore, an interesting tool for the treatment of 
diabetes complications. 
 Although there is a genetic component, oxidative stress may also, for some authors, be 
an important factor in the development and progression of type 2 diabetes, at least in some 
groups at risk – for example the obese people. According to this hypothesis, oxidative stress can 
be seen as a pathogenic mechanism linking insulin resistance (the first step of the development 
of type 2 diabetes), impaired glucose tolerance (IGT) and overt diabetes (West, 2000; Ceriello 
& Motz, 2004). In predisposed subjects, the combination of excess caloric intake and reduced 
physical activity induces a state of insulin resistance, during which blood glucose is maintained 
near normal levels by compensatory hyperinsulinemia. When β-cells are no longer able to 
compensate for insulin resistance, by adequately increasing insulin production, IGT appears. 
This is characterised by excessive postprandial hyperglycemia, with fasting glucose being in 
normal range. Persistence of imbalance between caloric intake and expenditure eventually leads 
to overt diabetes, characterised by high glycaemia in any condition whether fasting or 
postprandial (Ceriello & Motz, 2004). 
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 When caloric intake exceeds the energy expenditure, an excess of mitochondrial ROS is 
also generated increasing the activity of the citric acid cycle. As a compensatory mechanism 
against ROS, cells reduce glucose transporter type-4 (GLUT4) translocation to the plasma 
membrane, resulting in resistance to insulin-stimulated glucose uptake in muscle and adipose 
tissues (Ceriello & Motz, 2004). Because β-cells are notably not dependent on insulin for 
glucose uptake, which take here place via facilitative diffusion, these cells are even more 
susceptible to overfeeding. In addition, β-cells are particularly sensitive to ROS because they 
have low levels of antioxidant defences. Therefore, is not surprising that oxidative stress can 
markedly impair insulin secretion of β-cell during increased glucose metabolism (Ceriello & 
Motz, 2004). The increase of insulin resistance and/or the decrease in compensatory insulin 
secretory response can lead to the appearance of IGT. Repeated exposure to hyperglycemia may 
lead to β-cell dysfunction that may become irreversible over time. This in association with the 
dysregulation of insulin action in hepatocytes and peripheral tissues leads to overt diabetes 
(Ceriello & Motz, 2004). 
Concluding, in accordance with this last hypothesis and the overall oxidative stress 
involved in complications of diabetes, the antioxidant therapy, also based in natural compounds, 
can be seen as a good possible development to oppose the increasing epidemic of diabetes, a 
real emergency in our future. 
The lower antioxidant defences of diabetic patients make them, in addition, more 
vulnerable to other related diseases where oxidative stress is involved, such as cardiovascular 
diseases. 
 
1.7.3. Diabetes as a preventable disease 
 
The prevalence of type 2 diabetes is increasing worldwide due to a combination of 
different factors: increasing lifespan, sedentary lifestyle, excessive intake of high energy foods, 
increasing prevalence of overweight/obese people (Lai, 2002). Taking into consideration the 
increasing prevalence of type 2 diabetes and the high costs involved in its treatment, the primary 
prevention of this disease arises as an important issue (Lai, 2002; Costacou & Mayer-Davis, 
2003; Jermendy, 2005). 
Before the establishment of the disease, those individuals more at risk of developing 
type 2 diabetes present the first signs of abnormal glucose metabolism such as IGT and/or 
impaired fasting glucose (Simpson et al., 2003). This provides an asymptomatic period at the 
beginning of the progression of diabetes, where preventive interventions can be applied. There 
is now substantial evidence that type 2 diabetes could be considered as a preventable disease 
through changes in lifestyle that include, among others, dietary factors (Costacou & Mayer-
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Davis, 2003; Simpson et al., 2003; Jermendy, 2005). However, the difficulty in maintaining 
lifestyle changes over the long term justifies the need for pharmacotherapeutic support, and 
recent studies have shown beneficial effects of metformin and acarbose in the retardation of the 
progression from IGT to type 2 diabetes (Simpson et al., 2003). However, any pharmacological 
intervention in an asymptomatic population raises ethical considerations in addition to practical 
and economic issues. Dietary supplements with plasma glucose lowering properties could 
provide a culturally acceptable and economically viable alternative to pharmaceutical 
interventions at this stage. Plant extracts or natural compounds can easily be used as functional 
foods or food supplements and could have a beneficial impact in low cost prevention strategies 
of diabetes. In fact, some epidemiological evidences and recent studies of hypoglycaemic 
effects of plant extracts and polyphenols provide a promising future to the use of plant products 
in the prevention of diabetes (Costacou & Mayer-Davis, 2003; Scalbert et al., 2005; Mandel et 
al., 2005). 
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2.1. Chapter overview 
 
 Sage essential oil is widely used in the food, drug, beverage, cosmetic and fragrance 
industries. Previous experiments performed by Farag et al. (1989)1 showed a relatively weak 
antioxidant activity of sage EO. The authors measured the antioxidant activity of sage EO in a 
linoleic acid emulsion system. This antioxidant activity was then related to the ability of EO to 
inhibit rancidity in food materials, i.e. to act as food preservatives1. But, how can this 
antioxidant activity of sage EO be also observed in cells? To answer this question, the effect of 
EO was tested in vitro using freshly isolated rat hepatocytes. The use of hepatocytes, which are 
highly metabolic cells, is valuable also to verify potential toxic effects of sage EO. Sage EO has 
already some limitations in its use due to its known neurotoxic and convulsant effects, mainly 
related to the content in α-thujone and camphor2. However, the toxic as well as 
protective/antioxidant effects of sage EO to the liver was, to our knowledge, never been 
investigated. 
 When hepatocytes were exposed to t-BHP, sage EO was not able to protect cells from 
damage and, therefore, did not show antioxidant effects in this type of cell assays. However, 
although sage EO did not possess direct antioxidant effects in hepatocytes, there is still the 
possibility that these low molecular weight compounds have the ability to modulate certain 
proteins or cell signalling processes, such as the ones related to the antioxidant or detoxifying 
systems of cells (see chapter 3). 
 At reasonable concentrations, as the ones when EO is used as food supplement, sage EO 
did not show toxic effects to rat hepatocytes. However, at the concentration of 2 µl EO/ml 
significant hepatocyte cell death was observed. Interestingly, the toxic effect of the mixture of 
tens of compounds, present in sage EO, was not mediated by lipid peroxidation. This is in 
agreement with the effects of sage EO in inhibiting rancidity in food products. A significant 
decrease in GSH content was observed by sage EO. Because there was no significant increase in 
GSSG levels, depletion in GSH was most likely via conjugation reactions with some 
constituents (possibly terpenes and/or their metabolites) with electrophilic properties. The 
significant GSH depletion induced by sage EO provides an explanation for the toxic effects 
observed for higher concentrations in liver cells. Taking into account the hydrophobic properties 
of the EO, its direct solvent effect on cellular membranes can not be ruled out as a contributing 
factor for cell death. 
Our results did not indicate any antioxidant effects of S. officinalis EO on rat 
 
1 Cuppett SL & Hall CA, 1998. Antioxidant activity of the Labiatae. In: Advances in Food and Nutrition Research, 
Academic Press, London, pp. 245-271. 
2 Millet Y, Jouglard J, Steinmetz MD, Tognetti P, Joanny P & Arditti J, 1981. Toxicity of some essential plant oils. 
Clinical and experimental study. Clinical Toxicology 18, 1485-1498.
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hepatocytes, probably because of its poor concentration in monoterpenes with a hydroxyl group 
on an aromatic ring (e.g. eugenol and borneol) or with an ethylidene group (e.g. linalool)1. 
In conclusion, at doses higher than 200 nl/ml, acting directly on the liver, the EO may 
cause toxicity. The neurotoxicity of thujones and camphor, which are the major compounds of 
S. officinalis EO, as well as the hepatotoxicity of sage EO reported herein, justify some concern 
with the consumption of high doses of sage products containing EO. 
 
 
2.2. Methods 
 
 The following experimental protocols (see Appendix) were used in this chapter: 
• P1: Biological Models – Rat Hepatocyte Isolation and Use   
• P4: Cell Viability Assays – LDH Leakage 
• P6:  Cell viability Assays – Trypan Blue Staining 
• P7: Metabolite Measurements – TBARS (Lipid Peroxidation) 
• P8: Metabolite Measurements – Glutathione Levels 
• P10: Metabolite Measurements – Total Protein 
  
 
2.3. Publication 
 
 This chapter comprises the following publication: 
Lima CF, Carvalho F, Fernandes E, Bastos M, Santos-Gomes P, Fernandes-Ferreira M & 
Pereira-Wilson C, 2004. Evaluation of toxic/protective effects of the essential oil of Salvia 
officinalis on freshly isolated rat hepatocytes. Toxicology in Vitro 18(4), 457-465.  
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Abstract 
For this study the essential oil (EO) of sage (Salvia officinalis L.) was isolated from air-dried vegetative aerial parts of the plants 
by hydrodistillation and analysed by GC and GC-MS. A total yield of 12.07 mg of EO per g of plant dry mass was obtained and 
more than 50 compounds identified.  The major compounds were cis-thujone (17.4%), α-humulene (13.3%), 1,8-cineole (12.7%), E-
caryophyllene (8.5%) and borneol (8.3%). The EO fraction of sage tea was also isolated by partition with pentane and the respective 
components identified. The toxic and antioxidant protective effects of S. officinalis EO were evaluated on freshly isolated rat 
hepatocytes. Cell viability (LDH leakage), lipid peroxidation and glutathione status were measured in experiments undertaken with 
cells (suspensions of 1 × 106 cells per millilitre) exposed to EO alone (toxicity of the EO; t-BHP as positive control); and with cells 
exposed to EO and an oxidative compound (t-BHP) together (in EO protection evaluation; quercetin as positive control) for 30 min. 
The results show that the EO is not toxic when present at concentrations below 200 nl/ml; it was only at 2000 nl EO/ml that a 
significant LDH leakage and GSH decrease were observed indicating cell damage. In the range of concentrations tested, the EO did 
not show protective effects against t-BHP-induced toxicity. 
 
Keywords:  Salvia officinalis; Sage; Essential oil; Toxic effects; Antioxidant effects; Hepatoprotective effects; Hepatocytes. 
1. Introduction Recently several authors reported the antioxidant 
properties of sage and some of its constituents, mainly 
phenolic compounds such as carnosic, rosmarinic, caf-
feic and salvianolic acids as well as other phenolic 
structure-based compounds (Cuvelier et al., 1994; 
Hohmann et al., 1999; Lu and Foo, 2001; Wang et al., 
1998; Zupko et al., 2001). Sage is, therefore, one of the 
favourite candidate species as a source of natural an-
tioxidants in health care products. The essentaial oils 
(EOs) of some other plants have also been shown  
to have antioxidant and hepatoprotective activities 
(Cuppett and Hall, 1998; Teissedre and Waterhouse, 
2000), although the potentially hepatoprotective effects 
of sage EO have, to our knowledge, not been investi-
gated. However, potentially toxic effects of sage EO 
especially to the liver – the main detoxifying organ – 
may also exist and place limitations on the use of sage.  
 
Sage (Salvia officinalis L.) enjoys the reputation of 
being a panacea because of its wide range of medicinal 
effects: it has been used as an antihydrotic, spasmolytic, 
antiseptic and anti-inflammatory and in the treatment of 
mental and nervous conditions (Baricevic and Bartol, 
2000). Sage is also used traditionally in food prepara-
tion. 
 
 
 
Abbreviations: DMSO – dimethyl sulfoxide; EO – essential oil; GC – 
gas chromatography; GC-MS – GC coupled to mass spectrometry; GSH 
– reduced glutathione; GSSG – oxidised glutathione; GSx – total 
glutathione; LDH – Lactate dehydrogenase; TBARS – thiobarbituric 
acid reactive substances; t-BHP – tert-butyl hydroperoxide 
 
 Sage EO is a complex mixture of tens of volatile 
compounds including monoterpenes, sesquiterpenes and 
diterpenes. Importantly, the EO contributes the unique 
1 Present address: REQUIMTE, Department of Physical-Chemis-  
try, Faculty of Pharmacy, University of Porto, 4050-047 Porto,  
Portugal. 
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flavour of sage and justifies the use of sage as a food 
condiment. Although some data already exist relating to 
the toxicity or antioxidant properties of some individual 
compounds (such as thujone and eugenol, respectively) 
(Cuppett and Hall, 1998; Millet et al., 1981), to assess 
the effects of the complex mixture of EO as it reaches 
the consumer remains the best way to predict and 
prevent possible deleterious effects of its use.  
boiling water onto 2 g of the same dried plant material 
and allowing to steep for 5 min. The EO constituents of 
the tea were extracted, at room temperature, with 5 ml 
of n-pentane containing 5α-cholestane (1mg/ml). 
 
2.4. Analysis conditions of essential oils and procedures 
 
The samples of the EOs and EO constituents from tea 
containing the internal standard 5α-cholestane were 
analyzed by GC and GC-MS. GC analyses were per-
formed using a Perkin-Elmer Autosystem gas chro-
matograph equipped with a fused silica DB5 column (30 
m long × 0.25 mm i.d., 0.25 μm film thickness compo-
sed by 5% phenyl methylpolysiloxane, J & W Scienti-
fic). Injections were performed in a split/spliless injector 
with the splitter opened at the 1:13 split ratio under a 
column head pressure of 12.5 psi and H
The present study aims to evaluate the toxic versus 
antioxidant protective activities of the EO from S. offi-
cinalis on freshly isolated rat hepatocytes. As specific 
objectives the experiments had in view (a) to test whe-
ther the use of the S. officinalis EO of known composi-
tion has any adverse effects on the liver, and (b) test for 
any antioxidant effects of sage EO on liver cells chal-
lenged with an oxidizing agent (tert-butyl hydropero-
xide – t-BHP) and compare it to the effects of the 
reference antioxidant quercetin. 
2 as carrier gas at 
a flow rate of 1.49 ml/min. Oven temperature was pro-
grammed from 60 to 285 ºC at 3 ºC min-1 . Injector and 
detector temperatures were 300 and 320ºC, respectively. 
The same column and conditions were used in the 
analysis performed with the GC-MS with the exception 
of the carrier gas which was helium instead of H
 
2. Materials and methods 
 
2.1. Chemicals 2. The 
GC-MS consisted of a Perkin-Elmer 8500 gas chro-
matograph equipped with a fused silica DB5 column, the 
same as that for GC, connected to a Finnigan MAT ion 
trap detector (ITD; software version 4.1) operating in EI 
mode at 70 eV. Identification of the chromatogram 
peaks as well as quantification of the compounds was 
performed following the methodology previously des-
cribed (Santos-Gomes and Fernandes-Ferreira, 2001). 
 
All reagents were of analytical grade. The following 
reagents were obtained from Sigma (St. Louis, MO, 
USA): collagenase (grade IV), tert-butyl hydroperoxide 
(t-BHP), bovine serum albumin, HEPES (N-[2-hy-
droxyethyl]piperazine-N’-[2-ethane-sulfonic acid]), re-
duced glutathione (GSH), oxidised glutathione (GSSG), 
glutathione reductase (EC 1.6.4.2.), 5,5’-dithio-bis-(2-
nitrobenzoic acid) (DTNB), β-nicotinamide adenine 
dinucleotide phosphate reduced form (β-NADPH), β-
nicotinamide adenine dinucleotide reduced form (β-
NADH), quercetin and 2-thiobarbituric acid (TBA). 
 
2.5. Animals 
 
Adult male Wistar rats, weighing 200-250 g, were 
used as hepatocyte donors. The rats were kept in poly-
ethylene cages lined with wood shavings, with wire 
mesh top and acclimated to ambient temperature (20 ± 2 
ºC) and humidity and natural light/dark cycle. The 
animals had free access to standard rat chow and tap 
drinking water, and were kept in our facilities for at least 
2 weeks prior to use. 
 
2.2. Plant material and isolation of the essential oil 
 
The EO used in this study was obtained by hydro-
distillation of 226 g of air-dried vegetative aerial parts of 
S. officinalis plants cultivated in an experimental farm 
located in Arouca, Portugal, and collected on April, 
2001. The absolute quantification of each compound 
was tentatively achieved by GC using 5α-cholestane as 
an internal standard. For this purpose, sub-samples of 10 
g from the same plant material were sub-mitted to 
hydrodistillation in a Clevenger type apparatus over 1 h, 
using volumes of 1.0 ml of n-hexane, contain-ning 5α-
cholestane (1mg/ml), for retention of the hydrodistillate 
components. 
  
2.6. Hepatocyte isolation and incubation 
 
Hepatocyte isolation was performed between 10.00 
am and 11.00 am by collagenase perfusion of the liver as 
previously described (Moldeus et al., 1978) with some 
modifications. In brief, the liver was perfused in situ via 
the portal vein with a calcium-free Hank’s solution with 
0.67% albumin and 12.5 mM HEPES (pH 7.4) at 37 ºC 
at a flow rate of 10 ml/min, then with a Hank’s solution 
with 12.5 mM HEPES containing 0.025 % collagenase 
and 0.44% (w/v) CaCl
 
2.3. Preparation of sage tea and isolation of the 
essential oil constituents 
2 at the same flow rate and tem-
perature for 10 min. The cells were dispersed in Ca2+Considering that sage is traditionally used as a tea, an 
infusion of sage was prepared by pouring 150 ml of 
-
free Hank’s solution with 0.67% albumin and 12.5 mM 
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HEPES and washed by low speed centrifugation (50×g) 
for 2 min. The cells were then ressuspended in Krebs-
Henseleit solution with 12.5 mM HEPES and washed 
two more times. The hepatocytes viability was >80% as 
estimated by trypan blue exclusion. 
curve. The final concentrations of the assay reagents 
were 0.6 mM DTNB, 0.21 mM NADPH and 2 U/ml 
glutathione reductase. For the GSSG determination,  
100 μl of supernatant was derivatized with 2 μl of 2- 
vinylpyridine and 10 μl of 50% (v/v) ethanolamide and 
mixed continuously for 60 min. GSSG was then mea-
sured as described above for total glutathione. The GSH 
content was calculated by subtracting GSSG content 
from the total glutathione content. 
Incubations were performed at 37 ºC in suspensions 
of 106 viable cells per milliliter in Krebs-Henseleit 
solution with 12.5 mM HEPES (pH 7.4) gassed with 
carbogen (95% O2 and 5% CO2). The hepatocytes were 
always pre-incubated for 60 min at 37 ºC before the 
beginning of the experiments. Both toxic and protective 
effects of S. officinalis EO were tested on hepatocyte 
suspensions. In toxicity experiments the cells were 
incubated with 10 μl/ml of EO dissolved in DMSO at 
final concentrations of 0, 2, 20, 200 and 2000 nl/ml cell 
suspension for 30 min. tert-Butyl hydroperoxide (t-
BHP) 0.75 mM was used as a positive control for cell 
damage. In hepatoprotective experiments 10 μl/ml of 
EO dissolved in DMSO at final concentrations of 0, 2, 
20, 200 and 2000 nl/ml were added to the cell suspen-
sions 5 min before the addition of t-BHP 0.75 mM and 
allowed to incubate simultaneously for 30 minutes. The 
reference antioxidant quercetin was used as positive 
control in the protective experiments. The cells were in-
cubated with 10 μl/ml of quercetin dissolved in DMSO 
at final concentrations of 0, 1.6, 12.5, 50 and 200 μM for 
5 min before addition of t-BHP 0.75 mM for 30 min. At 
the end of experiments, aliquots of cell suspensions were 
taken for measurement of lactate dehydrogenase (LDH) 
leakage, malondialdehyde, GSH and GSSG contents. 
 
2.8. Statistical analysis 
 
Data are expressed as means ± SEM (n = 5) (cells 
obtained from 5 different rats). Significant differences 
between control and t-BHP treated cells were deter-
mined by Student’s t-test. Significant differences within 
EO series (EO toxic and protective evaluation) were 
determined by one-way ANOVA followed by Dunnett’s 
test. Differences were considered significant when 
P≤0.05. 
 
 
3. Results 
 
3.1. Essential oil and essential oil constituents of tea 
from S. officinalis leaves 
 
The yield of the EO obtained by hydrodistillation of 
air-dried sage aerial parts was 13.3 μl per gram of bio-
mass dry weight, corresponding to 1.2% (w/w). The 
composition of the S. officinalis EO used in the experi-
ments here reported is shown in Table 1, where com-
pounds are listed according to their Kovats retention 
indexes. The EO includes around 60 compounds most of 
which were identified (Santos-Gomes and Fernandes-
Ferreira, 2001). Around 88% of the compounds can be 
distributed into three terpene groups: oxygen-containing 
monoterpenes (47.7%), sesquiterpene hydrocarbons 
(24.5%), and monoterpene hydrocarbons (15.9%). The 
major compounds were cis-thujone (17.4%), α-humu-
lene (13.3%), 1,8-cineole (12.7%), E-caryophyllene 
(8.5%) and borneol (8.3%). 
2.7. Analytical procedures 
 
Cell death was estimated by quantification of LDH 
activity in the incubation medium versus total LDH 
activity in the samples (the results are shown as per-
centages of control cell viability). The enzyme activity 
was measured at room temperature by quantification of 
NADH by continuous spectrophotometry (at 340 nm) 
on a plate reader (Spectra Max 340pc, Molecular 
Devices). 
The extent of lipid peroxidation was determined 
indirectly by the malondialdehyde formation after the 
breakdown of polyunsaturated fatty acids, measured by 
the thiobarbituric acid reactive substances (TBARS) 
assay at 535 nm as described previously (Fernandes  
et al., 1995). 
In the preparation of the tea only 2.99% of total EO 
content was extracted from the biomass and found in the 
water giving a final concentration of 4.81 μg of EO per 
ml of tea (Table 1). However, the presence of the indi-
vidual essential oil constituents in tea was not propor-
tional to their specific amount in the oil extracted by 
hydrodistillation. From the approximate 60 compounds 
detected in the EO of S. officinalis only 25 were found 
as EO constituents of the respective tea (Table 1). 
Oxygen-containing monoterpenes corresponded to 86% 
of the tea EO constituents. The sum of cis-thujone and 
camphor concentrations (1.68 and 0.51 μg.ml
The glutathione content of cell suspensions was 
determined by the DTNB-GSSG reductase recycling 
assay as described in Anderson (1985), with some 
modifications. Briefly, 200 μl of cell suspension was 
added to 200 μl of 10% (w/v) 5-sulfosalicylic acid for 
protein precipitation and centrifuged 2 min at 12,000 
rpm. Supernatant aliquots were taken out for measure-
ment of total glutathione (GSx) following the DTNB 
oxidation at 415 nm and compared with a standard  
-1, 
respectively) corresponded to almost 45% of all the 
constituents (Table 1). With respect to the composition  
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Table 1 
Composition of the EO and EO constituents of tea prepared from vegetative aerial parts of S. officinalis L. plants collected in April, before anthesis 
Compound RIa EO from S. officinalis EO constituents from S. officinalis tea 
  % μg/g dry wt  % μg/g dry wt μg/ml of tea 
1-Butyl acetate   813 trb 2.1  - - - 
cis-2-Methyl-3-methylene-hep-5-ene   847 0.7 68.1  - - - 
trans-2-Methyl-3-methylene-hep-5-ene   857 0.1 7.6  2.1 5.2 0.069 
Tricyclene   920 0.1 11.3  - - - 
α-Thujene   924 0.1 8.9  - - - 
α-Pinene   930 4.1 399.1  tr 0.3 0.005 
Camphene   946 3.1 298.4  tr 0.4 0.006 
Sabinene   970 0.1 6.3  - - - 
β-Pinene   974 4.5 437.0  tr 0.5 0.007 
Myrcene   988 0.5 48.0  - - - 
n-Decane 1000 tr 1.3  - - - 
α-Phellandrene 1004 0.1 5.5  - - - 
α-Terpinene 1016 0.2 18.9  - - - 
p-Cymene 1022 0.1 13.7  - - - 
Limonene 1024 1.5 142.4  - - - 
1,8-Cineole 1033 12.7 1703.9  18.1 66.3 0.884 
Z-β-Ocimene 1034 0.3 26.5  - - - 
E-β-Ocimene 1044 0.4 39.2  - - - 
γ-Terpinene 1055 0.1 4.4  - - - 
cis-Linalool oxide 1072 0.1 6.7  - - - 
Terpinolene 1086 0.2 15.7  - - - 
n-Undecane 1100 tr 0.8  1.1 2.7 0.036 
Linalool 1101 tr tr   - - - 
cis-Thujone [= (-)-thujone] 1103 17.4 2491.4  34.0 125.9 1.678 
trans-Thujone [=(+)-thujone] 1114 3.9 518.5  5.3 20.1 0.268 
α-Campholenal 1125 0.1 13.5  - - - 
Not identified 1129 0.2 29.9  tr 0.9 0.013 
Camphor 1143 3.3 445.4  10.6 38.4 0.512 
cis-Pinocamphone [= (cis-3-)-Pinanone] 1160 0.7 97.8  1.1 4.3 0.057 
Borneol 1165 8.3 1109.5  13.8 52.3 0.697 
Pinocamphone isomer (T) 1172 0.2 30.3  1.1 2.0 0.027 
4-Terpineol 1176 0.2 25.6  tr 1.2 0.016 
α-Terpineol 1189 0.3 32.7  - - - 
Not identified 1201 0.3 43.0  2.1 9.2 0.123 
Bornyl acetate 1283 0.9 127.9  tr 1.3 0.017 
cis-Sabinyl acetate 1290 0.1 9.8  - - - 
Not identified 1322 0.3 47.2  - - - 
Not identified 1328 0.1 11.3  - - - 
δ-Elemene 1334 0.1 8.8  - - - 
trans-Carvyl acetate 1337 tr 0.5  - - - 
cis-Carvyl acetate 1362 0.1 18.5  - - - 
Neryl acetate 1364 0.3 38.8  - - - 
β-Bourbonene + Geranyl acetate 1383+1384 0.1 10.8  - - - 
Ε-Caryophyllene 1416 8.5 836.9  tr 1.0 0.014 
Aromadendrene or -Guaiene (?) 1436 0.8 82.2  - - - 
α-Humulene 1450 13.3 1305.7  1.1 1.6 0.022 
allo-Aromadendrene 1458 0.1 13.2  - - - 
Germacrene D isomer #3 1473 0.5 46.5  - - - 
Germacrene D 1477 0.1 4.6  - - - 
α-Selinene 1491 0.5 49.4  1.1 2.0 0.026 
δ-Cadinene 1520 0.6 62.9  - - - 
Caryophyllene oxide 1580 0.5 65.9  1.1 3.2 0.043 
Viridiflorol 1595 6.2 834.0  tr 1.4 0.019 
Widdrol (?) 1606 0.7 96.4  - - - 
Z-α-trans-Bergamatol acetate 1801 0.1 8.9  - - - 
Not identified 1903 tr 4.1  1.1 2.4 0.032 
Manool 2063 2.4 248.7  1.1 1.8 0.024 
n-Hexacosane 2600 tr 1.1  3.2 9.9 0.132 
n-Octacosane 2800 tr 2.6  2.1 6.5 0.087 
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Table 1 (continued) 
a EO from S. officinalis EO constituents from S. officinalis tea Compound RI
 %  % μg/g dry wt μg/g dry wt μg/ml of tea  
Grouped components        
Monoterpene hydrocarbons  15.9 1553.8  2.1 6.5 0.086 
Oxygen-containing monoterpenes  47.7 6565.5  86.2 320.6 4.274 
Monoterpenyl esters  1.8 243.7  0.0 1.3 0.017 
Sesquiterpene hydrocarbons  24.5 2410.2  2.1 4.6 0.062 
 Oxygen-containing sesquiterpenes  7.4 996.4 1.1 4.6 0.062 
 Sesquiterpenyl esters tr 8.9  - - - 
Oxygen-containing diterpenes  2.4 248.7  1.1 1.8 0.024 
Others  0.3 38.3  7.4 21.5 0.286 
        
Total  100.0  12065.4  100.0 360.8 4.810 
a    Kovats retention index relatively to n-alkanes in a DB-5 column. 
b tr, trace amounts (< 0.05).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of EO present in tea it is not surprising that oxygen-
containing monoterpenes, such as cis-thujone and 
camphor, are proportionately more abundant in tea  
than other EO constituents in view of the higher solu-
bility in water of this group of compounds relatively to 
the other ones.  
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Surprisingly, the values of the specific contents of 
the alkanes n-undecane, n-hexacosane and n-octacosane 
determined in the tea were higher than the correspon-
ding values determined in the EO (Table 1) obtained by 
hydrodistillation. The respective loss during hydroids-
tillation is a possibility that can not be ruled out. 
 
3.2. EO toxicity experiments 
 
EO toxicity was tested in hepatocyte suspensions ex-
posed to the EO (0-2000 nl/ml) and compared to that of 
t-BHP (0.75 mM). Cell viability measured by LDH 
leakage of rat hepatocytes (Fig. 1) did not change signi-
ficantly after 30 min incubation with 0 – 200 nl of EO 
per ml of cell suspension. However, 2000 nl/ml (0.2% 
(v/v)) caused a significant decrease in cell viability. 
Lipid peroxidation (Table 2) did not change after the in-
cubations with different concentrations of EO. Total glu-
tathione (GSx) (Table 2) was significantly lowered by 
incubation with the highest oil concentration tested 
(2000 nl/ml) but not by any of the other concentrations. 
Fig. 1. Effect of EO of S. officinalis on cell viability (measured by % of 
LDH leakage) in hepatocyte suspensions after 30 min of exposure 
(means ± SEM). n=5; # P≤0.05 between control and t-BHP treated  
cells; * P≤0.05 when compared with control cells. 
This decrease in GSx was accompanied by a decrease in 
GSH (Fig. 2), where incubations with 200 nl EO/ml also 
produced a significant decrease in GSH when compared 
to the control. There were no significant changes in 
GSSG content (Table 2) produced by incubation of the 
cells with the EO. 
 
 
Table 2 
Effect of 30 min exposure of hepatocyte suspensions to S. officinalis EO on GSSG and GSx content and on lipid peroxidation expressed as TBARS 
formation (means ± SEM) 
Parameter Sample 
t-BHP (0.75 mM)  EO (nl/ml) 
  0 (contr) 2 20 200 2000 
TBARS (nmol/million cells)   1.99 ± 0.16 #   0.94 ± 0.12   0.89 ± 0.11   0.87 ± 0.09   0.79 ± 0.14   0.89 ± 0.12 
35.2 ± 1.7 #GSx content (nmol/million cells) 45.1 ± 3.5 43.9 ± 4.2 43.4 ± 3.2 39.7 ± 4.1 28.4 ± 3.3 * 
GSSG content (nmol/million cells) 13.1 ± 1.6   9.2 ± 0.9   9.5 ± 0.8   9.8 ± 0.9 10.1 ± 1.7 10.2 ± 2.0 
n = 5. 
# P≤0.05 between control and t-BHP treated cells. 
* P≤0.05 when compared with control cells. 
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Fig. 2. Effect of EO of S. officinalis on hepatocyte suspensions GSH 
content after 30 min of exposure (means ± SEM). n=5; # P≤0.05  
between control and t-BHP treated cells; * P≤0.05 when compared  
with control cells. 
Fig. 3. Effect of EO of S. officinalis and quercetin (inset) on cell via-
bility (measured by % of LDH leakage) of hepatocyte suspensions 
damaged by t-BHP (0.75 mM) for 30 min (means ± SEM). n=5;  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The incubations of hepatocyte suspensions with the 
positive control 0.75 mM t-BHP for 30 min resulted in 
significant decreases in cell viability (Fig. 1), GSH (Fig. 
2) as well as GSx content and an increase in lipid pero-
xidation (Table 2). We also observed a perceptible in-
crease of GSSG content (P = 0.0556) with this toxicant. 
# P≤0.05 between control and cells treated only with t-BHP; * P≤0.05 
when compared with cells treated only with t-BHP. 
nl/ml) and t-BHP (0.75 mM) and the protective effects 
of the oil compared to those of quercetin.  
3.3. EO protection experiments The addition of 0.75 mM t-BHP to hepatocytes re-
sulted in significant cell death after 30 min was evident 
from LDH leakage (Fig 3). EO in the concentrations of 
2-2000 nl/ml did not reduce cell mortality. Quercetin, on 
Hepatoprotection of the EO was tested in hepatocyte 
suspensions exposed simultaneously to the EO (0-2000
 
Table 3 
Anti-hepatotoxic effect of quercetin (positive control) on hepatocyte suspensions damaged by t-BHP (0.75 mM) for 30 min, on GSSG and GSx   
content and on lipid peroxidation expressed as TBARS formation (means ± SEM) 
Parameter Sample 
 (-) Control t-BHP (0.75 mM) + EO (nl/ml) series 
  0 2 20 200 2000 
TBARS (nmol/million cells)   0.92 ± 0.09   2.08 ± 0.13 #   2.14 ± 0.23   2.20 ± 0.20   2.22 ± 0.30   2.88 ± 0.59 
GSx content (nmol/million cells) 44.6 ± 4.9 35.9 ± 2.2 31.1 ± 3.0 33.4 ± 2.6 29.4 ± 2.6 22.5 ± 3.3 
GSSG content (nmol/million cells) 10.5 ± 1.1 13.5 ± 1.9 12.7 ± 2.1 12.6 ± 1.8 11.7 ± 1.8 10.6 ± 1.8 
n = 5. 
# P≤0.05 between control and cells treated only with t-BHP. 
 
Table 4 
Anti-hepatotoxic effect of quercetin (positive control) on hepatocyte suspensions damaged by t-BHP (0.75 mM) for 30 min, on GSSG and GSx   
content and on lipid peroxidation expressed as TBARS formation (means ± SEM) 
Parameter Sample 
 (-) Control t-BHP (0.75 mM) + quercetin (μM) series 
  0 1.6 12.5 50 200 
TBARS (nmol/million cells)   0.92 ± 0.09   2.08 ± 0.13 #   2.09 ± 0.24   1.35 ± 0.15 *   0.72 ± 0.04 *   0.79 ± 0.10 * 
GSx content (nmol/million cells) 44.6 ± 4.9 35.9 ± 2.2 37.7 ± 1.9 37.0 ± 1.8 35.2 ± 1.0 31.9 ± 3.2 
GSSG content (nmol/million cells) 10.5 ± 1.1 13.5 ± 1.9 13.8 ± 1.9 12.7 ± 2.1 11.2 ± 1.8   8.7 ± 1.2 
n = 5. 
# P≤0.05 between control and cells treated only with t-BHP. 
* P≤0.05 when compared with cells treated only with t-BHP. 
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damage which causes progressive deterioration of ma-
cromolecules, cell structure and may lead to cell death. 
GSH level could therefore determine the cytotoxicity  
of a xenobiotic and its ultimate effects on cell survival. 
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Our data shows that sage EO was not toxic to rat 
hepatocyte suspensions when present in concentrations 
below 200 nl/ml for 30 min; it was only at 2000 nl of 
EO per ml of hepatocyte suspension that a significant 
LDH leakage and GSH decrease occurred indicating cell 
damage. cis-Thujone,  the major constituent of sage EO 
(17.4%, see Table 1), has been shown to be neurotoxic 
and implicated in the effects of absinth consumption 
(Hold et al., 2000, 2001). Results by Bonkovsky and co-
workers (Bonkovsky et al., 1992) and our own pre-
liminary data (not shown) indicates that cis-thujone in 
concentrations below 1 mM (960 nl EO/ml) does not 
decrease hepatocyte viability and seem therefore not to 
be toxic to the liver. Judging by thujone toxicity alone 
we would not expected toxicity to the liver of EO con-
centrations below 200 nl/ml. However, a decrease in 
hepatocyte GSH was apparent at this EO concentration 
indicating some degree of toxicity. This emphasises the 
need for the evaluation of the toxicity of the actual 
EO – a mixture of compounds – since the toxicity of the 
mixture can not in all cases be inferred from the toxicity 
of its individual compounds. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4. Effect of EO of S. officinalis and quercetin (inset) on GSH 
content of hepatocyte suspensions damaged by t-BHP (0.75 mM) for  
30 min (means ± SEM). n=5; # P≤0.05 between control and cells  
treated only with t-BHP. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the other hand, significantly reduced LDH leakage at 
200 μM. Lipid peroxidation induced by t-BHP (Table 4) 
was also significantly reduced by co-incubation with 
quercetin whereas the EO had no protective effects at 
any of the concentrations tested (Table 3). Addition of 
t-BHP significantly reduced cell GSH content but no 
protective effects on the glutathione balance could be 
detected for quercetin or the EO (Fig 4). Co-incubation 
of t-BHP with 2000 nl/ml EO seems to further decrease 
the GSH levels in the cells. 
The toxicity induced by t-BHP is well-known and is 
well characterized (Fernandes et al., 1995; Joyeux et al., 
1990; Tseng et al., 1997) and our results are in agree-
ment with these published reports. Our data also show 
that when compared with t-BHP-induced toxicity, which 
is the result of GSx and GSH depletion, GSSG increase 
and lipid peroxidation, cell death induced by the EO at 
2000 nl/ml on liver cells does not seem to be mediated 
by lipid peroxidation and GSH oxidation with concomi-
tant GSSG increase. The EO toxicity may be due to the 
presence of reactive compounds and/or reactive metabo-
lites generated by metabolism of EO. The depleted 
glutathione was possibly recruited to act as a nucleo-
philic scavenger of some compounds and/or their 
metabolites with electrophilic properties. The cellular 
death indicated by LDH leakage could also be due to a 
solvent effect of the EO, whereby the  hydrophobic 
compounds exert a direct effect on cellular membranes 
disturbing the physico-chemical properties of the bilayer 
culminating in the disruption of cellular volume and 
cell death (Berry et al., 1991; Kedderis, 1996). 
 
 
4. Discussion 
 
The liver is very active in metabolizing foreign com-
pounds. The biotransformation of xenobiotics by the 
liver involves chemical modifications that globally in-
crease their water solubility thereby facilitating their 
elimination from the organism in bile and urine.  These 
reactions may, however, result in the formation of 
compounds of greater toxicity. Although the large bio-
transforming ability of the liver allows efficient elimi-
nation of the most toxic compounds, it also makes 
hepatocytes a vulnerable target for toxic effects. Dama-
ge to the cell’s constituents such as lipid peroxidation 
may occur. GSH plays an important role in hepatocytes 
defence (Kedderis, 1996; Reed, 1990). The most 
common pathway of glutathione depletion in xeno- 
biotic toxicity is excessive consumption of GSH 
without recovery (Castell et al., 1997). Severe GSH 
depletion leaves cells more vulnerable to oxidative  
The hepatoprotective effects of the EO were tested 
by co-incubation with the toxicant t-BHP and compared 
with those of the reference antioxidant quercetin. 
Quercetin shows concentration-dependent protective 
effects against t-BHP-induced toxicity in almost all 
parameters measured. Quercetin was preferred to other 
known antioxidants as a positive control because of its 
plant origin, DMSO solubility and for having a well 
characterised protective effect against t-BHP-induced  
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toxicity (Joyeux et al., 1990). In contrast, the presence of 
sage EO did not reduce hepatocyte death due to t-BHP 
toxicity. The co-incubation with the EO resulted in a 
tendency for a further decrease in GSH and increased 
lipid peroxidation.  In spite of the reputation of some 
plant EOs as antioxidants and hepatoprotectants in 
animal models (Teissedre and Waterhouse, 2000 and 
references therein), our results do not show antioxidant 
protective effects of S. officinalis EO against t-BHP-
induced liver toxicity. 
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The EO obtained by hydrodistillation used in this 
study was somewhat lower than that obtained from fresh 
leaves of the same sage cultivar (Santos-Gomes and 
Fernandes-Ferreira, 2001). The composition of sage EO 
extracts varies and reflects extraction conditions as well 
as time of harvest and the plant’s growth conditions such 
as climate, soil composition and light intensity (Santos-
Gomes and Fernandes-Ferreira, 2001). In April, the 
composition of the EO from S. officinalis plants grown in
Portugal (Santos-Gomes and Fernandes-Ferreira, 2001) 
and in Israel (Putievsky et al., 1986) are characterrised by 
the lowest levels of cis-thujone and camphor. The levels 
of these two compounds in the EO used (Table 1), were 
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for the EO of S. officinalis - cis-thujone (18-43%), cam-
phor (4.5-24.5%) (Bruneton, 1999). It is therefore 
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In summary, our results indicate that the hepato-
protective properties attributed to S. officinalis seem not 
to be due to the EO fraction. At doses higher than 200 
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toxicity. The neurotoxicity of thujones and camphor, 
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3.1. Chapter overview 
 
The antioxidant activity of essential oils and extracts obtained from aromatic and 
medicinal plants by extraction with organic solvents has been extensively studied with several 
in vitro techniques. However, little is known about the antioxidant effects of polar extracts of 
these plants prepared as infusions or decoctions. Triantaphyllou et al. (2001) studied different 
water extracts from herbs of the Lamiaceae family, which included Salvia fruticosa but not 
Salvia officinalis. They concluded that these extracts were rich in polyphenols and had a 
remarkable capacity in retarding lipid oxidation1. Matsingou et al. (2003) also tested a S. 
fruticosa water extract and they concluded that this herb possesses interesting antioxidant 
effects, mainly due to polyphenolic and nonpolyphenolic (such as carnosic acid) substances 
present in the extract2.  
 Salvia officinalis is extensively used as a medicinal plant and several bioactivities for 
different types of extracts were already experimentally shown, including antioxidant activities. 
However, the most common form of consumption of this plant, the sage tea (prepared as an 
infusion), has received little attention. A question arises: does sage tea consumption really 
confer antioxidant protection in vivo or is this an utopia? To test whether sage tea has 
antioxidant potential in vivo, we studied the effects of sage tea drinking in mice and rats. Since 
the liver is the organ first passed by sage tea constituents and its metabolites after the 
gastrointestinal absorption, we focused the studies on liver cells. Moreover, the liver is a highly 
metabolic organ, which underscores the importance to perform the studies in these cells, since 
they are a good tool to look for potential toxic effects of chemicals. In an attempt to identify tea 
constituents associated with the observed bioactivities, phenolic and volatile compounds present 
in the sage tea were analysed. 
 Since sage tea was given to the animals replacing all the water they consumed, in the 
first set of experiments performed with mice, the potential toxic effects of sage tea drinking to 
the liver were evaluated. As shown by the plasma transaminase levels, the replacement of water 
with sage tea for 14 days did not induce liver toxicity. On the other hand, a significant increase 
in about 10% of liver GST and GR activities was observed in mice of sage drinking groups, 
which indicate already some antioxidant capacity of sage tea in vivo. 
 Then, in the second set of experiments, the potential antioxidant effects of sage tea were 
also tested in rats in experiments that comprised in vivo and in vitro studies. After 14 days of 
 
1 Triantaphyllou K, Blekas G & Boskou D, 2001. Antioxidative properties of water extracts obtained from herbs of 
the species Lamiaceae. International Journal of Food Sciences and Nutrition 52, 313-317. 
2 Matsingou TC, Petrakis N, Kapsokefalou M & Salifoglou A, 2003. Antioxidant activity of organic extracts from 
aqueous infusions of sage. Journal of Agricultural and Food Chemistry 51, 6696-6701. 
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sage tea drinking, rat hepatocytes were isolated for the establishment of primary cultures. 
Immediately after hepatocyte isolation, GST activity was significantly increased (24%) in 
hepatocytes isolated from sage tea drinking rats when compared with controls. After 4 hours in 
culture, GSH content of the hepatocytes increased. The increase in GSH levels was significantly 
higher in hepatocytes isolated from sage tea drinking rats. Also, GST activity remained itself 
significantly higher in hepatocytes from sage tea than from water drinking rats. These results 
showed an improvement of the antioxidant status of rat hepatocytes from sage tea drinking 
animals. Finally, when the hepatocyte cultures were exposed to an oxidant agent, t-BHP, 
although cell death was not prevented, some protection against t-BHP-induced lipid 
peroxidation and GSH depletion was conferred by sage tea drinking. 
 Therefore, this study showed that S. officinalis tea positively affects the antioxidant 
status of the liver and may have hepatoprotective potential that justifies further studies. The 
improvement of the antioxidant response by sage tea could possibly be beneficial in many liver 
diseases, where it is known that oxidative stress plays an important role. 
 The improvement of GST and GR activities and GSH levels afforded by sage tea may 
tentatively be attributed to the flavonoids and certain compounds present in the EO fraction. It is 
known that these compounds can induce phase II detoxifying enzymes such as GST. On the 
other hand, the higher GSH levels obtained in hepatocytes isolated from sage tea drinking rats, 
after 4 hours in culture, can be the result of an enhancement of de novo glutathione synthesis. 
For example, an up-regulation of both phase II enzymes and the key enzyme involved in de 
novo glutathione synthesis, by polyphenols, has already been observed1. So, although not 
studied here, there is the possibility that, also in this case, the interaction of some compounds 
present in sage tea with, for example, the antioxidant response element (ARE) could result in a 
higher GST activity and increased GSH recovery. 
 
 
3.2. Methods 
 
The following experimental protocols (see Appendix) were used in this chapter: 
• Biological Models – Mice were housed as described in P3 and used to see effects of 
sage tea drinking in the liver. 
• P1: Biological Models – Rat Hepatocyte Isolation and Use 
• P4: Cell Viability Assays – LDH Leakage 
 
1 Mulcahy RT, Wartman MA, Bailey HH & Gipp JJ, 1997. Constitutive and beta-naphthoflavone-induced expression 
of the human gamma-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response 
element/TRE sequence. The Journal of Biological Chemistry 272, 7445-7454. 
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• P6: Cell Viability Assays – Trypan Blue Staining 
• P7: Metabolite Measurements – TBARS (Lipid Peroxidation) 
• P8: Metabolite Measurements – Glutathione Levels 
• P10: Metabolite Measurements – Total Protein 
• P11: Enzyme Activities – GR 
• P13: Enzyme Activities – GST 
• P16: Enzyme Activities – ALT and AST 
 
3.3. Publication 
 
This chapter comprises the following publication: 
Lima CF, Andrade PB, Seabra RM, Fernandes-Ferreira M & Pereira-Wilson C, 2005. The 
drinking of a Salvia officinalis infusion improves liver antioxidant status in mice and rats. 
Journal of Ethnopharmacology 97(2), 383-389.  
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Abstract 
In this study, we evaluate the biosafety and bioactivity (antioxidant potential) of a traditional water infusion (tea) of common sage (Salvia 
officinalis L.) in vivo in mice and rats by quantification of plasma transaminase activities and liver glutathione-S-transferase (GST) and 
glutathione reductase (GR) enzyme activities. The replacement of water by sage tea for 14 days in the diet of rodents did not affect the body 
weight and food consumption and did not induce liver toxicity. On the other hand, a significant increase of liver GST activity was observed 
in rats (24%) and mice (10%) of sage drinking groups. The antioxidant potential of sage tea drinking was also studied in vitro in a model 
using rat hepatocytes in primary culture. The replacement of drinking water with sage tea in the rats used as hepatocyte donors resulted 
in an improvement of the antioxidant status of rat hepatocytes in primary culture, namely a significant increase in GSH content and GST 
activity after 4 h of culture. When these hepatocyte cultures were exposed to 0.75 or 1mM of tert-butyl hydroperoxide (t-BHP) for 1 h, some 
protection against lipid peroxidation and GSH depletion was conferred by sage tea drinking. However, the cell death induced by t-BHP as 
shown by lactate dehydrogenase (LDH) leakage was not different from that observed in cultures from control animals. This study indicates 
that the compounds present in this sage preparation contain interesting bioactivities, which improve the liver antioxidant potential. 
 
Keywords:  Salvia officinalis L. infusion; Glutathione status; Antioxidant effects; Rat hepatocytes; Mice; tert-Butyl hydroperoxide 
1. Introduction for their increased use. Salvia officinalis L. (Lamiaceae) is a 
common aromatic and medicinal plant native from mediter-
ranean countries that is in widespread use. 
 
The oxidative damage of biological molecules is an impor-
tant event in the development of a variety of human disorders 
that result from overwhelming the biological defense system 
against oxidative stress, drugs and carcinogens. The intake 
in the human diet of antioxidant compounds, or compounds  
that ameliorate or enhance the biological antioxidant mecha-
nisms, can prevent and in some cases help in the treatment  
of some oxidative-related disorders and carcinogenic events 
(Havsteen, 2002). 
Experimental evidence already exists for a variety of 
bioactivities for different types of extracts of Salvia offici-  
nalis such as antioxidant, anti-inflammatory, hypoglycaemic 
and anti-mutagenic activities (Cuvelier et al., 1994; Wang et  
al., 1998; Hohmann et al., 1999; Baricevic and Bartol, 2000; 
Baricevic et al., 2001; Zupko et al., 2001; Alarcon-Aguilar et 
al., 2002). However, the properties of sage infusion (hereafter, 
referred to as tea), the most common form of consumption of 
this plant, have received little attention. Natural plant products have been used empirically for this 
purpose since ancient times and a tendency is emerging today  Many bioactivities have been researched and detected  
in tea and in infusions (or water extracts) of other plants. 
Among them, the phenolic content of different plants have  
been shown to have antioxidant activities and the capacity  
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to modulate xenobiotic metabolizing enzymes involved in 
drug and carcinogen activation and detoxification (Ferguson, 
2001; Triantaphyllou et al., 2001). Several studies showed 
that black and green tea (Camellia sinensis) enhance phase 
II enzymes (Khan et al., 1992; Yu et al., 1997; Bu-Abbas et 
al., 1998). A water-soluble extract of rosemary also induced 
both phase I and phase II enzymes (Debersac et al., 2001a,b). 
However, the use of natural products may also result in toxic 
effects, which underscore the need to understand the biolo-
gical effects of natural compounds. Toxic effects to the liver, 
the main xenobiotic metabolizing organ, are particularly 
relevant. 
and identification of phenolic compounds by HPLC/DAD 
were performed as previously described (Santos-Gomes  
et al., 2002). The volatile constituents of the tea (150 ml) 
were extracted, at room temperature, with 5 ml of n-pentane 
containing 5α-cholestane (1 mg/ml). The volatile compounds 
were then identified by GC and GC-MS as previously 
described (Lima et al., 2004). 
 
2.3. Animals 
 
Female Balb/c mice (8–10 weeks) and male Wistar rats 
(150–200 g) were purchased from Charles River Laborato-
ries (Spain) and acclimated to our laboratory animal facili- 
ties for at least 1 week before the start of the experiments. 
During this period, the animals were maintained on a natural 
light/dark cycle at 20 ± 2ºC and given food and tap water ad 
libitum. The animals used in the two experiments were kept 
and handled in accordance to our University regulations. In 
experiment 1, mice were used to evaluate in vivo the liver toxi-
city of sage tea drinking for 14 days and changes in the liver 
glutathione levels as well as in the activities of glutathione- 
related enzymes. In experiment 2, rats from two different 
drinking groups (water and sage tea) were used for hepato-
cyte isolation for establishment of primary cultures. The pri-
mary cultures of hepatocytes isolated from sage tea and water 
drinking rats were challenged with the oxidant tert-butyl hy-
droperoxide and the antioxidant protection conferred by sage 
tea drinking evaluated. 
In the present study, we evaluate the biosafety and bioac-
tivities of sage tea in vivo with mice and rats and in vitro using 
rat hepatocytes in primary culture. Toxic effects to the liver of 
sage tea drinking are tested in vivo on mice monitoring the 
plasma transaminase activities. The liver glutathione content 
and glutathione reductase (GR) and glutathione-S-transferase 
(GST) activities in the mouse livers and freshly isolated rat 
hepatocytes were also evaluated. In addition, primary cultures 
of hepatocytes isolated from sage tea and water drinking rats 
were challenged with the oxidant tert-butyl hydroperoxide  
(t-BHP) and the antioxidant protection conferred by sage tea 
drinking evaluated. 
 
 
2. Materials and methods 
 
2.1. Chemicals  
2.4. Experiment 1  
Collagenase (grade IV), tert-butyl hydroperoxide, 
glutathione reductase (EC 1.6.4.2.), 5,5’-dithio-bis-(2- 
nitrobenzoic acid) (DTNB), William’s Medium E (WME) 
and Bradford reagent were purchased from Sigma (St. Louis, 
MO, USA). L-Lactate dehydrogenase (EC 1.1.1.27) and  
L-malate dehydrogenase (EC 1.1.1.37) were purchased from 
Roche (Germany). All others reagents were of analytical 
grade. 
 
Ten female Balb/c mice were randomly divided into two 
groups, given food ad libitum and either water (tap) or sage 
tea ad libitum for 14 days (beverage was renewed daily).  
On day 15, the animals were sacrificed by cervical disloca-
tion and blood samples collected for measurement of plasma 
transaminase activities (alanine aminotransferase (ALT) and 
aspartate aminotransferase (AST)). The livers were also col-
lected, frozen in liquid nitrogen and kept at -80ºC for later 
analysis of glutathione content and activities of glutathione 
reductase and glutathione-S-transferase. 
 
2.2. Plant material, preparation of sage tea and analysis 
of its phenolic and volatile compounds 
  
2.5. Experiment 2 Salvia officinalis L. plants were cultivated in an experi-
mental farm located in Arouca, Portugal, and were collected 
in April, 2001. The aerial parts of plants were lyophilized and 
kept a -20ºC. Considering that sage is traditionally used as  
a tea, an infusion of sage was routinely prepared by pouring 
150 ml of boiling water onto 2 g of the dried plant material 
and allowing to steep for 5 min. This produced an infusion of 
3.5 ± 0.1 mg (mean ± S.E.M., n = 6) of extract dry weight  
per ml of infusion (0.35%, w/v) and a yield of 26.3% (w/w) 
in terms of initial crude plant material dry weight. 
 
Eight male Wistar rats were randomly divided into two 
groups and given food ad libitum with either water (tap) or 
sage tea ad libitum for 14 days (beverage was renewed daily). 
On day 15, hepatocytes were isolated and used to establish 
primary cultures. 
Hepatocyte isolation was performed between 10:00 a.m. 
and 11:00 a.m. by collagenase perfusion as previously des-
cribed by Moldeus et al. (1978) with some modifications 
(Lima et al., 2004). Cell viability was >85% as estimated by 
the trypan blue exclusion test. Aliquots of the cell suspen-
sions were kept a -80ºC for measurement of GR and GST 
activities and quantification of glutathione levels at the start  
Phenolic compounds were analysed by HPLC/DAD. 
Freeze-dried (Labconco Freeze Dry System) extract (0.01 g) 
was redissolved in 1ml of ultrapure Milli Q water and aliquots 
of 20 μl were injected in an HPLC/DAD system. Separation  
 
70 
Chapter 3                                                                          Sage tea: does it really have antioxidant effects on the liver?
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
of the in vitro experiments, i.e., time zero of primary cultures. 
Then, cells were suspended in William’s medium E supple-
mented with 10% fetal bovine serum (FBS), 10
in ethanol) in 50 mM Hepes (pH 7.4). The activity was calcu-
lated using an extinction coefficient of 9.6 mM-1 -1cm  and 
expressed as nmol of conjugate per minute per milligram 
protein (mU/mg). 
-9 M insulin 
and 10-9 M dexamethasone and seeded onto six-well culture 
plates at a density of 1 × 106 cells/well. The culture plates 
were incubated at 37ºC in a humidified incubator gassed  
with 5% CO
 
2.6.1.3. LDH. To assess the extent of cell death caused by  
t-BHP, the determination of lactate dehydrogenase acti-  
vity in the culture medium was used as indicator of plasma 
membrane integrity of hepatocytes. The enzyme activity was 
measured at 30ºC by quantification of NADH (0.28 mM) 
consumption by continuous spectrophotometry (at 340 nm) 
on a plate reader using pyruvate (0.32 mM) as substrate in  
50 mM phosphate buffer (pH 7.4). The results are expressed 
as μmol of substrate oxidized per minute per milligram 
protein (U/mg). 
2/95% air. 
Three hours after plating, the culture medium was replaced 
with WME supplemented with 10% FBS and t-BHP 0, 0.75 
or 1mM for 1 h to induce cytotoxicity (Rush et al., 1985).  
To assess the protection conferred by sage tea drinking cul-
ture medium and cells were collected and the activities of 
lactate dehydrogenase (LDH), GR and GST determined. The 
levels of malondialdehyde (MDA) and glutathione were also 
measured. 
 
 2.6. Biochemical analysis 
2.6.2. Lipid peroxidation  
The extent of hepatocyte lipid peroxidation was esti-
mated by the levels of malondialdehyde. The thiobarbituric 
acid reactive substances (TBARS) assay at 535 nm was  
used as described previously (Fernandes et al., 1995) but  
with some modifications for cultured hepatocytes. Briefly, 
360 μl of culture medium was precipitated with 60 μl of  
50% trichloroacetic acid. After centrifugation, 300 μl of the 
supernatant were added to an equal volume of 1% thio-
barbituric acid and the mixture was heated for 10 min in a 
boiling water bath, allowed to cool and the absorbance 
measured at 535 nm. The results are expressed as nmol 
MDA/mg of protein using a molar extinction coefficient of 
1.56 × 10
2.6.1. Enzyme activities 
2.6.1.1. ALT and AST. The alanine aminotransferase and 
aspartate aminotransferase activities were measured spec-
trophotometrically in plasma of mice following NADH oxi-
dation (at 30ºC) at 340 nm on a plate reader (Spectra Max 
340pc, Molecular Devices). For ALT activity, the reaction 
mixture consisted of 200 mM L-alanine, 25 μM pyrido-
xalphosphate, 0.12 mM NADH, 12 units/ml L-lactate dehydro-
genase and 10.5 mM alpha-ketoglutarate in 50 mM imidazole 
(pH 7.4). For AST activity, the reaction mixture consisted  
of 40 mM aspartate, 25 μM pyridoxalphosphate, 0.12 mM 
NADH, 8 units/ml L-malate dehydrogenase and 7 mM alpha-
ketoglutarate in 50 mM imidazole (pH 7.4). The activities are 
expressed as μmol of substrate oxidized per minute per liter 
of plasma (U/L). 
5 -1 -1 M cm . 
 
2.6.3. Glutathione content 
The glutathione content of mice livers, time zero hepa-
tocyte aliquots and 4 h cultured rat hepatocytes were de-
termined by the DTNB-GSSG reductase recycling assay as 
previously described (Anderson, 1985), with some modifica-
tions (Lima et al., 2004). The results are expressed as nmol 
GSH per milligram of protein. 
 
2.6.1.2. GR and GST. For measurement of mice liver 
glutathione reductase and glutathione-S-transferase activi-
ties, the livers were homogenised individually in a 
phosphate/glycerol buffer pH 7.4 (Na2HPO4 20 mM; β- 
mercaptoethanol 5 mM; EDTA 0.5 mM; BSA 0.2% (w/v); 
aprotinine 10 μg/ml and glycerol 50%, v/v) and centrifuged at 
10,000 × g for 10 min at 4ºC and the supernatant collected.  
In the case of the cells collected after exposure to t-BHP (pri-
mary cultures of hepatocytes) as well as the time zero hepato-
cyte aliquots, the samples were homogenised by sonication in 
phosphate/glycerol buffer pH 7.4, centrifuged at 10,000 × g 
for 10 min at 4ºC and the supernatant collected. 
 
2.6.4. Protein 
Protein content was measured with the Bradford Reagent 
purchased from Sigma using bovine serum albumin as a 
standard. 
 
2.7. Statistical analysis The GR activity was measured spectrophotometrically  
at 340 nm following NADPH oxidation at 30ºC. The reac-
tion mixture consisted of 3 mM GSSG, 2.5 mM EDTA and 
0.12 mM NADPH in 50mM Hepes (pH 7.4). The activity is 
expressed as nmol of NADPH oxidized per minute per mil-
ligram protein (mU/mg). 
 
Data are expressed as mean ± S.E.M. The comparison be-
tween the means of treatment (sage tea) and control group 
was performed using Student’s t-test. For primary cultures  
of hepatocytes a two-way ANOVA followed by the Bon-
ferroni post-hoc test were employed to compare the in vivo 
treatments (water versus sage tea) and in vitro treatments  
(t-BHP concentrations). P-values ≤ 0.05 were considered 
statistically significant. 
The GST activity was measured spectrophotometrically  
at 340 nm following the formation of GSH conjugate with  
1-chloro-2,4-dinitrobenzene (CDNB) at 30ºC. The reaction 
mixture consisted of 1mM GSH and 1mM CDNB (dissolved  
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Table 1 
Phenolic and volatile compounds of sage tea 
Component      % μg/ml
Water 99.65 
Phenolic acids  
Rosmarinic acid 0.04 362.0
Flavonoids  163.7
Luteolin 7-glucoside 0.01 115.3
Others luteolin glycosides (3) < 0.01 48.5
Volatile components << 0.01 4.8
1,8-Cineole  0.9
cis-Thujone [= (-)-thujone]  1.7
trans-Thujone [=(+)-thujone]  0.3
Camphor  0.5
Borneol  0.7
Others (20)  0.7
Unknown 0.30 
Table 2 
Effect of sage tea on plasma transaminase activities, liver glutathione 
levels and liver glutathione-related enzyme activities after 14 days of 
treatment in mice 
 In vivo beverage 
Parameter 
   Water Sage tea 
ALT (U/L)   36 ± 6    30 ± 6 
AST (U/L)    90 ± 11    89 ± 11 
GR (mU/mg) 13.4 ± 0.1 14.7 ± 0.4 * 
GST (mU/mg)  107 ± 3  119 ± 2 * 
GSH (nmol/mg) 46.1 ± 0.9 47.4 ± 1.9 
GSSG (nmol GSH equiv/mg)   2.1 ± 0.1   2.0 ± 0.2 
Values are means ± S.E.M., n = 5. 
P ≤ 0.05 when compared with the respective control.   *
 
the experiment (data not shown). However, drinking was 
slightly different between the two groups - water drinking 
group: 11.0 ± 0.4 ml/day/100 g; sage tea drinking group:  
10.0 ± 0.5 ml/day/100 g of body weight. Plasma ALT and 
AST activities (Table 2) were not different between water  
and sage drinking animals. Also the levels of reduced 
glutathione (GSH) and oxidized glutathione (GSSG) in the 
mice livers were not different between the two groups  
(Table 2). 
2972.0
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Results 
 
3.1. Phenolic and volatile compounds in sage tea 
 
The infusion is composed of the phenolic compounds 
rosmarinic acid and four luteolin glycosides - luteolin-7-
glucoside being the most representative flavone (Table 1), 
which constitutes 0.05% of total wet weight. In this sage 
infusion, we also identified 25 volatile compounds with 1,8- 
cineole, cis-thujone, trans-thujone, camphor and borneol 
being the most representative (85% of total volatile fraction). 
The most representative volatile compounds and their quan-
tification are presented in Table 1. 
The activities of glutathione-related enzymes, GR and 
GST, were significantly higher (10%) in livers of sage tea 
drinking mice (Table 2). 
 
3.3. Experiment 2 
 
The replacement of drinking water with the sage tea did 
not affect food and drink consumption as well as body weight 
of rats (data not shown). 
 
3.2. Experiment 1 
Immediately after collagenase isolation glutathione levels 
of rat hepatocytes were similar in the two groups  
(Table 3), water and sage tea drinking, and smaller than  
 
Water replacement with sage tea for 14 days did not  
affect food consumption and body weight in mice during  
 
Table 3 
Effect of sage tea consumption (in vivo for 14 days) on t-BHP-induced toxicity in primary culture of rat hepatocytes and on liver glutathione levels and 
liver glutathione-related enzymes activities of rat hepatocytes after collagenase isolation 
Parameter In vivo beverage Rat hepatocytes (after isolation) Primary cultures of rat hepatocytes - t-BHP (mM) 
0 0.75 1 
LDHextr (U/mg) Water         - 0.06 ± 0.01 0.40 ± 0.03** 0.72 ± 0.09***
 Sage tea         - 0.09 ± 0.03 0.40 ± 0.07* 0.78 ± 0.14*** 
TBARS (nmol/mg) Water         - 0.10 ± 0.06 1.89 ± 0.09*** 3.38 ± 0.45*** 
 Sage tea         - 0.03 ± 0.02 1.30 ± 0.27* 2.62 ± 0.45*** 
GSH (nmol/mg) Water 21.9 ± 1.3 38.1 ± 2.7 25.0 ± 0.6*** 12.5 ± 1.2*** 
 Sage tea 20.4 ± 3.1 51.4 ± 3.6## 36.3 ± 1.4***## 23.3 ± 2.1***##
GSSG (nmol GSH equiv/mg) Water         tr   0.9 ± 0.5   7.9 ± 0.5**   8.4 ± 1.2*** 
 Sage tea         tr   0.7 ± 0.2   9.3 ± 2.3***   9.7 ± 1.2*** 
GR (mU/mg) Water 21.4 ± 1.6 22.0 ± 0.9 19.9 ± 2.2 20.4 ± 2.5 
 Sage tea 21.5 ± 1.2 25.5 ± 2.9 24.0 ± 1.7 19.9 ± 0.3 
GST (mU/mg) Water  209 ± 4  168 ± 9  162 ± 12  135 ± 8 
 Sage tea  260 ± 18#  210 ± 9#  184 ± 7  153 ± 4* 
Values are mean ± S.E.M., n = 4 (except rat hepatocytes after isolation, n = 3). * P ≤ 0.05, ** P ≤ 0.01 and *** P ≤ 0.001 when compared with the 
respective control. # P ≤ 0.05, ## P ≤ 0.01 and ### P ≤ 0.001 between the water and sage tea in the same situation, tr: trace amounts. 
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4. Discussion those of mice. GST activity was significantly enhanced  
in isolated rat hepatocytes from sage tea drinking animals 
(Table 3) with an increase of 1.24-fold relative to the wa-  
ter drinking group. No differences were observed in GR 
activity. 
 
The present study shows that sage tea drinking had no to-
xicity to the liver and no adverse effects on growth parameters 
neither in mice nor in rats. It also shows that sage tea drinking 
positively affected the antioxidant status of the liver, mainly 
the GST and GR activities of the mice livers and GST activity 
in rats. 
There was a marked increase in GSH values from time zero 
hepatocyte aliquots to 4 h cultured hepatocytes (Table 3), 
both from water and sage tea drinking animals. However, 
comparing the values (t-BHP 0 mM) measured in the primary 
cultures, a significantly higher GSH content (1.35-fold) was 
observed (Table 3) after 4 h of culture (3 h of pre-incubation 
plus 1 h with 0mM of t-BHP) in hepatocytes of sage drinking 
animals. After 4 h in culture, the GST activity decreased 
somewhat but remained higher (1.25-fold) in the cells from 
sage drinking animals. The GR activity was also somewhat 
increased in the hepatocytes of sage drinking rats although 
not significantly. 
The positive effects of sage tea drinking were also present 
in cultured hepatocytes. Immediately after isolation GST 
activity was higher in cells from sage tea drinking rats. At this 
point GSH levels were not different from those of control 
cells. After 4 h in culture, GSH content increased in both 
groups. However, this increase was dramatically higher in 
cells isolated from sage tea drinking animals indicating better 
recovery of this group of cells from the oxidative stress 
imposed by collagenase isolation. 
Also following treatment with t-BHP, GSH content and 
GST activity remained significantly higher in the cells from 
tea drinking animals. This higher antioxidant status was 
probably the cause of the smaller extent of lipid peroxi- 
dation induced by t-BHP to these cells compared to those  
of water drinking animals. However, in spite of this, cell 
death, as indicated by LDH leakage, was not prevented  
in the cells of sage tea drinking animals. Although not  
done in this study, cell recovery after the removal of the  
toxic might have been higher in cells of sage tea drinking 
animals. 
Incubation of rat hepatocyte primary cultures with t-BHP 
at 0.75 or 1 mM for 1 h resulted in significant cell damage  
as shown by a strong increase in LDH activity in the culture 
medium, higher cellular lipid peroxidation and GSSG levels, 
as well as a significant decrease in GSH levels (Table 3). 
t-BHP did not affect GR activity and only at the concentration 
of 1 mM was the GST activity significantly reduced (Table 3) 
when compared with the respective controls. 
The extent of t-BHP-induced lipid peroxidation was lower 
in cells of sage tea drinking animals. This effect was only 
marginally non-significant (P = 0.051). The GSH levels of 
hepatocytes challenged with t-BHP remained significantly 
higher in the cultures of sage tea drinking rats (Table 3). 
Following exposure to t-BHP the reduction of GSH in hepa-
tocytes of the sage tea drinking group was not as dramatic as 
the one observed in hepatocytes from water drinking animals 
(Fig. 1) being significantly different at 1 mM of t-BHP. How-
ever, when exposed to 0.75 or 1mM of t-BHP no protective 
effect of sage tea drinking was observed in LDH leakage nor 
in GSSG content (Table 3). 
An enhancement of GST activity and other phase II 
enzymes due to treatment with water extracts of plants, 
namely Camellia sinensis and Rosmarinus officinalis has 
been reported (Bu-Abbas et al., 1998; Debersac et al., 2001b), 
and related to cancer chemoprevention (Saha and Das, 2003). 
In accordance with this, we also found an enhancement of 
GST activity in the livers of both mice and rats due to sage 
tea drinking for 14 days. The observed increase in liver  
GST activity after tea drinking was smaller in comparison 
with other studies, for example with the water-soluble ex-
tract of rosemary (Debersac et al., 2001a,b) and Camellia 
sinensis (Bu-Abbas et al., 1998). Apart from the dif-  
ferences in extract composition, this may be due to the fact 
that our water extract was much more diluted, only  
about 0.35% (w/v), than that used in the above mentioned 
studies. 
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According to the work done by Debersac et al. (2001b), 
where individual compounds were administered orally to rats, 
rosmarinic acid (also the most abundant phenolic compound 
present in this sage tea) could not be responsible for the 
observed increase in GST activity. This effect could be due to 
the luteolin glycosides, since induction of GST activity has 
been reported as the result of dietary ingestion of certain an-
tioxidant flavonoids (Siess et al., 1996; Birt et al., 2001; Ross 
and Kasum, 2002; Ren et al., 2003). There is also a possi-
bility that components of the essential oil fraction present in 
sage tea could contribute to the increase in the GST activity, 
since monoterpenes (including camphor) have been reported  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1. Effect of sage tea consumption (in vivo for 14 days) on t-BHP-
induced decrease in GSH content of primary hepatocyte cultures, presented 
as percentage from control. Absolute values presented in Table 3. Values are 
mean ± S.E.M., n = 4. * P ≤ 0.05, significantly different with Student’s t-test. 
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References to induce phase II enzymes such as GST and UGT (Elegbede 
et al., 1993; Banerjee et al., 1995). Unidentified compounds 
present in this water extract belonging to other classes of 
compounds, such as aminoacids, organic acids, sugars and 
other polar compounds could also contribute to the observed 
effects. It should also be kept in mind that due to the com-
plexity of the mixture that plant extracts are, a synergistic in-
teraction between the compounds could be the ultimate cause 
for the observed effects. 
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4.1. Chapter overview 
 
The antioxidant activity of sage extracts obtained by organic solvents is well known, 
mainly based in several noncellular and subcellular in vitro techniques. However, little is known 
about their antioxidant effects at cellular level. Some previous experiments are, even so, 
indicative of a good cellular antioxidant activity for sage organic extracts. For example, an 
aqueous methanolic extract of Salvia officinalis conferred protective effects against enzyme-
dependent and enzyme-independent lipid peroxidation1. Until recently, only a small experiment 
using fibroblasts, performed by Masaki and its collaborators (1995), showed some cellular 
antioxidant effects of a sage hydro alcoholic extract2. Moreover, it was also now reported that a 
hydro alcoholic extract of sage possess neuroprotective effects against amyloid beta-induced 
toxicity to PC12 cells, and the effect attributed, at least in part, to the rosmarinic acid3. Apart 
from these studies with organic extracts, we previously also tested the potential biological 
activity of the sage essential oil fraction (chapter 2) and of a sage aqueous extract, prepared as a 
tea (chapter 3). Sage tea showed some potential antioxidant effects in liver cells, whereas sage 
essential oil did not. 
Therefore, in the following studies, the potential antioxidant and cytoprotective effects 
of a sage water (as an infusion) extract (SOI) and also a sage methanolic extract (SOME) were 
tested against oxidative damages induced by t-BHP to the hepatocyte cell line, HepG2. As 
stated before, the search for hepatoprotective activities is of particular interest since the liver is 
vulnerable to toxic effects from a variety of drugs and environmental contaminants, because of 
its high metabolic activity and anatomical positioning receiving blood from the gastrointestinal 
tract. Moreover, also due to the liver’s anatomical positioning, sage tea constituents and 
possible metabolites will accumulate in relative high concentrations in the liver, after the 
gastrointestinal absorption, which emphasise also the importance of these studies in liver cells. 
Since the antioxidant activity of sage has been attributed to the phenolic compounds, they were 
quantified in the sage extracts used (SOI and SOME). In addition, the potential hepatoprotective 
effect of their main phenolic compounds and other structure-related phenolic compounds were 
studied. 
 The hepatoprotective potential of both sage extracts and phenolic compounds were 
 
1 Hohmann J, Zupko I, Redei D, Csanyi M, Falkay G, Mathe I & Janicsak G, 1999. Protective effects of the aerial 
parts of Salvia officinalis, Melissa Officinalis and Lavandula angustifolia and their constituents against enzyme-
dependent and enzyme-independent lipid peroxidation. Planta Medica 65, 576-578. 
2 Masaki H, Sakaki S, Atsumi T & Sakurai H, 1995. Active-oxygen scavenging activity of plant extracts. Biological 
& Pharmaceutical Bulletin 18, 162-166. 
3 Iuvone T, De Filippis D, Esposito G, D'Amico A & Izzo AA, 2006. The spice sage and its active ingredient 
rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. Journal of Pharmacology 
and Experimental Therapeutics 317, 1143-1149. 
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tested against t-BHP-induced toxicity in HepG2 cells. All the extracts and phenolic compounds 
studied, when co-incubated with the toxicant, protected significantly HepG2 cells against cell 
death. The methanolic extract, with a higher content of phenolic compounds, conferred higher 
protection better than the water extract. The results obtained with the phenolic compounds 
underscored the importance of the compound’s lipophilicity in addition to its antioxidant 
potential for their biological activity. 
 In an attempt to explain the observed cytoprotective activities, the effects of sage 
extracts and phenolic compounds on three markers of cellular oxidative stress (lipid 
peroxidation, glutathione levels and DNA damage) were evaluated. Both sage extracts 
significantly prevented lipid peroxidation and GSH depletion, but failed to prevent DNA 
damage induced by t-BHP. The main phenolic compounds present in the extracts, rosmarinic 
acid and luteolin-7-glucoside, also significantly prevented lipid peroxidation and GSH 
depletion, but had poor ability to prevent DNA damage. This indicates, therefore, a good 
correlation between the biological effects of sage extracts and those of their main phenolic 
compounds. Only the flavonoid aglycones tested, luteolin and quercetin, significantly decreased 
DNA damage. Therefore, the lipophilicity of the natural antioxidants appeared to be of even 
higher importance for DNA protection than for cell survival. It seems that, based on other 
reports and in our own observations, the potential of sage extracts and phenolic compounds to 
protect against GSH depletion, at least in about 40%, was probably the most relevant effect for 
the observed hepatoprotection. 
Interestingly, sage extracts, when incubated alone with HepG2 cells for 5 hours, 
induced an increase in GSH levels, which indicates an improvement of the cells’ antioxidant 
potential. However, the above effect can not be attributed solely to the phenolic compounds, 
which did not induce the same effect, emphasising the importance of constituents other than 
phenolic compounds present in sage extracts. In fact, rosmarinic acid and luteolin-7-glucoside, 
as well as quercetin and luteolin, induced a slight decrease in GSH levels, when incubated alone 
with HepG2 cells for 5 hours. Since the increase in GSH levels, induced by sage extracts, was 
accompanied by an increase in total glutathione levels, sage extracts seem to have an ability to 
increase de novo glutathione synthesis. This is in accordance with previous observations (see 
chapter 3), where the ability of a same water extract (sage tea) to increase the de novo 
glutathione synthesis was suggested. In that study, after a stress-induced GSH depletion, sage 
tea given in vivo restored GSH levels, measured in vitro in rat hepatocytes, to a higher value 
than in controls. 
In conclusion, this study has shown cellular antioxidant effects of sage extracts, which 
could be attributed, at least in part, to their phenolic compounds. Other unknown compounds 
present in the extracts seem, in addition, to induce positive effects on basal GSH levels, which 
can be of interest against a situation of oxidative stress induced in liver cells. Therefore, sage 
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extracts can be considered as a possibility in the prevention and/or in the treatment of liver 
diseases where it is known that oxidative stress is involved. 
 
 
4.2. Methods 
 
The following experimental protocols (see Appendix) were used in this chapter: 
• P2: Biological Models – Culture of HepG2 Cells and Use 
• P4: Cell viability Assays – LDH Leakage 
• P5: Cell viability Assays – MTT Assay 
• P7: Metabolite Measurements – TBARS (Lipid Peroxidation) 
• P8: Metabolite Measurements – Glutathione Levels 
• P10: Metabolite Measurements – Total Protein 
• P11: Enzyme Activities – Glutathione Reductase 
• P12: Enzyme Activities – Glutathione Peroxidase 
• P13: Enzyme Activities – Glutathione S-Transferase 
• P17: Others – Comet Assay 
• P19: Others – Antiradical Activity: DPPH and Superoxide Radical 
 
 
4.3. Manuscript 
 
This chapter comprises the following manuscript: 
Lima CF, Valentao PCR, Andrade PB, Seabra RM, Fernandes-Ferreira M & Pereira-Wilson C, 
2006. Water and methanolic extracts of Salvia officinalis protect HepG2 cells from t-BHP 
induced oxidative damage. Submitted to Journal of Ethnopharmacology. 
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Water and methanolic extracts of Salvia officinalis 
protect HepG2 cells from t-BHP-induced oxidative damage 
a
 
 
Abstract 
Common sage (Salvia officinalis L., Lamiaceae) is an aromatic and medicinal plant well 
known for its antioxidant properties. In this study, we propose to evaluate the antioxidant effects 
of sage extracts at cellular level. For that, the antioxidant/hepatoprotective potential of two sage 
extracts (a water and a methanolic extract) against tert-butyl hydroperoxide (t-BHP)-induced 
toxicity to HepG2 cells was assessed. The most abundant phenolic compounds present in the 
extracts were rosmarinic acid and luteolin-7-glucoside. Both extracts, when co-incubated with 
the toxicant, protected significantly HepG2 cells against cell death. The methanolic extract, with 
a higher content of phenolic compounds than the water extract, conferred better protection, to an 
extent similar to the positive control, quercetin. Both extracts, tested in a concentration that 
protects 80% against cell death (IC80), significantly prevented t-BHP-induced lipid peroxidation 
and GSH depletion, but not DNA damage. The ability of sage extracts to protect 62% from 
GSH depletion was probably the most relevant contributor for the observed hepatoprotection. 
When incubated alone for 5 hours, sage extracts induced an increase in GSH levels in HepG2 
cells, which indicates an improvement of the antioxidant potential of the cells. In conclusion, 
this study demonstrates the antioxidant/hepatoprotective potential of sage extracts which 
suggest that may be used in the prevention or treatment of liver diseases where it is known that 
oxidative stress is involved. 
 
Keywords: Salvia officinalis L; Phenolic compounds; Antioxidant effects; HepG2 cells; tert-
Butyl hydroperoxide 
 
 
1. Introduction 
 
Reactive oxygen species (ROS) and other free radicals are produced during the normal 
cell metabolism and they are a necessary and normal process that provides important 
physiological functions (Cui et al., 2004; Willcox et al., 2004). The production of ROS and 
Cristovao F. Lima , Patricia C.R. Valentaob b, Paula B. Andrade , Rosa M. Seabrab, 
Manuel Fernandes-Ferreiraa, Cristina Pereira-Wilsona
a Department/Centre of Biology, School of Sciences, University of Minho, 4710-057 Braga, Portugal 
b REQUIMTE, Pharmacognosy Laboraory, Faculty of Pharmacy, University of Porto, 4050-047 Porto, Portugal 
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other free radicals is normally compensated by an elaborate endogenous antioxidant system. 
However, due to many environmental, lifestyle and pathological factors, an excess of radicals 
can be accumulated in cells resulting in oxidative stress. Because of their high reactivity, 
accumulation of radicals above cells’ defences may affect cellular functionality and integrity by 
damaging critical molecules, such as the DNA, proteins, carbohydrates and lipids, which 
ultimately can cause cell death. In fact, oxidative stress has been recognised to be involved in 
the aetiology of several diseases, including liver diseases (Loguercio and Federico, 2003; 
Vitaglione et al., 2004). The liver, because of its high metabolic activity and its anatomical 
positioning to receive blood from the gastrointestinal tract, is vulnerable to toxicity from a 
variety of drugs and environmental contaminants. Consequently, mechanisms of cytoprotection 
relevant to the liver are of particular interest. Natural antioxidants have been proposed and 
utilised as therapeutic agents to counteract liver damage (Loguercio and Federico, 2003; 
Vitaglione et al., 2004). 
Salvia officinalis L. (Lamiaceae) is an aromatic and medicinal plant of Mediterranean 
origin well known for its antioxidant properties, mainly due to its composition in phenolic 
compounds (Baricevic and Bartol, 2000). Sage extracts revealed strong antioxidant activity in 
several assays: by increasing the stability of food oils (Cuppett and Hall, 1998; Miura et al., 
2002; Zainuddin et al., 2002; Ozcan, 2003; Jaswir et al., 2005), in an assay based on the 
disappearance of methyl linoleate in a lipophilic solvent under strong oxidising conditions 
(Cuvelier et al., 1994; Cuvelier et al., 1996), by the ability to scavenge DPPH˙ (Lamaison et al., 
1991) and ABTS˙ free radicals (Shan et al., 2005) as well as by having oxygen radical 
absorbance capacity (ORAC assay) (Zheng and Wang, 2001). In addition, the reported 
superoxide and hydroxyl radicals scavenging activities using the electron spin resonance 
technique (Masaki et al., 1995) and the protective effects against enzyme-dependent and 
enzyme-independent lipid peroxidation (Hohmann et al., 1999; Zupko et al., 2001) of sage 
extracts also showed its antioxidant potential. Recently, the drinking of a sage infusion (tea) for 
14 days was reported to improve liver antioxidant status in mice and rats (Lima et al., 2005). 
Additionally, the treatment of rats with a water extract of sage for 5 weeks was shown to protect 
against the hepatotoxicity of azathioprine (Amin and Hamza, 2005). However, despite all these 
effects, little is known about the antioxidant effects of sage extracts at the cellular level. Only in 
a small experiment using fibroblasts, performed by Masaki et al. (1995), sage antioxidant 
effects were related with cytoprotective effects. In their study, a sage extract protect 
significantly against cell death induced by a superoxide-generating system (Masaki et al., 1995). 
Very recently, a hydro alcoholic extract of sage was reported to possess neuroprotective effects 
against amyloid β (Aβ)-induced toxicity in PC12 cells, and the effect attributed, at least in part, 
to the rosmarinic acid (Iuvone et al., 2006). 
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In this study we proposed to evaluate the potential antioxidant/hepatoprotective effects 
of two sage extracts (a water and a methanolic crude extracts) against tert-butyl hydroperoxide 
(t-BHP)-induced oxidative damages in HepG2 cells. This model of hepatotoxicity was recently 
used to evaluate the in vitro hepatoprotective effects of individual phenolic compounds, which 
included the two most representative ones of the above sage extracts – rosmarinic acid and 
luteolin-7-glucoside (Lima et al., 2006a). Here, the concentration of sage extracts that protected 
50% (IC50) against t-BHP-induced cell death were determined in order to establish their 
hepatoprotective potential. Subsequently, IC80 values, a concentration that effectively protects 
against cell death, were used to evaluate the effects of each extract on three markers of oxidative 
damage: lipid peroxidation, intracellular glutathione levels and DNA damage. The importance 
of modulation of these parameters by sage extracts in the protection against t-BHP-induced cell 
death is discussed. Throughout the experiment quercetin was used as a positive control. 
 
2. Materials and methods 
 
2.1. Chemicals 
 
Minimum Essential Medium Eagle (MEM), tert-butyl hydroperoxide, quercetin and Bradford reagent 
were purchased from Sigma (St. Louis, MO, USA). Fetal Bovine Serum (FBS) was obtained from Biochrom 
KG (Germany). All others reagents were of analytical grade. 
 
2.2. Plant material, preparation of sage extracts and analysis of their phenolic composition 
 
Salvia officinalis L. plants were cultivated in an experimental farm located in Arouca, Portugal, and 
were collected in April, 2001. The aerial parts of plants were lyophilised and kept at -20º C.  
The dried and powdered aerial plant material (4 g) was extracted with 2 × 100 ml of 90% methanol in 
water at room temperature, using an ultrasonic bath (15 min). The filtered extract (SOME) was evaporated to 
dryness under reduced pressure at 40ºC and a yield of 26.2% (w/w) was obtained. 
Considering that sage is traditionally consumed as a tea, an infusion of sage (SOI) was also prepared 
following a previous methodology (Lima et al., 2005). In brief, 300 ml of ultrapure Milli Q boiling water were 
poured over 4 g of dried aerial plant material and allowed to steep for 5 min. The filtered extract was 
lyophilised to dryness and a yield of 25.8% (w/w) was obtained.  
Phenolic compounds present on SOME and SOI extracts were identified and quantified by 
HPLC/DAD as described in Santos Gomes et al. (2002) and Lima et al. (2005) for each extract, respectively. 
 
2.3. Antiradical activity 
 
The free radical scavenging (antiradical) activity of sage extracts was studied against two radicals: the 
stable free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH˙) and the superoxide radical. 
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For DPPH scavenging activity, after addition of different concentrations of extract to DPPH (90µM), 
the percentage of remaining DPPH was determined at different times from the absorbance at 515 nm using a 
plate reader spectrophotometer. As suggested by Sanchez-Moreno et al. (1998), the amount of antioxidant 
necessary to decrease by 50% the initial DPPH concentration (IC50) was expressed in terms of initial 
concentration of DPPH. We also present the parameter antiradical efficiency (AE) (Sanchez-Moreno et al., 
1998) using the estimated T  – time needed to reach the steady state at the corresponding ICIC50 50 concentration, 
where AE = 1/(IC50 × T ).  IC50
The superoxide radical scavenging activity was determined using the phenazine methosulphate-
NADH non-enzymatic assay as previously described (Valentao et al., 2001). 
 
2.4. Cell culture 
 
HepG2 cells (hepatocellular carcinoma cell line) were obtained from the American Type Culture 
Collection (ATCC) and maintained in culture in 75 cm2 polystyrene flasks (Falcon) with MEM containing 10% 
FBS, 1% antibiotic-antimycotic solution, 1 mM sodium pyruvate and 1.5 g/l sodium bicarbonate under an 
atmosphere of 5% CO2 at 37ºC. 
 
2.5. Experimental outline 
 
2.5.1. Assay for protection against t-BHP-induced toxicity in HepG2 cells 
In order to determine the concentration of sage extract/quercetin that protects the cells 50% from the 
oxidative damage (IC50), cells were incubated with 2 mM of t-BHP for 5 h to induce significant cell death as 
previously described (Lima et al., 2006a). HepG2 cells were plated in 24-multiwell culture plates at 2.5×105 
cells per well. The prevention of LDH leakage (cell death) was measured in co-incubations with sage 
extract/quercetin dissolved in DMSO (1% v/v final concentration, controls with DMSO only) at several 
concentrations. The IC50 and the Hillslope – slope from the plotted sage extract/quercetin’s concentrations (in 
logarithm) versus cell death protection relative to the control (2 mM t-BHP, 5 h) – were calculated graphically 
using a computer program (GraphPad Prism, version 4.00, GraphPad Software Inc.). Based on the dose-
response curves of protection against cell death by sage extract/quercetin, the IC80 concentrations were 
estimated and used in the following experiments to evaluate the protective potential of the compounds on 
several cellular parameters as previously described (Lima et al., 2006a). Briefly: 
 
2.5.2. Evaluation of the effects of sage extract/quercetin at the IC80 concentration against t-BHP-induced 
lipid peroxidation and GSH depletion in HepG2 cells. 
In order to evaluate the potential protective effect of sage extract/quercetin at IC80 concentration 
against t-BHP-induced lipid peroxidation and GSH depletion, cells were incubated with 2 mM t-BHP for 5 h. 
HepG2 cells were plated in 6-multiwell culture plates at 7.5×105 cells per well. Forty hours after plating, the 
medium was discarded and fresh medium containing 2 mM t-BHP and/or the IC80 concentration of sage 
extract/quercetin was added. Five hours later, cell culture medium and cell scrapings were harvested and kept 
at -80ºC for following quantification of lipid peroxidation and glutathione levels. 
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2.5.3. Evaluation of the effects of sage extract/quercetin at the IC80 concentration against t-BHP-induced 
DNA damage in HepG2 cells 
In order to evaluate the potential protective effect of sage extract/quercetin at IC80 concentration 
against t-BHP-induced DNA damage, cells were incubated with 200 µM t-BHP for 1 h. HepG2 cells were 
plated in 6-multiwell culture plates at 5×105 cells per well. Sixteen hours after plating, the medium was 
discarded and fresh medium containing 200 µM t-BHP and/or the IC80 concentration of sage extract/quercetin 
was added to the cells. After 1 h incubation, cells were rinsed with warm PBS and then incubated for 5 min 
with 0.125% (w/v) trypsin in PBS. The cells were then harvested in PBS to be used in the alkaline version of 
the comet assay for evaluation of DNA damage. 
 
2.6. Biochemical analysis 
 
2.6.1. LDH 
To assess the extend of cell death caused by t-BHP, the determination of lactate dehydrogenase 
leakage to the culture determination of lactate dehydrogenase leakage to the culture medium was used as 
indicator of plasma membrane integrity of HepG2 cells. LDH activity was measured spectrophometrically at 
30ºC as previously described (Lima et al., 2005). 
 
2.6.2. Lipid peroxidation 
The extent of lipid peroxidation was estimated by the levels of malondialdehyde measured using the 
thiobarbituric acid reactive substances (TBARS) assay at 535 nm following a methodology previously 
described (Fernandes et al., 1995) with some modifications (Lima et al., 2005). The results are expressed as 
nmol/mg of protein using a molar extinction coefficient of 1.56×105 M-1cm-1. 
 
2.6.3. Glutathione content 
The glutathione levels of HepG2 cells were determined by the DTNB-GSSG reductase recycling 
assay as previously described (Anderson, 1985), with some modifications (Lima et al., 2004). The results are 
expressed as nmol GSH/mg of protein. 
 
2.6.4. Protein 
Protein content was measured with a Bradford Reagent purchased from Sigma using bovine serum 
albumin as a standard. 
 
2.7. Comet assay 
 
The alkaline version of the single cell gel electrophoresis (comet) assay was performed based in 
previous descriptions (Klaude et al., 1996; Uhl et al., 1999; Uhl et al., 2000) with slight modifications (Lima et 
al., 2006a). The comet images were analysed using the semiquantitative method of visual scoring (Duthie and 
Dobson, 1999). Each cell was classified in five classes according to the intensity of fluorescence in the comet 
tail, attributing a value of 0, 1, 2, 3 or 4 from undamaged to maximal damage. In this way, the total score for 
100 images can range from 0 (all undamaged) to 400 (all maximally damaged), the overall DNA damage of the 
cell population expressed in arbitrary units. 
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2.8. Statistical analysis 
 
Data are expressed as means ± SEM. Statistical significances were determined using a one-way 
ANOVA followed by the Student-Newman-Keuls post-hoc test. P values ≤ 0.05 were considered statistically 
significant. 
 
3. Results 
 
3.1. Phenolic composition of sage extracts and their anti-radical activity 
 
A methanolic (SOME) and a water (SOI) extract were prepared from aerial parts of 
Salvia officinalis and analysed for phenolic compounds by HPLC/DAD (Table 1). Eight 
phenolic compounds were identified, 5 phenolic acids and 3 flavonoids, SOME having the 
highest content. SOME’s main phenolic compound was rosmarinic acid whereas SOI’s were 
rosmarinic acid and luteolin-7-glucoside. 
The antiradical activity of both extracts was then evaluated against DPPH and 
superoxide radicals (Table 2). SOME, with higher content in phenolic compounds, had higher 
antiradical activity against DPPH presenting a lower IC50 and a higher AE than SOI extract. The 
activity of both extracts was smaller than the positive control quercetin. Regarding the activity 
against superoxide radical, SOI extract had a comparable antiradical activity to that of quercetin, 
higher than that of SOME. 
 
3.2. Potential hepatoprotective effects of sage extracts 
 
The potential hepatoprotective effects of both sage extracts against the cell death 
induced by t-BHP were evaluated in HepG2 cells (Table 3, Fig. 1). t-BHP 2 mM for 5 hours 
Table 1. Composition (µg/mg extract) in phenolic 
compounds of S. officinalis methanolic extract (SOME) 
and S. officinalis infusion (SOI) 
Compound SOME SΟΙ 
Phenolic acids  
Rosmarinic acid 132.2 52.0
Caffeic acid       tr 0.8
Ferulic acid       tr 0.5
3-Caffeoylquinic acid       tr                     tr 
5-Caffeoylquinic acid       tr                     tr 
Flavonoids  
Table 2. Antiradical activity of the sage extracts and 
quercetin against DPPH and superoxide radical 
 
Superoxide radicalcDPPH  
 Extract/Compound IC b50
Luteolin-7-glucoside 1.2 19.7
4’,5,7,8-Tetrahydroxyflavone 0.1 0.9
Apigenin-7-glucoside       tr 0.4
tr – trace amounts 
(g/kg DPPH)a AE  (×10
-3) IC50 (μg/ml) 
SOME  381 ± 14 0.22  162 ± 39 
 SOI  419 ± 9 0.18 14.4 ± 1.4 
 10.6 ± 1.0 Quercetin 96.6 ± 1.9 0.47 
a Values represent mean ± SD of 5 replicates. 
b AE - Antiradical efficiency  
c Values represent mean ± SD of 3 independent experiments with 3 
replicates each. 
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was previously shown to induce oxidative damage to HepG2 cells causing about 40-50% of cell 
death (Lima et al., 2006a). As shown in Fig. 1, both extracts protected against cell death in a 
dose-dependent manner. SOME had, however, higher hepatoprotective activity (lower IC
 
Fig. 1. Dose-response effect of the sage extracts against t-BHP-induced toxicity in HepG2 cells. After incubating 
HepG2 cells with 2 mM of t-BHP and sage extracts/quercetin for 5 h, protection against cell death (as measured by 
LDH leakage) versus sage extract/quercetin concentrations (in logarithm) were plotted in order to take the IC50 and 
Hillslope of each compound (Table 3). Values are mean ± SEM of at least 4 independent experiments. 
50) 
than SOI (Table 3), and in the same range of that of quercetin. The Hillslope was also higher in 
SOME than SOI (Table 3), which indicates a narrower concentration (in logarithm) range from 
0 to 100% of hepatoprotective activity of SOME (Fig 1). 
 
3.3. Effects of sage extracts on lipid peroxidation, glutathione levels and DNA damage 
 
To study the effects of sage extracts against lipid peroxidation, GSH depletion and 
DNA damage induced by t-BHP, concentrations that effectively protect against cell death (IC80) 
were used. IC80 concentrations were used to determine if the same level of cytoprotection for 
each extract correlate with similar effects on the above mentioned parameters. IC80 
concentration for each extract (Table 3) was estimated based on the curves presented in Fig. 1. 
As shown in Fig. 2, t-BHP-induced lipid peroxidation was significantly decreased by 
around 25% by both extracts. Quercetin also significantly protected against lipid peroxidation 
by 30%. None of the extracts, when incubated alone with HepG2 cells, induced significant lipid 
peroxidation. 
t-BHP-induced GSH (reduced 
glutathione) depletion was also signify-
cantly inhibited by both extracts by around 
62% while quercetin inhibited GSH 
depletion by only 40% (Fig. 3). The 
increase in GSSG levels induced by t-BHP 
was slightly decreased by both sage 
Table 3. Potential hepatoprotective effectsa of the sage 
extracts against t-BHP-induced toxicity in HepG2 cells 
Hillslope Extract/Compound IC50 (μg/ml) IC80 (μg/ml)
SOME     7.6 ± 0.5 1.89 ± 0.23     16 
SOI 101.4 ± 11.3 1.02 ± 0.13 ~250 
Quercetin     6.5 ± 0.5 1.95 ± 0.28     13 
a Tested in co-incubations with 2 mM of t-BHP (5 h) in HepG2 cells. IC50 
and the Hillslope were taken form the plotted dose-response curve (Fig. 1). 
IC80 concentration was estimated from the same dose-response curve. 
Values are mean ± SEM of at least 4 independent experiments. 
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Fig. 3. Effect of sage extracts at IC80 concentration 
against t-BHP-induced decrease in GSH levels in 
HepG2 cells. HepG2 cells were incubated with t-BHP 
2 mM (5 h) and/or with sage extract/quercetin at IC
Fig. 2. Effect of sage extracts at IC80 concentration 
against t-BHP-induced lipid peroxidation in HepG2 
cells. HepG2 cells were incubated with t-BHP 2 mM 
(5 h) and/or with sage extract/quercetin at IC
80
extracts and quercetin, although the effect was not statistically significant (data not shown). 
When the cells were incubated with the extracts alone, a significant increase in the basal GSH 
levels (Fig. 3) was observed for SOME (15%). On the other hand, quercetin induced a decrease 
in the basal levels of GSH. 
The incubation of HepG2 cells for 1 h with 200 µM of t-BHP induced significant DNA 
damages without cell death (Lima et al., 2006a), conditions that can be used to assess effects of 
compounds or extracts against DNA damage by the comet assay. As shown in Fig. 4, contrarily 
to what happened with quercetin, both sage extracts did not protect HepG2 cells against DNA 
damage induced by t-BHP. None of the tested extracts induced DNA damages at IC80 
concentration when incubated alone with HepG2 cells. 
80 
concentration and lipid peroxidation measured by 
TBARS assay. Values are mean ± SEM, n = 5 (100% = 
2.25 nmol/mg). *** P ≤ 0.001 when compared with the 
negative control. 
concentration and GSH levels determined by the DTNB-
GSSG reductase recycling assay. Values are mean ± 
SEM, n = 5 (100% = 72.4 nmol/mg). * P ≤ 0.05 and 
*** P ≤ 0.001 when compared with the negative control. 
## P ≤ 0.01 and ### P ≤ 0.001 when 
compared with the t-BHP control. 
## P ≤ 0.01 and ### P ≤ 0.001 when compared with the t-
BHP control. 
 
Fig. 4. Effect of sage extracts at IC80 concentration against t-BHP-induced DNA damage in HepG2 cells. HepG2 cells 
were incubated with t-BHP 200 µM (1 h) and/or with sage extract/quercetin at IC80 concentration and DNA damage 
evaluated by the comet assay. DNA damage was assessed by the semiquantitative method of visual scoring. Values 
are mean ± SEM, n = 4 (100% = 187.1 arbitrary units). *** P ≤ 0.001 when compared with the negative control.  
### P ≤ 0.001 when compared with the t-BHP control. 
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4. Discussion and conclusions 
 
Since oxidative stress has been recognised to be involved in the aetiology of several 
liver diseases (Loguercio and Federico, 2003; Vitaglione et al., 2004) and because the liver is 
very susceptible to toxic effects, natural antioxidants and plant extracts have been proposed as 
therapeutic agents to counteract liver damage. Salvia officinalis is well known for its antioxidant 
activity, mainly based in several subcellular and noncellular in vitro studies (Baricevic and 
Bartol, 2000). Recently, sage tea drinking was reported to improve liver antioxidant status in 
mice and rats (Lima et al., 2005). That was, however, not enough to protect against CCl4-
induced hepatotoxicity in mice and, instead, a herb-toxicant interaction was observed (Lima et 
al, 2006b). In another experiment, the treatment of rats with a water extract of sage for 5 weeks 
was, on the other hand, shown to protect against the hepatotoxicity of azathioprine (Amin and 
Hamza, 2005). However, despite all these effects, little is known about the antioxidant and 
protective effects of sage extracts at cellular level. 
Here, the potential antioxidant and hepatoprotective effects of sage crude extracts were 
tested against t-BHP-induced toxicity in HepG2 cells. Both a methanolic (SOME) and a water 
extract (SOI) of sage, in co-incubations with the toxicant, showed protective effects against t-
BHP-induced cell death. SOME extract revealed higher hepatoprotective activity than SOI. This 
is in agreement with the literature where sage’s antioxidant activity has been attributed to its 
phenolic compounds, more abundant in the methanolic extract. This was shown by the lower 
IC50 obtained for this extract against t-BHP-induced cell death compared to that of SOI extract. 
In this model of cytoprotection, because effects were tested in co-incubations with the toxicant, 
the antioxidant protection may reflect mainly direct actions on t-BHP toxicity (Lima et al, 
2006a). These direct effects would include, besides the antiradical scavenging or hydrogen-
donating activity measured in this study, the compounds’ ability to chelate metal ions (Rice-
Evans et al., 1996). Since ROS (Martin et al., 2001), t-BHP radicals (Davies, 1989; VanderZee 
et al., 1996) and intracellular iron ions (Hix et al., 2000) are involved in the toxicity of t-BHP, 
direct effects at both these levels would tend to reduce the extension of damage. Antiradical 
activity of sage was shown here against DPPH and superoxide radicals and also by previous 
studies (Lamaison et al., 1991; Cuvelier et al., 1994; Masaki et al., 1995; Zheng and Wang, 
2001; Shan et al., 2005). Considering the composition of the extracts in phenolic compounds, 
they most likely also possess the ability to chelate metal ions (Rice-Evans et al., 1996). 
Apart from the antiradical and metal chelation ability of the extracts, they will only act 
as intracellular antioxidants if the compounds permeate cell membranes. Previous results 
underscored the importance of the compound’s lipophilicity in addition to its antioxidant 
potential for biological activity (Lima et al., 2006a). The two main phenolic compounds present 
in these extracts, rosmarinic acid and luteolin-7-glucoside, were previously tested in this 
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experimental model and shown to possess similar hepatoprotective activities (IC50’s of 69 µM 
and 78 µM, respectively; Lima et al., 2006a). 
In an attempt to explain the observed cytoprotective effects of the sage extracts, we 
looked at their effects at IC80 concentration on three markers of cellular oxidative stress: lipid 
peroxidation, glutathione levels and DNA damage. Incubation of HepG2 cells with t-BHP 
induced significant lipid peroxidation, GSH depletion and DNA damage. At IC80, both sage 
extracts significantly prevented lipid peroxidation and GSH depletion, but failed to prevent 
DNA damage. In a previous study, both rosmarinic acid and luteolin-7-glucoside also 
significantly prevented lipid peroxidation and GSH depletion. Both these compounds had poor 
ability to prevent DNA damage induced by t-BHP (Lima et al., 2006a). There seems to be, 
therefore, a good correlation between the biological effects of sage extracts and those of their 
main phenolic compounds. 
Based on previous studies, lipid peroxidation and DNA damage seem not to be as 
relevant for the t-BHP-induced cell death as GSH depletion (Martin et al., 2001; Lima et al., 
2006a). GSH depletion has been suggested as the primary mechanisms of t-BHP-induced 
toxicity in liver cells (Jewell et al., 1986; Buc-Calderon et al., 1991; Martin et al., 2001). GSH 
plays an important role in hepatocyte defence against ROS, free radicals and electrophilic 
metabolites (Kedderis, 1996; Castell et al., 1997). A severe GSH depletion leaves cells more 
vulnerable to oxidative damage and is normally associated with calcium homeostasis disruption, 
which ultimately causes cell death (Castell et al., 1997). The prevention of t-BHP-induced GSH 
depletion in at least 40% has previously been suggested as a major contribution to 
cytoprotective effects in the experimental model used here (Lima et al., 2006a). Thus, the 62% 
protection against GSH depletion was probably the most relevant effect of the extracts used in 
this study. 
Although rosmarinic acid and luteolin-7-glucoside present in the extracts may 
contribute to the observed prevention of GSH depletion induced by t-BHP, they cannot be the 
sole explanation for the effects of sage extracts on the GSH levels. In the same experimental 
model, both phenolic compounds showed to decrease slightly GSH levels when incubated alone 
with HepG2 cells for 5 hours (Lima et al., 2006a), an effect similar to what was observed in this 
study with quercetin – the positive control. On the contrary, when sage extracts were incubated 
alone with HepG2 cells for 5 hours, a slight increase in GSH levels was observed, which was 
significant for the SOME extract. Compounds other than phenolics present in the extracts 
appear, therefore, to be important for this effect of sage extracts in HepG2 cells. Since the 
increase in GSH levels was accompanied by an increase in the total glutathione levels (and not 
to a reduction in GSSG levels), sage extracts seem to have an ability to increase the de novo 
synthesis of glutathione. A previous study also showed that, after a stress-induced GSH 
depletion, SOI given in vivo to rats restored GSH levels of subsequent hepatocyte cultures to a 
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higher value than controls (Lima et al., 2005). In that study, the ability of SOI to increase the de 
novo glutathione synthesis was also suggested. In agreement with this, Amin and Hamza (2005) 
showed the ability of sage to protect in vivo the hepatotoxicity of a drug that acts by depleting 
GSH levels. 
In conclusion, this study showed clearly the antioxidant effects at cellular level of sage, 
namely preventing cell death, lipid peroxidation and GSH depletion induced by t-BHP. These 
extracts seem also to have positive effects on GSH levels that can be relevant in the face of a 
situation of oxidative stress. The observed hepatoprotective effects suggest the use of sage in the 
treatment for liver diseases where it is known that oxidative stress is involved. The phenolic 
compounds present in the sage extracts are probably contributors to the observed 
hepatoprotection but other unknown compounds may also be important, mainly in the induction 
of glutathione synthesis. 
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This chapter comprises also the following publication: 
Lima CF, Fernandes-Ferreira M & Pereira-Wilson C, 2006. Phenolic compounds protect HepG2 
cells from oxidative damage: Relevance of glutathione levels. Life Sciences 79(21), 2056-2068. 
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Abstract 
In the present work, the potential hepatoprotective effects of five phenolic compounds against oxidative damages induced by tert-butyl 
hydroperoxide (t-BHP) were evaluated in HepG2 cells in order to relate in vitro antioxidant activity with cytoprotective effects. t-BHP induced 
considerable cell damage in HepG2 cells as shown by significant LDH leakage, increased lipid peroxidation, DNA damage as well as decreased 
levels of reduced glutathione (GSH). All tested phenolic compounds significantly decreased cell death induced by t-BHP (when in co-incubation). 
If the effects of quercetin are given the reference value 1, the compounds rank in the following order according to inhibition of cell death: luteolin 
(4.0) > quercetin (1.0) > rosmarinic acid (0.34) > luteolin-7-glucoside (0.30) > caffeic acid (0.21). The results underscore the importance of the 
compound's lipophilicity in addition to its antioxidant potential for its biological activity. All tested phenolic compounds were found to 
significantly decrease lipid peroxidation and prevent GSH depletion induced by t-BHP, but only luteolin and quercetin significantly decreased 
DNA damage. Therefore, the lipophilicity of the natural antioxidants tested appeared to be of even greater importance for DNA protection than for 
cell survival. The protective potential against cell death was probably achieved mainly by preventing intracellular GSH depletion. The phenolic 
compounds studied here showed protective potential against oxidative damage induced in HepG2 cells. This could be beneficial against liver 
diseases where it is known that oxidative stress plays a crucial role. 
 
Keywords:  Phenolic compounds; Liver; Oxidative stress; HepG2 cells; tert-butyl hydroperoxide; Antioxidants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 2004). The liver is particularly susceptible to toxicants since the 
portal vein brings blood to this organ after intestinal absorption. 
The absorbed drugs and xenobiotics in a concentrated form can 
cause ROS- and free radical-mediated damage that may result in 
inflammatory and fibrotic processes (Jaeschke et al., 2002). 
 
An overall increase in cellular levels of reactive oxygen 
species (ROS) above the cells' defenses results in oxidative 
stress that can ultimately cause cell death. Oxidative stress has 
been recognized to be involved in the etiology of several age-
related and chronic diseases such as cancer, diabetes, neurode-
generative and cardiovascular diseases (Tiwari, 2004; Cui et al., 
2004; Ceriello and Motz, 2004; Klaunig and Kamendulis, 2004; 
Willcox et al., 2004; Ballinger, 2005; Gibson and Huang, 2005). 
In particular with respect to liver diseases such as hepatocellular 
carcinoma, viral and alcoholic hepatitis and non-alcoholic 
steatosis, it is known that ROS and reactive nitrogen species 
play a crucial role in disease induction and progression (Adachi 
and Ishii, 2002; Loguercio and Federico, 2003; Vitaglione et al., 
Because oxidative stress plays a central role in liver diseases 
pathology, dietary antioxidants have been proposed as therapeutic 
agents to counteract liver damage (Vitaglione et al., 2004). This 
same idea has also been suggested for other oxidative stress-based 
chronic diseases (Tiwari, 2004; Willcox et al., 2004). In fact, 
several epidemiological studies have shown that diets rich in fruit 
and vegetables and other plant foods (including tea and wine) are 
associated with a decreased risk of premature death and mortality 
from chronic diseases, such as cardiovascular diseases and some 
types of cancer (Stanner et al., 2004; Scalbert et al., 2005). 
Phenolic compounds (PhC), and in particular polyphenols, are 
believed to be, at least in part, responsible for such effects. Results 
from some human clinical trials support the role of these  
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compounds in the prevention of some chronic diseases (Ren et al., 
2003; Spencer et al., 2004; Tiwari, 2004; Willcox et al., 2004; 
Scalbert et al., 2005). 
alkoxyl free radicals by cytochrome P450 enzymes and by free 
iron-dependent reactions. These free radicals can subsequently 
initiate lipid peroxidation, form covalent bonds with cellular 
molecules (such as DNA and proteins) and further decrease GSH 
levels. The latter effect, in addition to altering calcium homeo-  
stasis, affects mitochondrial membrane potential, eventually 
causing cell death (Rush et al., 1985; Nicotera et al., 1988; 
Masaki et al., 1989; Davies, 1989; Buc-Calderon et al., 1991; 
Kass et al., 1992; VanderZee et al., 1996; Hix et al., 2000). 
Today much is known about the chemistry and antioxidant 
potential of PhC as a result of in vitro chemical and sub-cellular 
studies (Rice-Evans et al., 1997; Croft, 1998). However,  besides 
their strong free radical scavenging activity, PhC can also act as 
antioxidants by chelating metal ions, preventing radical for-
mation, and indirectly by modulating enzyme activities and 
altering the expression levels of important proteins, such as 
antioxidant and detoxifying enzymes (Ferguson, 2001; Ross 
and Kasum, 2002; Ferguson et al., 2004). Few studies, however, 
address the biological effects of PhC, and the ones performed 
using cellular and in vivo models indicate a poor correlation 
between the antioxidant potency of PhC measured in vitro and 
the compound's biological activity. The biological effect of PhC 
and their in vivo circulating metabolites will ultimately depend 
on their cellular uptake and/or the extent to which they 
associate with cell membranes (Spencer et al., 2004). 
In this study we evaluate the hepatoprotective effects of PhC 
against t-BHP-induced oxidative damage inHepG2 cells, in order 
to relate in vitro antioxidant activity with cytoprotective effects. 
Two phenolic acids, caffeic acid and rosmarinic acid (an ester of 
caffeic acid and 3,4-dihydroxyphenyllactic acid), and three flavo-
noids, luteolin (flavone), luteolin-7-glucoside (flavone glycoside) 
and quercetin (flavonol), were used (Fig. 1). Firstly, the con-
centrations of PhC that protected by 50% (IC50) against t-BHP-
induced cell death were determined. Based on the IC50 values for 
each compound, biological activity was related to both antiradical 
efficiency and hydrophobicity. Subsequently, ICHepG2 cells, a human hepatoma cell line, are considered a 
good model to study in vitro xenobiotic metabolism and toxicity 
to the liver, since they retain many of the specialized functions 
which characterize normal human hepatocytes (Knasmuller et al., 
1998). In particular, HepG2 cells retain the activity of many phase  
I, phase II and antioxidant enzymes ensuring that they constitute a 
good tool to study cytoprotective, genotoxic and antigenotoxic 
effects of compounds (Knasmuller et al., 2004; Mersch- 
Sundermann et al., 2004). Recently, studies of cytoprotection 
by natural antioxidants in HepG2 cells have increasingly been 
using tert-butyl hydroperoxide (t-BHP), an organic hydropero-
xide, as the toxic agent (Thabrew et al., 1997; Kinjo et al., 2003; 
Mersch-Sundermann et al., 2004; Lee et al., 2005a,b; Alia et al., 
2006). t-BHP can bemetabolized in the hepatocyte by glutathione 
peroxidase, generating oxidized glutathione (GSSG) (Sies and 
Summer, 1975; Rush et al., 1985). GSSG is converted back to 
reduced glutathione (GSH) at the expense of NADPH by glu-
tathione reductase (GR). Depletion of GSH and NADPH oxi-
dation are associated with altered calcium homeostasis, leading to 
loss of cell viability (Bellomo et al., 1982; Martin et al., 2001). 
Alternatively, t-BHP can be converted into its peroxyl and 
a
80 values, a con-
centration that effectively protects 80% of the cells against t-
BHP-induced cell death, were used to evaluate the effects of each 
compound on several markers of oxidative damage, such as 
intracellular glutathione, lipid peroxidation, glutathione-related 
enzyme such as glutathione-S-transferase (GST), GR and gluta-
thione peroxidase (GPox), as well as on DNA damage. The 
relative importance of effects of PhC on these parameters to 
protection against t-BHP-induced cell death is discussed. 
 
Materials and methods 
 
Chemicals 
 
    Minimum Essential Medium Eagle (MEM), tert-butyl hydro-
peroxide, quercetin, rosmarinic acid, caffeic acid and Bradford 
reagent were purchased from Sigma–Aldrich (St. Louis, MO, 
USA). Fetal bovine serum (FBS) was obtained from Biochrom 
KG (Germany). Luteolin and luteolin-7-O-glucoside were 
purchase from Extrasynthese (Genay, France). All other reagents 
were of analytical grade. 
 
Fig. 1. Chemical structures of the phenolic compounds used in this study. 
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Cell culture with 0.125% (w/v) trypsin in PBS. The cells were then harvested 
in PBS to be used in the alkaline version of the comet assay for 
evaluation of DNA damage. To study the protective potential of 
PhC at IC
 
HepG2 cells (hepatocellular carcinoma cell line), obtained 
from the American Type Culture Collection (ATCC), were 
maintained in culture in 75 cm
80 concentration on t-BHP-induced DNA damage, cells 
were incubated with 200 μM t-BHP for 1 h to induce significant 
DNA damage. For that, 16 h after plating, the medium was 
discarded and fresh medium containing 200 μM t-BHP and/or the 
IC
2 polystyrene flasks (Falcon) with 
MEM containing 10% FBS, 1% antibiotic–antimycotic solu-
tion, 1 mM sodium pyruvate and 1.5 g/l sodium bicarbonate 
under an atmosphere of 5% CO2 at 37°C. 80 concentration of each PhC was added to the cells. After 1 h 
incubation, cells were treated as above to carry out the comet 
assay. 
 
Assay for t-BHP cytotoxicity and protection by phenolic compounds 
  
HepG2 cells were plated in 24-multiwell culture plates at 
2.5×10
Comet assay 
5 cells per well. To study t-BHP cytotoxicity, 40 h after 
plating, the medium was discarded and fresh medium contain-
ing t-BHP at various concentrations was added. At different 
time points, cellular viability was determined by the MTT assay 
(Mosmann, 1983) and by lactate dehydrogenase (LDH) leakage 
assay (Lima et al., 2005). In order to determine the concen-
tration of PhC that protects 50% of the cells from damage 
induced by the toxicant (IC
 
The single cell gel electrophoresis (comet) assay was per-
formed based on previous descriptions (Klaude et al., 1996; 
Uhl et al., 1999, 2000) with slight modifications. Briefly, 
40,000 cells in PBS were centrifuged (80 ×g, 2 min), the pellet 
was mixed with 100 μl of low melting agarose 0.5% (w/v) in 
PBS, at 37 °C and spread on agarose coated slides. The agarose 
was allowed to set at 4°C for 10 min, and then the slides were 
immersed in lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM 
Tris, pH 10 with NaOH, triton X-100 1% v/v added fresh) at 
4°C for 2 h. After being rinsed with distilled water, the slides 
were immersed in a horizontal electrophoresis tank with elec-
trophoresis buffer (300 mM NaOH, 1 mM EDTA, pH > 13) at 
4°C and exposed for 40 min to allow alkaline unwinding. 
Afterwards, electrophoresis was carried out under alkaline 
conditions for 20 min, 300 mA, at 0.8 V/cm in a cold room  
(4°C). Finally, the slides were neutralized by washing three 
times for 5 min each with 0.4 M Tris, pH 7.5, at 4°C, fixed with 
methanol and kept at 4°C until evaluation. For the analysis of 
the comet images, the DNA was stained with ethidium bromide 
and scored under a fluorescent microscope using a computer 
assisted image analysis system and/or a visual scoring method 
avoiding analyzing cells at the edges of the gel. The computer 
image analyses were done using a public domain image- 
analysis program — NIH image (Helma and Uhl, 2000), and 
the results expressed in terms of tail length, tail moment and % 
DNA in tail of 50 cells in 4 independent experiments. In the 
semiquantitative method of visual scoring, the comet images 
were classified in five classes according to the intensity of 
fluorescence in the comet tail, attributing a value of 0, 1, 2, 3 or 
4 from undamaged to maximal damage. In this way, the total 
score for 100 images can range from 0 (all undamaged) to 400 
(all maximally damaged) giving the overall DNA damage of 
the cell population expressed in arbitrary units (Duthie and 
Dobson, 1999; Duthie, 2003). 
50), cells were incubated with 2 mM 
of t-BHP for 5 h to induce significant cell death. The prevention 
of LDH leakage (cell death) was measured in co-incubations 
with PhC dissolved in DMSO (1% v/v final concentration, 
controls with DMSO only) at several concentrations. The IC50 
and the Hill slope — the slope of the PhC concentrations (in 
logarithm) plotted versus cell death protection relative to the 
control (2 mM t-BHP, 5 h) — were calculated graphically using a 
computer program (GraphPad Prism, version 4.00, GraphPad 
Software Inc.). Based on the dose–response curves of cell death 
protection by PhC against the t-BHP-induced oxidative damage 
in HepG2 cells, the IC80 concentrations were estimated and 
used in the following experiments to evaluate the protective 
potential of the compounds on several cellular parameters. 
 
Evaluation of the effects of t-BHP and PhC at the IC80 
concentration on lipid peroxidation, glutathione levels and 
glutathione-related enzyme activities in HepG2 cells 
 
HepG2 cells were plated in 6-multiwell culture plates at 
7.5×105 cells per well. 40 h after plating, the medium was 
discarded and fresh medium containing 2 mM t-BHP and/or the 
IC80 concentration of each PhC was added. 5 h later, cell culture 
medium and cell scrapings were harvested and kept at −80°C 
for following quantification of several parameters. Cell 
scrapings were harvested in lysis buffer (25 mM KH2PO4,  
2 mM MgCl2, 5 mM KCl, 1 mM EDTA, 1 mM EGTA, 100 μM 
PMSF, pH 7.5) after rinsing the cells with PBS (137 mM NaCl, 
2.7 mM KCl, 8.5 mM Na
 
2HPO4, 1.5 mM KH2PO4, pH 7.4).  
 Biochemical analyses 
Evaluation of the effects of t-BHP and PhC at the IC80 
concentration on DNA damage in HepG2 cells 
 
Lipid peroxidation 
 The extent of lipid peroxidation was estimated by the levels 
of malondialdehyde measured using the thiobarbituric acid re-
active substances (TBARS) assay at 535 nm following a metho-
dology previously described (Lima et al., 2005). The results  
are expressed as nmol/mg of protein using a molar extinction 
coefficient of 1.56×10
HepG2 cells were plated in 6-multiwell culture plates at 5×105 
cells per well. To study t-BHP-induced DNA damage, 16 h after 
plating, the medium was discarded and fresh medium containing 
t-BHP at various concentrations was added. After 1 h of incuba-
tion, cells were rinsed in warm PBS and then incubated for 5 min  5 M−1cm−1. 
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Fig. 2. t-BHP-induced toxicity in HepG2 cells. HepG2 cells were incubated with t-BHP 1 mM and 2 mM for different time periods and cell viability measured by LDH 
leakage (% of LDH in the extracelular medium) (A) and MTT assay (B). Time scale was logarithmized in order to obtain sigmoidal response curves. Values represent 
the mean ± SEM, n = 4. In A: *P ≤ 0.05 and ***P ≤ 0.001 when compared to the same time point in the control situation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Glutathione levels tioxidant necessary to decrease by 50% the initial DPPH con-
centration (ICThe glutathione levels from the cell cultures were determined 
by the DTNB–GSSG reductase recycling assay as previously 
described (Anderson, 1985),with some modifications (Lima et al., 
2004). The results are expressed as nmol GSH/mg of protein. 
50)was expressed in terms of initial concentration of 
DPPH to make the results easier comparable with other published 
results. However, we put the results of the PhC in terms of moles 
instead of grams to better relate the results with the chemical 
structures (Fig. 1) of the PhC studied. We also calculated the 
parameter antiradical efficiency (AE) (Sanchez-Moreno et al., 
1998) using the estimated T
 
Glutathione-related enzyme activities 
For measurement of the glutathione-related enzyme activities, 
the cell scraping homogenates were centrifuged at 10,000 ×g for 
10 min at 4°C and the supernatant collected. 
IC50 — the time needed to reach the 
steady state at the corresponding IC50 concentration, where 
AE = 1/(IC50×TIC50). Finally, a new parameter is also shown — 
the Hill slope, the graphically calculated slope from the plotted 
PhC concentration (in logarithm) versus the remaining DPPH 
concentration (GraphPad Prism). The higher this value, the nar-
rower the concentration range from 0 to 100% of antiradical 
activity. This graph was also used to calculate the IC
GST and GR activities were measured spectrophotometri-
cally at 30 °C as previously described (Lima et al., 2005) and 
the results expressed in nmol/min/mg protein (mU/mg). 
The selenium-dependent and -independent GPox activity 
was assayed as previously described (Martin-Aragon et al., 
2001) with some modifications. Briefly, GPox activity was 
measured at 30°C following NADPH oxidation at 340 nm on a 
plate reader spectrophotometer (SpectraMax 340pc, Molecular 
Devices, Sunnyvale, CA, USA) in the presence of 1 mM GSH, 
0.18 mM NADPH, 1 mM EDTA, 0.5 U/ml GR and 0.7 mM t-
BHP in 50 mM imidazole (pH 7.4). The activity was expressed 
as nmol of substrate oxidized per minute per mg of protein 
(mU/mg). 
50 of each 
compound. 
The superoxide radical scavenging activity was determined 
using the phenazine methosulphate-NADH nonenzymatic assay 
as previously described (Valentao et al., 2001). As for DPPH  
 
Protein 
 
Protein content was measured with the Bradford Reagent 
purchased from Sigma using bovine serumalbumin as a standard. 
 
Antiradical activity 
 
The free radical scavenging (antiradical) activity of PhC was 
studied against two radicals: the stable free radical 2,2-diphenyl-
1-picrylhydrazyl (DPPH) and the superoxide radical.  
Fig. 3. Dose–response effect of the tested PhC against t-BHP-induced toxicity 
in HepG2 cells. After incubating HepG2 cells with 2 mM of t-BHP and 
individual PhC for 5 h, protection against cell death (as measured by LDH 
leakage) versus PhC concentration (in logarithm) were plotted in order to take 
the IC
For DPPH scavenging activity, after the addition of different 
concentrations of PhC to DPPH (90 μM), the percentage of the 
remaining DPPH was determined at different times from the 
absorbance at 515 nm using a plate reader spectrophotometer. As 
suggested by Sanchez-Moreno et al. (1998), the amount of an-  
50 and Hill slope of each compound (Table 1). Values are the mean ± SEM 
of at least 4 independent experiments. 
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Table 1 
Potential hepatoprotective effects of the tested PhC against t-BHP-induced 
toxicity in HepG2 cells 
Hill slope Compound 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IC50 (μM) IC80 (μM)
Caffeic acid 114.1 ± 11.5 1.17 ± 0.16 370 
Rosmarinic acid   69.2 ± 5.3 1.48 ± 0.16 180 
Luteolin-7-O-glucoside   78.0 ± 7.6 1.47 ± 0.22 200 
Luteolin     5.9 ± 0.5 2.46 ± 0.44   11 
Quercetin   23.5 ± 1.4 2.12 ± 0.27   45 
Hepatoprotective effects of PhC were tested in co-incubations with 2 mM of t-BHP 
(5 h) in HepG2 cells. IC50 and the Hill slope were taken from the plotted dose– 
response curve (Fig. 3). IC80 concentration was estimated from the same dose– 
response curve. Values are the mean ± SEM of at least 4 independent experiments. 
assay, we also show the Hill slope from the graphics used to 
calculate the IC50 (GraphPad Prism).  
 Fig. 4. Effects of t-BHP and PhC at the IC80 concentration on reduced 
glutathione levels in HepG2 cells. HepG2 cells were incubated with t-BHP 
2 mM (5 h) and/or with individual PhC (CA - caffeic acid; RA - rosmarinic 
Measurement of the partition coefficients 
 
acid; L-7-G - luteolin-7-glucoside; L - luteolin; Q - quercetin) at ICThe degree of hydrophobicity of the PhC was examined by 
measuring the partition coefficients taken in logarithm using an 
n-octanol/HEPES system (K
80 
concentration and GSH levels measured. Values are the mean ± SEM, n = 5. 
***P ≤ 0.001 when compared with the negative control. #P ≤ 0.05, ##P ≤ 0.01 
and ow) as previously described (Areias 
et al., 2001), at ambient temperature (∼ 25°C). 
###P ≤ 0.001 when compared with the t-BHP control. 
 
Statistical analysis 
established (Sies and Summer, 1975; Cadenas and Sies, 1982; 
Bellomo et al., 1982; Rush et al., 1985; Jewell et al., 1986; 
Nicotera et al., 1988; Masaki et al., 1989; Davies, 1989; Buc- 
Calderon et al., 1991; Kass et al., 1992; Hix et al., 2000; Martin 
et al., 2001). Recently, HepG2 cells have been used to study the 
hepatotoxicity of t-BHP (Kim et al., 1998, 2000; Piret et al., 
2002, 2004; Alia et al., 2005), and this model suggested to 
evaluate the protective properties of natural compounds and 
plant extracts against oxidative damages (Thabrew et al., 1997; 
Kinjo et al., 2003; Lee et al., 2005a,b; Alia et al., 2006). 
However, because the cell's response to t-BHP depends on 
culture conditions, we first studied HepG2 cells' response to t-  
 
Data are expressed as the means ± SEM. Statistical signifi-
cances were determined using a one-way ANOVA followed by 
the Student–Newman–Keuls post-hoc test. P values ≤ 0.05 
were considered statistically significant. 
 
Results 
 
t-BHP cytotoxicity 
 
The cytotoxicity of t-BHP to liver cells has been extensively 
studied although its mechanisms of action have not been totally  
Table 2 Table 3 
Effects of t-BHP nad PHC at IC Effects of t-BHP nad PHC at IC80 concentration on lipid peroxidation and 
oxidized glutathione levels  in HepG2 cells 
80 concentration on glutathione-related enzyme 
activities in HepG2 cells 
t-BHP t-BHP Parameter Enzyme activity (mU/mg) Phenolic 
compound 
Phenolic compound 
2 mM, 2 mM, 
GST GR GPox TBARS (nmol/mg) GSSG (nmol GSH equiv/mg)~ 5 h ~ 5 h 
- 0.20 ± 0.05 1.2 ± 0.3 _ 
+ 2.25 ± 0.13*** 5.0 ± 0.4*** 
- 0.19 ± 0.10 1.2 ± 0.4 Caffeic acid 
+ 1.54 ± 0.10### 4.2 ± 0.1 
- 0.15 ± 0.05 1.2 ± 0.3 Rosmarinic 
acid + 1.71 ± 0.08### 3.5 ± 0.3#
- 0.15 ± 0.02 1.3 ± 0.2 Luteolin-7-
glucoside + 1.74 ± 0.08### 3.8 ± 0.5 
- 0.20 ± 0.07 1.6 ± 0.4 Luteolin 
+ 1.66 ± 0.12### 4.4 ± 0.4 
- 0.15 ± 0.06 1.5 ± 0.3 Quercetin 
+ 1.64 ± 0.12
###
4.6 ± 0.2 
HepG2 cells were incubated with t-BHP 2 mM (5 h) and/or with individual PhC 
at IC80 concentration and lipid peroxidation (as estimated by TBARS assay) and 
GSSG levels measured. Values are the mean ± SEM, n = 5 (TBARS), n = 4 
(GSSG). ***P ≤ 0.001 when compared with the negative control. #P ≤ 0.05 and 
###P ≤ 0.001 when compared with the t-BHP control. 
- 24.7 ± 1.0 25.9 ± 0.8 18.2 ± 0.5 _ 
+ 23.5 ± 0.5 21.8 ± 0.9*   6.3 ± 0.6***
- 24.4 ± 0.8 25.6 ± 1.3 17.8 ± 0.3 Caffeic acid 
+ 23.1 ± 0.9 23.2 ± 0.8   7.5 ± 0.8 
- 23.1 ± 0.4 23.6 ± 0.4 16.1 ± 0.5 Rosmarinic acid 
+ 24.5 ± 0.3 21.3 ± 0.9   5.5 ± 0.5 
- 20.6 ± 0.6** 23.6 ± 0.3 16.0 ± 0.5 Luteolin-7-glucoside 
+ 23.7 ± 0.6 22.7 ± 0.8   5.7 ± 0.5 
- 22.6 ± 0.6 24.6 ± 0.3 16.1 ± 0.7 Luteolin 
+ 26.1 ± 0.8 23.2 ± 0.8   5.6 ± 0.7 
- 24.0 ± 1.0 25.9 ± 1.0 17.2 ± 0.4 Quercetin 
+ 22.6 ± 0.8 22.9 ± 0.6   8.6 ± 1.1#
HepG2 cells were incubated with t-BHP 2 mM (5 h) and/or with individual PhC 
at IC80 concentration and the activities of GST, GR and Gpox measured. Values 
are the mean ± SEM, n = 5. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 when 
compared with the negative control. #P ≤ 0.05 and when compared with the t-BHP 
control. 
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Fig. 5. t-BHP-induced DNA damage in HepG2 cells. HepG2 cells were incubated with different concentrations t-BHP for 1 h and DNA damage assessed by the comet 
assay. Comet images were examined by computer assisted image analysis system (A — tail length; B — tail moment; C — % DNA in the tail) and by a 
semiquantitative method of visual scoring (D). The correlation coefficients between the semiquantitative method and the computer assisted parameters are given in 
graph E. Values are the mean ± SEM, n = 4. *P ≤ 0.05, **P ≤ 0.01 and ***P ≤ 0.001 when compared with the control. 
 
 
 
 
 
 
 
 
 
 
 
leakage (Fig. 3) in HepG2 cells. From the graphically computed 
values (Fig. 3), IC
BHP dose (1 mM and 2 mM) and incubation time (1–16 h) by 
measuring LDH leakage and by the MTT assay (Fig. 2). All our 
experiments with HepG2 cells were done with a culture medium 
containing 10% (v/v) FBS. LDH leakage and MTT assay gave 
similar results for effects on cell viability in response to t-BHP at 
both studied concentrations (Fig. 2). In the subsequent studies, 
cell incubations were performed with 2 mM of t-BHP for 5 h to 
induce 40–50% of cell death (Fig. 2) and used to evaluate the 
hepatoprotective potential of PhC against this oxidant insult. 
50 and Hill slope values for each compound 
were obtained (Table 1). As shown in Table 1, of the tested 
compounds, luteolin had the highest protective activity against t-
BHP-induced toxicity. The glycosylation of the hydroxyl group at 
position 7, present in luteolin-7-glucoside, significantly decreased 
both IC50 and Hill slope (Table 1). Quercetin, the flavonol of 
luteolin, in addition to a higher IC50 also had a lower Hill slope, 
indicating a lower hepatoprotective potential when compared to 
the flavone. Rosmarinic and caffeic acids had lower protective 
potentials against the oxidant insult to HepG2 cells when com-
pared to the flavonoids — higher IC
 
Potential hepatoprotective effects of the PhC against t-BHP-
induced toxicity in HepG2 cells 50 values and lower Hill 
slopes (Table 1). Comparing the phenolic acids (Table 1), the 
polyphenol rosmarinic acid had higher hepatoprotective potential 
than caffeic acid, which correlates well with the presence of one 
more ortho dihydroxy phenolic structure (Fig. 1). 
 
The potential hepatoprotective effects of the five PhC against 
the t-BHP-induced toxicity (2 mM, 5 h) was evaluated by 
determining the protection of cell viability, as measured by LDH  
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well as a decrease in GSH levels (Fig. 4). The toxicant also 
significantly decreased the GR and GPox activities and had no 
significant effect on GST activity (Table 3). 
All the PhC tested at IC80 concentration decreased sig-
nificantly the t-BHP-induced increase in lipid peroxidation 
(Table 2), caffeic acid being the most powerful with a 35% 
reduction and the weakest being luteolin-7-glucoside with a 
25% reduction. None of the PhC significantly changed lipid 
peroxidation and GSSG levels in cells incubated alone (without 
t-BHP) for 5 h. As shown in Table 2, all the compounds reduced 
the t-BHP-induced increases in GSSG levels, but the effect was 
significant only for rosmarinic acid. 
The decrease in the GSH levels induced by t-BHP was 
significantly attenuated by all of the PhC (Fig. 4). Luteolin-7- 
glucoside showed the best protective effect (81%) against the t-
BHP-induced decrease in GSH levels, followed by luteolin 
(53%), quercetin (40%), caffeic acid (36%) and rosmarinic acid 
(34%). When HepG2 cells were incubated alone with the PhC 
for 5 h, rosmarinic acid and the three tested flavonoids slightly 
decreased basal GSH levels, although not significantly (Fig. 4). 
When this effect is taken into consideration, luteolin-7-glu-
coside almost completely prevented the decrease of GSH in-
duced by the toxicant. 
 
Fig. 6. Effects of t-BHP and PhC at IC80 concentration on DNA damage in 
HepG2 cells. HepG2 cells were incubated with t-BHP 200 μM (1 h) and/or with 
individual PhC at IC80 concentration and DNA damage evaluated by the comet 
assay. DNA damage was assessed by the semiquantitative method of visual 
scoring. Values are the mean ± SEM, n = 4. ***P ≤ 0.001 when compared with 
the negative control. ###P ≤ 0.001 when compared with the t-BHP control. 
 
 
 
 
 
 
 
 
 
 
When incubated alone with HepG2 cells, luteolin-7-gluco-
side decreased significantly the GST activity by 17% (Table 3). 
As observed in Table 3, the t-BHP-induced decreases in GR and 
GPox activities were only slightly attenuated by the PhC, and 
only quercetin showed a significant protective effect (19%) on 
GPox activity. 
Based on the dose-response curves of protection from cell 
death, the PhC IC80 concentrations were extrapolated (Table 1) 
and used to evaluate the effects of each compound against t- 
BHP-induced oxidative injuries in HepG2 cells in terms of lipid 
peroxidation, glutathione levels, glutathione-related enzyme 
activities and DNA damage. The level of protection of cell 
viability obtained for each compound was correlated with 
the effect on each of the several parameters outlined above. 
 
t-BHP-induced DNA damage in HepG2 cells 
  
Effects of the t-BHP and PhC at the IC
 
Fig. 7. Dose-dependent protection of t-BHP-induced DNA damage in HepG2 cells by quercetin (A). HepG2 cells were incubated with t-BHP 200 μM (1 h) and/or with 
quercetin at different concentrations and DNA damage evaluated by the comet assay. DNA damage was assessed by the semiquantitative method of visual scoring. 
Values are the mean ± SEM, n = 4. ***P ≤ 0.001 when compared with the negative control. ###P ≤ 0.001 when compared with the t-BHP control. B—Representative 
pictures of the comet assay results. 
 
The extent of DNA damage produced by 1-hour incubations 
with increasing concentrations of t-BHP were determined by 
the comet assay and the images analyzed both by computer 
assisted program and visual scoring. This model of t-BHP-
induced DNA damage in HepG2 cells has been used by other 
authors (Woods et al., 1999, 2001). As stated previously, due to 
the effects of culture conditions a dose–response to t-BHP on  
80 concentration on 
lipid peroxidation, glutathione levels and glutathione-related 
enzyme activities in HepG2 cells 
 
The incubation of HepG2 cells with 2 mM t-BHP for 5 h 
decreased cell viability by 40–50% (Fig. 2), along with a signi-
ficant increase in lipid peroxidation and GSSG levels (Table 2), as  
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for quercetin (Table 1), luteolin gave better protection than the 
flavonol (76% and 58%, respectively) (Fig. 6). Both querce-
tin (Fig. 7) and luteolin (data not shown) showed a concen-
tration-dependent DNA protection. As shown in Fig. 7B, the 
protective effect of quercetin was visually clear in the comet 
assay images. Rosmarinic acid (14%) and luteolin-7-glucoside 
(18%) also protected significantly from DNA damages, al-
though to a much lower extent. At IC80 concentration, caffeic 
acid did not show protection of the DNA. None of the PhC 
tested induced DNA damage when incubated alone for 1 h at 
IC
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
80 concentration (Fig. 6).  
Fig. 8. Dose-dependent DPPH scavenging activity of caffeic acid. Different 
concentrations of caffeic acid were added to the ethanolic solution of DPPH and 
the discoloration measured spectrophotometrically at 515 nm. At the time point 
where all tested concentrations had reached the steady state (9 min), the 
percentages of the remaining DPPH were plotted against the corresponding 
caffeic acid concentrations (in logarithm). From this graph, the IC
 
Antiradical activity 
 
The antiradical activity of the PhC used in this study was 
evaluated by the DPPH and superoxide radical scavenging 
assays. Fig. 8 shows graphically the results from the DPPH 
scavenging assay of caffeic acid as an example, which was used 
to calculate the IC
50 and Hill 
slope were taken (Table 4). Values represent the mean ± SD of 5 replicates. 
DNA damage was studied. As shown in Fig. 5, t-BHP con-
centrations of 200 μM and higher result in significant DNA 
damage as visualized by the comet assay. The semiquantitative 
method of visual scoring used has been extensively validated 
by comparison with computerized image analysis systems and 
correlates well with more quantitative measures, such as % 
DNA in the tail and tail moment (Duthie, 2003). Our results 
also showed good correlations between the semiquantitative 
method and the parameters given by computer analysis system 
(Fig. 5E). To evaluate the effect of the PhC at IC
50 and the Hill slope for the compound. 
Rosmarinic acid had the best IC50 values both against DPPH 
and superoxide radicals (Tables 4 and 5). The IC50 values in 
both antiradical activity assays for caffeic acid were, as ex-
pected, significantly higher than those for rosmarinic acid, but 
both compounds showed similar Hill slopes. Quercetin pre-
sented lower IC50 values than the other flavonoids against both 
radicals (Tables 4 and 5). On the other hand, quercetin had the 
lowest AE (Table 4). Comparing luteolin with its glucoside, the 
aglycone had a slightly lower IC50 and a higher Hill slope 
against both radicals. In the case of the DPPH scavenging 
activity, the higher AE value with a similar IC
80 
concentration on t-BHP-induced DNA damage, HepG2 cells 
were co-incubated for 1 h with the different PhC plus 200 μM 
t-BHP, and the DNA damage was assessed using the alkaline 
version of the comet assay (results scored using the 
semiquantitative method). Incubation conditions of 1 h with 
200 μM t-BHP were chosen to test the protective effects of  
PhC because intermediate damage to the DNA was produced  
(∼ 200 AU). 
50 means that for 
luteolin-7-glucoside the time needed for it to reach the steady 
state at the corresponding IC50 concentration was shorter than 
for luteolin. 
The antiradical activity of some of these PhC has been 
extensively studied by many authors (Sanchez-Moreno et al., 
1998; Moridani et al., 2003; Butkovic et al., 2004; Parejo et al., 
2004; Kosar et al., 2004), and our results are, in general, in 
agreement with theirs. 
 
Effects of PhC at the IC80 concentration on t-BHP-induced 
DNA damage in HepG2 cells  
Partition coefficients  
 Of the PhC tested, quercetin and luteolin conferred the best 
protection against t-BHP-induced DNA damage (Fig. 6). Even 
if the IC
The degree of hydrophobicity of the PhC was examined by 
measuring the partition coefficients using an n-octanol/HEPES  80 concentration for luteolin is 4 times lower than that  
Table 4 Table 5 
DPPH scavenging activity of the tested PhC Superoxide radical scavenging activity of the tested PhC 
-3 (mmol/mol DPPH) Hill slope AE (× 10 ) Hill slope Compound IC Compound 50
Caffeic acid 179.6 ± 4.1 2.03 ± 0.06 0.81 
Rosmarinic acid 102.6 ± 2.2 2.07 ± 0.09 0.53 
Luteolin-7-O-glucoside 277.3 ± 14.9 1.48 ± 0.06 1.21 
Luteolin 263.9 ± 11.0 1.66 ± 0.03 0.70 
Quercetin 126.0 ± 2.4 1.66 ± 0.05 0.36 
Different concentrations of each PhC were added to the ethanolic solution of 
DPPH and the discoloration measured spectrophotometrically at 515 nm. From 
the results expressed as the percentage of the remaining DPPH obtained for each 
PhC concentration (Fig. 8), the IC50 and Hill slope were taken. From the results, 
the AE was also calculated for each PhC. Values represent the mean ± SD of 5 
replicates. 
IC50 (μM) 
Caffeic acid 99.1 ± 5.3 1.02 ± 0.06
Rosmarinic acid 21.0 ± 0.9 0.95 ± 0.04
Luteolin-7-O-glucoside 50.4 ± 2.4 0.93 ± 0.05
Luteolin 45.3 ± 3.0 1.70 ± 0.19
Quercetin 35.1 ± 3.3 1.69 ± 0.25
Using the phenazine methosulphate-NADH nonenzymatic assay, superoxide 
radicals were produced continuously and measured spectrophotometrically at 
560 nm. In co-incubations with individual PhC at several concentrations, the 
scavenging of superoxide radical was measured and from the plotted results the 
IC50 and the Hill slope were taken.Values represent the mean ± SD of 3 in-
dependent experiments with 3 replicates each. 
104 
Chapter 4                                                                                                              Sage: antioxidant effects in liver cells
 
 
 
 
 
 
 
 
Table 6 position 7 in the A ring to become luteolin-7-glucoside, the 
compound's hydrophobicity decreases dramatically. As a result, 
although the antiradical activity of luteolin-7-glucoside was only 
slightly affected (5% to 11%), its biological activity decreased 
dramatically (about 13 times lower) when compared with that for 
luteolin. The results observed for quercetin and luteolin also 
implicate hydrophobicity as an important factor for this 
cytoprotective antioxidant effect of compounds. The absence 
of the hydroxyl group at position 3 (C ring) decreases the 
antiradical (hydrogen-donating) activity of luteolin while 
increasing its hydrophobicity relative to quercetin. In agreement 
with the previously stated, in co-incubations with t-BHP, 
luteolin showed the best protection with an IC
Experimental partition coefficients values obtained for each tested PhC 
KPhenolic compound ow
Caffeic acid -0.89 ± 0.10
Rosmarinic acid -0.44 ± 0.13
Luteolin-7-glucoside  1.22 ± 0.01 
Luteolin  2.68 ± 0.05 
Quercetin  2.60 ± 0.09 
Partition coefficient values in logarithm (Kow) were measured in an n-octanol/ 
HEPES (20 mM, pH 7.4) system. Values are the mean ± SD of 3 independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
system. Flavonoids are much more hydrophobic than phenolic 
acids (Table 6). As expected, the glycosylation of the hydroxyl 
group at position 7 of luteolin decreased considerably the de-
gree of hydrophobicity of this compound. Luteolin had a 
slightly higher K
50 four times 
lower than that for quercetin. Also, in certain types of non-
cellular lipophilic oxidation systems, luteolin showed higher 
antioxidant effects than those of quercetin (Brown et al., 1998; 
Filipe et al., 2001; Hirano et al., 2001). ow than that of quercetin (Table 6). The experi-
mentally determined hydrophobicity of these two flavonoids 
has often been referred in the literature, but the results are 
controversial. Some authors describe luteolin as more hydro-
phobic than quercetin (Brown et al., 1998; Areias et al., 2001; 
Murata et al., 2004) whereas others hold the opposite to be true 
(Moridani et al., 2003). The computer program that can be 
accessed at http://www.esc.syrres.com, the KowWin (LogKow) 
software, gives a lower degree of hydrophobicity for quercetin 
than for luteolin, 1.48 and 2.36, respectively. This program uses 
fragmental analysis of the compound's structure for the 
prediction and the computed values show usually a high 
correlation with quoted experimental values (r
The importance of the compounds' hydrophobicity is also 
shown by comparing the results between rosmarinic acid and 
luteolin-7-glucoside. Although rosmarinic acid had higher 
antiradical scavenging activity, because the degree of hydro-
phobicity of luteolin-7-glucoside was higher than rosmarinic 
acid, both compounds showed similar biological effect (similar 
IC50 values). 
Because our model of cytoprotection tests the PhC in co-
incubations with the toxicant, their antioxidant effects may 
reflect mainly their direct actions on mediators of t-BHP tox-
icity. These direct effects include, besides the antiradical scav-
enging or hydrogen-donating activity measured in this study, 
the compounds' ability to chelate metal ions (Rice-Evans et al., 
1996). Iron chelation could indeed be important for the 
protection against t-BHP toxicity, which is known to be mediated 
by intracellular iron ions (Hix et al., 2000). PhC may also 
indirectly act as antioxidants in cells by modulating the activity 
of antioxidant, detoxifying and repairing enzymes as well as 
enzymes involved in the bioactivation of xenobiotics (Ferguson, 
2001; Ross and Kasum, 2002; Ferguson et al., 2004). In the 
present study, where short term simultaneous incubations were 
used, PhC protection through increased activity of glutathione-
related enzymes seems not to be relevant. In fact, the activity of 
GST, an important phase II detoxifying enzyme (Ferguson, 
2001; Ferguson et al., 2004), was decreased rather than 
increased in controls exposed to luteolin-7-glucoside, the only 
compound that had a significant effect on glutathione-related 
enzymes. Longer term pre-incubations would provide the op-
portunity for induction of proteins and enzymes, such as anti-
oxidant enzymes, by interaction with antioxidant response 
elements (Ferguson et al., 2004). 
2 = 0.95). 
 
Discussion 
 
The present work demonstrates that all the tested PhC 
possess protective effects against t-BHP-induced cell death in 
HepG2 cells. Conferred protection decreased in the following 
order: luteolin > quercetin > rosmarinic acid > luteolin-7-glucosi-
de > caffeic acid as shown by IC50 values. Considering the 
compounds' hydrophobicity (luteolin > quercetin > luteolin-7- 
glucoside > rosmarinic acid > caffeic acid) and the antiradical 
activity evaluated both for DPPH (rosmarinic acid > querce-
tin > caffeic acid > luteolin > luteolin-7-glucoside) and superox-
ide radical (rosmarinic acid > quercetin > luteolin > luteolin-7-
glucoside > caffeic acid) scavenging activities, the results show 
that the hepatoprotective potential of these PhC correlates 
primarily with their degree of hydrophobicity and only 
secondarily with their antiradical capacity. In fact, Rice-Evans 
et al. (1996) and Spencer et al. (2004) suggested that the 
antioxidant biological activity of PhC will depend more heavily 
on the extent to which they associate, interact and permeate cell 
membranes than on its antiradical activity alone. In agreement 
with this, it was only for compounds with comparable hydro-
phobicities, such as the two tested phenolic acids, that a direct 
correlation between biological activity and antiradical activity 
was obtained. 
t-BHP-induced cell death was accompanied by increased 
lipid peroxidation and GSSG levels, and DNA damage as well 
as decreased GSH levels and glutathione-related enzyme ac-
tivity. The increase in GSSG levels was not in the same range as 
the decrease in GSH levels. This indicates that t-BHP reduced 
GSH levels mainly through formation of GSH conjugates rather 
than oxidation to GSSG. These effects are in accordance with 
previous studies in liver cells (Sies and Summer, 1975; Bellomo 
et al., 1982; Rush et al., 1985; Jewell et al., 1986; Nicotera et al.,  
The importance of the compound's lipophilicity in addition to 
the antiradical capacity is corroborated by comparisons between 
structurally related compounds. When luteolin is glycosylated at  
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1988; Masaki et al., 1989; Buc-Calderon et al., 1991; Kass  
et al., 1992; Thabrew et al., 1997; Martin et al., 2001; Kinjo 
et al., 2003; Alia et al., 2005, 2006; Lee et al., 2005a,b). 
However, particularly in HepG2 cells, t-BHP exposure condi-
tions are different among different studies published so far 
(Thabrew et al., 1997; Kim et al., 1998, 2000; Piret et al., 2002, 
2004; Kinjo et al., 2003; Alia et al., 2005, 2006; Lee et al., 
2005a,b). Previous reports indeed alert to the fact that different 
origins of HepG2 clones, culture medium composition and 
cultivation time (age of cells) may affect the experimental 
outcome through differences in sensitivity towards drugs 
(Knasmuller et al., 2004; Mersch-Sundermann et al., 2004). It 
therefore becomes imperative to characterize the cells' response 
to the toxicant as well as the experimental conditions used for 
the detection of protective effects of test compounds. 
Thus, the potential of PhC to maintain GSH at reasonably high 
levels could be of great importance against t-BHP-induced 
toxicity. Therefore, the ability of the tested PhC in preventing 
against t-BHP-induced GSH depletion by about 40% was 
probably a major contribution to their cytoprotective effects. In 
the case of luteolin-7-glucoside, there was a higher protection 
(∼ 80%) of GSH levels that did not reflect higher cytoprotection 
(all compounds were tested at their IC80 concentration). This may 
have been due to the observed inhibitory effect of luteolin-7- 
glucoside on GST having a sparing effect on GSH. Because 
protection by PhC against increases of GSSG levels induced by 
t-BHP was weak, it seems that PhC protect against the decrease 
of GSH levels mainly by preventing the formation of GSH 
conjugates rather than oxidation to GSSG. 
In spite of this general protection of GSH, when incubated 
alone, PhC decreased GSH levels by 5%in the case of rosmarinic 
acid and between 10% and 14% for the tested flavonoids. 
Although not statistically significant, this effect seems to indicate 
some pro-oxidant activity of these compounds. Previous studies 
also found a decrease in GSH induced by flavonoids (Duthie 
et al., 1997; Galati et al., 2002). For flavonoids with a 3′,4′- 
dihydroxyl group on the B ring (catechol B ring), as is the case 
here, the decrease of GSH levels was found to be through 
formation of GSH conjugates instead of oxidation to GSSG 
(Galati et al., 2002). 
In an attempt to explain the observed cytoprotective effects 
of the tested PhC, we looked at their effects at IC80 con-
centration on several markers of cellular oxidative stress, such 
as lipid peroxidation, glutathione levels and DNA damage. 
t-BHP-induced lipid peroxidation in HepG2 cells was 
attenuated by all tested PhC at IC80 concentrations to a similar 
extent, of about 30% (25% to 35%). A good correlation seems 
to exist between hepatoprotective effects and the prevention of 
lipid peroxidation. The ability of PhC to chelate metal ions and/ 
or to act as chain breaking antioxidants by scavenging (as 
hydrogen donors) lipid alkoxyl and peroxyl radicals (Rice- 
Evans et al., 1996; Brown et al., 1998) could provide an 
explanation for the observed reduction in lipid peroxidation. 
Nevertheless, the extent of this reduction was relatively small, 
only about 30%. This indicates that it is most likely not only 
through reduction of lipid peroxidation that PhC protect HepG2 
cells against death. In agreement with this, previous reports 
indicated that t-BHP-induced toxicity was not mediated by lipid 
peroxidation (Rush et al., 1985; Jewell et al., 1986; Buc- 
Calderon et al., 1991; Martin et al., 2001). Moreover, our own 
observations (data not shown) and a previous work (Rush et al., 
1985) reported that incubations of liver cells with the oxidant 
pair ascorbate/iron induced massive cell lipid peroxidation 
without significantly affecting cell viability. Preservation of cell 
viability seems therefore to depend also on effects at other levels. 
Incubations of HepG2 cells with t-BHP induced DNA 
damage in a concentration-dependent manner, as visualized by 
the comet assay. Exposure to 200 μM t-BHP induced significant 
DNA damage without inducing cell mortality (data not shown). 
This seems to indicate that t-BHP-induced DNA damage was 
not implicated in the cell death induced by this organic peroxide 
in HepG2 cells. In fact, caffeic acid, at IC80 concentration, 
significantly decreased t-BHP-induced cell death without pro-
tecting DNA from damage. Also, previous reports showed  
a dissociation between the oxidative DNA damage induced by 
t-BHP from the killing of hepatocytes (Coleman et al., 1989; 
Latour et al., 1995). Latour and collaborators (1995) ruled out 
both the formation of oxidized DNA bases and the activa- 
tion of a calcium-dependent endonuclease as mechanisms by 
which t-BHP induces DNA single strand breaks. They showed 
that t-BHP causes DNA single strand breaks most likely by 
covalent binding of free radicals to DNA by mechanisms de-
pendent on iron ions (Latour et al., 1995). Iron-dependent 
reactions have been proposed as the key factor to the DNA 
damage induced by t-BHP since it can be prevented by iron 
chelators but not by free radical scavengers, such as butylated 
hydroxytoluene and trolox (Coleman et al., 1989; Latour et al., 
1995; Guidarelli et al., 1997; Sestili et al., 1998, 2002). 
Recently, another study using a different model showed the 
importance of iron chelation on DNA protection over free 
radical scavenger activity (Melidou et al., 2005). In our study, 
where the compounds were tested at their IC
All tested PhC also significantly attenuate the decrease of GSH 
levels induced by t-BHP at their IC80 concentrations. GSH plays 
an important role in hepatocyte defence against ROS, free radicals 
and electrophilic metabolites (Kedderis, 1996; Castell et al., 
1997). A severe GSH depletion leaves cells more vulnerable to 
oxidative damage by radicals and increases protein thiolation or 
oxidation of SH groups that may lead to alterations in cellular 
calcium homeostasis (Castell et al., 1997). A sustained increase in 
cytosolic calcium levels results in activation of enzymes 
(phospholipases, non-lysomal proteases, endonucleases) and 
cytoskeletal damage which ultimately causes cell death (Castell 
et al., 1997). The decrease of GSH levels has indeed been sug-
gested as one of the primary mechanisms of t-BHP-induced 
toxicity in liver cells (Jewell et al., 1986; Buc-Calderon et al., 
1991; Martin et al., 2001) that is generally followed by an increase 
in the intracellular levels of calcium (Bellomo et al., 1982; 
Nicotera et al., 1988; Buc-Calderon et al., 1991; Kass et al., 1992).  
80 concentration 
(concentration that protected 80% against cell death), only 
luteolin and quercetin conferred a very clear protection against 
DNA damage. An ortho dihydroxy phenolic structure is one of 
the requirements for PhC ability to chelate transition metal 
ions such as copper and iron (Rice-Evans et al., 1996; Williams  
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Referenceset al., 2004). All the compounds used in this study possess this 
element, but only luteolin and quercetin conferred noticeable 
protection against DNA damage. It seems therefore, that even 
more than in the case of preserved cell viability, the degree of 
hydrophobicity of the compound is an important factor for 
protecting from DNA damage, since this could explain the 
higher effects obtained for luteolin and quercetin. Also in 
accordance with this are the results obtained from the 
comparison between quercetin and luteolin themselves. Metal 
ion chelation ability of flavonoids appears to be not only 
dependent on the presence of the catechol B ring but also on an 
oxo group at position 4 in C ring in combination with a hydroxyl 
group either at position 5 or 3 (Mira et al., 2002; Williams et al., 
2004). Therefore, quercetin probably has higher metal ion 
chelation ability than luteolin, which lacks the OH group at 
position 3. In fact, previous results showed higher capacity of 
quercetin to chelate iron and copper than luteolin (Mira et al., 
2002). Our results show that luteolin, although at a concentration 
4 times lower, protected DNA against damage better than 
quercetin, which emphasizes the importance of the compounds' 
lipophilicity. Also others have already drawn attention to the fact 
that the biological effects of a compound would be a direct 
function of its lipophilicity, which is expected to increase the 
cellular uptake of these agents, as well as their subcellular 
localization in lipid compartments (Sestili et al., 2002; Spencer 
et al., 2004). Studies using other models and/or different cell types 
showed that luteolin had higher potential to decrease DNA 
damage than quercetin (Noroozi et al., 1998; Romanova et al., 
2001; Horvathova et al., 2004, 2005), or the opposite-quercetin 
having higher ability to reduce DNA damage than luteolin 
(Horvathova et al., 2003; Melidou et al., 2005). As well, higher 
cytoprotective effects of luteolin over quercetin were found by 
some authors (Kaneko and Baba, 1999; Sasaki et al., 2003), 
although others reported the opposite (Ishige et al., 2001). It 
seems, therefore, that the protective potential of luteolin and 
quercetin is cell type specific and/or dependent on the agent used 
to induce DNA damage. Nevertheless, although DNA damage 
induced by t-BHP in HepG2 cells seems not to be a crucial event 
for cell death, this experimental model can be of use to extensively 
study the protective potential of PhC against DNA damage. It 
would be, for example, a good model for structure–activity rela-
tionships between several classes of flavonoids. 
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4.5. Supplementary data 
 
Because previous reports have stressed the antioxidant potential of water extracts of a 
related specie of S. officinalis, Salvia fruticosa1,2, we present here the results of an additional 
study on the antioxidant potential of an infusion of this specie for comparison with S. officinalis 
(see section 4.3). 
Salvia fruticosa plants were cultivated in an experimental farm located in São Pedro de 
Merelim (Braga), Portugal, and were collected in September, 2003. The leaves and the smaller 
branches of the plants were lyophilised and kept at -20ºC. 
Salvia infusions (teas) were prepared in the same day following a previous methodology 
(see section 3.3), where 300 ml of ultrapure Milli Q boiling water was poured over 4g of 
lyophilised-plant material and allowed to steep for 5 min. The filtered extract was then 
lyophilised to dryness and the following yield in terms of initial dry weight plant material was 
obtained: 
- Salvia officinalis: 25.8% (w/w); 
- Salvia fruticosa: 20.4% (w/w). 
Phenolic compounds were then analysed by HPLC/DAD as previously described (see section 
3.3) and the results presented in the following table: 
 
   
Salvia officinalis Salvia fruticosa Phenolic Compound (µg/mg extract) (µg/mg extract) 
Phenolic acids   
Rosmarinic acid 52.00 71.49 
Caffeic acid   0.82   0.13 
Ferulic acid   0.52   0.03 
3-Caffeoylquinic acid    tr    tr 
5-Caffeoylquinic acid    tr    tr 
   
Flavonoids   
Luteolin-7-glucoside 19.74    tr 
6-Hydroxyluteolin-7-glucoside     - 22.66 
4´,5,7,8-Tetrahydroxyflavone   0.90 28.64 
Apigenin-7-glucoside   0.43   0.59 
   
 
 
1 Triantaphyllou K, Blekas G & Boskou D, 2001. Antioxidative properties of water extracts obtained from herbs of 
the species Lamiaceae. International Journal of Food Sciences and Nutrition 52, 313-317. 
2 Matsingou TC, Petrakis N, Kapsokefalou M & Salifoglou A, 2003. Antioxidant activity of organic extracts from 
aqueous infusions of sage. Journal of Agricultural and Food Chemistry 51, 6696-6701. 
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Although the yield of S. fruticosa infusion was lower than that of S. officinalis, the extract 
obtained had a higher content in phenolic compounds, and specially a higher content in 
flavonoids, that common sage. 
 The antiradical activity was, then, measured for both extracts against two radicals: 
DPPH and superoxide anion (see experimental protocol 19 - P19 - in the appendix section). The 
results are presented in the following table: 
 
 DPPH Superoxide radical 
Infusion 
IC50 (g/kg DPPH) AE (×10-3)  IC  (µg/ml) 50
Salvia officinalis          419 ± 9 0.18  14.4 ± 1.4 
Salvia fruticosa 350 ± 14  0.19        9.7 ± 0.9 
 
As expected from the composition of the extracts in phenolic compounds, S. fruticosa had 
higher antiradical activity than S. officinalis, as shown by the lower IC50’s and the high 
antiradical efficiency (AE) in the case of DPPH. 
 Considering these results, a high cellular antioxidant effects was expected for S. 
fruticosa. To test that, this extract was used to study the potential hepatoprotective effect of S. 
fruticosa against t-BHP-induced toxicity in HepG2 cells. Using the same methodology 
described in the section 4.3. and 4.4., the following graph was obtained for both plants: 
 
As expected, the above graph shows that S. fruticosa infusion has higher hepatoprotective 
activity than S. officinalis. The same can be observed in the following table, where the IC50 of S. 
fruticosa is lower than of that of common sage: 
 
Infusion IC50 (µg/ml) Hillslope 
Salvia officinalis 101.4 ± 11.3 1.02 ± 0.13 
Salvia fruticosa    54.0 ± 4.1 1.01 ± 0.09 
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Interestingly, the Hillslopes of both extracts were similar. 
 In conclusion, based on these results, S. fruticosa seems to be an interesting medicinal 
plant to be research in terms of antioxidant effects, with a higher activity than S. officinalis. The 
presence in the S. fruticosa infusion of a flavonoid aglycone, 4´,5,7,8-tetrahydroxyflavone, in 
much higher concentration than in S. officinalis, could help explain the much higher cellular 
antioxidant effects due to its high hydrophobicity than luteolin-7-glucoside. 
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5.1. Chapter overview 
 
 Chronic liver diseases are common worldwide and may range from steatosis to 
hepatocellular carcinoma. Increasing evidence suggests the involvement of free radicals and 
reactive oxygen species in the various steps that initiate and regulate the progression of liver 
diseases. Therefore, protective mechanisms relevant to the liver are of particular interest and, 
because oxidative stress is involved in that diseases, dietary antioxidants have been proposed, as 
therapeutic agents, to counteract liver damages. 
 Salvia officinalis is a medicinal plant that can be viewed as a possible agent for 
prevention and/or treatment of liver diseases. According to our previous studies, this can be, in 
fact, a possibility. Sage tea, the most common form of consumption of this plant, was shown to 
improve liver antioxidant status in mice and rats (chapter 3). Besides an enhancement of a phase 
II detoxifying enzyme (GST), sage tea induced a better recovery of rat hepatocytes, in culture, 
from the stress imposed by the collagenase isolation, namely with a significant increase in GSH 
content after 4 hours of culture. Moreover, protection against lipid peroxidation and GSH 
depletion induced by an oxidant insult in cultured rat hepatocytes showed that antioxidant 
protection was conferred to hepatocytes by sage tea drinking. In addition, sage tea was also 
tested in vitro against an oxidant insult using HepG2 cells (chapter 4). Sage tea has shown 
hepatoprotective effects and the ability to increase the basal glutathione levels, which also 
emphasise the antioxidant properties of sage at cellular level. Recently, Amin and Hamza 
(2005) reported the in vivo hepatoprotective effect of a water extract of sage1. The treatment of 
rats with that extract, for 5 weeks, was shown to protect against the hepatotoxicity induced by 
azathioprine, a drug that acts by decreasing GSH levels, emphasising the antioxidant properties 
of this extract. 
 In view of all these results, the in vivo hepatoprotective effect of sage tea was 
hypothesised against toxicity induced through free radical formation, such as that caused by the 
well known hepatotoxin, carbon tetrachloride. Therefore, the potential hepatoprotective effect of 
sage tea drinking for 14 days against a subsequent acute toxic dose insult with CCl4 were 
evaluated in mice of both genders. Contrary to what was expected, sage tea drinking 
significantly increased the CCl4-induced liver injury, as seen by increased plasma transaminase 
levels and histologic liver damage. In accordance with the previous study (chapter 3), sage tea 
drinking enhanced significantly GST activity. Additionally, glutathione peroxidase was also 
significantly increased by sage tea drinking. Since CCl4 toxicity results from its bioactivation 
mainly by CYP 2E1, the expression level of this protein was evaluated by Western Blot. An 
 
1 Amin A & Hamza AA, 2005. Hepatoprotective effects of Hibiscus, Rosmarinus and Salvia on azathioprine-induced 
toxicity in rats. Life Sciences 77, 266-278. 
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increase in CYP 2E1 protein was observed in sage tea drinking mice, which may explain, at 
least in part, the potentiation of CCl4-induced hepatotoxicity, conferred by sage tea. The 
modulatory effects of sage tea drinking expressed by increased GST and GPox activities, and 
possibly other detoxifying and antioxidant enzymes, seem to have been unable of neutralising 
the injuries inflicted to the cells. The CCl4-induced hepatotoxicity was shown to be higher in 
females than in males, which may be explained by gender differences observed in some 
parameters measured, such as CYP 2E1, GST and GPox. 
The drug-toxicant interaction between sage tea and CCl4 observed here, highlight 
possible herb-drug interactions between this extract and drugs metabolised by the liver. 
However, because there were no reports of herb-drug interactions between sage tea and 
pharmaceutical drugs, and because in this experiment sage tea replaced in almost 100% the 
water consumed by the animals, it seems unlikely that the normal consumption of sage tea by 
humans would result in interactions between sage tea and other drugs. We should, however, 
keep in mind that, if a sage product is taken over an extended period of time, an opportunity for 
enzyme induction could occur and mechanisms of interaction take place. 
In conclusion, these results indicate that, although sage tea did not have toxic effects of 
its own and, in fact, seemed to improve the antioxidant status of the liver, herb-drug interactions 
are possible that may affect the efficacy and safety of concurrent medical therapy with drugs 
that are metabolised by phase I enzymes. In addition, based on our previous studies and, also, in 
the study performed by Amin and Hamza (2005), the hepatoprotective effect of sage tea in vivo, 
using different toxicity models, must not be ignored. 
 
 
5.2. Methods 
 
The following experimental protocols (see Appendix) were used in this chapter: 
• P3: Biological Models – Mice as Experimental Model 
• P8: Metabolite Measurements – Glutathione Levels 
• P10: Metabolite Measurements – Total Protein 
• P11: Enzyme Activities – Glutathione Reductase 
• P12: Enzyme Activities – Glutathione Peroxidase 
• P13: Enzyme Activities – Glutathione S-Transferase 
• P14: Enzyme Activities – Cythocrome P450s 
• P15: Enzyme Activities – NADPH-Cythocrome P450 Reductase 
• P16: Enzyme Activities – ALT and AST 
• P18: Others – Western Blot of CYP 2E1 
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5.3. Publication 
 
This chapter comprises the following publication: 
Lima CF, Fernandes-Ferreira M & Pereira-Wilson C, 2006. Drinking of Salvia officinalis tea 
increases CCl4-induced hepatotoxicity in mice. Food and Chemical Toxicology, in press     
(DOI: 10.1016/j.fct.2006.09.009). 
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Abstract 
In a previous study, the drinking of a Salvia officinalis tea (prepared as an infusion) for 14 days improved liver antioxidant status in  
mice and rats where, among other factors, an enhancement of glutathione-S-transferase (GST) activity was observed. Taking in conside-
ration these effects, in the present study the potential protective effects of sage tea drinking against a situation of hepatotoxicity due to  
free radical formation, such as that caused by carbon tetrachloride (CCl4), were evaluated in mice of both genders. Contrary to what was 
expected, sage tea drinking significantly increased the CCl4-induced liver injury, as seen by increased plasma transaminase levels and 
histology liver damage. In accordance with the previous study, sage tea drinking enhanced significantly GST activity. Additionally, glu-  
tathione peroxidase was also significantly increased by sage tea drinking. Since CCl4 toxicity results from its bioactivation mainly by  
cytochrome P450 (CYP) 2E1, the expression level of this protein was measured by Western Blot. An increase in CYP 2E1 protein 
was observed which may explain, at least in part, the potentiation of CCl4-induced hepatotoxicity conferred by sage tea drinking. 
The CCl4-induced hepatotoxicity was higher in females than males. In conclusion, our results indicate that, although sage tea did not 
have toxic effects of its own, herb-drug interactions are possible and may affect the efficacy and safety of concurrent medical therapy 
with drugs that are metabolized by phase I enzymes. 
 
Keywords:  Salvia officinalis L. infusion; Mice; CCl -induced hepatotoxicity; Herb-drug interaction; Gender differences 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction steps that initiate and regulate the progression of liver 
diseases independently of the agent in its origin (Loguercio 
and Federico, 2003; Vitaglione et al., 2004). By virtue of its 
unique vascular and metabolic features, the liver is exposed 
to absorbed drugs and xenobiotics in concentrated form. 
Detoxification reactions (phase I and phase II) metabolize 
xenobiotics aiming to increase substrate hydrophilicity for 
excretion. Drug-metabolizing enzymes detoxify many 
xenobiotics but bioactivate or increase the toxicity of others 
(Jaeschke et al., 2002). In case of bioactivation, the liver 
is the first organ exposed to the damaging effects of the 
newly formed toxic substance. Therefore, protective mecha-
nisms relevant to the liver are of particular interest. 
 
Chronic liver diseases are common worldwide and are 
characterized by a progressive evolution from steatosis to 
chronic hepatitis, fibrosis, cirrhosis, and hepatocellular car-
cinoma (Loguer-cio and Federico, 2003; Vitaglione et al., 
2004). There are increasing evidences that free radicals 
and reactive oxygen species play a crucial  role  in the various
 
Abbreviations: CCl4, carbon tetrachloride; CYP, cytochrome P450; 
CYPR, NADPH-cytochrome P450 reductase; EROD, ethoxyresorufin-O-
dealkylation; GPox, glutathione peroxidase; GR, glutathione reductase; 
GSH, glutathione (reduced form); GSSG, glutathione (oxidized form); 
GST, glutathione-S-transferase; H&E, hematoxylin and eosin; 
PNP-H, para-nitrophenol hydroxylation; PROD, pentoxyresorufin-O-
dealkylation; t-BHP, tert-butyl hydroperoxide. 
Because free radicals and reactive oxygen species play a 
central role in liver diseases pathology and progression, 
dietary antioxidants have been proposed as therapeutic 
agents to counteract liver damage (Vitaglione et al.,  
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2004). Additionally, recent studies have suggested that 
natural antioxidants in complex mixtures ingested with the 
diet are more efficacious than pure compounds in preven-
ting oxidative stress-related pathologies due to particular 
interactions and synergisms (Vitaglione et al., 2004). Natural 
antioxidants may act as protectors of several patholo-  
gies not only as conventional hydrogen-donating 
compounds (antiradical activity) but, more importantly, 
may exert modulatory effects in cells through actions in 
antioxidant, drug-metabolizing and repairing enzymes as 
well as working as signaling molecules in important 
cascades for cell survival (Ferguson et al., 2004; Williams 
et al., 2004). 
decreases CCl4 hepatotoxicity. On the other hand, the 
induction of this cytochrome increases the drug’s hepato-
toxicity (Weber et al., 2003). Since pharmaceutical drugs 
may also be metabolized by CYP enzymes, drug-drug 
interactions are possible and have been recognized between 
herbal medicines and conventional drugs, which may affect 
the safety of phytomedicine users (Ioannides, 2002; Izzo, 
2005; Hu et al., 2005).  
Finally, gender is another factor that should be studied. 
Because CYP enzyme activities are known to be gender 
dependent (Kato and Yamazoe, 1992; Clewell et al., 
2002; Meibohm et al., 2002), the extension of cell damage 
caused by toxicants that are metabolized by phase I 
enzymes may be significantly different in males and 
females. We therefore evaluated the gender effect on the 
potential protection against CCl
Salvia officinalis L. (common sage) is a medicinal plant 
well known for its reputation of being a panacea and for 
its strong antioxidant properties attributed to its constitution 
in phenolic compounds (rosmarinic acid being the  
most representtative; Cuvelier et al., 1994; Baricevic and 
Bartol, 2000). In an in vivo study using rats, treatment with 
a sage water extract for 5 weeks protected against the 
hepatotoxicity of azathioprine, a drug that acts by reducing 
GSH levels, revealing the antioxidant properties of this 
extract (Amin and Hamza, 2005). Drinking of sage tea 
(prepared as an infusion) for 14 days also improved liver 
antioxidant status in mice and rats. It significantly  
increased the activity of a phase II detoxifying enzyme, 
glutathione-S-transferase (GST), and protected against lipid 
peroxidation and GSH depletion induced by an oxidant 
insult (tert-butyl hydroperoxide) in rat hepatocytes in pri-
mary culture (Lima et al., 2005). In view of these observa-
tions we hypothesized that sage tea would have protective 
effects in an in vivo situation of free radical-mediated 
hepatotoxicity, such as that caused by the well known 
hepatotoxin carbon tetrachloride (CCl
4-induced hepatotoxicity 
conferred by sage tea drinking in mice. 
 
2. Materials and methods 
 
2.1. Chemicals 
 
Glutathione reductase (EC 1.6.4.2.), glucose-6-phosphate dehydro-
genase (EC 1.1.1.49.), aprotinine, tert-butyl hydroperoxide (t-BHP), 7-
ethoxyresorufin, 7-pentoxyresorufin and Bradford reagent were purchased 
from Sigma (St. Louis, MO, USA). The rabbit polyclonal antibody 
against CYP 2E1 protein was purchased from StressGen (Victoria, 
Canada). All other reagents were of analytical grade. 
 
2.2. Plant material, preparation of sage tea and composition in 
phenolic and volatile compounds 
 
Salvia officinalis L. plants were cultivated in an experimental farm 
located in Arouca, Portugal, and were collected in April, 2001. The aerial 
parts of plants were lyophilized and kept at -20ºC. Considering that sage 
is traditionally used as a tea, an infusion of sage was routinely prepared as 
in a previous study by pouring 150 ml of boiling water onto 2 g of the 
dried plant material and allowing to steep for 5 min (Lima et al., 2005). 
This preparation produced a 3.5 ± 0.1 mg of dry weight extract per ml of 
infusion, with rosmarinic acid (362 μg/ml of infusion) and luteolin-7-
glucoside (115.3 μg/ml of infusion) as a major phenolic compounds and 
1,8-cineole, cis-thujone, trans-thujone, camphor and borneol as major 
volatile compounds (4.8 μg/ml of infusion; Lima et al., 2005). 
4). Therefore, in  
the present study, we evaluate the potential hepatoprotec-
tive effects of sage tea drinking for 14 days against a 
subsequent acute toxic dose of CCl4 in mice. 
In the liver, CCl4 metabolism begins with the formation 
of the trichloromethyl radical (˙CCl3) through the action of 
cytochrome P450 (CYP) enzymes, phase I drug-metaboli-
zing or detoxifying enzymes. This radical can also react 
with oxygen to form its highly reactive derivative trichlorome-
thylperoxy radical (CCl
 
2.3. Animals 
 
3OO˙). Both radicals initiate chain 
reactions of direct and indirect bond formation with cellular 
molecules (nucleic acids, proteins, lipids and carbo-
hydrates) impairing crucial cellular processes that may 
ultimately culminate in exten-sive cell damage and death 
(Weber et al., 2003). The bioactivation of CCl
Twenty male and twenty female Balb/c mice, 6-8 weeks (male:  
20.3 ± 2.4 g; female: 17.6 ± 1.9 g), were purchased from Charles River 
Laboratories (Spain) and acclimated to our laboratory animal facilities for 
at least one week before the start of the experiments. During this period, 
the animals were maintained on a natural light/dark cycle at 20 ± 2ºC 
and given food and tap water ad libitum. The animals used in this 
experiment were kept and handled in accordance to our Univer-sity regu-
lations that follows the Guidelines for the Humane Use and Care of 
Laboratory Animals. 
4 is mainly 
executed by the CYP 2E1 isozyme, but at higher concentra-
tions CYP 2B1, CYP 2B2 and CYP 3A (only in humans) 
are capable of attacking this haloalkane (Weber et al., 
2003). 
 
-induced hepatotoxicity in mice 2.4. CCl4
Because the bioactivation of the drug needs to occur in 
this model of hepatotoxicity, effects on the activity of CYP 
enzymes and in particular the expression of CYP 2E1 
should be considered when studying effects on CCl
 
Twenty male Balb/c mice were randomly divided into two groups (five 
per cage), given food ad libitum and either drinking water (tap) or sage tea 
ad libitum for 14 days (beverage was renewed daily). Twenty four hours 
before the end of the experiment, half the animals of each drinking group 
received an ip injection of CCl
4 toxi-
city. It is well known today that the inhibition of CYP 2E1  4 in order to observe the hepatic injury  
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resorufin formed/min/mg microsomal proteins using a standard curve of 
resorufin. 
effects (Chung et al., 2005). CCl4 was administered ip at 20 µl/kg in olive 
oil (8 ml/kg) to induce liver injury as previously described (Chen et al., 
2004), and controls received vehicle only. At the end of the experiment, 
animals were sacrificed by cervical dislocation and plasma collected for 
measurement of transaminase activities (ALT-alanine aminotransferase 
and AST-aspartate aminotransferase). The livers were also collected, 
frozen in liquid nitrogen and kept at -80ºC for later analysis and 
measurement of several liver parameters. 
para-Nitrophenol hydroxylation (PNP-H) in liver microsomes was 
assessed according to the methodology previously described by Allis and 
Robinson (1994), following specrophotometrically at 480 nm the forma-
tion 4-nitrocatechol. Briefly, 0.2 mg of microsomal proteins were pre-
incubated for 5 min at 37 ºC with 1 mM p-nitrophenol and 100 mM Hepes 
(pH 6.8). Five minutes after adding the NADPH-generating system, the 
formation of 4-nitrocatechol was followed at 480 nm at 37 ºC on a plate 
reader spectrophotometer and the results expressed as pmol 4-nitro-
catechol formed/min/mg microsomal proteins using the extinction 
coefficient of 3.567 mM
The same experimental outline was used for the twenty female Balb/c mice. 
 
2.5. Biochemical analysis -1
 
2.5.1. Histological examinations 
A fresh piece of the liver from each mouse, previously trimmed to 
approximately 2 mm thickness, was rapidly immersed in Bouin’s solution 
and kept for 24 h at 4ºC. Fixed tissues were then processed routinely for 
embedding in paraffin, sectioned (5 µm), deparaffinized and rehydrated 
using standard techniques. The extent of CCl4-induced liver damage was 
evaluated based on morphological changes in liver sections stained with 
hematoxylin and eosin (H&E) using standard techniques. Histological 
damage was expressed using the following score system: 0 - absent; + - 
few; + + - mild;    + + + - moderate; + + + + - severe; and, + + + + + - 
extremely severe. 
 
2.5.2. Liver homogenates and microsome isolation 
For measurement of the activities of GST, glutathione peroxidase 
(GPox), glutathione reductase (GR) and NADPH-cytochrome P450 
reductase (CYPR) in mice liver, a piece of tissue was homogenized indi-
vidually in a phosphate/glycerol buffer pH 7.4 (Na2HPO4 20 mM; β-
mercaptoethanol 5 mM; EDTA 0.5 mM; BSA 0.2% (w/v); aprotinine  
10 µg/ml and glycerol 50% (v/v)) and centrifuged at 10,000g at 4ºC for 
10 min and the super-natant collected.  
For measurement of the activities of cytochromes P450 and analysis of 
the expression level of CYP 2E1 protein, liver microsomes were isolated by 
differential centrifugation as described elsewhere (Barbier et al., 2000). In 
brief, a piece of the liver was homogenized in homogenization buffer  
(80 mM K2HPO4, 80 mM KH2PO4 (pH 7.4), 20% (v/v) glycerol,  1 mM 
EDTA, 1 mM dithiothreitol and 0.1 mM phenylmethanesulfonyl fluoride) 
and centrifuged at 12,000g at 4ºC for 20 min. The super-natant was 
collected and centrifuged at 105,000g at 4ºC for 1 h. Microsomal pellets 
were resuspended in homogenization buffer, rapidly frozen in liquid 
nitrogen and stored at -80 ºC. 
 
2.5.3. Enzyme activities 
Alanine aminotransferase (ALT), aspartate aminotrans-ferase (AST), 
GST and GR activities were measured spectrophotometrically as previ-
ously described (Lima et al., 2005). GPox activity was also measured as 
previously described by Lima et al. (2006). 
The CYPR activity was determined indirectly by measuring its 
NADPH-cytochrome c reductase activity as previously described (Phillips 
and Langdon, 1962) with the modifications introduced by Plaa and Hewitt 
(1982) and the results expressed as nmol cytochrome c reduced per 
minute per mg of protein (mU/mg). 
Microsomal ethoxyresorufin-O-dealkylation (EROD) and pentoxy-
resorufin-O-dealkylation (PROD) were determined according to Burke 
et al. (1985) with some modifications (Pearce et al., 1996). Briefly, liver 
microsomes (0.2 mg) were incubated at 37ºC in 1 ml (final volume) 
incubation mixture containing 100 mM KH2PO4 (pH 7.4), 7.5 mM 
MgCl2, 1 mM EDTA, 0.5 mM NADP – 5 mM glucose-6-phosphate/  
0.5 U/ml glucose-6-phosphate dehydrogenase and either 7-ethoxyresorufin 
(5 µM) or 7-pentoxyresorufin (10 µM) in the EROD or PROD activities, 
respectively. Reactions were started by addition of the NADPH-gene-
rating system and were stopped after 5 min by addition of 2 ml of ice-cold 
acetone. After centrifugation, the amount of resorufin was determined 
fluorometrically with a Perkin Elmer LS50 spectrophotometer (Perkin-
Elmer Ltd., Buckinghamshire, UK). The activity was expressed as pmol  
a  
.cm-1. 
 
2.5.4. Glutathione content 
The glutathione content of mice livers was determined by the DTNB-
GSSG reductase recycling assay as previously described (Lima et al., 
2004). The results are expressed as nmol GSH/mg of liver. 
 
2.5.5. Protein 
Protein content of liver homogenates was determined with Bradford 
Reagent using bovine serum albumin as a standard. Protein content of 
liver microsomes was determined by the Lowry method (Lowry et al., 
1951). 
 
2.6. CYP 2E1 expression analysis 
 
The expression of CYP 2E1 protein was analyzed by Western Blot. 
Electrophoretic separation of microsomal proteins (15 µg) was performed 
in 12% sodium dodecyl sulfate–polyacrylamide gels (SDS–PAGE) using 
the mini-PROTEAN 3 electrophoresis cell (Bio-Rad Laboratories, Inc., 
Hercules, California, USA) according to the method of Laemmli (1970). 
The separated proteins were electrotransferred to polyvinylidene difluo-
ride (PVDF) membranes (Amersham Biosciences, Buckinghamshire, UK) 
using the method of Towbin et al. (1979). The PVDF membranes were 
blocked with 5% nonfat dry milk overnight at 4°C and the immunoblots 
exposed to rabbit polyclonal antibody against CYP 2E1 protein. Immu-
nodetection was performed using horseradish peroxidase–labeled donkey 
anti-rabbit IgG antibody (Amersham Biosciences, Buckinghamshire, UK) 
and developed with ECL reagents (Amersham Biosciences) according to 
manufacturer’s instructions. The amount of protein was quantified by 
densitometry analysis on the SigmaScan Pro 5 program (SPSS Inc., San 
Rafael, CA, USA) and expressed as percentage of the protein level 
present in control situation. 
 
2.7. Statistical Analysis 
 
Data are expressed as means ± SEM (n = 5). Statistical significances 
(P values < 0.05) were evaluated by two-way ANOVA based on gender 
and treatment group (water drinking + saline ip; water drinking + CCl4 
ip; sage tea drinking + saline ip; sage tea drinking + CCl4 ip) followed 
by the Student-Newman-Keuls post hoc test. ALT and AST data were 
natural logarithm transformed prior to statistical analysis in order to 
stabilize the variance. 
 
3. Results 
 
The effect of drinking of sage tea for 14 days (instead of 
water) on the hepatotoxicity of CCl4 was evaluated in mice 
of both genders challenged with a single dose of CCl4 (20 µl/ 
kg, ip). Plasma transaminase activities were measured 24 h 
after CCl4 administration as markers of liver injury 
(Fig. 1). Elevated ALT and AST activities were observed 
due to CCl4 administration, which is always higher in 
females compared with males. Both males and females that 
had been drinking sage tea were significantly more sensitive  
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Fig. 1. Effects of sage tea drinking for 14 days on CCl4-induced increase in plasma transaminase activities. (A) ALT: alanine aminotransferase; (B) AST: 
aspartate aminotransferase. Values are means ± SEM, n = 5. For statistical evaluation, these data were natural logarithm transformed in order to stabilize   
the variance. Drinking groups of the same gender with the same letter notation are not significantly different from each other (P > 0.05). * P < 0.05, 
significantly different when compared with the same treatment group from males. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
to the hepatotoxic effects of CCl
 
 
 
 
 
 
 
 
4 than their control 
counterparts, as indicated by increased plasma transaminase 
activities. 
where CCl4 was not adminis-tered, although not statistically 
significant, sage tea drinking increased slightly, between 8% 
and 13%, the activity of CYP 1A and CYP 2E1 in both 
genders. The activities of CYP 2B and CYP 2E1 in females 
was lower and higher, respectively, when compared with 
males. Twenty four hours after administration, CCl
CCl4 is a hepatotoxicant known to produce a characte-
ristic centrilobular pattern of degeneration and necrosis 
(Weber et al., 2003). Histological examination of H&E-
stained liver sections was conducted 24 h after CCl
4 hepa-
totoxicity was also reflected in the decrease observed for 
the activities of the CYP’s measured as well as in the majo-
rity of the others enzyme activities (Table 3). Comparing 
drinking groups, the decrease in these enzyme activities 
after CCl
4 admi-
nistration to confirm the pattern of hepatotoxicity and 
compare the extent of liver injury between control and sage 
tea drinking animals (Table 1). Morphological findings were 
consistent with plasma transaminase observations. The  
CCl
4 administration was also consistent with the 
higher toxicity in sage tea groups, since it was in general 
significantly higher in sage tea than water drinking mice. 
4 induced histopathological changes a in the liver with 
significant degeneration and necrosis of hepatocytes in the 
centrilobular region and with perivenular inflammatory 
infiltrates. These CCl
The CYPR is an essential enzyme for microssomal P450-
mediated monooxygenase activity, which by interaction 
with the different CYP’s transfers the essential electron 
from NADPH (Backes and Kelley, 2003; Henderson 
et al., 2003). Therefore, its activity was measured (Table 
2), and was found to be significantly higher in female mice, 
which indirectly may contributed to higher toxicity of CCl
4-induced histopathological changes 
were significantly potentiated in the sage tea drinking group 
of mice with about 50-60% of total area presenting signs of 
degeneration, necrotic regions and higher leukocyte infiltra-
tion. Also histologically, the liver damage induced by the 
CCl4 in mice appeared to be higher in females than in males. 4 
in females. Sage tea drinking induced 21% the activity of 
this cytochrome, but only in female mice. 
CCl4 is a hepatotoxic chemical that requires metabolic 
activation by phase I drug-metabolizing enzymes and 
therefore it was important to monitor the effects of sage 
tea drinking on the activity of some CYP enzymes. For  
that, EROD, PROD and PNP-H were measured in liver 
microsomal fractions (Table 2). Comparing the groups  
The bioactivation of CCl4 is mainly executed by CYP 
2E1 (Weber et al., 2003). It is also known that modulatory 
effects on the expression of CYP 2E1 affects the CCl4-
induced hepatotoxicity (Weber et al., 2003). Therefore, in 
Table 1 
-induced hepatotoxicity as observed by liver histological examinations Effect of sage tea drinking for 14 days on CCl4
 Male Female Microscopic observation Drinking group 
 With  CCl With  CClWithout CCl Without CCl4 4 4 4
Water 0 + +  0 + + Hepatocyte degeneration (balooning) 
 Sage tea 0 + + + + 0 + + + + + 
Water 0 +  0 + + Hepatocyte necrosis 
 Sage tea 0 + + + 0 + + + + 
 Water + + + + + + + + Infiltration of leukocytes (inflammation) 
 Sage tea + + + + + + + + + + 
0 - Absent; + - few; + + - mild; + + + - moderate; + + + + - severe; + + + + + - extremely severe. 
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Table 2 
Effects of sage tea drinking (for 14 days) and CCl4 on CYP activities in mice liver 
Male   Female  Enzyme Drinking group 
Without CCl4 With CCl4  Without CCl4 With CCl4
Water 52.8 ± 3.1 a 39.3 ± 3.4 b  46.9 ± 4.8 a 33.1 ± 2.2 bCYP 1A (pmol/min/mg) 
Sage tea 58.8 ± 2.4 a 27.5 ± 1.4 c  53.0 ± 3.1 a 19.5 ± 3.2 c
Water   8.6 ± 0.7 a   7.7 ± 0.6 a  15.4 ± 2.9 a *   9.5 ± 0.9 bCYP 2B (pmol/min/mg) 
Sage tea   9.3 ± 0.8 a   5.1 ± 0.5 a  14.3 ± 1.3 a *   6.7 ± 1.6 b
Water 0.63 ± 0.05 a 0.28 ± 0.04 b  0.51 ± 0.06 a * 0.26 ± 0.03 bCYP 2E1 (pmol/min/mg) 
Sage tea 0.68 ± 0.02 a 0.16 ± 0.02 c  0.57 ± 0.04 a * 0.08 ± 0.03 c
Water 15.2 ± 0.7 a 13.4 ± 0.3 b  19.1 ± 0.5 a * 17.8 ± 0.7 a * CYPR (mU/mg) 
Sage tea 15.8 ± 0.6 a 10.2 ± 0.5 c  23.2 ± 0.5 b * 12.2 ± 0.6 c * 
Values are means ± SEM, n = 5. Drinking groups of the same gender with the same letter notation are not significantly different from each other 
(P > 0.05). *P < 0.05, significantly different when compared with the same treatment group from males. 
CYP 1A1/2, CYP 2B1/2, CYP 2E1, and CYPR represents EROD, PROD, PNP-H and CYP reductase activities, respectively. 
Table 3 
Effects of sage tea drinking (for 14 days) and CCl4 on glutathione-related enzymes, glutathione levels and soluble protein in mice livers 
Male   Female  Parameter Drinking group 
Without CCl4 With CCl4  Without CCl4 With CCl4
Water    305 ± 15 a    307 ± 12 a     128 ± 5 a *    115 ± 6 a * GST (mU/mg) 
Sage tea    369 ± 30 b    237 ± 23 c     144 ± 4 a *      76 ± 8 b * 
Water    432 ± 20 a    456 ± 14 a     779 ± 12 a *    772 ± 12 a * Gpox (mU/mg) 
Sage tea    493 ± 30 a    570 ± 25 b     888 ± 19 b *    694 ± 25 c * 
Water   24.1 ± 0.9 a   24.0 ± 0.3 a    20.1 ± 0.6 a,b *   21.1 ± 0.2 a * GR (mU/mg) 
Sage tea   25.2 ± 1.0 a   20.9 ± 1.1 b    22.4 ± 0.4 a *   18.3 ± 0.5 b * 
Water   7.61 ± 0.24 a   7.48 ± 0.22 a    7.46 ± 0.33 a   8.36 ± 0.16 aGSH (nmol/mg liver) 
Sage tea   6.53 ± 0.34 a   8.18 ± 0.56 a    6.71 ± 0.14 a   4.53 ± 1.09 b * 
Water   0.26 ± 0.02 a,b   0.23 ± 0.02 a,b    0.19 ± 0.02 a   0.27 ± 0.06 aGSSG (nmol/mg liver) 
Sage tea   0.19 ± 0.02 b   0.31 ± 0.03 a    0.22 ± 0.03 a 1.35 ± 0.20 b * 
Water 195.7 ± 4.3 a 200.4 ± 2.8 a  194.1 ± 3.6 a  180.1 ± 1.2 b * Protein (mg protein/g liver)a
Sage tea 215.8 ± 4.3 b 171.7 ± 4.2 c  214.3 ± 2.9 c 154.8 ± 4.9 d * 
Values are means ± SEM, n = 5. Drinking groups of the same gender with the same letter notation are not significantly different from each other  
(P > 0.05). *P < 0.05, significantly different when compared with the same treatment group from males. 
GST: glutathione-S-transferase; GPox: glutathione peroxidase; GR: glutathione reductase; GSH: glutathione (reduced form); GSSG: glutathione: 
(oxidized form). 
a Liver soluble proteins measured in the supernatant after a centrifugation of 10,000g for 10 min at 4ºC by the Bradford reagent using bovine serum 
albumin as a standard. 
addition to the measurement of some CYP enzyme activi-
ties which included the CYP 2E1, the expression of this 
cytochrome was evalu-ated by Western Blot (Fig. 2). Sage 
tea drinking for 14 days increased significantly the amount 
of CYP 2E1 protein in females (24%) but it only slightly 
increased in males (8%). In sage tea drinking mice, the 
decrease on CYP 2E1 protein induced by CCl4 was most 
severe in females. 
After bioactivation, CCl4-induced hepatotoxicity is 
mediated by primary and secondary bond formation of 
reactive species to critical cellular molecules such as 
DNA, lipids, proteins or carbohydrates (Weber et al., 
2003). Thus, detoxifying enzymes (such as GST) and anti-
oxidant enzymes (such as the pair GPox/GR) are impor- 
tant against the cell stress situation caused by CCl4. To 
monitor effects at this level, three glutathione-related 
enzymes were measured (Table 3) and gender dif-ferences 
were observed in all of them. The activity of GST in males 
was significantly increased by sage tea drinking, as previ-
ously observed in other study (Lima et al., 2005). GPox 
activity was also increased by sage tea drinking but signifi-
cantly only in females. Hepatic GSH is an important intra-
cellular antioxidant that can scavenge free radicals and 
could be important in the defense against radical-mediated 
hepatotoxicity. Alterations in GSH and oxidized glutathione 
(GSSG) levels are therefore an important indicator of 
oxidative stress. Comparing the groups where CCl4 was 
not administered, there was no effect of sage tea drinking 
on GSH and GSSG levels in male and female mice  
(Table 3). Twenty four hours after CCl4 administration, 
GSH levels decreased signi-ficantly only in females from 
the sage tea drinking group. GSSG levels increased signifi-
cantly after CCl4 administration in both genders but only in 
the sage tea drinking groups (Table 3). This increase was 
significantly higher in females than males. As a result, glu-
tathione data also suggest higher cell damage induced by 
CCl4 in the sage tea drinking groups in females.  
    Finally, soluble protein measured after 10,000g centrifu-
gation (Table 3) corroborates the previous results. Com-
paring the groups where CCl4 was not administered, the 
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 that leads to lipid peroxidation (Weber et al., 2003). Since 
sage tea drinking has also been shown to decrease lipid pe-
roxidation induced by tert-butyl hydroxide in rat hepatocyte 
primary cultures (Lima et al, 2005), this also suggested 
here possible beneficial effects against CCl
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4. However, con-
trary to our hypothesis, sage tea drinking increased signifi-
cantly the CCl4-induced hepatotoxicity in mice. 
CCl4 becomes toxic upon activation mainly through  
CYP 2E1, and an induction or an over-expression of this 
cytochrome correlates with higher CCl4 toxicity (Weber et 
al., 2003; Chan et al., 2005). Sage tea drinking for 14 days
increased the expression level of CYP 2E1. In agreement 
with this, the activity of this cytochrome was also slightly 
increased by sage tea drinking. This could provide an expla-
nation for the higher CCl4 toxicity in tea drinking mice. 
CYP 2E1 protein is localized predominantly in the central 
zone of the liver lobule (Forkert et al., 1991), which explains 
the typical centrilobular region of hepa-tocyte injury 
observed after CCl
 
Fig. 2. Effects of sage tea drinking (for 14 days) and CCl4 on expression of 
CYP 2E1 in the liver of male and female mice. Each gel lane was loaded 
with 15 µg of microsome proteins for the Western blotting analysis. (A) 
Results obtained from five mice of each group. Mean ± SEM. Groups of 
the same gender with the same letter notation are not significantly different 
from each other (P > 0.05). *P < 0.05, significantly different when com-
pared with the same treatment group from males. (B) Representative 
images of the imunodetection of CYP 2E1 by Western Blot from 2  
animals for each group. 
4 administration. This pattern of centri-
lobular toxicity was more extensive in sage tea versus water 
drinking mice. After CCl4 bioactivation, the resulting ˙CCl3 
radical binds covalently to CYP 2E1, either to the active site 
of the enzyme or to the heme group, thereby causing suicide 
inactivation (Weber et al., 2003). After drug administration 
to sage tea drinking mice, CYP 2E1 levels, originally higher, 
decreased to significant lower levels. A decrease in CYP 2E1 
expression and activity after CCl
. 
 4 exposure seem to reflect 
inactivation of the protein, which is consistent with the 
increased CCl
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
higher soluble protein found in the sage tea drinking  
groups suggests induc-tion of protein expression. The 
decrease in soluble protein, with concomitant precipitation 
of damaged proteins, found after the haloalkane adminis-
tration suggests higher toxicity of CCl
4 hepatotoxicity in this drinking group. 
However, to confirm increased CCl4 bioactivation through 
CYP 2E1 in sage tea drinking mice than the water drinking 
cohorts, measurement of covalent binding of 4 in the sage tea 
drinking groups and in females. 
14CCl4- 
derived radiolabel to liver tissue would have to be done. 
The simultaneous increases in GST and GPox activities  
by sage tea drinking, and possibly other detoxifying and 
antioxidant enzymes, seem to have been incapable of 
neutralizing increased CCl
 
4. Discussion 
 
In a previous study, sage tea drinking significantly 
increased (rat and mouse) liver GST activity and protected 
against GSH depletion and lipid peroxidation induced by  
an oxidant agent (Lima et al., 2005). Considering these 
beneficial effects on liver antioxidant status, the present 
study was carried out in order to evaluate whether sage  
tea drinking would reduce the extent of hepatic injury 
induced by CCl
4 toxicity. Also, the previously 
observed beneficial effect of sage tea against lipid peroxida-
tion (Lima et al., 2005) seemed to be insufficient to block 
CCl4-induced damage. The increased levels of CYP 2E1 
protein and activity induced by sage tea drinking may, thus, 
at least in part, provide an explanation for the obtained 
results – an herb-toxicant interaction between sage tea and 
CCl4 in male and female mice. In a recently 
published work, GST was implicated as an important 
defence mechanism during the early stages (1–6 h) of the 
CCl
4 that potentiated the haloalkane’s toxicity. 
    Herb-drug interactions have been described for a variety 
of plants used as phytomedicines, many of them by case 
reports of interactions between herbs and pharmaceutical 
drugs (Izzo, 2005; Hu et al., 2005). CYP isozymes are 
particularly vulnerable to modulation by the diverse active 
constituents of herbs (Zhou et al., 2003). This important 
phase I drug-metabolizing enzyme system is responsible 
for the metabolism of a variety of xenobiotics and some 
important endogenous substances such as steroids and 
prostaglandins (Anzenbacher and Anzenbache-rova, 2001; 
Tamasi et al., 2003). Although CYP-mediated reactions 
are primarily detoxification processes, certain substrates 
are metabolically activated resulting in the generation of  
4-induced liver injury (Dwivedi et al., 2006). GST is a 
phase II enzyme that plays a key role in cellular detoxifica-
tion of xenobiotics, electrophiles and reactive oxygen 
species through their conjugation to GSH (Mates, 2000). 
Besides an essential substrate to GST and GPox, GSH is 
also an important intracellular antioxidant (hydrogen-
donating compound) that spontaneously neutralizes several 
electrophiles and reactive oxygen species (Lu, 1999).  
After bioactivation of CCl4, in addition to dangerous free 
radical formation and subsequent reactive oxygen species 
formation, a sequence of chain reactions can be initiated 
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reactive intermediates with increased toxicity and muta-
genicity (Jaeschke et al., 2002; Tamasi et al., 2003). Many 
pharmaceutical drugs are also metabolized by these phase 
I enzymes and modulation of CYPs by herbs may either 
exacerbate the undesirable effects (by increasing toxicity) 
or antagonize the actions (by increasing clearance) of con-
current medical therapy (Stedman, 2002). In addition, 
severe hepatic injury may be caused by chemicals or natural 
toxins metabolically activated by drug-metabolizing 
enzymes as a result of occupational, household or environ-
mental exposure, emphasizing the need for understanding 
mechanisms of action of herbal extracts. Thus, although 
interspecies differences in xenobiotic metabolism are well 
documented (Caldwell, 1992), the drug-toxicant interaction 
between sage tea and CCl
monoterpenic compounds (Elegbede et al., 1993; Banerjee 
et al., 1995; Birt et al., 2001; Ren et al., 2003; Ferguson 
et al., 2004). Flavonoids are a diverse group of polyphenols 
that are produced by several plants (Havsteen, 2002). In 
relation to phase I and phase II drug-metabolizing  
enzymes, flavonoids have been reported to possess several 
modulatory effects, either inducing or decreasing the 
expression of these enzymes and also either as potent inhi-
bitors or stimulators of enzyme activities, depending on 
structure, concentration, and assay conditions (Zhou et al., 
2003; Ferguson et al., 2004). Rosmarinic acid is the 
predominat phenolic compound in sage tea (Lima et al., 
2005). The oral administration of rosmarinic acid in rats 
was previously shown not to induce phase I and phase II 
enzymes (Debersac et al., 2001), and, therefore, was pos-
sibly not the responsible for the effects observed in our study. 
Luteolin-7-glucoside, the major flavonoid present in sage 
tea, and also monoterpenes present in the essential oil frac-
tion, could, on the other hand, be good candidates. 
However, pre-treatment of rats with luteolin-7-glucoside was 
recently found to protect significantly against CCl
4 reported here highlight possible 
herb-drug interactions between this extract and drugs 
metabolized by the liver. However, as far as we know, there 
were no reports of drug-drug interactions between sage tea 
and pharmaceutical drugs or environmental contaminants. 
In this particular study, where a herb-drug interaction was 
observed, sage tea replaced almost 100% the water that the 
animal consumed, since food is provided as dry pellets. 
Therefore, by taking 1 or 2 cups of sage tea, a person never 
reaches the dose of sage extract ingested by mice in this 
study. So, it seems that the moderate, traditional drinking 
of sage tea by people most likely does not result in adverse 
interactions with other drugs. It should, however, be kept 
in mind that, if a phytomedicine with a higher dose of sage  
is taken over an extended period of time, an opportunity 
for enzyme induction could occur and undesirable interac-
tions take place. Additionally, interindividual differences in 
drug metabolism, for example due to genetic polymorphism 
of CYP genes (Tamasi et al., 2003; Wu and Cederbaum, 
2005), could increase the susceptibility of different 
populations or individuals for herb-drug interactions. 
4-induced 
toxicity, and its effects attributed to the compound’s anti-
oxidant properties acting as scavenger of reactive oxygen 
species (Zheng et al., 2004). Most likely, the sage tea effects 
observed here were a result of interactions and synergisms 
among the different compounds and metabolites present, 
which makes it difficult to attribute them to any particular 
compound or family of compounds. 
In conclusion, the present work showed that sage tea 
drinking for 14 days significantly potentiated CCl4-induced 
hepatic injury in mice, to a higher degree in females, as a 
result, at least in part, of an induction of CYP 2E1. In addi-
tion, although sage tea did not have toxic effects of its own 
and in fact seemed to improve the antioxidant status of the 
liver, the observed herb-toxicant interaction may affect the 
efficacy and safety of concurrent medical therapy with 
drugs that are metabolized by phase I enzymes. 
    Many of these drug-metabolizing enzymes and also anti-
oxidant enzymes are known to be gender dependent 
(Chaubey et al., 1994; Clewell et al., 2002; Sverko et al., 2004), 
which may ultimately differentially affect the toxicity of 
drugs between male and female individuals of the same specie 
(Kato and Yamazoe, 1992; Meibohm et al., 2002; Chanas et 
al., 2003). The hepatotoxicity of CCl
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6.1. Chapter overview 
 
Besides the important function as biotransforming organ, the liver also plays a major 
role in glucose homeostasis. It maintains normal concentrations of blood glucose within a 
narrow range by its ability to store glucose as glycogen and to produce glucose through 
glycogen breakdown or from gluconeogenic precursors. In type 2 diabetes, deregulation of 
insulin action (insulin resistance) has marked effects on hepatic glucose homeostatic pathways 
resulting in high circulating glucose levels. Therefore, the liver could be seen as a potential 
target for the treatment of diabetes and, because the available medication is far from being 
100% efficient, plants are again being screened in the search for new potential agents that can 
help manage the disease. 
Salvia officinalis is one of the plants used for the traditional treatment of diabetes 
mellitus1 and some of its extracts have shown to have hypoglycaemic effects in normal and 
diabetic animals. Alarcon-Aguilar et al. (2002) showed that a water-ethanolic extract from S. 
officinalis, injected intraperitoneally, had hypoglycaemic effects in fasted normoglycaemic mice 
and in fasted mildly alloxan-induced diabetic mice2. In addition, Eidi et al. (2005) showed, 
recently, that a sage methanolic extract, given intraperitoneally, reduced significantly serum 
glucose in fasted streptozotocin-induced diabetic rats without changes in insulin levels3. Sage 
EO has also been referred to possess hypoglycaemic activity4. 
Considering the reputation of S. officinalis in the regulation of glucose levels, the 
hypoglycaemic properties of a sage tea was evaluated using normal mice and rats. Replacing 
water with sage tea for 14 days lowered fasting plasma glucose in normal mice but had no effect 
on glucose clearance in response to an intraperitoneal glucose tolerance test. This indicated 
effects at level of the liver, namely on gluconeogenesis. Therefore, in a following set of 
experiments, hepatocyte primary cultures of sage tea drinking rats showed, after stimulation 
(incubation with high concentrations of glucose), high glucose uptake capacity and decreased 
gluconeogenesis in response to glucagon. Sage EO, added in vitro to the cultures, further 
increased hepatocyte sensitivity to insulin and inhibited gluconeogenesis. Overall, these effects 
resemble those of the pharmaceutical drug metformin, a known inhibitor of gluconeogenesis 
 
1 Swanston-Flatt SK, Day C, Flatt PR, Gould BJ & Bailey CJ, 1989. Glycaemic effects of traditional European plant 
treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetes Research 10, 69-73. 
2 Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL & Aguirre-Garcia F, 2002. Investigation on the 
hypoglycaemic effects of extracts of four Mexican medicinal plants in normal and alloxan-diabetic mice. 
Phytotherapy Research 16, 383-386. 
3 Eidi M, Eidi A & Zamanizadeh H, 2005. Effect of Salvia officinalis L. leaves on serum glucose and insulin in 
healthy and streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 100, 310-313. 
4 Baricevic D & Bartol T, 2000. The biological/pharmacological activity of the Salvia genus. In: Kintzios SE (Ed.), 
SAGE - The Genus Salvia, Harwood Academic Publishers, Amsterdam, pp. 143-184. 
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used in the treatment and prevention of type 2 diabetes mellitus. The results also show an 
important role of the essential oil fraction for the hypoglycaemic effects of sage. In primary 
cultures of rat hepatocytes isolated from streptozotocin-induced diabetic rats, none of these 
activities induced by sage tea drinking were, however, observed. 
The metformin-like effect of sage tea indicates, nevertheless, a possible type 2 diabetes 
preventive potential, mainly in people at risk of developing it as is the case of those who present 
impaired glucose tolerance. In fact, there is now substantial evidence that type 2 diabetes could 
be considered as a preventable disease through changes in lifestyle that include, among others, 
dietary factors. Therefore, sage products can easily be utilised as a functional food or food 
supplements that could have a beneficial impact in low cost prevention strategies of diabetes. 
Besides the potential use of sage in diabetes prevention, further studies with other 
animal models of type 2 diabetes could provide additional information on the therapeutical 
effects of sage tea and/or sage EO. 
Nevertheless, the regular consumption of sage tea can, in addition to help preventing 
type 2 diabetes through its metformin-like effect, be a source of antioxidants with their wide 
range of health benefits. In particular on the liver, the previous studies (chapter 3, 4 and 5) 
showed the ability of sage in potentiating the antioxidant defences. In turn, the beneficial effects 
of sage tea on the liver glutathione levels may, apart from the antioxidant and detoxifying 
function, also be important to glucose homeostasis. As suggested by Guarino et al. (2003), liver 
glutathione may indirectly improve the liver mediated insulin response in vivo1. Since oxidative 
stress is involved in diabetic complications and possibly in the onset of diabetes (see section 
1.7.2), the antioxidant effects of sage may also help, indirectly, in the prevention and treatment 
of diabetes. Therefore, although little is known about the sage effects in this field, the study 
presented here opened a range of research opportunities that should be explored. For example, it 
is known that the erythrocyte glutathione content of patients with type 2 diabetes is significantly 
decreased, lowering their antioxidant potential2. Also in diabetic rat models, GSH content is 
decreased in several organs including the liver when compared with healthy controls3. 
Therefore, the beneficial effects of sage tea on GSH levels could also contribute to increase the 
antioxidant potential of patients with type 2 diabetes, whose defences are normally decreased, 
 
1 Guarino MP, Afonso RA, Raimundo N, Raposo JF & Macedo MP, 2003. Hepatic glutathione and nitric oxide are 
critical for hepatic insulin-sensitizing substance action. American Journal of Physiology - Gastrointestinal Liver 
Physiology 284, G588-G594. 
2 Bravi MC, Armiento A, Laurenti O, Cassone-Faldetta M, de Luca O, Moretti A & de Mattia G, 2006. Insulin 
decreases intracellular oxidative stress in patients with type 2 diabetes mellitus. Metabolism Clinical and 
Experimental 55, 691-695. 
3 Kamalakkannan N & Prince PSM. 2006. Rutin improves the antioxidant status in streptozotocin-induced diabetic rat 
tissues. Molecular and Cellular Biochemistry, in press (DOI: 10.1007/s11010-006-9244-1). 
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helping them to face an oxidative stress condition. 
 
 
6.2. Methods 
 
The following experimental protocols (see Appendix) were used in this chapter: 
• P1: Biological Models – Rat Hepatocyte Isolation and Use 
• P3: Biological Models – Mice as Experimental Model 
• P4: Cell Viability Assays – LDH Leakage 
• P9: Metabolite Measurements – Glucose 
• P10: Metabolite Measurements – Total Protein 
• P20: Others – Coating with Collagen 
 
 
6.3. Publication 
 
This chapter comprises the following publication: 
Lima CF, Azevedo MF, Araujo R, Fernandes-Ferreira M & Pereira-Wilson C, 2006. 
Metformin-like effect of Salvia officinalis (common sage): is it useful in diabetes prevention? 
British Journal of Nutrition 96(2), 326-333. 
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Metformin-like effect of Salvia officinalis (common sage): is it useful in
diabetes prevention? 
 
Cristovao F. Lima, Marisa F. Azevedo, Rita Araujo, Manuel Fernandes-Ferreira and 
Cristina Pereira-Wilson 
 
Department of Biology, Centre of Biology, School of Sciences, University of Minho, 4710-057 Braga, Portugal 
Common sage (Salvia officinalis L.) is among the plants that are claimed to be beneficial to diabetic patients, and previous studies have suggested that 
some of its extracts have hypoglycaemic effects in normal and diabetic animals. In the present study, we aimed to verify the antidiabetic effects of an 
infusion (tea) of common sage, which is the most common form of this plant consumed. Replacing water with sage tea for 14 d lowered the fasting 
plasma glucose level in normal mice but had no effect on glucose clearance in response to an intraperitoneal glucose tolerance test. This indicated 
effects on gluconeogenesis at the level of the liver. Primary cultures of hepatocytes from healthy, sage-tea-drinking rats showed, after stimulation, a 
high glucose uptake capacity and decreased gluconeogenesis in response to glucagon. Essential oil from sage further increased hepatocyte sensitivity  
to insulin and inhibited gluconeogenesis. Overall, these effects resemble those of the pharmaceutical drug metformin, a known inhibitor of gluco-
neogenesis used in the treatment and prevention of type 2 diabetes mellitus. In primary cultures of rat hepatocytes isolated from streptozotocin     
(STZ)-induced diabetic rats, none of these activities was observed. The present results seem to indicate that sage tea does not possess antidiabetic 
effects at this level. However, its effects on fasting glucose levels in normal animals and its metformin-like effects on rat hepatocytes suggest            
that sage may be useful as a food supplement in the prevention of type 2 diabetes mellitus by lowering the plasma glucose of individuals at risk. 
Salvia officinalis L.: Diabetes: Metformin: Rat hepatocyte: Hypoglycaemic effects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: EO, essential oil; FBS, fetal bovine serum; IpGTT, intraperitoneal glucose tolerance test; STZ, streptozotocin. 
 
 
Diabetes mellitus is a disease characterised by increased 
plasma glucose levels that is the result of an insufficient pro-
duction of (type 1 diabetes) and/or decreased tissue response 
to (type 2 diabetes) the pancreatic hormone insulin. Type 1 
diabetes involves an autoimmune disease in which the insu-
lin-secreting β-cells of the pancreas are destroyed by the indi-
vidual’s immune system. In type 2 diabetes, insulin resistance 
in the peripheral tissues strains insulin secretion, which leads 
to subsequent failure of the β-cells of the pancreas (Klover & 
Mooney, 2004). Type 2 diabetes accounts for the majority 
(85–90%) of cases and is likely to become even more preva-
lent over the coming decades because of the increasing rates 
of childhood and adult obesity and the tendency for develo-
ping countries to embrace Western lifestyles (Williams & 
Pickup, 2004). Nowadays, diabetes mellitus is a major  
public health concern that has in many countries attained epi-
demic proportions. 
the peripheral tissues, thereby preventing hyperglycaemia. 
During periods when there is no intestinal glucose absorption, 
blood levels do not decrease drastically because the liver 
releases glucose into the circulation in response to the counter-
regulatory pancreatic hormone glucagon, which stimulates 
both glycogen breakdown (glycogenolysis) and gluconeoge-
nesis (i.e. the formation of new glucose from substrates, for 
example glycerol, lactate and amino acids such as alanine). 
    The anti-hyperglycaemic effects of insulin include the sup-
pression of glucose output from the liver, inhibiting both gly-
cogenolysis and gluconeogenesis. In healthy individuals, 
relatively low concentrations of insulin are needed to suppress 
hepatic glucose output (Roden & Bernroider, 2003; Williams 
& Pickup, 2004). In type 2 diabetes, however, not only does 
hyperglycaemia exist postprandially, where it reveals the 
inability of insulin to increase peripheral glucose uptake, but 
also elevated blood glucose levels persist even during fasting 
owing to increased gluconeogenesis in the liver (Roden & 
Bernroider, 2003; Klover & Mooney, 2004). 
    Glucose is an essential nutrient for the human body, and 
mechanisms of glucose homeostasis aim to maintain the blood 
glucose level within a narrow range, about 5–7 mmol/l 
(Klover & Mooney, 2004; Williams & Pickup, 2004). In healthy 
individuals, blood glucose concentrations are maintained by the 
balance between glucose entry into the circulation from intesti-
nal absorption and glucose uptake into peripheral tissues such as 
muscle and adipose tissue. Circulating levels of insulin increase 
after meals, stimulating GLUT-4-mediated glucose uptake by 
    Before the disease has become established, those individuals 
more at risk of developing type 2 diabetes show the first signs of 
abnormal glucose metabolism, such as impaired glucose tole-
rance and/or impaired fasting glucose (Simpson et al. 2003). 
This provides an asymptomatic period at the beginning of the 
progression of type 2 diabetes, during which preventive inter-
ventions can be applied. Previous studies have shown that  
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changes in dietary habits and sedentary behaviour can reduce the 
progression from impaired glucose tolerance to type 2 diabetes 
by 50–60% (Chiasson et al. 2002; Simpson et al. 2003). How-
ever, the difficulty of maintaining lifestyle changes in the long 
term justifies the need for pharmacotherapeutic support, and 
recent studies have shown beneficial effects of metformin and 
acarbose during the progression from impaired glucose tole-
rance to type 2 diabetes (Simpson et al. 2003). Metformin 
mainly inhibits gluconeogenesis, whereas acarbose reduces 
intestinal glucose absorption. But any pharmacological inter-
vention in an asymptomatic population raises ethical conside-
rations in addition to practical and economic issues. 
The aerial parts of plants were lyophilised and kept at -20ºC. 
The sage tea was routinely prepared as in a previous study by 
pouring 150 ml boiling water onto 2 g dried plant material and 
allowing it to steep for 5 min (Lima et al. 2005). This preparation 
produced a 3·5(SEM 0·1) mg extract dry weight per ml infusion, 
with rosmarinic acid (362 μg/ml infusion) and luteolin 7-gluco-
side (115·3 μg/ml infusion) as major phenolic compounds, and 
1,8-cineole, cis-thujone, trans-thujone, camphor and borneol 
as the major volatile components (4·8 μg/ml infusion; Lima  
et al. 2005). The EO was obtained by hydrodistillation, and 
the compounds were identified by GC and GC–MS in a previous 
work (Lima et al. 2004). The EO included approximately sixty 
compounds, the most abundant being cis-thujone (17·4 %), 
alpha-humulene (13·3 %), 1,8-cineole (12·7 %), E-caryophyl-
lene (8·5 %) and borneol (8·3 %; Lima et al. 2004). 
    Dietary supplements with glucose-lowering properties could 
provide a culturally acceptable and economically viable 
alternative to pharmaceutical interventions at this stage. How-
ever, in spite of growing interest in the effects of herbs and 
food supplements on glucose control in diabetes, information 
remains insufficient (Day, 1998; Yeh et al. 2003). Plants 
have for centuries been used in folk medicine, and their 
beneficial effects have been well described. Salvia officinalis 
L. (common sage) is among those which are reputed to 
possess antidiabetic properties (Baricevic & Bartol, 2000). 
 
Animals 
Female Balb/c mice (8–10 weeks) and male Wistar rats  
(150–200 g) were purchased from Charles River Laboratories 
(Barcelona, Spain) and acclimated to our laboratory animal 
facilities for at least 1 week before the start of the 
experiments. During this period, the animals were maintained 
on a natural light–dark cycle at 20(SD 2) ºC and given food 
and tap water ad libitum. The animals used in the experiments 
were kept and handled in accordance with our university regu-
lations, which follow the Principles of Laboratory Animal 
Care (National Institutes of Health, 1985). 
    Recently, Alarcon-Aguilar et al. (2002) showed that a water 
ethanolic extract from S. officinalis injected intraperitoneally 
had hypoglycaemic effects in fasted normoglycaemic mice 
and in fasted mildly alloxan-induced diabetic mice. In addition, 
Eidi et al. (2005) showed that a sage methanolic extract given 
intraperitoneally significantly reduced serum glucose level in 
fasted streptozotocin (STZ)-induced diabetic rats without 
changes in insulin level. Sage has a high essential oil (EO) con-
tent (Giannouli & Kintzios, 2000). The EO has also been tested 
and proved to be hypoglycaemically active in normal and in 
alloxan-induced diabetic rats (Baricevic & Bartol, 2000) but 
not in STZ-induced diabetic rats (Eidi et al. 2005). 
To study the effects of sage-tea-drinking, sage tea was 
given to mice and rats ad libitum for 14 d as a replacement 
for their water, as previously performed (Lima et al. 2005). 
The volumes consumed were not significantly different 
between water and sage tea in both normal mice and rats 
(Lima et al. 2005). Diabetes was induced in rats by the intra-
peritoneal injection of a freshly prepared STZ solution (50 mg/ 
kg in 0·1 M-citrate buffer, pH 4·5). Experiments with diabetic 
rats were carried out 1 week after STZ injection. During this 
period, diabetes was well established, with polydipsia, poly-
uria and non-fasting blood glucose levels of over 250 mg/dl. 
The animals were used in four different experiments. 
With the present study, we aimed to evaluate the hypogly-
caemic properties of a sage infusion (hereafter referred to as 
sage tea), the most common form of human sage consumption, 
and to shed some light on possible mechanisms of action. In 
mice and rats treated for 14 d with sage tea, we evaluated in 
vivo the response to an intraperitoneal glucose tolerance test 
(ipGTT), and, in primary cultures of hepatocytes isolated 
from normal and STZ-induced diabetic rats, the effect on 
responses to glucose, insulin and glucagon. The in vitro effects 
of sage EO were also investigated. 
 
Experiment 1 
This experiment aimed to evaluate the hypoglycaemic poten-
tial of the sage tea in normal mice, an ipGTT being performed 
on animals from two different groups (water and sage-tea-
drinking). Twenty female Balb/c mice were randomly divided 
into two groups, and given food and either tap water or sage 
tea ad libitum for 14 d (the beverage being renewed daily). 
On day 15, an ipGTT (intraperitoneal injection of 300 g glu-
cose/l in physiological saline in a dose of 5·83 ml/kg mouse) 
was performed in mice that had been fasted for 3 h (half of 
the animals from each group being a control group, with an 
intraperitoneal injection of saline alone). Blood samples  
were collected 45 min after the intraperitoneal injection, and 
plasma was used for glucose measurements. 
 
Materials and methods 
Chemicals 
Collagenase (grade IV), William’s medium E, Dulbecco’s 
modified Eagle’s medium, dexamethasone, insulin, glucagon, 
1,1-dimethylbiguanide hydrochloride (metformin), STZ and 
Bradford reagent were purchased from Sigma-Aldrich  
(St Louis, MO, USA). Glucofix for glucose measurements 
was acquired from A. Menarini Diagnostics (Firenze, Italy). 
All others reagents were of analytical grade. 
 
Plant material, preparation of sage tea, isolation of essential 
oil and analysis of its constituents 
 
Experiment 2 
In this experiment, primary cultures of rat hepatocytes from 
overnight fasted normal animals, in a medium with low 
Salvia officinalis L. plants were grown in an experimental farm 
located in Arouca, Portugal, and were collected in April, 2001.  
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concentrations of glucose and a gluconeogenic substrate (lac-
tate), were used to evaluate the modulation by sage tea of hepato-
cyte glucose production. Eight male Wistar rats were randomly 
divided into two groups and given food ad libitum with either tap 
water or sage tea ad libitum for 14 d (the beverage being renewed 
daily). Hepatocyte isolation was performed between 10.00 and 
11.00 hours by collagenase perfusion, as previously described 
by Moldeus et al. (1978) with some modifications (Lima et al. 
2004), from overnight-fasted normal animals. Cell viability 
was over 85%, as estimated by a trypan blue exclusion test. 
similar intake of tea dry weight to that of the rats in expe-
riments 2 and 3. 
    Hepatocyte isolation from diabetic animals were per-
formed as above, and cells were suspended in Dulbecco’s 
modified Eagle’s medium containing either 5·6 mM or  
22 mM-glucose, supplemented with 10 mM-lactate, 100 ml 
FBS/l, 10-9 -9 M-insulin and 10  M-dexamethasone, and  
seeded onto six-well culture plates at a density of 1 × 106 
cells/well. The culture plates were incubated at 37ºC in a 
humidified incubator gassed with 50 ml/l CO2/air. After pla-
ting, culture medium was replaced with Dulbecco’s modified 
Eagle’s medium supplemented with 10 mM-lactate, 100 ml 
FBS/l and none, one or more of the following compounds: 
glucose (to a final concentration of 22 mM), 10
Cells were suspended in Dulbecco’s modified Eagle’s 
medium (containing 5·6 mM-glucose) supplemented with  
10 mM-lactate, fetal bovine serum (FBS; 100 ml/l), 10-9 M-insulin 
and 10-9 -7 M-dexamethasone, and were seeded onto six-well 
culture plates at a density of 1 × 10
 M-insulin, 
106 -7 -3 cells/well. Cells were incu-
bated at 37ºC in a humidified incubator gassed with 50 ml/l CO
 M-glucagon, 10  M-metformin and/or 4 nl sage  
EO/ml. After 24 h incubation, the medium was recovered  
for glucose quantification. Metformin was used as a positive 
control. 
2/ 
air. After plating (to allow for cell attachment), culture medium 
was replaced with Dulbecco’s modified Eagle’s medium sup-
plemented with 10 mM-lactate, 100 ml FBS/l and none, one or 
more of the following compounds: 10
    Plating periods of 24 h were used in cell cultures from nor-
mally fed animals for cell attachment. In an attempt to 
preserve the altered physiological conditions, introduced by 
both the fasting and the STZ-induced diabetes, cells were 
plated for 3 h before exposure to the different test conditions. 
In the fasted condition, the results of plating for 24 h are also 
presented for comparison. 
-7 -3 M-glucagon, 10  M-
metformin and/or sage EO (4 nl/ml). After 24 h incubation, the 
medium was recovered for glucose quantification. Metformin 
was used as positive control. 
 
In all experiments with rat hepatocytes, lactate dehydroge-
nase activity was measured in the media to ensure no toxicity of 
the treatment on the cell layer. 
Experiment 3 
In this experiment, primary cultures of normal rat hepatocytes 
in media with high (11 and 22 mM) concentrations of glucose 
(to mimic postprandial and diabetic conditions) were used to 
evaluate the effect of the sage tea on the glucose consumption 
capacity of the cells. Eight male Wistar rats were randomly 
divided into two groups and given food ad libitum with  
either tap water or sage tea ad libitum for 14 d (the beverage 
being renewed daily). 
 
Biochemical analysis 
The concentrations of glucose in the mouse plasma and culture 
media were measured using a colorimetric enzymatic method 
(Glucofix) following the manufacturer’s specifications. 
Hepatocytes were isolated from normal animals as described 
above, and cells were suspended in William’s medium E (con-
taining 11 mM-glucose) supplemented with 100 ml FBS/l, 
10
    The lactate dehydrogenase activity of the culture media was 
used as an indicator of hepatocyte plasma membrane integrity. 
The activity of the enzyme was measured at 30ºC by quanti-
fying NADH consumption by continuous spectrophotometry 
on a plate reader (Spectra Max 340pc; Molecular Devices, 
Sunnyvale, CA, USA; Lima et al. 2005). 
-9 -9 M-insulin and 10  M-dexamethasone, and seeded onto 
six-well culture plates at a density of 1 × 106 cells/well. Cells 
were incubated at 37ºC in a humidified incubator gassed with 
50 ml/l CO
 
2/air. After plating, culture medium was replaced 
with William’s medium E supplemented with 100 ml FBS/l 
and none, one or more of the following compounds: glucose  
(to a final concentration of 22 mM), 10
Protein content was measured with the Bradford reagent 
purchased from Sigma-Aldrich using bovine serum albumin 
as a standard. 
-7 M-insulin and/or 4 nl 
sage EO/ml. After 24 h incubation, the media were recovered for 
glucose quantification. 
 
Statistical analysis 
Data are expressed as means with standard errors of the 
means (SEM). Two-way ANOVA followed by the Stu-  
dent–Newman–Keuls post hoc test (SigmaStat, version  
2.03; SPSS Inc., San Rafael, CA, USA) was employed in 
experiment 1 to compare the effects of the in vivo beverage 
(water v. sage tea) and the ipGTT (intraperitoneal saline v. 
intraperitoneal glucose). In experiments 2, 3 and 4 (in  
which two replicates were used for each experimental con-
dition), the same statistical test was employed to compare the 
effects of the in vivo beverage (water v. sage tea) and  
the in vitro treatments (in this case, when a significant  
effect was obtained, a paired student’s t test was employed  
to find the differences between each treatment). P values  
≤ 0·05 were considered statistically significant.  
 
Experiment 4 
In this experiment, primary cultures of hepatocytes from  
STZ-induced diabetic rats were used in media with low  
and high concentrations of glucose (both containing the 
gluconeogenic substrate lactate) to evaluate effects of  
sage-tea-drinking on cell glucose production. Eight STZ-  
induced diabetic rats (male Wistar) were randomly divided  
into two groups and given food ad libitum with either tap  
water or sage tea ad libitum for 14 d (the beverage being  
renewed daily). Because the diabetic rats were polydipsic,  
sage-tea-drinking animals were pair-fed with the non-dia-  
betic animals given diluted sage tea, in order to ensure a 
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although consumption was higher in cells isolated from the 
sage-tea-drinking animals. In co-incubations with insulin, 
sage EO significantly potentiated the hormone’s effects on 
glucose consumption (Fig. 2(A,B)). 
Results 
Experiment 1 
A period of 14 d of sage-tea-drinking significantly lowered 
fasting (3 h and 45 min) plasma glucose concentration from 
8·8 mM to 6·8 mM (P≤0·01) in normal mice (Table 1). In 
response to an ipGTT, a significant increase in plasma glucose 
was observed at 45 min in both groups (Table 1), although no 
differences were observed between the water and sage-tea-
drinking groups. 
 
Experiment 4 
In contrast with the situation for cells from healthy animals, 
when hepatocytes from STZ-induced diabetic rats were 
plated with medium containing 22 mM-glucose (and 10 mM-
lactate), glucose production (and not consumption) was 
observed. There was no stimulation of glucose consumption 
by insulin (Fig. 3). Sage-tea-drinking did not modify this situ-
ation. In addition, EO did not inhibit hepatocyte glucose pro-
duction. Only metformin was able to reduce the glucose 
production of hepatocytes isolated from diabetic water and 
sage-tea-drinking rats (Fig. 3). 
 
Experiment 2 
When hepatocytes from overnight fasted rats were plated with 
5·6 mM-glucose- and 10 mM-lactate-containing medium, there 
was a release of glucose (mainly due to gluconeogenesis)  
into the medium. Hepatocyte glucose production increased  
in response to glucagon (Fig. 1(A)) in cells from water-drin-
king animals but was not statistically significant in cells from 
sage-tea-drinking animals (Fig. 1(A,B)). In general, hepato-
cyte glucose production (Fig. 1(A)) was lower in cells isolated 
from sage-tea-drinking rats than in those of  
water-drinking controls (P≤0·05), and the difference  
became significant in the glucagon + EO groups (Fig. 1(A)). 
When incubated with sage EO, a significant decrease in hepa-
tocyte glucose production was observed in both drinking 
groups (Fig. 1(A)). In co-incubations with glucagon, sage  
EO significantly decreased glucose production in response to 
glucagon (Fig. 1(A)). 
    When hepatocytes from STZ-induced diabetic rats were 
plated with 5·6 mM-glucose (and 10 mM-lactate) containing 
medium, glucose production was similar in cells isolated 
from both water and sage-tea-drinking rats (Fig. 4). Glucagon 
did not further stimulate glucose production (Fig. 4). As 
above, no effect was observed for EO. Once again, metformin 
significantly reduced (by about 60%) hepatocyte glucose pro-
duction in cells from both water and sage-tea-drinking rats 
(Fig. 4). 
All the treatments in the primary cultures did not induce 
lactate dehydrogenase release to the medium, an indicator 
that there was no cell toxicity in any of the in vitro treatments.
Metformin (a known inhibitor of gluconeogenesis) signifi-
cantly lowered hepatocyte glucose production capacity, even 
when co-incubated with glucagon, in cells from both  
water- and tea-drinking animals (Fig. 1(B)). 
 
Discussion 
The present work shows that sage-tea-drinking significantly 
reduced fasting plasma glucose level in mice. This suggested 
an inhibition of gluconeogenesis and/or glycogenolysis in the 
liver. In agreement with this, rat overall hepatocyte glucose 
production was lower in cells isolated from sage-tea-drinking 
animals than controls. Furthermore, stimulation with glucagon 
did not increase gluconeogenesis significantly in cells from 
sage-tea-drinking animals. Sage EO, although not as effective 
as metformin, produced a significant decrease in hepatocyte 
gluconeogenesis. In addition, the response of the hepatocytes 
to insulin was significantly increased by sage EO. These  
data suggests a metformin-like effect for sage tea and in par-
ticular for the EO fraction of Salvia officinalis L. These effects 
were, however, not observed in hepatocytes isolated from STZ 
diabetic animals, in which only metformin, a drug used in the 
treatment and prevention of type 2 diabetes, was effective in 
reducing glucose production. The effects of metformin were 
not modified by sage-tea-drinking, which seems to imply  
that sage tea, although not effective in diabetics, would not 
interfere negatively with metformin therapy. 
 
Experiment 3 
Hepatocyte glucose consumption measured after 24 h incu-
bation was higher in 22 mM-glucose medium (Fig. 2(B))  
than in 11 mM-glucose medium (Fig. 2(A)), and increased in 
response to insulin. Glucose consumption was significantly 
higher (P≤0·01) in cells isolated from tea dinking rats  
under all circumstances tested. 
    When the cells were incubated with sage EO, no significant 
differences in hepatocyte glucose consumption were obtained, 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Plasma glucose concentration in mice in response to an intra-
peritoneal glucose tolerance test (ipGTT; 45 min) performed on mice 
fasted for 3 h previously treated with or without sage tea for 14 d 
(Values are means and standard errors of the mean, n 5)  
 
Plasma glucose (mM) 
    Although using a different extract and experimental metho-
dology, the hypoglycaemic effects of sage have previously been 
reported by others (Alarcon-Aguilar et al. 2002; Eidi et al. 
2005). Alarcon-Aguilar et al. (2002) showed that, 4 h after an 
intraperitoneal injection of a sage water ethanolic extract, 
blood glucose decreased significantly in fasted normal mice 
and in fasted mildly alloxan-diabetic mice, but not in fasted 
severely alloxan-diabetic mice. Although the authors stated 
that insulin might have mediated the hypoglycaemic effect of  
Group In vivo beverage Mean SEM 
Water   8·8 0·6 Control 
Sage tea   6·8 ** 0·4 
Water 10·5 * 0·3 
ipGTT ††† 0·4 Sage tea 10·4 
Mean values were significantly different compared with the water + control group     
*P ≤ 0·05, **P ≤ 0·01. 
Mean values were significantly different when compared with the water + control 
group: ††† P ≤ 0·001. 
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Fig. 1. Hepatocyte glucose production (24 h) by primary cultures of rat hepatocytes (isolated from overnight-fasted animals; □) and the effects of previous in vivo 
treatment with sage tea (for 14 d, ■) on hepatocyte responses to glucagon (10
(A) (B) 
 
-7 -3 M), essential oil (EO; 4 nl/ml) and metformin (10  M). The initial glucose concen-
tration of the medium was 5·6 mM, and experiments were performed 24 h (A) or 3 h (B) after plating. Values were means with standard errors of the means shown 
by vertical bars (n 4). (A) Water-drinking rats: 100% = 6·4 (SEM 0·6) μmol glucose/mg protein; sage-tea-drinking rats: 100% = 6·2 (SEM 0·6) μmol glucose/mg 
protein. (B) Water-drinking rats: 100% = 8·2 (SEM 1·2) μmol glucose/mg protein; sage-tea-drinking rats: 100% = 9·5 (SEM 0·8) μmol glucose/mg protein. Mean 
values were significantly different compared with the respective control group: *P ≤ 0·05, **P ≤ 0·01. Mean values were significantly different compared with the 
respective glucagon group: †P ≤ 0·05, ††P ≤ 0·01. Mean values were significantly different compared with the respective EO group (A) or metformin group (B):       
‡P ≤  0·05, ‡‡P ≤ 0·01, ‡‡‡P ≤ 0·001. Mean value was significantly different between the water and sage tea groups: §P ≤ 0·05. 
 
 
 
 
 
 
 
 
Fig. 2. Glucose consumption (24 h) by rat hepatocytes in primary cultures (□), and effects of previous in vivo treatment with sage tea (for 14 d; ■) on hepatocyte 
responses to insulin (10-7 M) and essential oil (EO; 4 nl/ml). The initial glucose concentrations of the medium were 11 mM (A) and 22 mM (B). Values were means 
with standard errors of the means shown by vertical bars, n 4. Mean values were significantly different compared with the respective control group: *P ≤ 0·05, 
**P ≤ 0·01. Mean values were significantly different compared with the respective insulin group: †P ≤ 0·05, ††P ≤ 0·01. Mean values were significantly different 
compared with the respective EO group ‡P ≤ 0·05, ‡‡P ≤ 0·01. Mean value was significantly different between the water and sage tea gruops: §P ≤ 0·05. Mean 
value was almost significant compared with respective control group: ║P = 0.573. 
 
 
the extract, once the animals were tested in the fasted condition, 
it seems likely that an inhibition of gluconeogenesis was the 
cause of the effects observed in their study, as indeed suggested 
by the present results. Additionally, Eidi et al. (2005) showed 
that, 3 h after an intraperitoneal injection of a sage methanolic 
extract, blood glucose decreased significantly in fasted  
STZ-diabetic rats but not in fasted normal rats. This effect was
not accompanied by an increased release of insulin (Eidi et al. 
2005). 
    In human subjects, the abnormal glucose metabolism 
observed in both prediabetic states and in overt type 2 diabetes 
results in part from a deregulation of glucose production by  
the liver, which is mainly caused by an unrestrained glucagon 
stimulation of gluconeogenesis. In these individuals, therefore, 
(A) (B) 
141 
Effects of Salvia officinalis in the liver: Relevance of glutathione levels                                                       C.F. Lima
 
 preventing the liver’s contribution to hyperglycaemia in 
groups at risk. Metformin is a derivative of guanidine, the 
active compound of goat’s rue (Galega officinalis; Williams & 
Pickup, 2004). It acts by reducing liver glucose production and 
increasing the action of insulin (Chiasson et al. 2002). Also, in 
the present experiments, metformin showed these effects in 
both hepatocytes isolated from normal and STZ diabetic rats. 
 
 
 
 
 
 
 
 
    Generally, sage-tea-drinking increased rat hepatocyte glucose 
consumption, decreased fasting gluconeogenesis and inhibited 
the stimulation of hepatic glucose production by glucagon. 
However, in spite of decreasing plasma glucose, sage tea did 
not, after an in vivo ipGTT in mice, improve glucose clearance, 
which suggests that sage tea did not increase the insulin response 
in vivo. In addition, the stimulatory effects of in vitro insulin on 
glucose consumption were observed only in co-incubations with 
EO. This suggests a role for EO in the increase in sensitivity to 
insulin. Increased insulin sensitivity has been suggested as a 
possible mechanism of action of other plant extracts with attri-
buted hypoglycaemic activities (Li et al. 2004; Qin et al. 2004; 
Saxena & Vikram, 2004; Han et al. 2005). The presence of 
low amounts of EO in sage tea, about 4·8 mg/ml (Lima et al. 
2004), could explain the lack of an increase in insulin sensitivity 
observed after tea-drinking both in vivo and in vitro. We cannot 
exclude the fact that higher doses of the tested compounds admi-
nistered by either gavage or intraperitoneal injection could pro-
duce similar effects as in vitro. 
 
    
 
 
 
 
 
Fig. 3. Hepatocyte glucose production (24 h)  by primary cultures of rat  hepa-
tocytes (isolated from streptozotocin-induced diabetic animals; □), and the 
effects of previous in vivo treatment with sage tea (for 14 d; ■) on hepatocyte 
responses to insulin (10-7 M), essential oil (EO; 4 nl/ml) and metformin  
(10-3 M). The initial glucose concentrations of the medium were 22 mM, and 
experiments were performed 3 h after plating. Values were means with stan-
dard errors of the means shown by vertical bars, n 4. Water-drinking rats: 
100% = 8·4 (SEM 1·7) μmol glucose/mg protein, sage-tea-drinking rats: 
100% = 8·7 (SEM 0·9) μmol glucose/mg protein. Mean values were signifi-
cantly different compared with the respective control group: *P ≤ 0·05. Mean 
values was significantly different compared with the respective insulin group: 
†P ≤ 0·05. 
    Also, in STZ-induced diabetic rat hepatocytes, sage-tea-
drinking and EO in vitro lead to no significant improvement 
in the response to insulin. The liver (and hepatocytes) usually 
suppresses glucose release in response to insulin (Klover & 
Mooney, 2004). In STZ rat hepatocytes, insulin adminis-
tration failed to suppress glucose production. Previous studies 
have also indicated that insulin is incapable of stimulating 
glucose utilisation in vitro by hepatocytes from STZ-induced 
diabetic rats (Salhanick et al. 1983; Amatruda et al. 1984; 
Hussin & Skett, 1988). The insulin resistance imposed by 
STZ treatment was not reversed by sage tea and/or EO.  
The lack of effect of sage tea/EO on STZ hepatocytes  
seems to indicate that sage requires an intact insulin signal-
ling pathway to produce its effects. In the STZ diabetic rat, 
stimulation of the hepatocytes with glucagon did not enhance 
gluconeogenesis. Others have also failed to significantly 
stimulate gluconeogenesis in vitro in hepatocytes from STZ-
induced diabetic rats (Dunbar et al. 1989). 
 
 
 
 
gluconeogenesis is active even when plasma glucose concen-
trations are already elevated, which further aggravates hypergly-
caemia (Roden & Bernroider, 2003). By analogy with the effects 
of the drug metformin, used in the prevention and treatment of 
diabetes, the observed decrease in hepatocyte glucose pro-
duction of sage-tea-drinking animals could be favourable, by 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    One possibility for the lack of glucagon stimulation of glu-
coneogenesis in diabetic hepatocytes is that gluconeogenesis, 
in vivo, had been maximally stimulated. Cells are, however, 
metabolically competent and respond to metformin with a 
decrease in glucose production. In STZ-treated rats, insulin 
deficiency increases gluconeogenesis through enhanced lactate 
and pyruvate uptake and flux through the enzyme phospho-
enolpyruvate carboxykinase (Large & Beylot, 1999). Metfor-
min has been shown to reduce substrate flux through this 
enzyme (Large & Beylot, 1999) and to inhibit phosphoenol-
pyruvate carboxykinase gene expression (Cheng et al. 2001; 
Yuan et al. 2002), thereby decreasing gluconeogenesis. This 
inhibition of gene expression seems to occur mainly through 
an insulin-independent pathway (Yuan et al. 2002). This 
agrees with the possibility that sage tea and/or sage EO 
requires an intact insulin signalling pathway to produce its 
effects, which were observed only in normal rats.  
Fig. 4. Hepatocyte glucose production (24 h) by primary cultures of rat hepa-
tocytes (isolated from streptozotocin-induced diabetic animals; □), and the 
effects of previous in vivo treatment with sage tea (for 14 d; ■) on hepatocyte 
responses to glucagon (10-7 M), essential oil (EO; 4 nl/ml) and metformin 
(10-3 M). The initial glucose concentration of the medium was 5·6 mM, and 
experiments were performed 3 h after plating. Values were means with stan-
dard errors of the means shown by vertical bars, n 4. Water-drinking rats: 
100% = 7·9 (SEM 1·0) μmol glucose/mg protein, sage-tea-drinking rats: 
100% = 7·6 (SEM 0·3) μmol glucose/mg protein). Mean values were signifi-
cantly different compared with the respective control group: **P≤ 0·01,  
***P ≤ 0·001. Mean values were significantly different compared with the 
respective glucagon group: †P ≤ 0·05, ††P ≤ 0·001. 
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The reduction in fasting plasma glucose shown in healthy 
animals indicates the potential for sage extracts to help pre-
vent type 2 diabetes through a metformin-like effect, mainly 
in people at risk of developing it, as is the case of those  
who present impaired glucose tolerance and impaired fasting 
glucose. Taking into consideration the high worldwide, and 
increasing, prevalence of type 2 diabetes and the high costs 
involved in its treatment, the primary prevention of this dis-
ease is an important issue (Lai, 2002; Costacou & Mayer- 
Davis, 2003; Jermendy, 2005). Considering that there is now 
substantial evidence that type 2 diabetes could be considered 
to be a preventable disease through changes in lifestyle that 
include, among others, dietary factors (Costacou & Mayer- 
Davis, 2003; Schernthaner, 2003; Simpson et al. 2003; 
Stoeckli & Keller, 2004; Jermendy, 2005), the search for pre-
ventive strategies should be actively promoted. Sage products 
can easily be considered as functional foods or food sup-
plements that could have a beneficial impact in low-cost pre-
vention strategies for diabetes. In addition, there are health 
benefits from the use of plant extracts as sources of antioxi-
dants. With particular regard to the liver, sage tea has been 
shown not to have toxic effects and to improve liver gluta-
thione levels (Lima et al. 2005). Among other effects, this 
may indirectly improve the liver-mediated insulin response  
in vivo (Guarino et al. 2003). We are currently undertaking  
a pilot study with human volunteers to test the effects on  
the control of glycaemia in individuals at risk of developing 
diabetes. Experiments with animal models of type 2 diabetes, 
such as the Zucker rat (Sreenan et al. 1996), could also pro-
vide additional information on the therapeutic effects of 
sage tea. 
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7.1. General discussion and conclusions 
 
 This section aims at making an integrated discussion of the most relevant results 
presented and discussed in detail in the previous chapters. 
Salvia officinalis L is an aromatic and medicinal plant very popular worldwide with 
reputation in the treatment of different ailments. However, few pharmacological effects have 
been experimentally investigated, until today, in order to confirm their recognised benefits. 
Some studies have focused on their anti-inflammatory, anti-viral, estrogenic and memory-
improving activities, and some experiments were already performed in patients, in addition to 
using cells and laboratory animals. 
 With the studies presented in this thesis, the main objective was to increase our 
knowledge about two attributed effects of S. officinalis – the antioxidant and antidiabetic 
effects. Regarding the first aim, the antioxidant power of sage is well known. However, the 
majority of the studies performed until the beginning of these studies used chemical and 
subcellular assays and, therefore, studies with cells and organisms were awaited. Regarding the 
second aim, few studies were performed to confirm the antidiabetic and/or hypoglycaemic 
activity of sage, and the ones performed were often inconclusive. 
 The antioxidant and antidiabetic studies were focused on the liver since sage 
compounds first pass by this organ after gastrointestinal absorption, which gives an opportunity 
to concentrate them. The liver is also a biotransforming organ, which renders it particularly 
susceptible to the toxic effects of xenobiotics. In addition, the liver is affected by several liver 
diseases where oxidative stress is involved. Therefore, cytoprotective activities relevant to the 
liver are of particular interest. These studies allowed also the observation of possible toxic 
effects of sage and its interactions with other drugs. 
 Regarding sage constituents, the studies were focused on the essential oil fraction 
(extract rich in low weight volatile compounds), a methanolic extract (extract rich in phenolic 
compounds) and a sage water extract prepared as a tea (extract rich in very polar compounds, 
which include also phenolic compounds). The last extract is also very important to study since it 
is the most common form of human consumption of this plant. Some major phenolic 
compounds of the extracts were also tested alone in some experiments (chapter 4). 
 The major studies reported, focused on the antioxidant effects of sage at cellular 
(hepatocyte) and organ (liver) levels. To assess the antioxidant effects of the sage extracts, 
conventional markers of cell oxidative stress were used, such as, lipid peroxidation, glutathione 
levels and DNA damage. The monitorisation of GSH levels seemed very important in view of 
its central role on oxidative stress defence and prevention of cell damage and death. 
Furthermore, the measurement of glutathione-related enzyme activities was, as much as 
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possible, performed in order to give a broader idea of the possible involved mechanisms of cell 
defence.  
Firstly, the potential antioxidant effects of sage EO was tested in freshly isolated rat 
hepatocytes (chapter 2). Although sage EO is considered to have some antioxidant effects, these 
were to our knowledge never tested in cell systems. Our study demonstrated that sage EO does 
not have antioxidant effects in liver cells. On the contrary, at high concentrations (more than 2 
µl/ml), sage EO induced significant cell death accompanied by GSH depletion, but not by lipid 
peroxidation. The GSH depletion induced by sage EO could be an explanation for its toxic 
effects. The lack of antioxidant effects of sage EO may be a result of the relative low 
concentration of compounds considered as antioxidants in this sage extract. This study revealed 
the toxic effects of high concentrations of sage EO to the liver besides their known neurotoxic 
effects due to its constitution in thujones and champhor. 
Then, after an in vivo experiment with mice, where sage tea drinking (for 14 days) 
strengthened the liver antioxidant status (chapter 3), such as an improvement of GST activity 
and GSH levels as well as the prevention of lipid peroxidation and GSH depletion, the direct 
effects of a sage water (as a tea) extract and a methanolic extract were studied on HepG2 cells 
(chapter 4). Both extracts protected against cell death induced by t-BHP (a toxicant that induces 
oxidative stress), revealing the direct antioxidant effects of sage at cellular level. Sage was 
capable of acting at a cell critical parameter, namely GSH, preventing GSH depletion. A severe 
GSH depletion is known to mediate cell death by different mechanisms. The increase on 
GSSG/GSH ratio tends to decrease protein thiols that lead to severe toxicological implications, 
such as, disruption of cytoskeleton and calcium homeostasis as well as an increase of 
mitochondria permeability. Also, because GSH is an important intracellular antioxidant, GSH 
depletion leaves cells more vulnerable to oxidative stress. The studies presented in chapter 4 
showed a dependence of the cytoprotective effects on the total content of phenolic compounds 
and the antiradical activity of the sage extracts. The results obtained with the phenolic 
compounds underscored the importance of the compound’s lipophilicity, in addition to its 
antioxidant potential, for the overall biological activity. The lipophilicity of the natural 
antioxidants appeared to be of an even greater importance for their ability to protect DNA from 
oxidative damage. 
Also in chapter 4, not only did sage extracts prevent GSH depletion in a situation of 
oxidative stress, they also increased basal GSH levels in HepG2 cells. This indicates a capacity 
of sage extracts to improve cell antioxidant defences. However, according to the results, this can 
not be attributed directly to the phenolic compounds content of sage extracts, which emphasises 
the importance of other types of compounds. The increase in basal GSH levels may be the result 
of induction of de novo glutathione synthesis. This is corroborated by the results in chapter 3, 
where sage tea, given in vivo, restored GSH levels in vitro in rat hepatocytes to higher values 
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than those obtained in controls. Sage tea was, in addition, capable of inducing significantly GST 
(chapter 3 and 5) as well as GPox, NADPH cytochrome P450 reductase and also, slightly, some 
CYP enzymes in mice liver (chapter 5). This leaves liver cells better prepared to face oxidative 
stress and toxicants. All these observations show the ability of sage to have indirect antioxidant 
effects, for example, by inducing the activity/expression levels of important enzymes and 
proteins in detoxification and antioxidant defence. 
However, some of these effects of sage do not, in certain situations, result in protective 
effects. The ability of sage to increase the expression of certain proteins, such as CYP enzymes, 
can result in herb-drug interactions. In fact, that was what happened between sage tea and CCl4. 
In chapter 5, and contrarily to what was expected, sage tea drinking (for 14 days) did not protect 
mice from CCl -induced hepatotoxicity. Instead, sage tea potentiated the toxicity of CCl4 4 in the 
liver of both male and female mice. Since sage tea increased significantly the expression levels 
of CYP 2E1, the cytochrome that bioactivates CCl4 into its toxic radicals, this effect can, at least 
in part, explain the observed herb-toxicant interaction between sage tea and CCl4. Thus, these 
results draw attention to possible undesired herb-drug interactions between sage tea and drugs 
metabolised by the liver. However, because in this experiment sage tea replaced almost 100% 
the water consumed by the animals, the normal consumption of sage tea by humans (taking 1 or 
2 cups of tea per day is, comparatively, a much smaller quantity than the one used in the assay) 
seems unlikely to result in dangerous or undesired interactions with other drugs. Nevertheless, if 
a phytomedicine with a reasonable dose of sage is taken over an extended period of time, an 
opportunity for enzyme induction is created, and mechanisms of interaction may take place. 
Altogether, these results indicate that sage products may improve the antioxidant status 
of the liver that can be relevant in the face of oxidative stress. Sage extracts can be viewed as a 
possible therapeutical target of research, with potential for applications in the treatment of liver 
diseases where oxidative stress is known to be involved. 
In chapter 6, some experiments were also performed regarding the antidiabetic effects 
of S. officinalis, mainly focusing on the liver. For that purpose, rat hepatocytes were isolated 
from both control and sage tea drinking rats and cultured in vitro. Primary cultures of rat 
hepatocytes were established both from normal fed animals (to induce glycolysis) and from 
normal overnight fasted animals (to induce gluconeogenesis); hepatocyte glucose consumption 
and hepatocyte glucose production were measured, respectively. The primary cultures 
established from normal fed animals were incubated with 11 mM and 22 mM of glucose to 
mimic postprandial and diabetic conditions, respectively. A similar experimental outline was 
also performed in primary cultures of hepatocytes isolated from streptozotocin-induced diabetic 
rats. 
In experiments with mice (also in chapter 6), sage tea drinking was found to lower 
fasting plasma glucose but had no effect on glucose clearance in response to an intraperitoneal 
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glucose tolerance test. This fact indicated effects at liver level namely on gluconeogenesis. This 
was confirmed in the experiments using rat hepatocytes in culture, where sage tea drinking 
decreased significantly the glucagon-induced gluconeogenesis. In addition, sage tea drinking 
increased, after stimulation, glucose uptake capacity. Sage EO, added in vitro to the cultures, 
further increased hepatocyte sensitivity to insulin and inhibited gluconeogenesis. Overall these 
effects resemble those obtained with the pharmaceutical drug metformin, a known inhibitor of 
gluconeogenesis used in the treatment and prevention of type 2 diabetes mellitus. The results 
also stressed an important role of the EO fraction for the hypoglycaemic effects of sage. 
However, none of these effects were observed in cells isolated from diabetic animals. This 
could indicate the lack of antidiabetic effects of sage or an inappropriate animal model of type 2 
diabetes. 
In general, these results confirmed the hypoglycaemic effects of sage and shed some 
light on its possible mechanism of action. Although more research has to be done to study the 
therapeutic potential of sage in diabetes, the observed metformin-like effect of sage indicates a 
possible type 2 diabetes preventive potential, mainly in people at risk of developing it as is the 
case of those who present IGT. Moreover, due to the antioxidant effects of sage and because 
oxidative stress is involved in a variety of diabetic complications and possibly also in the onset 
of diabetes, the beneficial effects of sage through their antioxidant effects is a possibility that 
should be explored. Interestingly, an important function of GSH levels on glucose homeostasis 
has been suggested. Therefore, the positive effects of sage on GSH levels may also indirectly 
improve the liver mediated insulin response in vivo. Also, because GSH values are decreased in 
type 2 diabetes, sage could be helpful restoring the antioxidant defences in these patients, which 
are normally overwhelmed. 
In conclusion, although more research efforts have to be made in order to apply sage 
products safely as a therapeutical tool for diabetes and liver diseases, such as hepatocellular 
carcinoma, viral and alcoholic hepatitis and non-alcoholic steatosis, they can be useful in 
preventive strategies. Sage products can be considered as a functional food or food supplements 
that could have a beneficial impact in low cost prevention strategies of diabetes and liver 
diseases. In addition, other types of diseases where it is known that oxidative stress is involved, 
such as cancer, neurodegenerative and cardiovascular diseases, may also be prevented by the 
regular consumption of sage. However, we should be aware that high doses of sage should not 
be taken over an extended period of time in combination with certain conventional medical 
drugs, since undesired herb-drugs interaction may take place. 
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7.2. Future perspectives 
 
 Before this work, Salvia officinalis already enjoyed its reputation as a strong antioxidant 
medicinal plant. However, that idea was based solely in chemical and subcellular experiments 
and on its known constituent antioxidant compounds, such as rosmarinic acid. In fact, due to its 
antioxidant activity, sage is used today as additive in the food processing and cosmetic 
industries. Based on these applications and on extrapolations from other examples, it has been 
considered that the consumption of S. officinalis have beneficial antioxidant effects for human 
beings. However, this had never been tested to confirm this idea. 
The work performed here, in addition with other works done at the same time by 
different authors, confirmed for the first time the cellular and in vivo antioxidant effects of sage 
extracts. The circulating compounds in the body, after absorption, are in small concentrations 
and, many times as metabolites, different from the compounds ingested. As a result of extensive 
metabolisation and poor gastrointestinal absorption, the in vitro cellular effects may not be 
directly extrapolated to an in vivo situation, where bioavailability and metabolisation of the 
compounds have to be considered. In addition, an organism is a much more complex 
experimental model with many uncontrolled factors, playing in it roles that may cause 
unexpected interferences. Nevertheless, in vitro experiments, as the ones already performed in 
liver and neuronal cells, are useful to elucidate mechanisms of action. And, as observed in our 
studies, some of the in vitro effects are also, then, observed in the in vivo experiments. 
Therefore, these studies confirmed the attributed antioxidant effects of sage at cellular and 
organismal levels, which can explain the success of the ancient and traditional uses of sage in 
the treatment of several diseases. 
These studies also shed some light on possible mechanisms of action of sage, such as an 
enhancement of phase II detoxifying and antioxidant enzymes and positive effects in the 
intracellular glutathione levels. However, some questions arise from our studies, which remain 
to be elucidated: is there an enhancement of de novo glutathione synthesis involved and 
responsible for the observed sage-induced increase in GSH levels? Are the increases in phase I 
and II enzymes, and possibly γ-glutamylcysteine synthetase, a key enzyme in de novo 
glutathione synthesis, regulated by the same mechanism, for example by the transcriptional 
regulation of the antioxidant response element? Or, are these different effects regulated by 
different mechanisms? And the antioxidant enzymes, such as GPox, is their enhancement 
managed directly by sage compounds or is it the result of indirect effects, for example, mediated 
through the induction of slight oxidative stress? 
On the other hand, as observed by our preliminary studies (section 4.5.), Salvia 
fruticosa seems to have an even higher antioxidant effect than S. officinalis. This aromatic plant 
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also has a high content in EO but, contrarily to common sage, it is known to contain fewer toxic 
compounds, such as thujones. Therefore, the consumption of S. fruticosa has not been 
associated with undesirable effects due to the toxicity of the EO fraction. So, if S. fruticosa has 
higher antioxidant activity than common sage and its consumption is not so dangerous, this 
medicinal plant is probably of higher value and more investigations are awaited. 
In the case of antidiabetic properties of S. officinalis, some experimental studies were 
already performed demonstrating some potential. However, although its hypoglycaemic effects 
were clearly shown, its therapeutical use against diabetes is far from clear. The use of a more 
suitable animal model of type 2 diabetes, such as the Zucker rat for example, could help 
elucidate the antidiabetic effects of sage. Nevertheless, in view of the metformin-like effect of 
sage, its use in the prevention of diabetes seems to be promising. 
Another perspective that should be investigated related with diabetes is the sage 
potential to reduce and/or prevent post-diabetic complications. Since it is known that oxidative 
stress is involved in these complications, such as atherosclerosis, nephropathy, retinopathy and 
neuropathy, it is probable that the antioxidant effects of sage would have a beneficial impact. It 
is, in effect, an awaited and fruitful area of research. According with some theories, the 
antioxidant effects could also be helpful in the prevention of diabetes, which makes sage a good 
candidate to be tested. 
In conclusion, in all the work reported in this thesis, a contribution was made to the 
elucidation of the biological (antioxidant and hypoglycaemic) effects of sage. In addition, the 
possible application of sage products, at least, in the prevention of liver diseases and diabetes is 
suggested. The use of sage products as a therapeutical tool for diabetes, liver diseases and 
possibly other oxidative stress-related diseases requires, however, more studies. In view of the 
increasing interest in the phytopharmaceutical products, this should be an area of increasing 
investment and research. 
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P1 Rat Hepatocyte Isolation and Use 
  Experimental Protocol 1 
  
  
Materials required Isolation of rat hepatocytes was performed by colagenase 
perfusion of the liver as previously described by Moldeus and 
collaborators (1978)
Dissection plate 
Cannula 
1 with some modifications. 
Ligature 
 Peristaltic Pump 
Principle Connecting tubing 
Scissors 
The liver parenchyma (hepatocytes) is permeated by a 
collagenous fibrillar network, which provides a mechanical 
stabilization to the liver, embedded in an extracelular matrix 
composed by a complex mixture of proteoglycans and elastin
Nylon mesh (100 µm) 
Centrifuge 
; 5% CO ) Carbogen gas (95% O2 2
 2,3. 
The extracellular matrix, adhesion glycoproteins, Ca Special reagents: 2+ ions and 
cell surface receptors play an important role in maintaining cell 
anchorage, shape, polarity and function
Collagenase (grade IV) 
EGTA and albumin (defatted and crystalline) 
2. Each hepatocyte is 
attached to, and communicates with, a number of neighbouring 
hepatocytes by means of junctional complexes
 
Buffer Solutions 
2. The knowledge 
of these morphological aspects of the liver resulted in the 
modern methods of hepatocyte isolation and culture. 
Buffer Solution 1 (BS1): 
Hanks modified buffer supplemented with 
EGTA, albumin and Hepes, pH 7.4 
137 mM NaCl 
Therefore, the method used here involves the treatment of the 
hepatic tissue in 3 steps: 
5.4 mM KCl 
0.81 mM MgSO4
0.34 mM Na HPO2 42+• exposure to Ca -free medium - liver is perfused by the 
portal vein with an oxygenated Ca
0.44 mM KH PO2 4
2+-free balanced salt 
solution, which also contains a chelating agent for this ion, 
EGTA. Consequently, the extracellular concentration of Ca
25 mM NaHCO3
0.06 mM EGTA 
2+ 
decreases significantly resulting in an irreversible cleavage of 
the desmosomes (junctional complexes)
0.67% (w/v) albumin 
12.5 mM Hepes, pH 7.4 
 
2,3.  
1 Moldeus P, Hogberg J & Orrenius S, 1978. 
Isolation and use of liver cells. Methods in 
Enzymology 52, 60-71. 
• collagen digestion - liver is perfused by a second oxygenated 
balanced solution containing calcium and collagenase. This 
enzyme is a protease capable of a specific and hydrolytical 
cleavage of collagen molecules in their native conformation, 
which needs Ca
2 Puviani AC, Ottolenghi C, Tassinari B, 
Pazzi P & Morsiani E, 1998. An update on 
high-yield hepatocyte isolation methods and 
on the potential clinical use of isolated liver 
cells. Comparative Biochemistry and 
Physiology Part A 121, 99-109. 
2+ for its activity3. The addition of Ca2+ in this 
solution does not have effects on the cellular adhesion, since 
the cleavage of the junctional complexes is irreversible
3 Berry MN, Edwards AM & Barritt GJ, 1991. 
Isolated hepatocytes: preparation, properties 
and applications. In: Burdon RH & van 
Knippenberg PH (Eds.), Laboratory 
Techniques in Biochemistry and Molecular 
Biology. Vol. 21, Elsevier Science Publishers 
B.V., Amsterdam. 
2,3. 
• gentle mechanical dissociation – after gentle disruption of 
the liver capsule, cells are dispersed in an appropriate 
1.1 
 solution by gentle mechanical dissociation.  
Buffer Solutions 
The obtained cellular suspension has, however, several non-
parenchymal cells, making it, therefore, necessary to proceed to 
hepatocyte purification. Since hepatocytes have a higher density 
than non-parenchymal and dead cells, a highly enriched 
hepatocyte suspension is obtained after low-speed density 
gradient centrifugation. 
Buffer Solution 2 (BS2): 
Hanks modified buffer supplemented with 
collagenase, CaCl  and Hepes, pH 7.4 2
137 mM NaCl 
5.4 mM KCl 
0.81 mM MgSO4
0.34 mM Na HPO2 4
 0.44 mM KH PO2 4
Animals 25 mM NaHCO3
0.05% (w/v) collagase (grade IV) 
From a surgical point of view, rats of 150-300 g body weight are 
the most convenient. This procedure can be applied to the 
preparation of hepatocytes from rats in either fed or fasted states 
and it is desirable to maintain consistency in regards to the strain, 
sex and weight of rats for reliable results. Additionally, a regular 
schedule for the surgical procedure is important. Moreover, for 
experiments relating to oxidative stress, the hepatocyte isolation 
procedure should be in the morning, where some intracellular 
antioxidants, such as GSH, are in higher concentration. 
4 mM CaCl2
12.5 mM Hepes, pH 7.4 
 
 
 
 
 
 
 
Fig. 1. 
 
Apparatus 
Liver can be perfused in situ or ex situ (Fig. 1). For the 
oxygenation of the solutions, a glass oxygenator reservoir is 
recommended (3a,b,c and d of Fig. 1). Alternatively, 
oxygenation can be achieved by bubbling carbogen directly in 
the solution. 
1 – Thermostatted water bath 
2 – Peristaltic pump 
3a – Gas inlet 
3b – Perfusion medium inlet 
3c – Perfusion medium outlet (liver) 
3d – Gas outlet and medium overflow to 
reservoir 
4 – On/off tap 
 
 
 
 
 
 
 
 
         
B
Termóstato
1
2
44
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3d
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3c 3c
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Ther ostat
 
 
Fig.1. Schematic representation of perfusion apparatus (A – solution BS1; B – solution BS2). 
1.2 
 Preparation of Stock Solutions P1 
 (i) Krebs-Henseleit  2 × 
Buffer Solutions Prepare a two-times concentrated stock balanced salt solution 
comprising 13.87 g NaCl, 0.711 g KCl, 0.323 g KH
Buffer Solution 3 (BS3): 
2PO4, 0.591 
g MgSO
Krebs-Henseleit buffer supplemented with 
Hepes, pH 7.4 4.7H2O, 0.760 g CaCl2.2H2O dissolved in about 800 ml 
of H 119 mM NaCl 2O. Bubble carbogen for about 5-10 min to exclude the 
following precipitation of calcium as CaCO 4.8 mM KCl 3. Then, add 4.18 g 
NaHCO PO1.2 mM KH2 43 and make up the solution with water until 1000 ml. The 
solution is stable at 4ºC for a few days. 
1.2 mM MgSO4
2.6 mM CaCl2
(ii) Hank 10 × 25 mM NaHCO3
12.5 mM Hepes, pH 7.4 
Prepare a ten-times concentrated stock of balanced salt solution 
comprising 20 g NaCl, 1 g KCl, 0.5 g MgSO
 
4.7H2O, 0.12 g 
Na
 
2HPO4, 0.15 g KH2PO4 dissolved in 250 ml of H2O. The 
solution is stable at 4ºC for a few days. 
 
 
 
(iii) CaCl2 5.88 % 
 
Dissolve 5.88 g of CaCl2.2H2O in 100 ml H2O. Stable a 4ºC.   
Notes  
 Preparation of Working Solutions 
The working solutions should be prepared 
fresh daily just before the surgical procedure. BS1/2 
 
Dissolve 0.63 g NaHCO3 and 0.9 g Hepes in 30 ml Hanks stock 
(10×) and 270 ml H
 
2O. Bubble the solution with carbogen for 
about 2-3 min and adjust the pH to 7.4. 
 
 
 
• BS1 - dissolve 1.5 mg albumin and 50.2 mg EGTA in 
220 ml of BS1/2 by stirring the solution for 15 min. 
Adjust the pH to 7.4. 
 
 
 
BS2) Collagenase (grade IV) should be added 
to the solution just after the cannulation of the 
portal vein has been succeeded. This avoids 
the lost collagenase (a high cost enzyme) in 
case of unsuccess. 
• BS2 - dissolve 20 mg collagenase in 800 µl CaCl2 stock 
(5.88%) and 80 ml of BS1/2. Adjust the pH to 7.46. 
BS3  
 Dissolve 0.9 g Hepes in 150 ml Krebs-Henseleit stock (2×) and 
150 ml H
 
2O. Bubble the solution with carbogen for about 2-3 
min and adjust the pH to 7.4. 
 
 
  
 
Before the surgical procedure, BS1 and BS2 solutions should be 
warmed to 37ºC, while gassing with carbogen, in the working 
apparatus. 
Using our apparatus set, the thermostatted 
water bath should be to 39ºC so that the 
temperature of the solution flowing from the 
cannula is approximately 37ºC. 
1.3 
 Protocol – Rat Hepatocyte Isolation  
Notes 
(I) Flow diagram  
 Anaesthetize the rat (150-300g) 
  
 Place the rat with the abdomen upwards on the dissection plate 
  
 Open the abdomen with a V-shaped incision (Fig. 2) 
 
 
 
Portal vein cannulation 
 
 
 
In situ perfusion of the liver with BS1 for 5-10 min 
 
  
In situ perfusion of the liver with BS2 for 8-10 min  
  
Disperse cells in BS3  
  
Cell washing (3 × centrifugation and resuspension in BS3)  
  
Determination of cell number and viability  
  
 Use for cell suspension assays or primary cultures of rat 
hepatocytes  
 
 
 
(II) Detailed protocol  
1) Dose of pentobarbital: 60 mg sodium 
pentobarbitone/kg rat body weight. 1) Anaesthetize the rat with intraperitoneal pentobarbital 
(60mg/kg) or diethylether (by inhalation). Place the unconscious 
animal, abdomen upwards, on the dissection plate securing the 
legs with rubber bands (Fig. 2). Open the abdomen with a V-
shaped incision. Reflect the intestine to your right-hand side, 
thereby exposing the liver (Fig. 2). Gently push the two main 
lobes of the liver towards the animal’s head to undercover the 
portal vein and, lying deeper, the inferior vena cava. 
Because this procedure ends with the death of 
the animal, anaesthesia with diethylether may 
be acceptable but requires training.  
Additionally, during the surgical procedure 
the anaesthesia must be maintained using 
cotton soaked with diethylether near the rat 
nose.  
The portal vein is the major vessel that 
supplies the liver. 
 
 
2) Before performing this point, with the aid 
of a small pair of curved forceps draw a 
cotton ligature under the portal vein. This will 
make easier and rapid to tight the cannula to 
the portal vein. 
2) Puncture the portal vein 1.5 cm from the point where the vein 
branches to enter the liver lobes. Insert the cannula to lie about 
0.5 cm proximal to the branch point with the pump delivering 
approximately 5 ml/min of BS1. Pull tight the ligature round the 
portal vein. After, cut the inferior vena cava, with a pair of 
scissors, below the level of the kidney. Finally, and very 
Using our pump (Gilson – Minipulse 3), 
tubing of 2.50 CC/M (Gilson) and the buffer 
temperature, to have a flow of approximately 
5 ml/min, set to 15 rpm. 
1.4 
 importantly, puncture the diaphragm (near the liver) of the 
animal to kill the unconscious rat. 
P1 
 
3) Set the pump to deliver approximately 10 ml/min of BS1. If 
the liver is too big, press the inferior vena cava proximal to the 
cut from time to time in order to perfuse all of the liver. 
Maintain the perfusion with BS1 for about 5-10 min. 
Notes 
3) Take great care to avoid air bubbles. Do 
not forget to continuously bubble carbogen in 
BS1 and BS2 in the thermostatted water bath. 
Using our pump, tubing and the buffer 
temperature, to have a flow of approximately 
10 ml/min, switch it for 26 rpm. 4) Then, change the pumping solution to BS2 (which already 
contains collagenase), maintaining the flow at 10 ml/min. After 
approximately 8 min, the consistency of the liver will have 
become soft, moderately swollen and have a speckled 
appearance. If gentle pressure with a finger tip on a liver lobule 
results in fracture of the liver surface, digestion can be taken as 
complete. 
At this stage add the collagenase in BS2. 
4) A higher yield of cells, with no apparent 
decrease in cell quality, can be obtained if 
perfusion continues until fissures form 
spontaneously in the liver without any applied 
pressure or manipulation. 
Because of variation in the quality of 
collagenase, it is not feasible to prescribe an 
exact perfusion time and some experience is 
required in making a judgement as to when 
perfusion should be terminated. 
5) At the end of the digestion period, remove the softened and 
disintegrated liver. With care pull it away from the ligamentous 
attachments to the mesentery with the help of scissors. Transfer 
the extirpated organ to a Petri plate containing BS3 and disrupt 
the liver capsule gently. Cells disperse in the BS3 solution by 
gentle mechanical dissociation. 
5) Before using BS3, bubble it with carbogen 
for about 5 min. 
 
Liver
Portal vein
Cannula
Kidney
   Inferior 
venna cava
Abdominal
    cavity
 
Fig.2. Schematic representation of the surgical procedure and cannulation of portal vein. Adapted 
from Berry et al.,19913. 
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 6) Pass cell suspension through a nylon mesh (100 µm pore-
size) into a clean 100 ml beaker. Distribute the suspension 
between two ice-cold 50-ml centrifuge tubes and dilute the 
suspension to 50 ml in each tube. Centrifuge the tubes at 50 × g 
for 2 min. Aspirate the supernatants carefully and repeat the 
washing with BS3 and centrifuging procedures twice. At each 
step carefully resuspend each cell pellet in about 5 ml of BS3 by 
slowly tilting side ways the tube.  
 
Notes 
6) BS3 should be on ice for the washing 
procedures. 
Using our centrifuge (Heraeus Sepatech - 
Megafuge 1.0) and the respective rotor, 50 ×g 
is obtained at 500 rpm. However, 
centrifugations at 300 rpm can also be used. 
After the third centrifugation the supernatants 
should be relatively clear. If not, wash the 
pellets again. 
 
7) Combine the pellets in 10 ml of BS3 for determination of cell 
number and viability in a Neubauer chamber using trypan blue 
0.4% (w/v). 
7) Cells must be maintained on ice. 
The hepatocytes viability should be higher 
than 80%. 
 
  
 Protocol – Hepatocyte Suspensions Assay 
 
Dilute the cells for the appropriate concentration in BS3 and 
incubate in 20-ml glass flasks at 37ºC in a reciprocating water-
bath at 60-80 cycles/min, constantly gassing the top of each 
flask with carbogen.  
 
Before performing the experiments with the 
freshly isolated hepatocytes, pre-incubate 
them at 37ºC at least for 30 min. The 
experiments should be done within 4 hours 
after obtaining the hepatocyte suspension 
 
 
 
Protocol – Primary Cultures of Rat Hepatocytes 
 
 i) Add 2.5 ml of antibiotic/antimicotic solution 100 × (Sigma) to 
the hepatocyte suspension (final volume: 12.5-20 ml) and let be 
the cells in ice at least for 30 min. 
i) From time to time gently resuspend the 
cells. 
 
 ii) Centrifuge the necessary volume of the hepatocyte 
suspension to obtain the desire volume of culture medium with a 
certain concentration of hepatocytes. 
6ii) A concentration of 1 × 10  hepatocytes/ml 
is normally used. 
 
 
iii) In the laminar flow chamber, add the necessary culture 
medium containing 10
iii) Use William’s Medium E supplemented 
with 10% FBS (fetal bovine serum), 1% 
antibiotic/antimicotic solution (100 ×), 2.2 g 
sodium bicarbonate and 10 mM Hepes as 
culture medium. It can be also supplemented 
with 2 g of BSA (bovine serum albumin). 
-9 M of insulin and 10-9 M dexamethasone 
to the hepatocytes pellet. Resuspend gently the hepatocytes. 
iv) Seed the hepatocytes onto 6-well culture plates, previously 
coated with rat tail collagen, and incubate at 37ºC in a 
humidified incubator gassed with 5% CO
The insulin and dexamethasone helps the 
hepatocyte attachment. 
2/95% air. iv) See protocol P20 for isolation of collagen 
and coating of culture plates. 
v) Leave hepatocytes to attach for 3 h and replace the culture 
medium before performing the experiments. 
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P2 Culture of HepG2 Cells and Use 
  Experimental Protocol 2 
  
  
For more information about this cell line see 
the ATCC (American Type Culture 
Collection) product information sheet for 
HepG2 – HB-8065 (www.atcc.org) 
HepG2 cells, a human hepatoma cell line, have been isolated 
from a liver biopsy of a male Caucasian aged 15 years with a 
well differentiated hepatocellular carcinoma. HepG2 cells are of 
epithelial morphology and have been grown successfully in 
large scale cultivation systems. 
 
Materials required 
Humidified CO  incubator 2
Laminar flow chamber  
Room of biosafety level 1 Principle 
Culture plates and flasks 
Animal cell lines, obtained from certain cancer cells and from 
genetic engineering, grow and replicate indefinitely in culture 
with the appropriate nutrients (and growth factors). They can be 
used in vitro for several kinds of experiments. 
Neubauer chamber 
 
Special reagents: 
Minimum essential medium Eagle (MEM) 
from Sigma 
FBS (fetal bovine serum) 
 
Antibiotic/antimicotic solution (100 ×) 
Preparation of Solutions Hepes (e.g., # H4034, Sigma) 
 MEM 
Solutions 
i) Add MEM powder (enough for 1 l of culture medium), 2.2 g 
NaHCO
Complete Grow Culture Medium 
(MEM), pH 7.4: 3, 110 mg sodium pyruvate (cell culture tested) and 
2.383 g Hepes  (cell culture tested) into 890 ml of ultrapure 
water. Dissolve them by continuous agitation. 
Minimum essential medium Eagle (Sigma) 
supplemented with 2.2 g sodium bicarbonate 
(NaHCO3), 1 mM pyruvate, 10 mM Hepes, 
10% FBS and 1% antibiotic/antimicotic 
solution (100 ×). 
ii) Adjust pH between 7.2-7.3. 
 
iii) Filter the medium into an autoclaved 1 l-flask using a 0.2 µm 
Filtropur unit (Sarstedt) in a laminar flow chamber. All the 
operations from this point on should be carried out under strict 
aseptic conditions. 
Cryoprotectant Medium 
95% (v/v) MEM 
5% (v/v) DMSO 
 
PBS (Phosphate Buffered Saline) 
iv) After filtration add 100 ml FBS and 10 ml 
antibiotic/antimicotic solution (100 ×) and keep the flask at 4ºC. 
137 mM NaCl 
2.7 mM KCl 
HPO8.5 mM Na2 4
 
1.5 mM KH PO , pH 7.4 2 4
Cryoprotectant Medium Sterile filtered (0.2 µm) 
Add 5 ml of DMSO (sterile filtered – Sigma) to 95 ml of culture 
medium MEM. 
 
2.1 
 Protocol – Defrosting Cells  
Notes 
Cells are frozen in vials in liquid nitrogen (liquid phase: -196ºC; 
vapour phase: -130ºC). Be careful, liquid nitrogen is dangerous 
– cause severe burnings. 
 
 
 
1) Get the vial from liquid nitrogen 
immediately before the thawing procedure. 1) Thaw the vial by gentle agitation in 37ºC water bath. To 
reduce the possibility of contamination, keep the O-ring and cap 
out of the water. 
Thawing should be rapid (approximately 2 
min). 
 
 2) Remove the vial from the water bath as soon as the contents 
are thawed, and decontaminate by spraying with 70% ethanol. 
All of the operations from this point on should be carried out 
under strict aseptic conditions. 
3) It is important to avoid excessive alkalinity 
of the medium during recovery of the cells. It 
is suggested that, prior to the addition of the 
vial contents, the culture flask containing 
MEM be placed into the incubator for at least 
15 min to allow the medium to reach its 
normal pH. 
3) Transfer the vial content to 75 cm2 tissue culture flasks and 
dilute with MEM to 15 ml. 
It is not necessary to remove the 
cryoprotectant agent if the vial is diluted in 15 
ml of MEM. 
4) Incubate the culture at 37ºC in a humidified incubator gassed 
with 5% CO
4) Change medium within 24 h after seeding. 
2/95% air.  
 
 
 
Protocol – Subculturing  
 When cells are confluent, subculturing is necessary. In case of 
few cells being subcultured, HepG2 cells start to grow in islets 
(in 3 dimensions) and subculturing also becomes necessary.  
Volumes used in this protocol are for 75 cm2 
flasks; proportionally reduce or increase 
amount of dissociation medium for culture 
flasks of other sizes. 
 1) Remove and discard culture medium. 
 
2) Briefly rinse the cell layer with warm sterile PBS.  
2) This removes all traces of serum which 
contains trypsin inhibitors. 3) Add 3 ml of Trypsin-EDTA solution and 1 ml of sterile PBS. 
Incubate at 37ºC. 3) Trypsin-EDTA solution (Sigma):  
0.25% (w/v) trypsin-0.02% (w/v) EDTA in 
saline buffered solution 4) After 7-8 min observe cells under an inverted microscope. 
They should be rounded and cell layer begin being dispersed. 4) If necessary for cell detachment hit the 
flask. However this should be avoided since it 
clumps the cells. 5) Add 11 ml of MEM and dissociate cells by gently pipetting. 
 
6) Add appropriate aliquots of cell suspension to new culture 
flasks. 
 
6) If cells are to be seeded in culture plates for 
cell assays, determination of cell number in 
the cell suspension using the Neubauer 
chamber is necessary        Subcultivation Ratio: 1:4 to 1:6 
           or 3-4 × 106 cells/75 cm2 flask 
7) Incubate cultures at 37ºC in a humidified incubator gassed 
with 5% CO2/95% air. 
2.2 
 8) Renew MEM at least twice a week. After 1 week, cell layer 
are normally confluent and ready for subculturing. 
P2 
 
 Notes 
Protocol – Freezing Cells  
 
HepG2 cells can be stored as stocks in liquid nitrogen using 
Cryoprotectant Medium at density of 2-4 × 10
 
6 cells/ml in 1 ml-
vials. Do not store cells at -80ºC, it will result in loss of viability. 
 
 
 
1) Harvest cells in the same manner used for routine subculture. 
 
2) Prepare cryoprotectant medium by allowing 1 ml for each vial 
to be frozen. 
 
 
3) Using our centrifuge (Heraeus Sepatech - 
Megafuge 1.0) and the respective rotor, 100 
×g is obtained at 800 rpm. 
3) Centrifuge cell suspension at 100 ×g for 2 min. 
4) Resuspend the cell pellet in the cryoprotectant medium to 
give a final cell concentration of ~3 × 10
 
6   cells/ml and aliquot 1 
ml into each sterile vial. The vials should be clearly marked.  
5) During the freezing procedure, a cooling 
rate between 1-3ºC/min should be used. There 
are programmable freezers that perform this. 
However, polystyrene boxes or other 
commercial available boxes can instead be 
used in a -80ºC freezer.  
5) Freeze the cells in a polystyrene box in a -80ºC freezer for 4-5 
hours prior to transfer to liquid nitrogen. 
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P3 Mice as Experimental Model 
  Experimental Protocol 3 
  
  
 
 During the studies for this thesis, mice were used in two 
experimental models: (1) intoxicated with CCl
 
4 as an in vivo 
model of hepatocellular injury; (2) to perform an intraperitoneal 
glucose tolerance test (ipGTT). 
 
 
 
 
 
 
  
 
Animals  
 
 Male and female Balb/c mice (albino inbred strain) with 6-10 
weeks of age were used and acclimated to the laboratory animal 
facilities in a regular light/dark cycle and constant temperature 
(20 ± 2 ºC) and humidity. Food and tap water were given ad 
libitum to the animals for at least one week before the start of 
the experiments. 
 
 
 
 
 
 
 
 
 
 
 
  
 
CCl -induced hepatotoxicity  4  
 
Principle  
 
 CCl4 is a hepatotoxicant that induces damage effects in the liver 
upon its bioactivation mainly by cytochrome P450 2E1
 
1  . After 
bioactivation, the trichloromethyl (˙CCl
 
3) and 
triclhoromethylperoxy (CCl
 
 
3OO˙) radicals are formed, which 
initiate chain reactions of direct and indirect bond formation 
with cellular molecules (nucleic acids, proteins, lipids and 
carbohydrates) impairing crucial cellular processes that may 
ultimately culminate in extensive cell damage and death
 
 
1 Weber LWD, Boll M & Stampfl A, 2003. 
Hepatotoxicity and mechanism of action of 
haloalkanes: Carbon tetrachloride as a 
toxicological model. Critical Reviews in 
Toxicology 33, 105-136. 
1. 2 Mansour MA, 2000. Protective effects of 
thymoquinone and desferrioxamine against 
hepatotoxicity of carbon tetrachloride in mice. 
Life Sciences 66, 2583-2591. 
The protective effects of an extract or compound against the 
CCl4-induced hepatotoxicity can be studied given the 
extract/compound before or after administration of the toxicant. 
The extract can be given by gavage or intraperitoneal. To induce 
hepatotoxicity CCl
3 Chen JH, Tipoe GL, Liong EC, So HSH, 
Leung KM, Tom WM, Fung PCW & Nanji 
AA, 2004. Green tea polyphenols prevent 
toxin-induced hepatotoxicity in mice by 
down-regulating inducible nitric oxide-
derived prooxidants. American Journal of 
Clinical Nutrition 80, 742-751. 
4 is administered by ip injection in a dose of 
20 µl/kg dissolved in olive oil (0.25%, v/v)2,3. To observe the 
hepatic injury effects of CCl
4 Chung H, Hong DP, Jung JY, Kim HJ, Jang 
KS, Sheen YY, Ahn JI, Lee YS & Kong G, 
2005. Comprehensive analysis of differential 
gene expression profiles on carbon 
tetrachloride-induced rat liver injury and 
regeneration. Toxicology and Applied 
Pharmacology 206, 27-42. 
4, the experiment should be stopped 
between 2-48 hours after toxicant administration4. 
 
3.1 
 Protocol  
Notes 
1) After animal treatment with plant extract or pure compound, 
inject CCl
1) Make a fresh solution of CCl4 in olive oil 
before ip injections. Be careful with CCl 4 ip in a dose of 20 µl/kg body weight dissolved in 
olive oil (0.25%, v/v). Controls receive vehicle only (8 ml/kg). 
4 – it 
is very toxic. 
 
2) Anaesthesia with diethylether can be used 
considering that this is a terminal experiment. 
2) After 24 h (other time points can be chosen), anaesthetise 
animals for blood collection. In an unconscious animal, collect 
blood from the eye artery after removal of the eyeball. 
Immediately after, sacrifice the mouse by dislocation of cervical 
vertebrae. 
 
 
 
 
3) Freeze the liver immediately in liquid 
nitrogen and keep at -80ºC until use. 3) Collect the liver for histology and other determinations. 
 
 
 
Intraperitoneal Glucose Tolerance Test (ipGTT)  
 Principle 
 
A glucose tolerance test permormed in mice that excludes the 
effect of glucose absortion in the intestine. 
 
 
 
 
 
Protocol  
 
1) After animal treatment with plant extract or pure compound, 
in 3 hours fasted mice, a glucose solution is injected ip in a dose 
of 5.83 ml/kg bwt. Controls receive vehicle only (physiologic 
solution). 
1) Glucose solution: 
       300 g/l in physiologic saline (NaCl 0.9%) 
With a dose of 5.83 ml/kg, this gives a final 
dose of 1.75 g/kg bwt. 
 
2) After 45 min (other time points can be chosen for a time-
course experiment) collect blood samples from the tail. In case 
of terminal experiment, blood can be collected as in the above 
protocol. 
2) For plasma collection, use heparinised 
tubes. 
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P4 LDH Leakage 
  Experimental Protocol 4 
  
  
1 Berry MN, Edwards AM & Barritt GJ, 
1991. Isolated hepatocytes: preparation, 
properties and applications. In: Burdon RH & 
van Knippenberg PH (Eds.), Laboratory 
Techniques in Biochemistry and Molecular 
Biology. Vol. 21, Elsevier Science Publishers 
B.V., Amsterdam. 
The LDH leakage was used as marker of cell membrane 
integrity to estimate cell viability. 
 
Principle 
 
When the cell membrane are damaged cytosolic enzymes pass 
into the extracellular medium. The measure of the enzyme 
leakage can give an estimation of cell damage (death) for a 
sample. The lactate dehydrogenase (LDH) is the most 
commonly used enzyme to measure cell membrane integrity. 
LDH is an enzyme located almost entirely in the cytoplasm 
which catalyses the reversible reduction of pyruvate to lactate in 
the last step of anaerobic glycolysis
Materials required 
96-well plates 
Plate reader spectrophotometer 
Sonicator 
 
Special reagents: 
NADH 
 
Buffer Solutions 1. 
PBS (Phosphate Buffered Saline) 
 L-lactate + NAD+            pyruvate + NADH + H+
LDH leakage can be given as the percentage of LDH activity in 
the extracellular medium from the total activity in the sample. 
The LDH activity can be obtained by measuring the continuous 
oxidation of NADH (0.28 mM) to NAD+ spectrophotometrically 
at 340 nm on a plate reader using pyruvate (0.32 mM) as 
substrate in 50 mM phosphate buffer (pH 7.4). 
 
Protocol 
Sample preparation 
1) Extracellular LDH 
Collect extracellular medium to a tube. 
In the case of a cell suspension, centrifuge an aliquot (ex: 200 
µl) at 10,000 rpm (~10,000 ×g) in a microcentrifuge for 1 min at 
room temperature. Transfer a portion of the supernatant to a 
clean tube. 
2) Total LDH 
In the case of a cell suspension, take an aliquot to a tube. 
137 mM NaCl 
2.7 mM KCl 
8.5 mM Na2HPO4
1.5 mM KH2PO4, pH 7.4 
 
Lysis Buffer 
25 mM KH2PO4
2 mM MgCl2
5 mM KCl 
1 mM EDTA 
1 mM EGTA, pH 7.5 
100 μM PMSF (added fresh from a stock sol.)
 
Phosphate Buffer (PB) 
50 mM KH2PO4, pH 7.4 
 
Notes 
1) Use a 1.5 ml tube. 
Centrifuge normally used: Centrifuge 5415 C, 
Eppendorf. 
2) If LDH leakage is to be presented as 
extracellular enzyme activity, this step is not 
performed. 
L-LDH 
4.1 
 In the case of a cell layer, total LDH is quantified as the sum of 
extracellular LDH plus the intracellular LDH. To measure 
intracellular LDH, rinse the cells with warm PBS. Then scrap 
the cell layer in PBS or Lysis Buffer and transfer it to a tube. 
 
Notes 
4) Sonicator used: Ultrasonic Processor GEX 
400. Sonicate at 20% of amplitude for 10 sec. 
 
Stock Solutions 3) Then, keep samples at 4ºC if LDH is assayed on the same day 
or at -80ºC for later measurement of LDH activity 
0.32 mM NADH 
2.27 mg/10 ml PB (20 ml/plate) 
4) Before determining the LDH activity in cell suspension (total 
LDH) or cell scraps (intracellular LDH), lyse the cells in a 
sonicator to liberate all intracellular LDH. 
Freshly prepared and stable for 3 h on ice. 
 
7.36 mM Pyruvate 
8.1 mg/10 ml PB (1 ml/plate) 
 Freeze in 1-ml aliquots at -20ºC. Maintain at 
4ºC when used. 
Assay for LDH activity 
 
Notes 1) In a 96-well plate, pipette to each well: 
1) Use a repetitive pipette to pipette NADH 
and pyruvate into the wells.  - 10-20 µl sample (make duplicates) 
2) This allows both consuming the pyruvate 
present in the sample (in case of cell culture 
medium) and the solution reaching 30ºC. 
 - 200 µl NADH (0.32 mM) 
2) Incubate for 2 min at 30ºC in the plate reader. The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 3) Add as fast as possible 10 µl of pyruvate (7.36 mM) and read 
the absorbance at 340 nm on a plate reader every 10 sec for 3 
min. 
Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
4) A linear (negative) slope inferior to 100 mDO/min should be 
obtained. If not, dilute samples accordingly. 
3) Use the ‘kinetic’ function of SOFTmax Pro 
4) Use only the linear part for the 
calculations. 
  
Express LDH leakage as percentage of extracellular LDH 
activity from total LDH activity taking into account dilutions 
and total volumes of extracellular medium and homogenisation 
medium with cell scraps. 
 
 
 
 
 
 
 
To express LDH leakage as the activity of LDH in the 
extracellular medium use the following formula: 
-1U - µmol.min
Vmax - slope in mDO.min-1
      Vmax × 0.332  
  1000 × 6.22 × Vsample
 
The activity can then be expressed per mg of protein (protein of 
the cell scraps). 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1 U/ml = 
-1εNADH = 6.22 mM .cm-1
V  - volume of the sample used in the     
assay in ml (ex: 0.01 ml). 
sample
 
4.2 
   
P5 MTT Assay 
  Experimental Protocol 5 
  
  
1 Mosmann T, 1983. Rapid colorimetric assay 
for cellular growth and survival: application 
to proliferation and cytotoxicity assays. 
Journal of Immunological Methods 65: 55-63.
The MTT assay was used as marker of cell metabolic capacity to 
estimate cell viability. 
 
 
Materials required 
Principle 96-well plates 
Metabolically active cells have the capacity to reduce the 
soluble yellow tetrazolium MTT (3-(4, 5-dimethylthiazolyl-2)-2, 
5-diphenyltetrazolium bromide) in an insoluble purple formazan 
by the action of intracellular dehydrogenase enzymes, at the 
expense of reducing equivalents such as NADH and NADPH. 
The resulting intracellular purple formazan can be solubilised 
and quantified spectrophotometrically and is proportional to 
viable cells
Plate reader spectrophotometer 
Sonicator 
 
Special reagents: 
MTT 
 
Buffer Solutions 
PBS (Phosphate Buffered Saline) 
1. 137 mM NaCl 
2.7 mM KCl 
 
HPO8.5 mM Na2 4
Protocol 
1.5 mM KH PO , pH 7.4 2 4
Sterile filtered (0.2 µm) 1) After cell incubation with the potential toxic compound for 
the desire time in a 24-cell culture plate (with 1ml of culture 
medium), add 100 µl of MTT stock solution (final concentration 
~0.5 mg/ml) to each well. 
 
Organic Solvent 
Acidic Isopropanol 
0.04 M HCl in absolute isopropanol 
2) Incubate at 37ºC for 2 hours in the humidified CO2 incubator.  
Stock solution 
3) At the end of the incubation period, take off the medium and 
add 1 ml of acidic isopropanol to solubilise the purple formazan 
dye. 
MTT (5 mg/ml) 
Add 50 mg of MTT to 10 ml of sterile PBS. 
Sonicate the solution if necessary. This 
solution can be kept at -20ºC for later use.  
Note: MTT is a light-sensitive compound. 4) Carefully sonicate each well to solubilise completely the 
converted dye. 
 
Notes 
5) Transfer 200 µl of the dye solution of each well for a 96-well 
plate in duplicate. 
1) Do not forget to use the appropriate 
controls: a negative control (without any 
compound added); a blank (without MTT 
added); and also a positive control (with a 
compound with known toxicity). 6) Read the absorbance at 570 nm using 690 nm as reference in 
a plate reader spectrophotometer. 2) The time chosen can vary from 30 min to 4 h, depending on cell density and cell type. 
Do not forget to include this time in the time 
action of the potential toxic compound. 
7) Express the results as % of sample absorbance in relation to 
the absorbance in the negative control. 4) Sonicator used: Ultrasonic Processor GEX 
400. Sonicate at 20% of amplitude for 30 sec. 
 
5.1 
 Calculations  
Notes 
1) Subtract the blank absorbance value from all other values. 
This can be done automatically in the SOFTmax Pro Software. 
6) (previous page) Plate reader 
spectrophotometer used: SpectraMax 340 PC 
(Molecular Devices) in combination with its 
software SOFTmax Pro 4.0. 
2) For each well express the absorbance as: 
Use the ‘endpoint’ function of SOFTmax Pro. 
  Abs 570 nm – Abs 690 nm 
 
This can be also done automatically in the SOFTmax Pro 
Software. 
2) Formazan absorbs light at 570 nm but not 
at 690 nm. Absorbance at 690 nm results from 
cell debris and well imperfections. 
3) Express the results as percentage of cell survival:  
 
(absorbance treated wells / absorbance of control wells) × 100%  
 
 Dose response curves can be calculated for the compounds 
tested over a range of concentrations, enabling IC 50 values to be 
obtained (i.e. concentration of chemical that reduces cell 
survival by 50%) 
 
 
 
  
 
 
5.2 
   
P6 Trypan Blue Staining 
  Experimental Protocol 6 
  
  
1 Berry MN, Edwards AM & Barritt GJ, 
1991. Isolated hepatocytes: preparation, 
properties and applications. In: Burdon RH & 
van Knippenberg PH (Eds.), Laboratory 
Techniques in Biochemistry and Molecular 
Biology, Vol. 21. Elsevier Science Publishers 
B.V., Amsterdam. 
The trypan blue staining was used to measure cell viability of rat 
hepatocyte suspensions after isolation and HepG2 cells routinely 
in the subculturing procedures. It can also be used in other 
experiences with cells in suspension. 
 
 
 
Materials required 
Principle 
Improved Neubauer haemocytometer 
Light (inverted) microscope Trypan blue is an organic amine dye that is excluded by cells 
with intact membranes, whereas damaged cells readily take it 
up
 
Special reagents: 
1. Trypan blue is negatively charged and it seems likely that 
the dye is excluded as a result of an energy-dependent 
maintenance by the cell of a plasma membrane potential 
(negative inside)
Trypan blue 
 
Buffer Solutions 
1. Loss of this potential due to cell injury may 
allow penetration of trypan blue. The percentage of cells that 
exclude trypan blue from the total number of cells gives an 
estimation of cell viability in a sample. 
PBS (Phosphate Buffered Saline) 
137 mM NaCl 
2.7 mM KCl 
HPO8.5 mM Na2 4
1.5 mM KH PO , pH 7.4 2 4
  
Protocol Stock solution 
Trypan Blue 0.04% (w/v)) 
1) Prepare a haemocytometer with the coverslip. 
Add 0.4 g trypan blue to 100 ml of PBS. 
Filter the solution with a 0.2 µm-membrane. 2) Pipette into a 1.5 ml-tube 50 µl of trypan blue and 50 µl of 
cell suspension and mix gently with slow inversions of the tube. 
If cell suspension is too concentrated, dilute it with PBS 
appropriately. 
 
Notes 
1) To mount the haemocytometer chamber 
lightly moisten the supporting ridges and 
apply the coverslip pressing firmly so that 
light interference patterns appear. 
3) Allow one drop of the mixed suspension to flow smoothly by 
capillary action under the coverslip of the haemocytometer, so 
as to fill the measuring compartment completely, yet not 
overflowing. 
2) In each counting square the number of cells 
should be inferior to 100. 
4) With a light microscope, count at least 200 cells using 
different chamber fields (and different counting squares) and 
calculate the percentage of viable cells (cells that exclude trypan 
blue). See Fig. 1. 
5) Considering the dilutions made, calculate the concentration of 
viable cells per millilitre of suspension. 
6.1 
 Calculations  
Notes 
1) Cell Viability 1) Example: 
After counting 4 counting squares: i) In the same area (for example, 4 counting squares – Fig. 1), 
count the viable cells (cells that exclude trypan blue – bright 
cells) and the nonviable cells (cells stained in blue). 
viable cells – 230 
nonviable cells – 18 
total cells – 248 
ii) Sum viable and nonviable cells for the total number of 
cells. 
 
viability = 230/248 ×100 = 92.7% 
 
iii) Calculate viability as follows:  
number of viable cells × 100 / number of total cells  
2) Example: 2) Concentration of viable cells in the suspension 
VC – 230/4 = 57.5 
i) Calculate the average of viable cells (VC) per each counting 
square. 
Dilution made: 
50 µl cell suspension + 50 µl PBS 
and then,  50 µl of above + 50 µl trypan blue 
ii) Considering the volume of each counting square 
(shadowed square – Fig 1) to be 0.1 mm
therefore, dilution factor – 2 × 2 = 4 
3 (1 mm × 1 mm × 0.1 
mm; the same as 1×10
 
-4 ml) and considering the dilution made, 
calculate the concentration of viable cells per ml in the 
suspension as follows: 
-4 6 = 2.3×10  cells/ml [VC] = 57.5 × 4 /1×10
 
 
 
 [VC] = VC × dilution factor / 1×10-4 
   
A B 
1 mm
           
 
Fig. 1. Illustration of a haemocytometer chamber. A) General representation. The circle indicates 
approximately the microscopic field with an magnification of 100× (10× ocular plus 10× objective) 
The shadowed area represents the counting square (B). Since the depth of the chamber is 0.1 mm, each 
counting square have a volume of 0.1 ml; B) Magnification of the counting square (shadowed) of (A). 
The symbol O indicates cells that must be counted and the symbol ∅ indicates cells that must not. 
Therefore, only cells over two margins of the counting square must be counted. 
6.2 
   
P7 TBARS (Lipid Peroxidation) 
  Experimental Protocol 7 
  
  
1 Ohkawa H, Ohishi, N & Yagi K, 1979. 
Assay for lipid peroxides in animal tissues by 
thiobarbituric acid reaction. Analytical 
Biochemistry 95, 351-358. 
One of the targets for reactive species is the phospholipid 
bilayer, comprised of cellular and subcellular membranes, 
initiating the lipid peroxidation. Lipid peroxidation in 
biomembranes is believed to proceed via lipid peroxyl radical 
(LOO˙)-mediated radical chain reaction, where lipid 
hydroperoxides (LOOH) accumulate in the membranes as 
primary oxidation products. Several different secondary 
oxidation products were also formed, which are used to estimate 
lipid peroxidation.  
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
Water bath 
 
Special reagents: 
TBA 
 
 
Solutions 
Principle Trichloroacetic acid (TCA) 10% (w/v) 
Dissolve 10 g of TCA in a total volume of 
100 ml of water One of the secondary products formed and used to estimate lipid 
peroxidation is malondialdehyde (MDA). It can be measured by 
chromatographic techniques and both spectrophotometrically 
and fluorometrically after the reaction with thiobarbituric acid 
(TBA). Here, a spectrophometric method is described to 
determine lipid peroxidation, which measures the thiobarbituric 
acid reactive substances (TBARS). The reaction of MDA with 
TBA produces a red chromophore that can be detected at 535 
nm
 
TCA 50% (w/v) 
Dissolve 50 g of TCA in a total volume of 
100 ml of water 
 
TBA 1% (w/v) 
Dissolve 200 mg of TCA in a total volume of 
20 ml of water. Use a water bath with warm 
water to help dissolving TBA. This solution 
must be made just before use. 1. 
  
 Protocol 
 
Sample preparation Notes 
1) & 2) The final concentration of TCA 
should be around 6.75% (w/v) for 
precipitation of proteins before the TBARS 
assay. Therefore, if other volume ratios are 
required, make TCA solutions accordingly.  
1) Cell Suspensions. Add 250 µl of cell suspension to 500 µl of 
10% (w/v) TCA, which is already in a 1.5 ml-tube. Make a 
blank tube with the buffer. 
2) Cell cultures. Add 360 µl of culture medium to 60 µl of 50% 
(w/v) TCA, which is already in a 1.5 ml-tube. Make a blank tube 
with culture medium that was not in contact with cells. 
3) If not measured immediately afterwards, keep the tubes at      
-80ºC for later measurement of TBARS. 
 
7.1 
 TBARS assay  
Notes 
1) Centrifuge tubes at 10,000 rpm (~10,000 ×g) in a 
microcentrifuge for 1 min at room temperature. 
1) Centrifuge normally used: 
Centrifuge 5415 C, Eppendorf. 
 
2) Transfer 300 µl of supernatant to a clean 1.5 ml-tube. 3) The TBA solution must be prepared 
immediately before use. Do not let the 
solution cool too much; otherwise the TBA 
will precipitate again. 
3) Add 300 µl of TBA 1% (w/v). 
4) Make a little pin hole in the cap of each tube.  
 
5) Put the tubes floating in a boiling water bath for 10 min. 
5) Do not immerse excessively the tubes; 
otherwise some water can enter in the tubes. 6) After cooling the tubes, transfer 300 µl of each sample/blank 
for a well of a 96-well plate. 
6) After cooling the tubes, do a short spin to 
them to collect any condensate at the bottom 
of the tube. 
7) Read the absorbance at 535 nm against the blank in a plate 
reader spectrophotometer. 
7) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
 Use the ‘endpoint’ function of SOFTmax Pro. 
Express lipid peroxidation as nmol MDA/mg protein using a 
molar extinction coefficient of 1.56 × 10
 
5 M-1.cm-1. In the case 
of cell cultures, have into account dilutions and total volumes of 
extracellular medium and homogenisation medium with cell 
scraps, where the protein is measured. 
 
 
 
 
 
 
Formula: 
Calculate nmol MDA/ml using the following formula: 
1000 – to give the results in nmol 
         1000 × (Asample - Ablank)  – absorbance of the sample A
             156 × 0.904 
 
Then, express it per mg of protein (protein of cell suspensions or 
protein of the cell scraps in case of cell cultures). 
 
 
 
 
 
 
 
sample nmol MDA/ml = 
 - absorbance of the blank Ablank
-1156 = εMDA in µmol .ml.cm-1
0.904 = lightpath of 300 µl solution in a well 
of 96-well plate 
 
 
7.2 
   
P8 Glutathione Levels 
  Experimental Protocol 8 
  
  
1 Castell JV, Gomez-Lechon MJ, Ponsoda X 
& Bort R, 1997. In vitro investigation of the 
molecular mechanisms of hepatotoxicity. In: 
Castell JV & Gomez-Lechon MJ (Eds.), In 
Vitro Methods in Pharmaceutical Research, 
Academic Press, London, pp. 375-410. 
Glutathione is an intracellular antioxidant tripeptide that plays 
an important role in cell defence. Severe GSH (reduced 
glutathione) depletion leaves cells more vulnerable to oxidative 
damage, which causes progressive deterioration of 
macromolecules, cell structure and may lead to cell death
2 Anderson, 1985. Determination of 
glutathione and glutathione disulfide in 
biological samples. Methods in Enzymology 
113, 548-555. 
1. 
Glutathione levels could therefore determine the cytotoxicity of 
a xenobiotic and its ultimate effects on cell survive. The ratio 
between GSH and oxidised glutathione (GSSG) are normally 
used to determine the cell’s oxidative state. 
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
 Microtubes shaker device 
 
Principle 
Special reagents: 
There are different procedures (e.g., chemical, enzymatic, 
chromatographic) for the determination of GSH and GSSG in 
biological samples. Here, an enzymatic method is described 
based in the methodology of Anderson (1985)
DTNB 
NADPH (e.g., # N1630, Sigma) 
GR (e.g., # B2633, Sigma) 
SSA 2.  
2-vinylpyridine 
To maintain initial GSH levels in the biological samples, they 
must be acidified quickly. Then several acids are used for 
deproteinisation, but 5-sulfosalicylic acid (SSA) (usually 5% 
w/v, final concentration) is preferable. Then, total glutathione 
levels (GSH + GSSG) can be measured enzymatically by the 
DTNB-GSSG reductase recycling assay. As indicated in the 
reaction (1), GSH is oxidised by 5,5’-dithiobis(2-nitrobenzoic 
acid) (DTNB) to give GSSG with stoichometric formation of 5-
thio-2-nitrobenzoic acid (TNB). GSSG is reduced back to GSH 
by the action of the highly specific glutathione reductase (GSSG 
reductase or GR) and NADPH (2). The rate of TNB formation is 
followed at 415 nm and is proportional to the sum of GSH and 
GSSG present in the sample. 
GSH 
GSSG 
 
Solutions 
SSA 10% (w/v) 
Dissolve 10 g of SSA in a total volume of 100 
ml of water 
 
SSA 50% (w/v) 
Dissolve 50 g of SSA in a total volume of 100 
ml of water 
 
Buffer Solutions 
PBS (Phosphate Buffered Saline) 
137 mM NaCl 
2.7 mM KCl 2 GSH + DTNB → GSSG + TNB  (1) 
HPO8.5 mM Na
      GSSG + NADPH + H+  →   2 GSH+ NADP+ (2) 
To determine the GSSG levels in the biological samples, the 
previous methodology is used after treating GSH with 2-
vinylpyridine. GSH levels are obtained by subtracting GSSG 
levels from the total GSH. 
2 4
1.5 mM KH2PO4, pH 7.4 
 
Phosphate Buffer (PB) 
6.3 mM EDTA 
143 mM NaH2PO4, pH 7.5 
GR 
8.1 
 Protocol 
Notes 
Sample preparation 1 & 2) The final concentration of SSA should 
be 5% (w/v) for precipitation of proteins 
before the assay. Therefore, if other volume 
ratios are required (e.g., to concentrate or 
dilute the sample), make SSA solutions 
accordingly. 
1) Cell Suspensions. Add 200 µl of cell suspension to 200 µl of 
10% (w/v) SSA, which is already in a 1.5 ml-tube. 
 2) Cell cultures. To measure GSSG, add 360 µl of culture 
medium to 40 µl of 50% (w/v) SSA, which is already in a 1.5 
ml-tube. Then scrap the cells in 1 ml of PBS (a well from a 6-
well plate) and add 360 µl of cell suspension to 40 µl of 50% 
(w/v) SSA to measure GSH levels. 
Assay Solutions 
GSH and GSSG standards 
Prepare the following GSH standards in SSA 
5% (w/v): 2, 4, 8, 16, 32, 64 nmol GSH/ml  
Prepare the following GSSG standards in SSA 
5% (w/v): 1, 2, 4, 8, 16, 32 nmol GSSG/ml  
3) Vortex the tubes. Stock solutions with higher concentrations 
have to be prepared first. Then, freeze stocks 
and standards solutions for reuse. 4) If not measured immediately afterwards, keep the tubes at      
-80ºC for later measurement of glutathione levels.  
DTNB 3 mM (Final Conc. 0.6 mM) 
 5,95 mg/ 5 ml PB  (5 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. DTNB-GSSG Reductase Recycling Assay 
 1) Centrifuge tubes at 10,000 rpm (~10,000 ×g) in a 
microcentrifuge for 1 min at room temperature and use the 
supernatant. 
NADPH 0.35 mM (F. Conc. 0.21 mM) 
2,92 mg/ 10 ml PB  (15 ml/96-well plate) 
Prepare a fresh solution daily and maintain in 
ice. Prepare only 10% more solution than 
necessary – expensive compound! 2) In a 96-well plate, pipette to each well: 
  - 30 µl of sample/standard (make duplicates) 
GR 25 U/ml (F. Conc. 2 U/ml) 
 - 50 µl DTNB (3 mM) ?? µl/ 1 ml PB  (2 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. Prepare only 10% more solution than 
necessary – expensive enzyme! 
 - 150 µl NADPH (0.35 mM) 
3) Incubate for 15 min at 30ºC in the plate reader. 
? – Calculate for each enzyme lot. Each lot 
has a different concentration of enzyme. 
4) Add as fast as possible 20 µl of GR (25 U/ml) and read the 
absorbance at 425 nm on a plate reader every 10 sec for 3 min at 
30ºC. 
 
Notes 
1) Centrifuge normally used: 
Centrifuge 5415 C, Eppendorf. 
5) A linear (positive) slope should be obtained. If not, dilute 
samples accordingly. The concentration of your samples can be 
directly obtained using the standard curve (linear response) in 
the SOFTmax Pro. 
2) Use a repetitive pipette to pipette DTNB 
and NADPH into the wells. 
3) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both the Winter and Summer. 
4) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
6) Express glutathione levels as nmol GSH/mg protein, 
considering dilution factors. In the case of cell cultures, have 
into account dilutions and total volumes of extracellular medium 
and homogenisation medium with cell scraps, where the protein 
is measured. 
Use the ‘kinetic’ function of SOFTmax Pro. 
 
 
 
8.2 
 Sample preparation for measuring GSSG 
P8 
 1) Pipette into a 1.5-ml tube 100 µl of sample/standard (GSSG). 
Notes 2) Under a fume wood, pipette into each tube 2 µl of 2-
vinylpyridine and mix. 
2) 2-Vinylpyridine has a low vapor pressure 
and constant exposure may be irritating. 
2 & 3) Use a repetitive pipette to pipette 2-
vinylpyridine and triethanolamine into the 
tube. 
3) Then, also under a fume wood, pipette 10 µl of 
triethanolamine 50% (v/v) to the side of the tube and vigorously 
mix the solution.   
 
4) Using a microtube shaker device, shake the tubes 
continuously for 1 hour at ambient temperature. 
 
5) Due to 2-vinylpyridine, pipette the samples 
in to the 96-well plate also under a fume 
wood. 5) Finally, the derivatised samples are assayed as described 
above in the DTNB-GSSG reductase recycling assay. 
At the end of the assay, fill the wells of the 
96-well plate with HCl 1 N. Afterwards, get 
rid of all to the hazardous waste. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
8.3 

   
P9 Glucose 
  Experimental Protocol 9 
  
  
1 Glucofix, A. Menarinini diagnostics, 
Firenze, Italy. Glucose is an important metabolite in the organism that is 
strictly regulated. The measurement of glucose is used for the 
diagnosis and monitoring of diabetes and other disorders of 
carbohydrate metabolism.  
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
  
Solutions 
Principle 
Kit Reagent 
The concentration of glucose in a sample can be measured using 
a colorimetric enzymatic method
Use as provided. 
1. Glucose oxidase (GOD) 
oxidises glucose to gluconic acid, with formation of H
 
Kit Standard 
2O2. In the 
presence of peroxidase (POD), the H Use as provided. 2O2 reacts with phenol and 
4-aminoantipyrine, to produce a coloured complex (red) whose 
absorbance maximum is found at 505 nm
 
 1: 
 
Glucose + O2 + H2O → Gluconic acid + H2O2
H2O2 + Phenol + 4-Aminoantipyrine → Coloured Complex + 
       H2O 
The absorbance at 505 nm is directly proportional to the 
concentration of glucose in the sample. 
Here, is described an adaptation of the method Glucofix 
(Menarini) useful to be used in a plate reader spectrophotometer. 
 
Protocol 
1) In a 96-well plate, pipette to each well: 
 - 8 µl of sample/standard (make duplicates), in the case 
of your sample having less than 12 mM glucose. 
or, - 4 µl of sample/standard (make duplicates), in the case 
of your sample having less than 24 mM glucose. 
 - 250 µl Kit reagent 
2) Incubate for 15 min at 30ºC in the plate reader. 
3) Read the absorbance at 505 nm against the blank in a plate 
reader spectrophotometer. 
 
 
 
 
 
 
 
 
 
 
Notes 
1) The sample can be any clear (without 
precipitates) solution. 
Use a repetitive pipette to pipette Kit reagent 
into the wells. 
2) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
3) Use the ‘endpoint’ function of SOFTmax 
Pro. 
If the template is done accordingly, the 
program already subtracts the blank value to 
the samples and standard. This is important 
for subsequent calculations. 
 
 
GOD 
POD
9.1 
  
Calculate glucose concentration using the standard with the 
following formula: 
         Asample × Conc. Standard 
             Astandard
 
In the case of cell cultures, the glucose concentration can be then 
be expressed per mg of protein (protein of the cell scraps). For 
example, nmol glucose produced/mg protein or nmol glucose 
consumed/mg protein. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Notes 
Formula: 
Conc. Standard – concentration of the 
standard used. If you use the kit standard, the 
concentration is 5.56 mM or 100mg/dl. 
Glucose [mM] = 
 – absorbance of the sample Asample
 - absorbance of the standard Astandar
Use the absorbance of samples and standard 
with the blank value already subtracted. 
 
9.2 
   
P10 Total Protein 
  Experimental Protocol 10 
  
  
1 Bradford Reagent, # B6916, Sigma, 
Missouri, USA. The measurement of total protein in samples is very important 
for normalizing the quantity of other metabolites and enzyme 
activities of the same sample per mg of protein. It is also 
important routinely in several biologic techniques, such as, 
western blotting. It also gives an idea when compared with a 
control situation if any treatment induce a general over-
expression of proteins or decrease total soluble protein due to 
toxic effects.  
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
 
Solutions 
Bradford Reagent 
Use as provided. 
 
 Protein Standard 
Principle Make a Standard Stock of 2 mg/ml with the 
solution where your protein is present – 
sample buffer (e.g. lysis buffer). The concentration of proteins in a sample can be measured 
spectrophotometrically using the Bradford Reagent Dissolve 10 mg of bovine serum albumin (BSA) in 5 ml of sample buffer. Make 
aliquots of 500 µl and keep at -20ºC for later 
use. 
1. The 
procedure is based on the formation of a complex between the 
dye, Brilliant Blue G, and proteins in solution. The protein-dye 
complex causes a shift in the absorption maximum of the dye 
from 465 to 595 nm. The amount of absorption at 595 nm is 
proportional to the protein present. 
 
 
 
 
  
 The Bradford Reagent is compatible with reducing agents (ex. 
DTT and 2-Mercaptoethanol). Reducing agents are often used to 
stabilise proteins in solution. Other protein assay procedures 
(Lowry and BCA) are not compatible with reducing agents. The 
Bradford Reagent should be used in place of these protein assays 
if reducing agents are present. However, the Bradford reagent is 
only compatible with low concentrations of detergents (see 
compatibility chart in ref. 
 
 
 
 
 
 
 
1). If the protein sample to be assayed 
has detergent(s) present in the buffer, it is suggested to use the 
BCA or Lowry protein determination procedure. 
 
 
Here, is described an adaptation of the method explained in ref. 1 
(Sigma) useful to be used in a plate reader spectrophotometer. 
 
 
 
10.1 
 Protocol  
Notes 
1) Gently mix the Bradford Reagent in the bottle: 2) Prepare for example the following 
standards: 0.125, 0.25, 0.5, 1 and 2 mg/ml. 
2) Prepare protein standards in the sample buffer ranging from 
0.125 - 2 mg/ml using a BSA standard (2 mg/ml). 
3) For the blank, pipette 10 µl of sample 
buffer. 
Use a repetitive pipette to pipette Bradford 
Reagent into the wells. 3) In a 96-well plate, pipette to each well: 
4) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
 - 10 µl of sample/standard/blank (make duplicates). 
 - 250 µl Bradford Reagent 
Use the ‘endpoint’ function of SOFTmax Pro. 
4) Let the samples incubate at room temperature for 10 minutes. 
Then measure the absorbance at 595 nm in the plate reader 
spectrophotometer. The protein-dye complex is stable up to 60 
min. 
 
 
 
 
 
5) The concentration of your samples can be directly obtained 
using the standard curve (quadratic response) in the SOFTmax 
Pro. 
 
 
 
 
 
 
 This method can also be used using only one standard 
concentration (500 µg/ml) instead of using a standard protein 
range. For that, you may use the following formula: 
Formula: 
Conc. Standard – concentration of the 
standard used: 500 µg/ml. 
 × Conc. Standard          A – absorbance of the sample A samplesample
             Astandard
If the protein concentration of the unknown sample(s) is greater 
than 1 mg/ml, you must dilute the sample accordingly. 
 
If protein concentration of your sample is quite low, you can 
increase the volume of your sample/standard/blank in the assay 
(e.g., 20µl). However, you have to change the standard protein 
range accordingly. For example, to use 20 µl of sample, you 
should use a standard protein range of: 0.0625, 0.125, 0.25, 0.5 
and 1 mg/ml. 
 
 
 
 
Astandar - absorbance of the standard 
Protein [µg/ml] = 
Use the absorbance of the sample and 
standard with the blank value already 
subtracted. 
 
10.2 
   
P11 Glutathione Reductase 
  Experimental Protocol 11 
  
  
1 Carlberg I & Mannervik B, 1985. 
Glutathione reductase. Methods in 
Enzymology 113, 484-490. 
Glutathione reductase (GR) is a flavoprotein catalysing the 
NADPH-dependent reduction of glutathione disulfide (GSSG – 
glutathione oxidised form) to GSH (glutathione – reduced form):  
 
Materials required 
GSSG + NADPH + H+ → 2 GSH + NADPP+
The reaction is essential for the maintenance of glutathione 
levels in reduced form. GSH has a major role as a reductant in 
oxidation-reduction processes and also in detoxification 
reactions. 
 
Principle 
The oxidation of NADPH is followed spectrophotometrically at 
340 nm1.  
Here, a procedure based in the methodology of Carlberg & 
Mannervik (1985)1 is described to measure the GR activity in a 
plate reader spectrophotometer. The assay is performed at 30ºC 
following NADPH oxidation at 340 nm in the presence of 3 mM 
GSSG, 0.12 mM NADPH, 2.5 mM EDTA, in 50 mM Hepes (pH 
7.4). 
 
Protocol 
Sample preparation 
Use a post-mitochondrial fraction of any cell homogenate. For 
that, centrifuge cell or tissue homogenates at 10,000 ×g for 10 
min at 4ºC. Use supernatant as your sample. 
 
Enzyme Soup 
Just before the enzyme assay, make the following enzyme soup 
(25 ml/96-well plate): 
 
96-well plates 
Plate reader spectrophotometer 
 
Special reagents: 
NADPH (e.g., # N1630, Sigma) 
GSSG 
 
Buffer Solutions 
Hepes 50 mM 
50 mM Hepes, pH 7.4 
 
Assay Solutions 
EDTA 50 mM (Final Conc. 2.5 mM) 
18.6 mg/ 1 ml Hepes (1.5 ml/96-well plate) 
 
GSSG 50 mM (Final Conc. 3 mM) 
32.8 mg/ 1 ml Hepes (1.8 ml/96-well plate) 
Maintain on ice. It can be be freezed for later 
use. 
 
Starter Reaction Solution 
NADPH 3.24 mM (F. Conc. 0.12 mM) 
2,83 mg/ 1 ml Hepes  (1 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. Prepare only 10% more solution than the 
necessary – expensive compound! 
 
GR 
11.1 
        (27)  (22)         (17)  
Notes 
EDTA 50 mM     1.35 ml            1.1 ml       1.02 ml 
Enzyme Soup 
GSSG 50 mM     1.62 ml            1.32 ml        850 µl Number in brackets ( ): Volume in ml used 
for the calculations – it have in count the 
volume of the sample and the starter reaction 
solution. 
Hepes       22 ml             17.58 ml     13.13 ml 
Total       25 ml               20 ml       15 ml 
 
  
 
Enzyme Assay 
 
1) In a 96-well plate, pipette to each well: 1 & 4) Use a repetitive pipette to pipette 
Enzyme Soup and NADPH. 
 - 10 µl sample (make duplicates)  
2) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 
 - 250 µl Enzyme Soup 
2) Incubate for 2 min at 30ºC in the plate reader. Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
3) Measure the non-specific activity by reading the absorbance 
at 340 nm on a plate reader every 10 sec for 3 min. 
3 & 4) Use the ‘kinetic’ function of SOFTmax 
Pro 
4) Add as fast as possible 10 µl of NADPH (3.24 mM) and read 
the absorbance at 340 nm on a plate reader every 10 sec for 3 
min. 
5) Use only the linear part for the 
calculations. 
 
 
5) A linear (negative) slope inferior to 100 mDO/min should be 
obtained. If not, dilute samples accordingly. 
 
 
  
To calculate GR activity, subtract the slope obtained from the 
non-specific activity (step 3) from the specific activity (step 4). 
This gives the Vmax for each sample. Then, the activity can be 
expressed as µmol NADPH oxidised per min per ml (U/ml) 
using the following formula: 
 
 
 
 
 
-1U - µmol.min
 Vmax - slope in mDO.min-1
      Vmax × 0.332  
  1000 × 6.22 × Vsample
 
The specific activity of GR (U/mg protein) is then calculated 
dividing the above value per the value “mg protein/ml” - protein 
of the sample. 
 
 
 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1 U/ml = 
-1εNADH = 6.22 mM .cm-1
V  - volume of the sample used in the     
assay in ml (ex: 0.01 ml). 
sample
 
11.2 
   
P12 Glutathione Peroxidase 
  Experimental Protocol 12 
  
  
1 Flohe L & Gunzler WA, 1984. Assays of 
glutathione peroxidase. Methods in 
Enzymology 105, 114-121. 
Glutathione peroxidase (GPox) is an antioxidant enzyme that 
reduces H2O2 (and other peroxides) to water in the presence of 
glutathione in reduced form (GSH): 
2 Martin-Aragon S, de las Heras B, Sanchez-
Reus MI & Benedi J, 2001. Pharmacological 
modification of endogenous antioxidant 
enzymes by ursolic acid on tetrachloride-
induced liver damage in rats and primary 
cultures of rat hepatocytes. Experimental and 
Toxicologic Pathology 53, 199-206. 
2 GSH + H2O2 → 2 H2O + GSSG 
 
Principle 
Glutathione peroxidase catalyses the reduction of peroxides to 
water with oxidation of GSH to GSSG. GSSG can be then 
reduced back to GSH by GR with expense of NADPH: 
GSSG + NADPH + H+ → 2 GSH + NADPP+
Therefore, GPox activity can indirectly be measured following 
the decrease of NADPH, i.e. oxidation to NADPP+, 
spectrophotometrically at 340 nm.  
Here, a procedure based in the methodology of Flohe & Gunzler 
(1984) 1 and Martin-Aragon et al. (2001)2 is described to 
measure the selenium-dependent and -independent GPox 
activity in a plate reader spectrophotometer. The assay is 
performed at 30ºC following NADPH oxidation at 340 nm in the 
presence of 1 mM GSH, 0.18 mM NADPH, 1 mM EDTA, 0.5 
U/ml GR and 0.7 mM t-BOOH in 50 mM imidazole (pH 7.4). 
 
Protocol 
Sample preparation 
Use a post-mitochondrial fraction of any cell homogenate. For 
that, centrifuge cell or tissue homogenates at 10,000 ×g for 10 
min at 4ºC. Use supernatant as your sample. 
 
Enzyme Soup 
Just before the enzyme assay, prepare the following enzyme 
soup (25 ml/96-well plate): 
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
 
Special reagents: 
NADPH (e.g., # N1630, Sigma) 
GSH 
Glutathione Reductase (GR) (e.g., # B2633,  
      Sigma) 
tert-Butyl hydroperoxide (t-BOOH) 
(e.g., # G3664, Sigma) 
 
Buffer Solutions 
Imidazole (Imdz.) 50 mM 
50 mM Imidazole, pH 7.4 
 
Assay Solutions 
EDTA 50 mM (Final Conc. 1 mM) 
18.6 mg/ 1 ml Imdz. (1 ml/96-well plate) 
 
GSH 27 mM (Final Conc. 1 mM) 
8.3 mg/ 1 ml Imdz. (1.1 ml/96-well plate) 
Maintain on ice. It can be be freezed for later 
use. 
 
NADPH 3.24 mM (F. Conc. 0.18 mM) 
2,83 mg/ 1 ml Imdz  (1.6 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. Prepare only 10% more solution than the 
necessary – expensive compound! 
 
GR (F. Conc. 0.5 U/ml) 
Use as provided. Calculate the necessary 
volume for enzyme lot. Each lot has a 
different concentration of enzyme. 
GPox 
GR 
12.1 
        (27)  (22)         (17)  
Notes 
EDTA 50 mM     540 µl             440 µl        340 µl 
Enzyme Soup 
GSH 27 mM       1 ml              815 µl        630 µl Number in brackets ( ): Volume in ml used 
for the calculations – it have in count the 
volume of the sample and the starter reaction 
solution. 
NADPH 3.24 mM    1.5 ml            1.22 ml        944 µl 
GR *         ??  ??           ?? 
* ??: Depends of the lot of enzyme stock. Do 
the necessary calculations for each lot. Imdz       22 ml           17.52 ml     13.09 ml 
 Total       25 ml              20 ml        15 ml 
Starter Reaction Solution 
 18.9 mM t-BOOH (F. Conc. 0.7 mM) 
2.43 µl/1 ml PB (1.2 ml/plate) Enzyme Assay 
Prepare fresh. 
1) In a 96-well plate, pipette to each well:  
Notes  - 10 µl sample (make duplicates) 
1 & 4) Use a repetitive pipette to pipette 
Enzyme Soup and t-BOOH.  - 250 µl Enzyme Soup 
2) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 
2) Incubate for 2 min at 30ºC in the plate reader. 
3) Measure the non-specific activity by reading the absorbance 
at 340 nm on a plate reader every 10 sec for 3 min. 
Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
4) Add as fast as possible 10 µl of t-BOOH (18.9 mM) and read 
the absorbance at 340 nm on a plate reader every 10 sec for 3 
min. 
3 & 4) Use the ‘kinetic’ function of SOFTmax 
Pro 
5) Use only the linear part of the curve for the 
calculations. 
 5) A linear (negative) slope inferior to 100 mDO/min should be 
obtained. If not, dilute samples accordingly. 
 
 
  
To calculate GPox activity, subtract the slope obtained from the 
non-specific activity (step 3) from the specific activity (step 4). 
This gives the Vmax for each sample. Then, the activity can be 
expressed as µmol NADPH oxidised per min per ml (U/ml) 
using the following formula: 
 
 
 
 
-1U - µmol.min
Vmax - slope in mDO.min-1
 
      Vmax × 0.332  
  1000 × 6.22 × Vsample
 
The specific activity of GPox (U/mg protein) is then calculated 
dividing the above value per the value “mg protein/ml” - protein 
of the sample. 
 
 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1
εNADPH = 6.22 mM-1.cm-1 U/ml = 
V  - volume of the sample used in the     
assay in ml (ex: 0.01 ml). 
sample
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P13 Glutathione S-Transferase 
  Experimental Protocol 13 
  
  
1 Habig WH, Pabst MJ & Jakoby WB, 1974. 
Glutathione S-transferases. The first 
enzymatic step in mercapturic acid formation. 
Journal of Biological Chemistry 249, 7130-
7139. 
Glutathione S-transferase (GST) is a phase II enzymes that 
participates in detoxification of many xenobiotics, electrophiles 
and reactive oxygen species through their conjugation to GSH. 
 
 Materials required 
Principle 96-well plates 
Plate reader spectrophotometer The conjugation of aromatic substrates to GSH by GST is 
followed spectrophotometrically
 
1. Special reagents: 
1-chloro-2,4-dinitrobenzene (CDNB) 
   (e.g., # C6396, Sigma) Here, a procedure based on the methodology of Habig et al. 
(1974)1 is described to measure GST activity in a plate reader 
spectrophotometer using the aromatic substrate 1-chloro-2,4-
dinitrobenzene (CDNB). The assay is performed at 30ºC 
following the formation of GSH conjugate at 340 nm in the 
presence of 1 mM GSH and 1 mM CDNB in 50 mM Hepes (pH 
7.4). The activity is calculated using the extinction coefficient of 
9.6 mM
GSH 
 
Buffer Solutions 
Hepes 50 mM 
50 mM Hepes, pH 7.4 
 
Assay Solutions -1.cm-1 and expressed as µmol of conjugate produced per 
min per mg of protein. 
CDNB 27 mM (Final Conc. 1 mM) 
5.57 mg/ 1 ml ethanol (1.1 ml/96-well plate) 
  
Starter Reaction Solution Protocol 
GSH 27 mM (Final Conc. 1 mM) 
Sample preparation 
8.3 mg/ 1 ml Hepes (1.1 ml/96-well plate) 
Maintain on ice. It can be be freezed for later 
use. 
Use a post-mitochondrial fraction of any cell homogenate. For 
that, centrifuge cell or tissue homogenates at 10,000 ×g for 10 
min at 4ºC. Use supernatant as your sample. 
 
 
  
 
Enzyme Soup Notes 
Enzyme Soup Just before the enzyme assay, make the following enzyme soup 
(25 ml/96-well plate): 
Number in brackets ( ): Volume in ml used 
for the calculations – it have in count the 
volume of the sample and the starter reaction 
solution.        (27)  (22)         (17) 
 CDNB 27 mM      1 ml                815 µl        630 µl 
 Hepes       24 ml             19,2 ml       14.4 ml 
 
Total       25 ml               20 ml       15 ml  
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 Enzyme Assay  
Notes 
1) In a 96-well plate, pipette to each well: 
1 & 4) Use a repetitive pipette to pipette 
Enzyme Soup and GSH. 
 - 10 µl sample (make duplicates) 
2) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer.  - 250 µl Enzyme Soup 
Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
2) Incubate for 2 min at 30ºC in the plate reader 
3) Measure the non-specific activity by reading the absorbance 
at 340 nm on a plate reader every 10 sec for 3 min. 3 & 4) Use the ‘kinetic’ function of SOFTmax Pro 
5) Use only the linear part of the curve for the 
calculations. 
4) Add as fast as possible 10 µl of GSH (27 mM) and read the 
absorbance at 340 nm on a plate reader every 10 sec for 3 min.  
 5) A linear (positive) slope inferior to 200 mDO/min should be 
obtained. If not, dilute samples accordingly.  
 
 
 
To calculate GST activity, subtract the slope obtained from the 
non-specific activity (step 3) from the specific activity (step 4). 
This gives the Vmax for each sample. Then, the activity can be 
expressed as µmol of conjugated produced per min per ml 
(U/ml) using the following formula: 
 
 
 
 
 
  
-1U - µmol.min
      Vmax × 0.332  
  1000 × 9.6 × Vsample
 
The specific activity of GST (U/mg protein) is then calculated 
dividing the above value per the value “mg protein/ml” - protein 
of the sample. 
 
 
Vmax - slope in mDO.min-1 U/ml = 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1
-1εconjugated = 9.6 mM .cm-1
V  - volume of the sample used in the     
assay in ml (ex: 0.01 ml). 
sample
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P14 Cytochrome P450s 
  Experimental Protocol 14 
  
  
1 Rastogi S, Das M & Khanna SK, 2002. A 
novel approach to study the activity and 
stoichiometry simultaneously for microsomal 
pentoxyresorufin-O-dealkylase reaction. 
FEBS Letters 512, 121-4. 
Cytochrome P-450 (CYP) is regarded as the collective name of a 
superfamily of hemeproteins, which carry out the oxidative 
conversion of various exogenous and endogenous compounds, 
usually by hydroxylation, turning a hydrophobic compound into 
a more water soluble substance which can be excreted. Their 
principal function requires molecular oxygen, a supply of 
reducing equivalent from NADPH and a substrate
2 Barbier O, Lapoint H, el Alfy M, Hum DW 
& Belanger A, 2000. Cellular localization of 
uridine diphosphoglucuronosyltransferase 2B 
enzymes in the human prostate by in situ 
hybridization and immunohistochemistry. The 
Journal of Clinical Endocrinology & 
Metabolism 85, 4819-4826 1. Liver 
microsomes are rich in these enzymes. 
 
 
  
Preparation of Liver Microsomes Materials required 
Refrigerated Centrifuge 
Principle 
Ultracentrifuge 
CYP’s are located within the cell in the membranes of 
endoplasmic reticulum. When the cell are homogenised in the 
appropriate buffer, the endoplasmic reticulum forms small 
vesicles in aqueous solution (microsomes) with a specific 
density that precipitate at 100,000 ×g by centrifugation. By 
differential centrifugation is possible to isolate the microsomes 
from the other constituents of the cell. 
Mini-Beadbeater homogenizer 
 
Buffer Solutions 
Phosphate buffer (PB) 200 mM, pH 7.4 
100 mM KH PO2 4
100 mM K HPO , pH 7.4 2 4
Stable at 4ºC. 
 
Here, an adaptation from the method used by Barbier et al. 
(2000)
 
 2 is described in order to use low volumes of tissue 
homogenate (max. 1.5 ml).  
 
 
 
Protocol 
Notes 
1) Prepare freshly the following homogenisation buffer (HB) for 
a total volume of 50 ml: 
1)  DTT - Dithiothreitol 
PMSF - Phenylmethylsulfonyl fluoride 
* From a stock of 40 mM PMSF in ethanol 
(kept at -20ºC)   Final Concentration Weight/Volume 
 DTT  1 mM   7.72 mg  
EDTA  1 mM   18.6 mg 
Glycerol 20% (v/v)  10 ml 
PMSF  0.1 mM   125 µl* 
PB  160 mM   till 50 ml 
Keep on ice until use. 
14.1 
 2) In the appropriate tube (about 2 ml max) put some glass beads 
(1 mm diameter). Weigh the tube and put them on ice. 
 
Notes 
3 & 4) All these operations (except weighing 
the tubes should be done in a 4ºC room. Make 
the calculations necessary to know the volume 
to add to each sample as fast as possible in 
order to prevent deterioration of the samples. 
3) Put about 150-300 mg of liver tissue and weigh newly the 
tubes. Keep the tubes on ice and be fast as much as possible. 
4) For each sample leave at least 5 min on ice 
before the second homogenisation procedure. 4) Homogenise the tissue in the ratio 1/5 (1+4) with HB two 
times for 20 sec at 42,000 rpm with the Mini-Beadbeater. (e.g.: 
200 mg + 800 µl) 
Homogenizer used: Mini-Beadbeater, Biospec 
Products, Bartlesville, OK, USA. 
5) Centrifuged used: Sigma 2K15, B. Braun, 
West Germany. 5) Centrifuge at 12,000 ×g, 20 min at 4ºC. 
6) Centrifuge used: Beckman XL-90 
Ultracentrifuge, Ceckman Instruments, Inc., 
California, USA. 6) Centrifuge the supernatant at 105,000 ×g, 1 hour at 4ºC. For 
these small volumes use the adapter for 1.5/2 ml tubes. 105,000 ×g ≈ 35,000 rpm with the rotor 90Ti 
in this centrifuge. 
7) Resuspend the pellet in 1 ml of HB (use a 200µl pipette and 
ultimately the ultrasound bath for 10sec), and centrifuge again at 
105,000 ×g, 1 h at 4ºC. 
Before using the adapters, ask for Senior 
Researcher how to use them. The adapters 
must be filled with water and rigorously 
calibrated. 
7) A white pellet, heavier, also usually 
appears and represents the glycogen. If 
possible discard it. 
8) Resuspend the pellet in about 500 µl of HB (use a 25G needle 
to resuspend it) and aliquot in 100 µl aliquots.  Freeze in liquid 
nitrogen and keep them at -80ºC until use. 
 
3 Binda D, Lasserre-Bigot D, Bonet A, 
Thomassin M, Come MP, Guinchard C, Bars 
R, Jacqueson A & Richert L, 2003. Time 
course of cytochromes P450 decline during 
rat hepatocyte isolation and culture: eﬀect of 
L-NAME. Toxicology in Vitro 17, 59–67. 
9) Use a small aliquot of the sample obtained above to measure 
the protein content. Preferably, measure the protein content on 
the same day of isolation using the Lowry method. Do not forget 
to make the protein standards in HB to eliminate possible 
interferences. If necessary, dilute samples also in HB. 
4 Deserbac P, Vernevaut MF, Amiot MJ, 
Suschetet M & Siess MH 2001. Eﬀects of a 
water-soluble extract of rosemary and its 
purified component rosmarinic acid on 
xenobiotic-metabolizing enzymes in rat liver. 
Food and Chemical Toxicology 39, 109–117.  
Activities of CYP 1A and 2B Families 5 Burk MD, Thompson S, Elcombe CR, 
Halpert J, Haaparanta T & Mayer RT, 1985. 
Ethoxy-, pentoxy- and benzyloxyphenoxa-
zones and homologues: a series of substrates 
to distinguish between different induced 
cytochromes P-450. Biochemical 
Pharmacology 34, 3337-3345. 
Principle 
The activities of these two cytochrome families can be measured 
with fluorescent substrates using their specific dealkylation 
activity of different phenoxazones
6 Pearce RE, McIntyre CJ, Madan A, Sanzgiri 
U, Draper AJ, Bullock PL, Cook DC, Burton 
LA, Latham J, Nevins C & Parkinson A, 
1996. Effects of freezing, thawing, and 
storing human liver microsomes on 
cytochrome P450 activity. Archives of 
Biochemistry and Biophysics 331, 145-169. 
3: 
CYP 1A: ethoxyresorufin-O-dealkylation  (EROD)3 
CYP 2B: pentoxyresorufin-O-dealkylation  (PROD)4 
Here, an adaptation of the method of Burk et al. (1985)5 and 
Pearce et al. (1996)
 
6 is described. Briefly, the dealkylation of the 
specific substrates is made at 37ºC in phosphate buffer (100 
mM, pH 7.4) containing specific enzyme substrate (see below), 
microsome protein (~200 µg/ml), 3 mM MgCl
Materials required 
Spectrofluorimeter 
Thermostatted water bath 
 
2, 1 mM EDTA 
and a NADPH-generating system
Special reagents: 
3,6 or 250 µM NADPH5Ethoxyresofurin (Resorufin ethyl ether) 
   (e.g., # E3763, Sigma) 
. 
At an exact time the reaction is stopped with ice cold acetone 
and the fluorescence measured with an excitation wavelength 
Pentoxyresorufin (Resorufin pentyl ether) 
(e.g., # P0928, Sigma) 
14.2 
 (λEx) of 530 nm and emission wavelength (λEm) of 584 nm6. 
Zero time incubations serve as blanks. 
P14 
 
The activity is presented as pmol substrate produced/min/mg 
protein using the molar extinction coefficient (ε) of 73.2       
mM
Buffer Solutions 
Phosphate Buffer 2 (PB2) 100 mM: 
-1.cm-1 or by a standard curve with resorufin1. Usually the 
assay using a NADPH-generating system gives the higher 
activities and best results. 
100 mM KH PO , pH 7.4 2 4
Stable at 4ºC. 
 
Stock Solutions 
 
Substrate Stock 1 (EROD) 1 mM: 
Protocol Ethoxyresofurin 
 
Substrate Stock 2 (PROD) 1mM: 1) Prepare freshly the following Enzyme Soup (25 ml/24 
samples): 
Pentoxyresorufin 
Prepare a 1 mM stock solution of the 
respective substrate (light sensitive) in DMSO 
(don’t put in ice otherwise freeze 
immediately) and divide it into 100-200µl 
aliquots. Store at -20ºC. 
  Final Concentration Weight/Volume 
MgCl2  7.5 mM   38.2 mg  
EDTA  1 mM   9.3 mg  
PB2  100 mM   till 25 ml Fluorescent standard 
Substrate: 1 mM Resorufin (e.g., # 230154, Aldrich) 
          EROD 5 µM   125 µl* Prepare a 1 mM stock solution of resorufin 
(light sensitive) in DMSO and divide it into 
aliquots. Store at -20ºC. or       PROD 10 µM   250 µl* 
 
Keep on ice until use. 
Stop Reaction Solution 
2) Prepare freshly one of the following Start Reaction Solution 
(1.25 ml/24 samples): 
Ice cold Acetone 
Put about 25 ml acetone (enough for 24 
samples) on ice before use. 
     (a) NADPH  
Notes 
Final Concentration Weight/Volume 
1) * Pipette just prior use. 
     NADPH 250 µM   38.2 mg (5 mM) 
2) Final Concentration: final concentration in 
the assay (1 ml).      PB2  100 mM   1.25 ml 
Number in brackets ( ): The real concentration 
made in the Start Reaction Solution. or      (b) NADPH-generating System 
??: Depends of the lot of enzyme stock. Do 
the necessary calculations for each lot. Do not 
forget that the real concentration in the 
NADPH-generating system must be 10 U/ml. 
Final Concentration Weight/Volume 
     NADP 500 µM   9.56 mg (10 mM) 
G-6-P: glucose-6-phosphate      G-6-P 1 mM   38 mg (100 mM) 
G-6-PD: G-6-P dehydrogenase 
     G-6-PD 0.5 U/ml  ?? 
 
     PB2  100 mM   ~1.25 ml  
3) To measure EROD activity use an Enzyme 
Soup with EROD substrate; to measure 
PROD activity use Enzyme Soup with PROD 
substrate. 
3) To a glass round bottom tube add: 
 - ~200 µg microsome protein (50 µl max.) 
 
 - 900µl Enzyme Soup 
 
4) Stabilize the assay temperature at 37ºC in a thermostatted 
14.3 
 water bath (e.g. 5 min).  
Notes 
5) Begin the reaction with 50 µl of Start Reaction Reagent and 
incubate also at 37ºC with frequent agitation of the tubes 
(agitation is very important). 
5) To initiate and stop the enzyme reaction in 
a set of tubes at precise time points, you 
should phase the operations for a set of 
samples (e.g. begin each tube of a set from 
half in half minute). 
6) After 20 min, stop the reaction with 2 ml of ice cold Stop 
Reaction Solution and put the tubes on ice. Do not forget to 
make a blank tube with no protein added. 
6) Protect the tubes as most as possible from 
light. Just after adding the Stop Reaction 
Solution, vortex the tube. 
 
7) Centrifuged used: Kubota 2100, Kubota 
Corporation, Tokyo, Japan. 7) Centrifuge the tubes at 4,000 rpm for 2 min. 
8) Spectrofluorimeter used: Luminescence 
Spectrometer LS 50, Perkin Elmer, Perkin-
Elmer Ltd., Buckinghamshire, UK. 
8) Read the fluorescence in a spectrofluorimeter at λEx 530 nm 
and λEm 592 nm (put excitation and emission slits at 10nm). 
An λEm of 584 nm is recommended but an 
λEm of 592 nm was observed to be the peak 
of resorufin. 9) Express the activity as pmol/min/mg protein using a standard 
curve with resorufin. Easier, you can pipette a known 
concentration of resorufin and see the change in fluorescence 
and extrapolate for your results. You should, however, 
previously tested you are using a concentration within the linear 
response of the standard curve. Do not forget to subtract the 
blank value to all samples and standard. 
 
 
 
 
 
 
 
Xpmol: correspondent pmol of resorufin for 
the fluorescence value obtained for ach 
sample. 
Therefore, you can use the corresponding pmol of resorufin for 
each sample and use in the following formula to have the CYP 
activity (CYP A): 20: 20 min of the assay. 
0.2: 0.2 mg of protein used in the assay. 
 CYP A = Xpmol/20/0.2 pmol/min/mg  
7 Allis JW & Robinson BL, 1994. A kinetic 
assay for p-nitrophenol hydroxylase in rat 
liver microsomes. Analytical Biochemistry 
219, 49-52. 
 
Activity of CYP 2E1 
 Principle 
Materials required 
The activity of this cytochrome can be measured 
spectrophotometrically by the conversion of p-nitrophenol 
(PNP) to 4-nitrocatechol followed at 480 nm using NADPH or 
NADPH-generating system
96-well plates 
Plate reader spectrophotometer 
 
 
7. Special reagents: 
p-nitrophenol (4- or para-nitrophenol) Here, an adaptation of the method of Allis & Robinson (1994)7 
is described in order to be used in a plate reader spectropho-
tometer. Briefly, the conversion of the substrate is made at 37ºC 
in Hepes buffer (100 mM, pH 6.8) containing specific enzyme 
substrate, microsome protein (~300 µg/ml), and a NADPH-
generating system. MgCl
(e.g., # 1048, Sigma) 
 
Buffer Solutions 
Hepes Buffer (HB) 100 mM: 
100 mM Hepes, pH 6.8 
Stable at 4ºC. 
2 is not included in the generating 
system or the assay mixture because it has been reported to 
inhibit the PNP hydroxylase reaction. All reagents are mixed 
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 except for the NADPH-generating system and incubated at 37ºC 
for 5 min. The reaction is started by adding the generating 
system and incubated for 37ºC for an additional 5 min before 
recording the absorbance for 10 min. The second 5 min 
incubation it is desirable because a small decrease in absorbance, 
centered near 600 nm, interferes with the assay at 480 nm7. This 
interfering reaction is complete within 5 min and the assay for p-
nitrophenol subsequently becomes linear. The solution of p-
nitrophenol should be at room temperature and allowed to stand 
for at least one hour after preparation or chilling, to eliminate the 
absorbance changes of this solution. With this kinetic method, 
no additional processing of samples is required eliminating 
several potential sources of experimental error7. 
 
Protocol 
1) Prepare freshly the following Enzyme Soup (20 ml/45 
samples in duplicate): 
  Final Concentration Volume 
PNP  0.1 mM   2 ml 
HB  100 mM   18 ml 
Maintain at room temperature. 
2) Prepare freshly the following Start Reaction Solution – 
NADPH-generating System (1 ml/45 samples in duplicate): 
Final Concentration Weight/Volume 
NADP  500 µM   9.95 mg (13 mM) 
G-6-P  5 mM   39.5 mg (130 mM) 
P14 
 
Stock Solutions 
p-Nitrophenol (PNP) 1 mM 
Dissolve 1.39 mg in 10 ml of HB. 
Prepare in the assay day and keep the solution 
at room temperature at least for 1 hour. 
 
 
 
 
 
 
 
 
 
Notes 
1) PNP stock solution should had be done at 
least 1 hour above. 
 
 
 
 
 
 
2) Final Concentration: final concentration in 
the assay (~ 260 µl). 
Number in brackets ( ): The real concentration 
made in the Start Reaction Solution. 
??: Depends of the lot of enzyme stock. Do 
the necessary calculations for each lot. Do not 
forget that the real concentration in the 
NADPH-generating system must be 26 U/ml. 
G-6-PD  1 U/ml   ?? G-6-P: glucose-6-phosphate 
HB  100 mM   ~1 ml G-6-PD: G-6-P dehydrogenase 
 
3) In a 96-well plate, pipette to each well: 
3 & 5) Use a repetitive pipette to pipette 
Enzyme Soup and Start Reaction Solution.  - 300 µg microsome protein (make duplicates) 
 
 - 200 µl Enzyme Soup  
4) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
4) Incubate for 5 min at 37ºC in the plate reader. 
5) Add 10 µl of Start Reaction Solution (or only HB for blanks) 
and incubate also at 37ºC for more 5 min. 5) Make blanks for each sample. 
 
6) Read the absorbance at 480 nm on a plate reader every 20 sec 
for 10 min (at 37ºC). 
6) Use the ‘kinetic’ function of SOFTmax Pro
 
14.5 
 7) A linear (positive) slope should be obtained.  
Notes 
Because it is difficult to see a linear response in this kinetic 
assay due to its low activity, alternatively, you can increase the 
incubation time and, because the response is linear, do the 
following: 
 
 
 
 
 
 1. Add 10 µl of Start Reaction Solution (or HB for 
blanks) and incubate also at 37ºC for more 5 min. Read the 
absorbance at 480 nm –> A
 
 
0 = Absorbance at 0 min.  
  2. Incubate for more half an hour mixing the plate every 
5 min and read the absorbance again at 480 nm –> A
 
30 = 
Absorbance at 30 min. 
7.3) Multiply this slope per 1000 to have the 
units in mDO.min-1. 
 
3. Calculate the slope manually: ΔA = (A0 – A30)/30.  
 8) Express the activity as nmol/min/mg protein using the ε of 
3.567 mM -1.cm-1. 
-1.mg A - nmol.min
To express the activity (A) in the sample use the following 
formula: 
Vmax - slope in mDO.min-1
 Vmax × 0.332 
                 3.567 × 0.3 
Note: Because Vmax is in mDO.min-1, it is not necessary to 
multiply the value by 1000 to have the results in     
nmol.min-1.mg-1. 
 
 
 
 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1
ε4-nitrocatechol = 3.567 mM-1.cm-1
0.3 – protein used in the assay 
A = 
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P15 NADPH-Cytochrome P450 Reductase 
  Experimental Protocol 15 
  
  
1 Guengerich FP, 1982. Microsomal enzymes 
involved in toxicology – analysis and 
separation. In: Hayes AW (Ed.), Principles 
and Methods of Toxicology, Raven Press, 
New York, pp. 609-634. 
The NADPH-cytochrome P450 reductase (CYPR) is an essential 
enzyme for microsomal P450-mediated monooxygenase activity, 
which by interaction with the different cytochrome P450’s 
transfers the essential electron from NADPH. 
 
Materials required 
 96-well plates 
Principle Plate reader spectrophotometer 
 
CYPR activity is conveniently measured indirectly by its 
NADPH-cytochrome c reductase activity stimulated by high salt 
concentration conditions
Special reagents: 
NADPH (e.g., # N1630, Sigma) 
1. If the activity is assayed in the 
presence of mitochondria, KCN (1 mM) may be added as a 
precautionary measure to block non-microsomal activity. 
Instead of cytochrome c, the reduction of other compounds, such 
as tetrazoliums, may also be used to assay activity
Cytochrome c (nitroblue tetrazolium can also 
be used) 
 
Buffer Solutions 
Phosphate Buffer (PB) 300 mM 
1. 300 mM KH PO , pH 7.7 2 4
Stable at 4ºC. Here, a procedure based in the methodology of Phillips & 
Langdon (1962) described by Guengerich (1982)
 1 is adapted to 
measure the CYPR activity in a plate reader spectrophotometer. 
The assay is performed at 30ºC following the reduction of 
cytochrome c at 550 nm in the presence of 100 µM NADPH and 
40 µM cytochrome c in 300 mM phosphate buffer (pH 7.7). 
Assay Solutions 
Cytochrome c 224 µM (Final C. 40 µM) 
2.8 mg/ 1 ml PB (5 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. Prepare only 10% more solution than 
necessary – expensive compound! 
 The activity is calculated using the extinction coefficient of 21.1 
mM NADPH 2.8 mM (F. Conc. 0.1 mM) -1.cm-1 and expressed as µmol of cytochrome c reduced per 
min per mg of protein. 2, 3 mg/ 1 ml PB (1 ml/96-well plate) 
Prepare a fresh solution daily and maintain on 
ice. Prepare only 10% more solution than 
necessary – expensive compound!  
Protocol  
 
Sample preparation 
 
Use a post-mitochondrial fraction of any cell homogenate. For 
that, centrifuge cell or tissue homogenates at 10,000 ×g for 10 
min at 4ºC. Use supernatant as your sample. It can also be used 
the microsomal fraction (see P14). 
 
 
15.1 
 Enzyme Assay  
Notes 
1) In a 96-well plate, pipette to each well: 
1 & 4) Use a repetitive pipette to pipette 
cytochrome c, PB and NADPH. 
 - 20 µl sample (make duplicates) 
 
 - 50 µl cytochrome c (224 µM)  
 
 - 200 µl PB 
2) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 2) Incubate for 3 min at 30ºC in the plate reader. 
Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
3) Measure the non-specific activity by reading the absorbance 
at 550 nm on a plate reader every 10 sec for 3 min. 
3 & 4) Use the ‘kinetic’ function of SOFTmax 
Pro 4) Add as fast as possible 10 µl of NADPH (2.8 mM) and read 
the absorbance at 550 nm on a plate reader every 10 sec for 3 
min. 
 
5) Use only the linear part of the curve for the 
calculations. 
5) A linear (positive) slope inferior to 200 mDO/min should be 
obtained. If not, dilute samples accordingly. 
 
 
  
 To calculate CYPR activity, subtract the slope obtained from the 
non-specific activity (step 3) from the specific activity (step 4). 
This gives the Vmax for each sample. Then, the activity can be 
expressed as µmol cytochrome c reduced per min per ml (U/ml) 
using the following formula: 
 
 
 
 
-1.ml-1U - µmol.min
 Vmax - slope in mDO.min-1
      Vmax × 0.332  
  1000 × 21.1 × Vsample
 
The specific activity of CYPR (U/mg protein) is then calculated 
dividing the above value per the value “mg protein/ml” - protein 
of the sample. 
 
 
 
Vassay/l (lightpath) =constant (0.332) in ml.cm-1
εreduced cytochrome c = 21.1 mM-1.cm-1
U/ml = 
V  - volume of the sample used in the     
assay in ml (ex: 0.02 ml). 
sample
 
15.2 
   
P16 ALT and AST 
  Experimental Protocol 16 
  
  
1 Plaa GL & Hewitt WR, 1982. Detection and 
evaluation of chemically induced liver injury. 
In: Hayes AW (Ed.), Principles and Methods 
of Toxicology, Raven Press, New York, pp. 
407-445. 
Alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) are both transaminase enzymes that are found mainly in the 
liver. After liver damage, high levels of these enzymes are present 
in plasma making them, therefore, good markers of liver injury. 
 
Materials required 
 96-well plates 
Principle Plate reader spectrophotometer 
 
ALT enzyme converts alanine and α-ketoglutarate to glutamate 
and pyruvate. On the other hand, AST converts aspartate and α-
ketoglutarate to glutamate and oxaloacetate. If these enzyme 
processes are coupled with ones in which NADH is converted to 
the oxidised form, the activity of the transaminases can be 
indirectly measured following NADH oxidation spectrophoto-
metrically at 340 nm
Special reagents: 
L-Alanine 
Aspartate 
α-Ketoglutarate 
Pyridoxalphosphate 
Lactate dehydrogenase (LDH; free of 
ammonium sulphate; e.g. # 10127221001, 
Roche) 1.  
Malate dehydrogenase (MDH; in glycerol;        
e.g. # 10127248001, Roche) 
To measure the ALT activity, the assay is performed at 30ºC 
following NADH oxidation at 340 nm in the presence of 200 
mM L-alanine, 25 µM pyridoxalphosphate, 0.12 mM NADH, 12 
U/ml L-lactacte dehydrogenase and 10.5 mM α-ketoglutarate in 
50 mM imidazole (pH 7.4). To measure the AST activity, the 
assay is performed at 30ºC following NADH oxidation at       
340 nm in the presence of 40 mM aspartate, 25 µM 
pyridoxalphosphate, 0.12 mM NADH, 8 U/ml L-malate 
dehydrogenase and 7 mM α-ketoglutarate in 50 mM imidazole 
(pH 7.4). The activities are expressed as µmol of substrate 
oxidised per min per liter of plasma/serum. 
 
Buffer Solutions 
Imidazole (Imdz.) 50 mM 
50 mM Imidazole, pH 7.4 
 
Assay Solutions 
Aspartate 1.08 M (Final Conc. 40 mM) 
168 mg/ 1 ml Imdz. (1 ml/96-well plate) 
Can be frozen once.  
 
α-Ketoglutarate 283.5 mM 
41.4 mg/ 1 ml Imdz. (1 ml/96-well plate) 
 Freshly prepared and stable for 3 h on ice. 
 Protocol 
NADH 2.4 mM (F. Conc. 0.12 mM) 
Sample preparation 8,51 mg/ 5 ml Imdz  (1.5 ml/96-well plate) 
Freshly prepared and stable for 3 h on ice. Use plasma or serum as your sample. 
  
Pyridoxalphosphate 5 mM (F.C.. 25 µM)
Enzyme Soup 1.24 mg/ 1 ml Imdz  (0.2 ml/96-well plate) 
Unstable compound. Last solution to be 
prepared. Just before the enzyme assay, make the following enzyme soups 
for ALT and AST, respectively (25 ml/96-well plate): 
16.1 
 (1) ALT  
Notes    Final Conc. Weight/Volume 
Final Conc.: final concentration in the assay 
(270 µl). NADH (2.4 mM)  120 µM  1.35 ml 
L-alanine  200 mM  481 mg ??: Depends of the lot of enzyme stock. Do 
the necessary calculations for each lot. Do not 
forget that you should use a total volume of 
27 ml for the calculations in order to have in 
consideration the sample volume and the start 
reaction solution. 
PyridoxalP. (5 mM) 25 µM  135 µl 
LDH   12 U/ml     ?? 
Imdz (50mM)  50 mM  23.5 ml 
LDH: lactate dehydrogenase  
MDH: malate dehydrogenase 
(2) AST 
 
   Final Conc. Volume  
NADH (2.4 mM)  120 µM  1.35 ml  
α-ketoglutarate  7 mM  667 µl  
 PyridoxalP. (5 mM) 25 µM  135 µl 
 MDH   8 U/ml     ?? 
 
Imdz (50mM)  50 mM  22.85 ml 
 
 
 
Enzyme Assay  
 
1) In a 96-well plate, pipette to each well: 
1 & 4) Use a repetitive pipette to pipette 
Enzyme Soup and Start Reaction Solution. 
 - 10 µl sample (make duplicates) 
 
 - 250 µl Enzyme Soup (ALT or AST) 2) The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 2) Incubate for 3 min at 30ºC in the plate reader 
Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
3) Measure the non-specific activity by reading the absorbance 
at 340 nm on a plate reader every 10 sec for 3 min. 
4) Use the ‘kinetic’ function of SOFTmax Pro 
4) Add as fast as possible 10 µl of Start Reaction Solution 
[ALT: α-ketoglutarate (283.5 mM); or, AST: aspartate (1.08 
M)] and read the absorbance at 340 nm on a plate reader every 
10 sec for 3 min. 
 
 
 
5) Use only the linear part of the curve for the 
calculations. 
 5) A linear (negative) slope inferior to 100 mDO/min should be 
obtained. If not, dilute samples accordingly.  
 
  
To calculate transaminase activities, subtract the slope obtained 
from the non-specific activity (step 3) from the specific activity 
(step 4). This gives the Vmax for each sample. Then, the activity 
can be expressed as µmol NADH oxidised per min per L of 
plasma/serum (U/L) using the following formula: 
-1U - µmol.min
Vmax - slope in mDO.min-1
      Vmax × 0.332  
       6.22 × Vsample
Vassay/l (lightpath) =constant (0.332) in ml.cm-1
-1εNADH = 6.22 mM .cm-1
V  - volume of the sample used in the     
assay in ml (ex: 0.01 ml). 
sample
-1Because Vmax is in mDO.min , it is not 
necessary to multiply the value by 1000 to 
have the results in U/L. 
U/L = 
16.2 
  
Comet Assay  
P17  
   Experimental Protocol 17  
The single cell gel electrophoresis assay or “comet assay” is a 
sensitive, quick and simple method for measuring DNA damage 
in single cells. 
 
1 Duthie SJ, 2003. The comet assay: 
protective effects of dietary antioxidants 
against oxidative DNA damage measured 
using alkaline single cell gel electrophoresis. 
In: Cutler RJ, Rodriguez H (Eds), Critical 
Reviews of Oxidative Stress and Aging, World 
Scientific, Singapore, pp. 309-323. 
In general, the alkaline comet assay (the most used) consists of 
several stages beginning with isolation of cells, agarose 
embedding, lysis with high salt and detergent, alkaline 
unwinding and electrophoresis, neutralizing, staining and 
analysis. In the unwinding conditions used (pH > 13), the high 
alkalinity of the solution allows the separation of the DNA 
strands, which means that the assay detects DNA single-strand 
breaks and alkali labile sites in individuals cells, delaying repair 
sites of DNA
2 Rojas E, Lopez MC & Valverde M, 1999. 
Single cell gel electrophoresis assay: 
methodology and applications. Journal of 
Chromatography B 722, 225-224. 
 
Materials required 
Horizontal electrophoresis tank 
Fluorescent microscope 
 2. 
Special reagents: 
 
Low melting agarose 
Principle  
Buffer Solutions 
When embedded, the cell forms a cavity in the agarose gel. 
Following lysis, when all the cellular proteins are stripped away 
and have dissolved through the gel, only the nuclear scaffold 
proteins remain and the DNA expands to occupy the cavity
PBS (Phosphate Buffered Saline) 
137 mM NaCl 
2.7 mM KCl 
1. HPO8.5 mM Na2 4
1.5 mM KH PO , pH 7.4 2 4
 
 
Fig. 1. Protocol outline of the comet 
assay. After embedding isolated 
cells in low melting agarose (LMA), 
cells are lysed for at least 1 hour. 
Then, DNA is unwound and 
electrophored in a horizontal 
electrophoresis tank and then 
neutralised. Finally, DNA is stained 
and visualised under a fluorescent 
microscope and the comet images 
analysed. Image taken from Rojas et 
al. (1999).  
 
17.1  
 This core of supercoiled DNA is termed a “nucleoid”. Following 
alkaline unwinding and electrophoresis, the negatively charged 
DNA is pulled towards the anode. However, only loops of DNA 
which contain breaks are released from the supercoiling and 
migrate in the gel. These loops extend from the head of the 
nucleoid to form the comet tail
 
3 Klaud M, Eriksson S, Nygren J & Ahnstrom 
G, 1996. The comet assay: mechanisms and 
technical considerations. Mutation Research 
363, 89-96. 
4 Uhl M, Helma C & Knasmuller S, 1999. 
Single cell gel electrophoresis assay with 
human derived hepatoma (HepG2) cells. 
Mutation Research 441, 215-224. 1. Comet images can be viewed 
and analyzed by fluorescence microscopy. The intensity of the 
comet tail reflects the extent of DNA breakage.  
5 Uhl M, Helma C & Knasmuller S, 2000. 
Evaluation of the single cell gel 
electrophoresis assay with human hepatoma 
Hep G2 cells. Mutation Research 468, 213-
225. 
Here, a procedure based in the methodology of Klaud et al. 
(1996)
6 Tice RR, Agurell E, Anderson D, Burlinson 
B, Hartmann A, Kobayashi H, Miyamae Y, 
Rojas E, Ryu JC & Sasaki YF, 2000. Single 
cell gel/comet assay: guidelines for in vitro 
and in vivo genetic toxicology testing. 
Environmental and Molecular Mutagenesis 
35, 206-221. 
3, Uhl et al. (1999, 2000)4,5 & Tice et al. (2000)6 is 
described to perform the alkaline version of the comet assay 
with HepG2 cells. 
  
Assay Solutions Assay Solutions 
Normal Melting Point Agarose 1% (w/v) 
Prepare the following assay solutions: 
Dissolve 200 mg normal melting point (NMP) 
agarose in 20 ml of PBS, heat in microwave 
for 1-2 minutes at full power until dissolved. 
When required, melt immediately before use. 
(1) Lysis Solution, pH 10 
For 1 L:  
   Final Conc.  Weight Low Melting Point Agarose 0.5% (w/v) 
NaCl   2.5 M   146.1 g Dissolve 100 mg of low melting point (LMP) 
agarose in 20 ml of PBS, heat in microwave 
for 1-2 minutes at full power until dissolved. 
Aliquot 2 ml samples into cryotubes (more 
resistant to melting), and store in refrigerator 
(4ºC). When required, melt immediately 
before use and maintain at 37ºC in a 
thermostated water bath. 
Na2EDTA  100 mM   37.22 g 
Tris Base  10 mM   1.211 g 
NaOH to pH of 10 (approx 8.0 g) 
Pure water added to give a final volume of 990 ml. 
 
Store at 4ºC. Ethidium Bromide Staining Solution 
Prepare a working solution from a stock 
solution 10 mg/ml. Add immediately prior to use: 
TRITON X-100 1% (v/v) (e.g. 1 ml per 100 ml) Dissolve 50 µl of stock solution in 50 ml of 
Tris-HCL to give a final concentration of     
10 µg/ml. Store at 4ºC, in the dark.  
(2) Electrophoresis Buffer (300 mM NaOH, 1 mM 
Na
Be aware, carcinogenic compound. 
2EDTA, pH 13)  
   Final Conc.  Weight Notes 
NaOH   3 N   120 g (2) With 300 mM NaOH, the pH is around 13. 
You do not need to check the pH. 
Add distilled water to 1 L. Store at room temperature or 4ºC. 
 
  
Na2EDTA  200 mM   3.722 g  
Add distilled water to 50 ml. Store at room temperature or 4ºC.  
  
 Make up Electrophoresis Buffer immediately prior to use. Use 
freshly made electrophoresis buffer for each set of gels run. For 
 
17.2 
 1 L electrophoresis buffer, mix 100 ml 3N NaOH, 5 ml 200 mM 
EDTA, and 895 ml of distilled water.  
P17 
 
The pH of this solution should be 13 or >13. Be aware of this 
solution, it’s caustic. 
Notes 
 
  
(3) Neutralisation Buffer (Tris-HCl, pH 7.5)  
For 500 ml:  
    Final Conc.  Weight 
 Tris Base  0.4 M   24.23 g 
 
Add distilled water near to 450 ml and adjust to pH 7.5 using 
concentrated HCl. Finally adjust the volume with water till      
500 ml. Store at 4ºC. 
 
 
 
  
 
Protocol  
 
Slide Preparation 
Slide Preparation) Use the up-side layer, 
which did not contact with any surface.  Dip conventional microscope slides (avoiding slides designated 
as super clean) in NMP agarose 1% (w/v) and then allowing the 
gel to dry horizontally at room temperature for 10 min. Take off 
bottom-side layer, label and dry the slides overnight at 37ºC. Use 
them within a few days. 
 
 
 
 
 
  
 
Cell Preparation  
 
1) Incubate 5 × 105 cells per well in a 6-well plate overnight. 
 
2) Treat the cells as desired. 3) Do not use a solution containing Ca and 
Mg to wash the cells. 
3) After the treatment, wash the cells with warm PBS.  
4) You can dilute commercial trypsin solution 
1:1 with PBS. 4) Incubate the cells with warm 0.125% trypsin (in PBS) for 5 
minutes. Do not exceed the 5 minutes. 
 
5) Aspirate the trypsin medium and suspend the cells in 1 ml of 
PBS with the pipette. 
5) The viability of the cell suspension should 
be greater than 80%. You can use the Trypan 
Blue Staining (P6) to see it. 
6) Take off enough volume to another microtube in order to have 
about 50.000 cells. 
 
 
  
7) Centrifuge normally used: 
Alkaline Single Cell Gel Electrophoresis Centrifuge 5415 C, Eppendorf 
8) Melt previously LMN agarose and 
maintain at 37ºC using a thermo stated water 
bath. Do not add the LMP agarose  
7) Centrifuge the cells for 1 minute at 5,000 rpm (~5,000 ×g). 
8) Remove supernatant from centrifuged cells; resuspend cells in 
17.3  
 100 µl LMP agarose by gently pipetting.  
Notes 
9) Apply one drop of ~75µl LMP agarose/cell suspension on top 
of the base layer of NMP agarose. Label the slides with a pencil. 
8 cont.) immediately after melting it. Let first 
the temperature reaches 37ºC in the water 
bath. 
9) Using a pencil, the label is not erased by 
the subsequent procedures. 10) Cover each drop with a 22×22 mm coverslip and place the 
slides into fridge for 10 minutes. 9 & 10) Normally, two samples can be settled 
in each slide. 
11) Prepare the working lysis solution (add Triton X-100). 11) You may need only to add and dissolve 
Triton X-100. 
12) Gently slide off coverslips, place slides in the appropriate 
container and add lysing solution to fully immerse slides. 
12) You have to be careful with the agarose 
layer from this point forward, because it 
easily takes off from the slide. 
For example, use the lids from multiwell 
plates as containers. The horizontal position 
prevents the layer from taking off. 
13) Incubate for 2 hours at 4ºC, in the dark to lyse the cells. 
14) Meanwhile make up electrophoresis buffer, and pour into 
the electrophoresis tank at 4ºC. 
 
 
 15) After incubation, remove slides from the lysis solution, rise 
slides in distilled water and then in electrophoresis buffer. 
 
 
16) Transfer slides into the electrophoresis chamber. 16) Preferably put the slides with the labelled 
end towards the anode. 
17) Allow the slides to incubate in the alkaline electrophoresis 
buffer for 40 minutes at 4ºC to allow the DNA to unwind. 
 
 
 
18) Turn on power supply and set to 300 mA and 21 V          
(0.8 V/cm), run the electrophoresis for 20 minutes at 4ºC. 
18) The voltage to be use depends of the 
distance between the anode and cathode. Use 
a ratio of 0.8 V/cm. 
19) Remove slides from electrophoresis tank, and immerse in 
neutralisation buffer for 5 minutes. 
19) Use also, for example, the lids from 
multiwell plates. 
 
20) Wash two more times for 5 min.  
 
21) Fix (dehydrate) the slides for 5 minutes in 100% ethanol (or 
methanol), two times. 
21) Use also, for example, the lids from 
multiwell plates. 
The slides can be kept at 4ºC for a week until 
analysis. 22) For analysis, apply 20 µl Ethidium Bromide Stainning 
Solution (working solution) to each sample and apply 
coverslips. 
22) Be careful, carcinogenic solution. Use 
gloves when applying the solution and dry the 
excess (if some). 
 
23) Evaluate DNA damage under a fluorescent microscope 
using the appropriate filter setting. Do at least 4 independent 
experiments. 
 
 
 
 
Evaluation of DNA damage 
For evaluation of DNA damage, observations should be made 
using a 20× or 40× objective (depending on the cell size) on a 
fluorescent microscope. One should avoid analysing cells at the 
17.4 
 edges of the gel, where it has been observed that high levels of 
damage can be seen. 
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One of the methods of comet analysis is a quantitative method 
using image analysis programs. There are several image analysis 
systems commercially available for quantification of data, e.g. 
Komet analysis system developed by Kinetic Imaging Ltd., 
Comet Assay II developed by Perceptive Instruments, etc. There 
is one that is free and uses a public domain, which is well 
explained in the paper published by Helma C & Uhl M (2000)
7 Helma C & Uhl M, 2000. A public domain 
image-analysis program for the single cell gel 
electrophoresis (comet) assay. Mutation 
Research 466, 9-15. 
 
 
 
 
7.  
 With this quantitative method, at least 50 cells per sample should 
be analysed. The results are normally expressed in terms of tail 
length, tail moment and % DNA in tail
 
 
7. 
 
Examples of the five classes of the comet 
images that are used in the semiquantitative 
method of visual scoring: 
 
It is also possible to analyse comets semiquantitatively without 
image analysis software. A scheme has been developed by 
Collins AR et al. (1997)
Class 0 
 
see ref. 2 for visual scoring based on 5 
recognisable classes of comet, from class 0 (undamaged, no 
discernible tail) to class 4 (almost all DNA in tail, insignificant 
head). Each comet is given a value according to the class it is put 
into, so that an overall score can be derived from the gel (from 0 
to 400). In this case, count 100 cells per slide. The analysis 
should be blind, i.e. without the knowledge of what sample is 
being analysed. For that use a code to label the samples that was 
unknown for the person that is analysing the comet images. Use 
only one person to analyse the comets. 
 
Class 1 
 
Class 2 
 
Visit also the following websites: 
 
www.geocities.com/cometassay/ Class 3 
www.predictive-toxicology.org/comet/ 
 
  
Class 4 
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P18 Western Blot of CYP 2E1 
  Experimental Protocol 18 
  
  
1 Morgan K, French SW & Morgan TR, 2002. 
Production of a cytochrome P450 2E1 
transgenic mouse and initial evaluation of 
alcoholic liver damage. Hepatology 36, 122-
134. 
The cytochrome P450 2E1 (CYP 2E1) is involved in the 
oxidation of ethanol, acetone, acetaminophen, halothane, and 
other xenobiotics via a NADPH-dependent mechanism. In 
mammals, CYP 2E1 is constitutively expressed in many tissues 
but is found in highest concentrations in the liver. Within the 
liver, it is membrane bound in the smooth endoplasmic 
reticulum of hepatocytes
2 Laemmli UK, 1970. Cleavage of structural 
proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680-685. 
3 Towbin H, Staehelin T & Gordon J, 1979. 
Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: 
procedure and some applications. 
Proceedings of the National Academy of 
Sciences of the United States of America 76, 
4350-4354. 
1. 
 
Principle 
 
Materials required This protein can be quantified by Western Blot using a specific 
antibody. For that, microsomal protein is separated in a 
denaturated discontinuous polyacrylamide gel by electrophoresis 
following the methodology of Laemmli (1970)
Mini-Protean III electrophoresis system (Bio-
Rad Laboratories, Inc.) 
Mini Trans-Blot System (submerged type) 
(Bio-Rad Laboratories, Inc.) 2. Then, the 
separated proteins were electrotransferred to a membrane using 
the method of Towbin et al. (1979)
Polyvinylidene difluoride (PVDF) membranes 
(Amersham Biosciences) 
3 and the CYP 2E1 detected 
by using a specific antibody against this protein. 
Roller Mixer SRT1 (Stuart, Barloworld 
Scientific Limited) 
 
 Special reagents: 
Protocol Rabbit polyclonal antibody against CYP 2E1 
protein (StressGen) 
Flow diagram Horseradish peroxidase–labeled donkey anti-
rabbit IgG antibody (Amersham Biosciences) 
Separate protein samples by denaturated electrophoresis ECL reagents (Amersham Biosciences) 
  
Transfer protein to membrane 
 
Block non-specific sites 
 
Incubate with primary antibody 
 
Incubate with secondary antibody 
 
Incubate with detection reagents 
 
           Expose      or      Chemiluminescence 
      to film                   detection system 
Buffer Solutions 
PBS (Phosphate Buffered Saline) 
137 mM NaCl 
2.7 mM KCl 
8.5 mM Na2HPO4
1.5 mM KH2PO4, pH 7.4 
 
2× SDS Sample Buffer 
125 mM Tris-HCl, pH 6.8 
20% (v/v) Glycerol 
4% (w/v) SDS 
200 mM DTT 
0.01% (w/v) Bromophenol blue 
18.1  
 Sample preparation  
Buffer Solutions 
1) Use microsomal protein as your sample (see P14).  
Towbin Buffer 
2) Take 15 µg of protein to a microtube (preferably, it should be 
in a volume lower than 10 µl). 
25 mM Tris base 
192 mM glycine 
20% (v/v) methanol 
3) Add 10 µl of 2× SDS Sample Buffer and boil immediately the 
protein samples for 5 min. 
 
Blocking Buffer 
5% (w/v) nonfat dry milk 4) Do a small spin to the microtubes to collect the condensate at 
the bottom of the tube. 0.05% (v/v) Tween 20 
PBS 
  
Incubation Buffer Gel Electrophoresis – Reducing Conditions 
1% (w/v) BSA (bovine serum albumin) 
5) Prepare a 12% (w/v) polyacrylamide discontinuous (with 
stacking gel) gel using, for example, the Mini-Protean III 
electrophoresis system. 
0.05% (v/v) Tween 20 
PBS 
 
Notes 
6) Load protein samples and control (All Blue, Bio-Rad). 
2) Whereas 2× SDS Sample Buffer is not 
added to the samples, place the microtubes on 
ice. 7) Start electrophoresis at 90 V for about 10 min and increase 
(after the dye front has moved into the separating gel) then for 
180 V. Stop electrophoresis when the dye front reaches the 
bottom of the gel (around 50 min). 
3 & 4) These steps should be done 
immediately before the loading of protein 
samples in the polyacrylamide gel, for 
example during the polymerization of the 
stacking gel. 
5) For details see for example the protocol 
present in: Ausubel FM et al, 1996. Current 
Protocols in Molecular Biology, Vol. 2, John 
Wiley & Sons, Inc, USA. 
 
Protein Transfer 
7) Run the electophoresis using the Towbin 
Buffer supplemented with 0.1% (w/v) SDS. 8) Transfer separated protein bands to PVDF membranes 
following manufacturer’s instructions. Briefly:  
 
9) Equilibrate gel and membrane in Towbin Buffer for 15 min.  
 10) Using a submerged transfer-type system (e.g. Mini Trans-
Blot System, Bio-Rad) assemble the apparatus according to 
manufacturer’s instructions. 
 
 
 
11) Transfer at 4ºC (or use a cooling coil) for 1 h at 100 V, using 
Towbin Buffer. 
11) At no time should the apparatus or buffer 
be allowed to become hot. Use a cooling coil 
or run the transfer in a cold room (4ºC) to 
avoid the generation of gas bubbles in the 
sandwich.  
 
Antibodies Incubations 
 
13) Block non-specific binding sites on membrane with 
Blocking Buffer overnight at 4ºC. 
 
 
14 & 16 & 18) Wash at room temperature 
with moderate agitation. 14) Wash three times with PBS/0.05% (v/v) Tween 20 for 5 min 
per wash. 
18.2 
 15) Incubate the membrane with the primary antibody (rabbit 
polyclonal antibody against CYP 2E1 protein) for 1 hour at 
room temperature using the Roller Mixer. 
P18 
 
Notes 
16) Wash three times with PBS/0.05% (v/v) Tween 20 for 5 min 
per wash. 
15) Dilute 1:5,000 the antibody in 10 ml of 
Incubation Buffer supplemented with 0.05% 
(w/v) NaN  (sodium azide). 3
The use of sodium azide allows the reuse of 
the antibody solution, since the compound 
prevents the growth of microorganisms. For 
that, keep the solution at 4ºC. 
17) Incubate the membrane with the secondary antibody 
(horseradish peroxidase–labelled donkey anti-rabbit IgG 
antibody) for 1 hour at room temperature using the Roller Mixer. 17) Dilute 1:30,000 the antibody in 10 ml of 
Incubation Buffer. Do not use sodium azide, 
since it inhibits peroxidase. 18) Wash three times with PBS/0.05% (v/v) Tween 20 for 5 min 
per wash.  
 
  
 
Detection 
 
19) Incubate membranes with ECL detection reagents for 1 min 
following manufacturer instructions. 
 
 
 
20) Drain off excess detection reagent by holding the membrane 
gently with forceps and touching the edge against a tissue. Place 
the membrane, protein side up, between two sheets of suitable 
plastic clean surfaces and gently smooth out any air bubbles. 
 
 
 
 
 
21) Place the wrapped blots, protein side up, in an X-ray film 
cassette and expose to an autoradiography film. Then develop 
the film 
 
 
 
 or 
 
22) Place the wrapped blots, protein side up, under a 
chemiluminescence detection system and acquire the image. 
22) Chemiluminescence detection system 
used: Chemi Doc XRS, Bio-Rad Laboratories, 
Inc. 
  
 
Quantification  
 
23) Quantify the bands in the developed film by densitometry 
using, for example, the SigmaScan Pro 5 program (SPSS Inc., 
San Rafael, CA, USA), or, if using the chemiluminescence 
detection system, with the attached program (Quantity One, Bio-
Rad Laboratories, Inc.). 
 
 
 
 
 
24) Using the Quantity One the value ‘Adj. 
Volume’ corresponds to the Band Area 
Intensity. 
24) Express the results as Band Area Intensity (band area × band 
average intensity). 
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P19 
Antiradical Activity:  
Experimental Protocol 19DPPH and Superoxide Radical 
   
 1 Sanchez-Moreno C, Larrauri JA & Saura-
Calixto F, 1998. A procedure to measure the 
antiradical efficiency of polyphenols. Journal 
of the Science of Food and Agriculture 76, 
270-276. 
Several methods to determine free radical scavenging 
(antiradical) activity have been reported, but those utilising the 
xanthine-xanthine oxidase system, phenazine methosulphate-
NADH system and the reaction with 2,2-diphenyl-1-
picrylhydrazyl (DPPH) have received more attention
 
 
 1. 
 Here, we describe two methods to determine antiradical activity 
of phenolic compounds and plant extracts: (1) against DPPH 
radical; and, (2) against superoxide radical using the phenazine 
methosulphate-NADH system 
 
 
 
 
 
 
(1) DPPH 
Materials required 
Principle 96-well plates 
Plate reader spectrophotometer 
 The antiradical activity of phenolic compounds (PheOH) 
depends mainly on different structural features such as O-H 
bound dissociation energy, resonance delocalisation of the 
phenol radical (PheO˙) and steric hindrance derived from bulky 
groups substituting hydrogen in the aromatic ring
Special reagents: 
2,2-diphenyl-1-picrylhydrazyl (DPPH)  
  (e.g., # D9132, Sigma) 
 
1. The rate 
constants of the reaction of PheOH with free radicals will 
indicate the order of reactivity. 
Stock Solutions 
DPPH 1 mM 
3.94 mg/ 10 ml absolute ethanol 
Light sensitive 
The main reaction involving DPPH would be1: 
Aliquot in 1.2 ml and keep at -20ºC. 
 DPPH˙ + PheOH → DPPHH + 
Assay Solutions 
[PheO˙(I) ↔ PheO˙(II) ↔ PheO˙(III) . . .] DPPH 100 µM (Final Conc. 90 µM) 
Dilute 1.1 ml of DPPH 1 mM in a total 
volume of 11 ml of absolute ethanol, 
immediately before use. 
where (I), (II), (III) . . . are resonance structures. 
The concentration of antioxidant needed to decrease by 50% the 
initial substrate concentration (IC
Light sensitive, maintain at room temperature.
50) is a parameter widely used 
to measure the antioxidant power. The lower the IC
(volume enough to test one compound/extract 
in the conditions described in the assay) 50 the higher 
the antioxidant power. Sanchez-Moreno et al. (1998) also 
introduced a new parameter, the antiradical efficiency (AE), 
which involves the potency (IC
 
 
) and the reaction time (T ): 50 IC50
 × T )  AE = 1/(IC50 IC50
19.1  
 The lower the IC50, the lower the TIC50 and the higher AE. TIC50 
is defined as the time needed to reach the steady state at the 
concentration corresponding to IC
 
Notes 
 
50
1. For more details about this 
parameters see the paper of Sanchez-Moreno et al. (1998)
 1. 
 
  
Sample preparation) Protocol 
Example:  
Sample preparation If you want to test the concentrations of 1, 
2.5, 5, 10, 20, 35 and 50 µM of a compound, 
you have to make the following set of 
concentrations for the assay: 10, 25, 50, 100, 
200, 350 and 500 µM. 
The following assay is adapted in order to test 7 different 
concentrations of the compound/extract. Therefore, for each 
compound/extract chose 7 different concentrations to be tested. 
Then, immediately before the assay, make the corresponding   
10 times more concentrated solutions (at least 200 µl each) 
dissolved in DMSO for each concentration chosen. 
The set of concentrations must include from 
0% DPPH discoloration to 100% (or near). To 
know what the ideal set of concentrations is 
you have to do a preliminary experiment. 
 
1) Use a repetitive pipette to pipette DPPH 
and absolute ethanol into the wells. 
 Follow the following scheme (use half of a 96 
well plate): 
DPPH Assay  
C0 C0 C0 C0 C0 C0 
1) In a 96-well plate, pipette to each well: C1 C1 C1 C1 C1 C1 
C2 C2 C2 C2 C2 C2 
 - 19.4 µl sample/blank (DMSO) (6 wells each in a row) 
C3 C3 C3 C3 C3 C3 
 - 175 µl DPPH (100 µM)/ absolute ethanol (pipette first C4 C4 C4 C4 C4 C4 
C5 C5 C5 C5 C5 C5                  the absolute ethanol) 
C6 C6 C6 C6 C6 C6 
2) Immediately after, read the absorbance at 515 nm on a plate 
reader every 20 sec for 20 min. (at room temperature) 
C7 C7 C7 C7 C7 C7 
C0 – blank  - 19.4 µl DMSO 
C1 – lower concentration of the 
compound/extract 3) After 20 min, if the discoloration of DPPH did not reach a 
steady state continue reading for more a 20 min-period. …… 
C7 – higher concentration of the 
compound/extract  
 
Calculations 
4) Take the absorbance from a time point where all 
concentrations reached the steady state. Use the same time point 
for each well. 
5) Then, for each row, subtract the corresponding blank value 
(again use the same time point for blank as well samples). 
6) Calculate the remaining DPPH for each well using the 
following formula: 
      % DPPH = AbsCx/ AbsC0 × 100 
 
7) Using the GraphPad Prism (GraphPad Software Inc.), plot the 
 
 
 
 
2) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
Use the ‘kinetic’ function of SOFTmax Pro. 
Do not use the blank function for the blank 
column. As well samples, refer them as 
unknowns. 
6) AbsCx – Absorbance of a well that contains 
tested compound/extract, where was added 
DPPH, in a chosen time point. 
AbsC0 – Absorbance average of the row C0, 
where was added DPPH, in a chosen time 
point. 
175 µl DPPH 
175 µl absolute ethanol
19.2  
 corresponding % DPPH for each compound/extract 
concentration (in logarithm) and take the IC
P19 
50 (with the 
experimental setup outlined above for each compound/extract 
you have an independent experiment with 5 replicates). 
 
Notes 
8) In case of a pure compound, express in 
mmol/mol DPPH by dividing the IC50 in µM 
by 0.09 (because we use 90 µM of DPPH in 
the assay)  
8) Express IC50 value in terms of initial concentration of DPPH 
to make the results easily comparable with other published 
results.  
In case of an extract, express in g/Kg DPPH 
by dividing the IC50 in µg/ml by 0.0355 
(because 90 µM of DPPH in the assay 
correspond to 0.0355 × 10-3 Kg). 9) You can also take the Hill slope value from the GraphPad 
Prism. Hill slope correspond to the graphically calculated slope 
from the plotted compound/extract concentration (in logarithm) 
versus the remaining DPPH concentration. The higher this value, 
the narrower the concentrations range from 0 to 100% of 
antiradical activity. 
 
 
 
 
 
 
 
10) Calculate also Antiradical Efficiency (AE) using the method 
well described by Sanchez-Moreno et al. (1988)
 
1.  
  
 
(2) Superoxide Radical 2 Valentao P, Fernandes E, Carvalho F, 
Andrade PB, Seabra RM & Bastos ML, 2001. 
Antioxidant activity of Centaurium erythraea 
infusion evidenced by its superoxide radical 
scavenging and xanthine oxidase inhibitory 
activity. Journal of Agricultural and Food 
Chemistry 49, 3476-3479. 
Principle 
The antiradical activity against superoxide radical can be 
measured using a nonenzymatic assay using a phenazine 
methosulphate (PMS)-NADH system. Superoxide radicals were 
generated by the NADH/PMS system reducing the nitroblue 
tetrazolium (NBT) to a blue chromagen. Therefore, the 
production of superoxide radicals can be followed 
spectrophotometrically at 560 nm
 
Materials required 
96-well plates 
Plate reader spectrophotometer 
 
Special reagents: 2. A compound/extract present 
in the assay with scavenging activity against superoxide radical 
will compete with NBT for superoxide radicals inhibiting, 
therefore the production of the blue chromagen. The superoxide 
dismutase (SOD) can be used as a positive control. The 
concentration of antioxidant needed to decrease by 50% the 
control’s blue chromogen production (IC
Phenazine methosulphate (PMS)  
  (e.g., # 68600, Fluka) 
Nitroblue tetrazolium (NBT) 
 
Buffer Solutions 
Phosphate buffer (PB) 19 mM 
19 mM KH PO , pH 7.4 2 4
50) is a parameter that 
can be used to measure the antioxidant power. 
 
Stock Solutions 
Here, a procedure based in the methodology of Valentao et al. 
(2001)
PMS 7.05 mM 
2 is described to measure superoxide scavenging activity 
of phenolic compounds/plant extracts in a plate reader 
spectrophotometer. The reaction mixture consists of NADH  
(166 µM), NBT (43 µM) and PMS (2.7 µM) in 19 mM 
2.16 mg/ 1 ml PB 
Highly light sensitive. 
Aliquot in 20 µl and keep at -20ºC. 
 
19.3  
 phosphate buffer, pH 7.4. Phenolic compounds were dissolved 
in DMSO. The production of blue chromogen is followed over 
time at 560 nm. 
 
Protocol 
Sample preparation 
The following assay is adapted in order to test 7 different 
concentrations of the compound/extract. Therefore, for each 
compound/extract chose 7 different concentrations to be tested. 
Then, immediately before the assay, make the corresponding   
10 times more concentrated solutions (at least 200 µl each) 
dissolved in DMSO for each concentration chosen. 
 
Superoxide Assay 
1) In a 96-well plate, pipette to each well: 
 - 26.1 µl sample/blank (DMSO) (3 wells each in a row) 
- 75 µl NADH (578 µM) 
- 150 µl NBT (75 µM) 
2) Incubate for 3 min at 30ºC in the plate reader. 
3) Add as fast as possible 10 µl of PMS (70.5 µM) and read the 
absorbance at 560 nm on a plate reader every 10 sec for 3 min. 
4) A linear (positive) slope (approximately 110 mDO.min-1) is 
obtained in the control (C0). If the compounds/extracts have 
superoxide scavenging activity, they should decrease the slope 
value in accordance to the concentration. 
 
Calculations 
5) Take the slope value (average) from each condition. 
6) Calculate for each concentration the percentage of inhibition 
of blue chromogen production using the following formula: 
      % inhibition = SCx/ SC0 × 100 
7) Using the GraphPad Prism (GraphPad Software Inc.), plot the 
corresponding % inhibition for each compound/extract 
concentration (in logarithm) and take the IC50 (with the 
175 µl D H PP
 
Assay Solutions 
NBT 75 µM (Final Conc. 43.3 µM) 
1.23 mg/ 20 ml PB (15 ml/96-well plate) 
Light sensitive. 
 
NADH 578 µM (Final Conc. 166 µM) 
4.1 mg/10 ml PB (7.5 ml/96-well plate) 
Freshly prepared and stable for 3 h on ice. 
 
PMS 70.5 µM (Final Conc. 2.7 µM) 
Dilute 10 µl of PMS 7.05 mM in 1 ml of PB. 
(1 ml/96-well plate) 
Dilute only immediately before use. Highly 
light sensitive. 
 
Notes 
Sample preparation) 
Example:  
If you want to test the concentrations of 1, 
2.5, 5, 10, 20, 35 and 50 µM of a compound, 
you have to make the following set of 
concentrations for the assay: 10, 25, 50, 100, 
200, 350 and 500 µM. 
The set of concentrations must include from 
0% inhibition of blue chromogen production 
to 100% (or near). To know what the ideal set 
of concentrations is you have to do a 
preliminary experiment. 
 
1) Follow the following scheme (use half of a 
96 well plate): 
 
C0 C0 C0 C0 C0 C0 
C1 C1 C1 C1 C1 C1 
C2 C2 C2 C2 C2 C2 
C3 C3 C3 C3 C3 C3 
C4 C4 C4 C4 C4 C4 
C5 C5 C5 C5 C5 C5 
C6 C6 C6 C6 C6 C6 
C7 C7 C7 C7 C7 C7 
C0 – blank  - 26.1 µl DMSO 
C1 – lower concentration of the 
compound/extract 
…… 
C7 – higher concentration of the 
compound/extract 
 
 
 
 
1 & 3) Use a repetitive pipette to pipette 
NADH, NBT and PMS into the wells. 
 
Compound/Extract A 
Compound/Extract B 
19.4  
 experimental setup outlined above for each compound/extract 
you should do three independent experiments with 3 replicates). 
P19 
 
9) You can also take the Hill slope value from the GraphPad 
Prism. Hill slope correspond to the graphically calculated slope 
from the plotted compound/extract concentration (in logarithm) 
versus the % of inhibition of blue chromogen production. The 
higher this value, the narrower the concentrations range from 0 
to 100% of antiradical activity. 
Notes 
2) Plate reader spectrophotometer used: 
SpectraMax 340 PC (Molecular Devices) in 
combination with its software SOFTmax Pro 
4.0. 
The temperature of 30ºC allows the 
acquisition of reproducible measurements in 
both Winter and Summer. 
3) Use the ‘kinetic’ function of SOFTmax 
Pro.  
 
6) SCx – Average slope value from a chosen 
concentration of the tested compound/extract.  
SC0 – Average slope value from the control 
situation C0.  
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P20 Coating with Collagen 
  Experimental Protocol 20 
  
  
1 Freshney RI, 2000. Culture of Animal Cells: 
a Manual of Basic Technique, 4th Edition, 
Wiley-Liss, Inc, USA. The coating of surfaces with collagen is normally used in 
primary cultures of hepatocytes. Collagen isolated from rat tails 
is used to coat cell culture plates or flaks and then seeded with 
hepatocytes. 
 
 
 
  
 
(1) Collagen Isolation Materials required 
Dialysis membranes Principle 
 
Collagen is soluble in liquid solution at low pH and salt 
concentration. Increasing the pH to 7.4 and increasing the ionic 
strength causes the collagen to gel. 
Buffer Solutions 
PBS (Phosphate Buffered Saline) 
137 mM NaCl 
2.7 mM KCl 
Here, a procedure based in the methodology present in Freshney 
(1998)
HPO8.5 mM Na2 4
1 is described to isolate collagen from rat tails. Rat tail 
tendons are dissolved in 0.5 M acetic acid and dialysed against 
PBS. 
1.5 mM KH PO , pH 7.4 2 4
Sterilise by autoclaving. 
 
Acetic acid 0.5 M  
0.5 M C H O2 4 2
Protocol Sterilise by autoclaving. 
 
1) Cut off rat tail and soak in 70% ethanol for 1 min. 
Notes 
2) Fracture progressively from the tip and pull out the tendons. 1) You can freeze the tails at -20ºC for later 
use. 
3) Dissolve tendons from 20 tails in 200 ml of 0.5 M sterile 
acetic acid. Stir overnight at 4ºC. 
2) Handle with sterile gloves and keep 
tendons sterile. 
 
4) Filter through sterile muslin gauze.  
 
5) Dialyse against 4 L sterile PBS (pH 7.4) for 24 hours at 4ºC 
with slow agitation. 
 
 
6) Adjust pH of PBS to 4. 6) Then, dialyse against 4 L sterile PBS (pH 4) for 24 hours at 
4ºC with slow agitation.  
7) Centrifuged used: Beckman Avanti J-25I 
(Beckman Instruments, Inc., USA) with the 
rotor JA-25.50. 
7) Centrifuge to clarify at 50,000 ×g for 2 hours. 
8) Keep the clarified collagen at -80ºC for later use. 
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 (2) Collagen Coating  
Materials required 
Principle Culture dishes/flasks/plates (could be without 
any special surface treatment) 
 Collagen gel may be derivatised by carbodiimide to increase its 
adherence to the plastic substrate. This new type of collagen 
surface allows extended culture survival, improved microscopy 
and dry storage of coated culture dishes/flasks/culture plates
Special reagents: 
Carbodiimide (Cyanamide)   
 (e.g., # C1920, Sigma) 
1.  
Stock Solutions Collagen is derivatised to plastic by a cross-linking reagent, 1-
cyclohexyl-3-(2-morpholinoethyl)-carbidiimide-metho-p-
toluenesulfonate (carbodiimide). In comparison to conventional 
ammonia-polymerised or adsorbed surfaces show superior 
culture viability and improved optical characteristics. 
Collagen (~500µg/ml) 
Collagen solution diluted in acetic acid at 
protein concentration of approximately 500 
µg/ml. 
To know approximately the concentration of 
collagen in your solution (see above collagen 
isolation) dry 1 ml of collagen solution and 
weigh the dry powder. Here, a procedure based in the methodology present in Freshney 
(1998) 1 is described for a simple covalent bonding of collagen 
fibrils to active groups on tissue culture plastic. A large supply 
of coated dishes/flasks/plates can be prepared in a single 5-hours 
session and stored for later use. 
Solutions 
Ultra-Pure Water 
Sterilise by autoclaving. 
 
  
Protocol  
Notes Do the following operations in a sterile laminar flow chamber: 
 
1) Place about 2 mg of carbodiimide in each of several 15-ml 
sterile tube. 
1) Normally, you can place a small granule of 
compound without weighing it. 
You can use them immediately or seal them 
and store at 4ºC until used. 2) Add 14 ml of sterile ultra-pure water at room temperature to 
each tube containing carbodiimide to be used. 2) Each prepared tube will coat 15 35-mm culture dishes or 2.5 6-well culture plates or 5 
25-ml culture flasks. 
3) Vortex each tube for approximately 10 sec. and set aside.  
 4) Add 1 ml of stock collagen solution to one tube containing 
carbodiimide solution (~130 µg/ml) and rapidly vortex until 
uniform. 
 
 
 
5) Rapidly transfer collagen-carbodiimide solution to 
dishes/flaks/plates, generously covering the bottoms. 
5) Transfer approximately 1 ml in a 35-mm 
dish or 1 ml into a well of a 6-well culture 
plate or 3 ml in a 25-ml flask. 
The rapidity of transfer minimises 
derivatisation to the solution tube and 
maximises early contact with the culture 
plastic. 
6) Incubate dishes/flasks/plates at 25ºC for 3 hours. 
7) Wash 3 times with sterile ultra-pure water. 
 
8) Air dry at room temperature for 1 hour.  
 9) Sterilise under ultraviolet irradiation for 1 hour or overnight. 
 
10) Use coated dishes/flaks/plates immediately or store dry at 
4ºC for later use. 
20.2  
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